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Trypanosoma brucei is a protozoan parasite, and the causative agent of Human 
African Trypanosomiasis and Nagana in cattle. The life cycle and cell cycle of 
the parasite is complex and unusual.  In particular, cytokinesis regulation in T. 
brucei is divergent, and significantly does not involve the formation of an 
actomyosin contractile ring; instead, a furrow ingresses longitudinally along the 
cell following the axis of the subpellicular microtubules which form a 
cytoskeletal cage around the cell body. As the organelles are positioned 
longitudinally in the posterior half of the cell, and in different positions 
according to life cycle stage, the cleavage axis is therefore subject to a number 
of constraints which must be overcome for symmetrical allocation of organelles 
to the daughter cells. It is highly likely that the subpellicular microtubule 
cytoskeleton plays important roles in cytokinesis furrow ingression.  Presumably 
this process must involve microtubule and membrane remodelling at the site of 
the furrow apex to form the two discrete daughter cell bodies, and this is likely 
to require changes in microtubule dynamics, at least locally. Additionally, the 
cytoskeleton could influence the position of the cleavage plane by denoting 
polarity, or the timing of furrow initiation through mechanosensing.  
The divergent nature of T. brucei cytokinesis implies that regulators of this 
process could be exploited as a source of potential novel drug targets.  The Polo-
like kinase, PLK, has previously been shown to be required for furrow ingression 
during cytokinesis in bloodstream form T. brucei.  This study aimed to further 
our understanding of the regulation of cytokinesis by PLK by investigating how its 
activity is regulated in vitro and in vivo.  In other organisms, PLK is known to 
influence microtubule dynamics, and given the likelihood that microtubule 
dynamics are important for furrow ingression in T. brucei, this study also aimed 
to investigate the role of the cytoskeleton in cytokinesis.  An orthologue of a 
microtubule-associated protein required for cytokinesis in plants, AIR9, was 
functionally characterised in T. brucei, and the role of subpellicular 
microtubules in cytokinesis was investigated via the use of microtubule 
inhibitors.   
xix 
Soluble and active recombinant PLK was purified from E. coli as a 6X Histidine 
fusion protein (6XHis:PLK).  6XHis:PLK autophosphorylated prolifically, and 
removal of these phosphorylations with lambda protein phosphatase significantly 
reduced the ability of 6XHis:PLK to transphosphorylate generic kinase substrates. 
Further, the importance of a conserved threonine residue (T198) in the T-loop of 
T. brucei PLK, which is a major site for regulation by upstream kinases in other 
organisms, was investigated. Substitution of T198 with a non-polar (alanine or 
valine) or a phosphomimetic (aspartic acid) residue revealed that this residue 
was important for PLK activity in vitro.  However, expression of T198 variants in 
vivo showed T198V and T198D to be functional, suggesting that PLK activity is 
not regulated in vivo by phosphorylation at this site.   The role of the polo box 
domain (PBD) of PLK in regulating PLK activity was also investigated.  In PLKs 
from other organisms, the PBD autoinhibits PLK activity.  Here, while 
recombinant 6XHis:PBD could pull down full length ty:PLK from T. brucei lysates, 
kinase assays indicated that the PBD did not inhibit the activity of full length 
PLK.  Thus, regulation of the activity of PLK in T. brucei appears to be 
divergent. 
Functional characterisation of T. brucei AIR9 by RNAi mediated depletion 
revealed roles for this protein in the relative positions of organelles and the 
position of the cleavage plane in both life cycle stages. However, the 
phenotypes observed during RNAi experiments differed between procyclic and 
bloodstream form parasites. For procyclic form parasites, the defective 
cytokinesis resulting in non-equivalent progeny seemed to occur in cells with 
organelle positioning defects suggesting that problems with cytokinesis were 
secondary to the major organelle positioning defect. Abnormal organelle 
positioning was far less frequent in bloodstream form parasites, which none the 
less seemed impaired in the accurate positioning of the cleavage axis.  
AIR9 was shown to localise to the cytoskeleton of bloodstream and procyclic 
trypanosomes using two different epitope tagging approaches, and following 
induction of AIR9 RNAi, AIR9 was preferentially depleted from the posterior end 
of the cell, supporting a designation of AIR9 as a microtubule-associated protein.  
However, data do not support a role for AIR9 in cytoskeletal stability, since 
transmission electron microscopy showed the structure of cytoskeletal 
microtubules was not affected following depletion of AIR9.  Hence, I suggest 
xx 
that AIR9 is more likely to be a scaffold protein potentially involved in the 
integration of signalling pathways to control cell polarity and cytokinesis. 
This study also demonstrated through the application of inhibitors of 
microtubule dynamics that microtubule dynamics are important for cytokinesis 
in T. brucei. Vinca alkaloid treatment of bloodstream form parasites arrested 
furrow ingression, while taxol inhibited initiation of cytokinesis in bloodstream 
form parasites and affected cleavage plane positioning in procyclic cells. In 
addition, organelle positioning was inhibited through the application of the vinca 
alkaloid, vinblastine, to procyclic form cells. Thus, although these studies 
indicate that there are differences in the cytoskeleton makeup of bloodstream 
and procyclic trypanosomes, the data obtained are consistent with microtubule 






1.1 Cause and geographical distribution of the African 
Trypanosomiases 
 
The African Trypanosomiases are a group of infectious vector-borne diseases 
caused by protozoan parasites of the genus Trypanosoma and transmitted by the 
bite of infected tsetse flies (Glossina species). Trypanosoma brucei species can 
infect humans, livestock and wild animals, and disease foci correspond to areas 
within tsetse fly habitats (10 million km2) incorporating 37 sub-Saharan African 
countries and putting 50 million people and 48 million cattle at risk(Ilemobade, 
2009). Human African Trypanosomiasis (HAT) is caused by the subspecies T. b. 
gambiense and T. b. rhodesiense, which are found in west and central Africa, 
and east and southern Africa, respectively. T. b. brucei is non-human infective, 
and causes the disease Nagana in livestock throughout sub-Saharan Africa.  
In 2009, 9877 cases of  HAT were reported (World Health Organisation, 2010), 
although due to incomplete surveillance and diagnosis, the real number of cases 
is likely to be far higher. In addition to the impact on public health, financial 
losses due to the effects of Nagana on the agricultural economy are believed to 
amount to $4.5 billion annually (Torr, 2005). The disease progression and 
epidemiology of HAT depends on the parasite species. Gambian sleeping sickness 
(caused by T. b. gambiense) accounts for 90 % of HAT cases; the clinical stages 
of this disease include a long asymptomatic period (which can last for several 
years after disease onset), followed by sub-acute febrile illness and finally late-
stage chronic meningoencephalitis, which if untreated, can be fatal. This 
contrasts with the acute form of the disease, Rhodesian sleeping sickness which 
is characterised by a rapid onset of the late stage occurring within just a few 
months after infection. Disease progression for both types of HAT does not 
always occur with such predictable outcomes, and there is a spectrum of rates 
of progression and severity of pathology, thought to be influenced by both host 
and parasite genetics, and the presence of multiple infections in a single host 
(Sternberg, 2010). Environmental factors, such as exposure to tsetse flies may 
also play a role (Caljon et al., 2006).  
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The transmission cycles of T. b .gambiense and T. b. rhodesiense are different. 
T. b. gambiense has been isolated from wild and domestic animals; however, the 
epidemiological consequences of animal reservoirs have yet to be determined 
(Njiokou et al., 2006). It has been suggested that whilst these reservoirs may not 
be important during human epidemics, they may serve to maintain and circulate 
parasites to low levels, facilitating reemergence and reinfection of the human 
population. By contrast, both wild and domestic animal reservoirs have been 
shown to be important for the transmission cycle of the zoonotic species, T. b. 
rhodesiense, and trading of infected domestic cattle has been linked to disease 
foci of human epidemics (Fevre et al., 2001). T. b. brucei also has sylvatic hosts, 
which are of increasing relevance as climate change, population increases and 
altered land use lead to encroachment of cattle onto tsetse fly-infested regions 
populated by wild species (Van den Bossche et al., 2010). Understanding the 
transmission cycles of Trypanosoma species is important for the design and 
implementation of control programmes, and may become increasingly vital 
towards tackling the possible resurgence of zoonotic diseases in a changing 
environment. 
1.2 Disease history and pathology  
Trypanosomiasis is an ancient disease, and the Glossina-Trypanosome complex is 
believed to have existed before the divergence of hominid species, and to have 
played a role in hominid evolution (Lambrecht, 1985), which is a notion that has 
more recently been supported by phylogenetic evidence (Stevens and Gibson, 
1999), and which may explain how arboreal primates (which live high above the 
tsetse fly swarming range) are trypanosensitive, whilst humans are largely 
trypanotolerant (with the exception of their sensitivity to T. b. gambiense and 
T. b. rhodesiense). The symptoms of trypanosome infection have been described 
since Antiquity, and it is believed that some early cattle rearing practices and 
tribal migrations were a  reflection of the impact of Nagana on the lives of early 
peoples (Steverding, 2008). Despite this long shared evolutionary history, 
trypanosomes were only discovered to be the causative agent of Nagana and 
sleeping sickness in 1895 (by David Bruce) and 1902 (by Aldo Castellani), 
respectively, and it was only in 1903 that the transmission cycle was determined 
(by David Bruce). Astonishingly, treatments and intervention methods, which 
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proved hugely successful in controlling large epidemics at the turn of the 
century, are still in use today. 
The earliest symptoms of infection include local inflammation at the site of the 
tsetse fly bite caused by proliferation of parasites at this lesion (Sternberg, 
1998). Parasites rapidly multiply in the blood and lymphatic system, which can 
lead to the swelling of the lymph nodes referred to historically as 
‘Winterbottom’s sign’. This may be accompanied by febrile episodes as 
successive waves of parasitaemia occur. The cyclical nature of parasite 
proliferation is the result of alternating immune evasion and destruction of 
circulating parasites facilitated by changes to the parasite surface antigen. 
Recognition and destruction of one particular antigenic type followed by 
emergence of a different, novel antigenic type allows the parasite to establish a 
chronic infection, and the high levels of circulating immunoglobulins resulting 
from the constant pressures on the immune system can cause anaemia. 
Eventually, parasites migrate into a variety of tissues including the spleen, liver 
and heart and ultimately the central nervous system. Transmigration across the 
blood brain barrier is associated with the release of inflammatory mediators, 
and alterations in the natural balance of pro- and anti-inflammatory molecules is 
thought to contribute to the clinical manifestations of late stage disease. 
Symptoms of neuroinflammation include mental disturbances, motor and sensory 
system involvement, sleep disturbances and finally if untreated, coma and 
death. Disturbance of natural sleep pattern led to description of the disease as a 
‘sleeping sickness’, which despite the implications of the name, can refer to 
night time insomnia as well as day time somnolence.  
1.3 Treatment of Human African Trypanosomiasis 
There are no vaccines available for prophylactic immunisation against HAT, and 
the prospects of vaccine development are poor due to the ability of the 
parasites to frequently change their surface antigen. Current treatments are 
restricted to just four drugs: pentamidine, suramin, melarsoprol and eflornithine 
(also known as difluoromethylornithine (DFMO)), which, with the exception of 
eflornithine, were developed over 60 years ago (Burchmore et al., 2002). All 
four available drugs may be used to treat the early stage of the disease, 
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although pentamidine and eflornithine are ineffective against T. b. rhodesiense, 
and only melarsoprol and eflornithine are effective against the late stage of the 
disease. Application of all four drugs requires hospitalisation of the patient due 
to the mode of drug application and level of monitoring required. Suramin, 
melarsoprol and eflornithine are administered intra-venously and pentamidine, 
via intra-muscular injection; treatment regimes involve administration of these 
drugs over several days, sometimes with intervening recovery periods. Not only 
is current chemotherapy impractical and expensive, the toxicity of these drugs 
can also cause painful and serious side effects, particularly in the case of 
melarsoprol, which has a 5 % fatality rate due to the reactive encephalopathy 
which can ensue following treatment. Repeated application of the same drugs 
has led to drug resistance. Treatment failures of up to 30 % and 16 % have been 
recently reported for melarsoprol and eflornithine, respectively, suggesting that 
second stage drugs could soon be ineffective in the field (Balasegaram et al., 
2009). Mechanisms of drug resistance have been shown to involve the loss of 
drug transporters: for example, the P2 amino-purine and HAPT1 transporters 
have been observed in pentamidine-resistant parasites, and loss of the P2 amino-
purine transporter has also been implicated in melarsoprol resistance (Barrett et 
al., 2007). Pentamidine, suramin and melarsoprol are trypanolytic and the 
modes of action of these drugs are not understood, although inhibition of 
glycolysis (melarsoprol and suramin), interaction with kinetoplast DNA 
(pentamidine) and interaction with trypanothione (melarsoprol) have been 
proposed as possible explanations for trypanolytic activity. Eflornithine, by 
contrast, is a known inhibitor of ornithine decarboxylase, and was developed as 
an analogue of this enzyme for the treatment of neoplasmas. Inhibition of 
ornithine decarboxylase deprives cells of polyamines, resulting in growth arrest. 
As this drug has a trypanostatic effect, patients must have a functioning immune 
system to clear the growth-arrested parasites and therefore, this is an 
unsuitable treatment for patients suffering from immunosuppressive disorders. 
More recently, nifurtimox, a drug licensed for the treatment of Chagas disease, 
has been tested in drug trials, and although it is not sufficient to cure 
trypanosomiasis as a monotherapy, it has been used successfully in combination 
with other drugs. Trials using a combination of eflornithine and nifurtimox 
(Nifurtimox Eflornithine Combination Therapy, NECT) were successful at clearing 
T. b. gambiense infections using a reduced number of infusions for shorter 
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durations (Priotto et al., 2006), and as a result, in 2009, NECT was added to the 
WHO Essential List of Medicines for the treatment of human African 
trypanosomiasis (World Health Organisation, 2009).  
The current situation is clearly not acceptable; without good prospects of a 
vaccine, rises in drug resistance and few compounds capable of treating late 
stage disease, it is critical that new, safer and cheaper drugs are developed.   
1.4 Drug development approaches and new treatment 
prospects 
Attempts to develop a vaccine are still ongoing, despite the problems associated 
with surface antigen variation. Vaccination with tubulin or the microtubule-
associated proteins, p52 and p15, resulted in humoral protection against 
trypanosomes in mouse models (Balaban et al., 1995;Lubega et al., 2002;Rasooly 
and Balaban, 2004). Interestingly, immunisation with adenovirus expressing 
recombinant p15 caused a strong CD8+ T-cell response and an effective but non-
specific clearance of trypanosomes (Rasooly and Balaban, 2004). However, the 
development of an effective vaccine that can be used clinically is still a long way 
off. 
The drugs currently in use were developed from existing veterinary or 
antineoplastic compounds. This type of ‘piggy back’ approach is still useful, and 
a more recent example of this approach is Acivicin, an antineoplastic agent 
which targets CTP synthetase and has been shown to successfully treat 
trypanosomiasis in the mouse model (Fijolek et al., 2007). The sequencing of the 
T. brucei genome (Berriman et al., 2005), and the subsequent publications of 
the T. brucei kinome (Parsons et al., 2005) and phosphoproteome (Nett et al., 
2009) have facilitated investigation into T. brucei protein kinases as potential 
drug targets and given that many of these kinases are conserved regulators of 
the mammalian cell cycle and already targeted by existing antineoplastic 
agents, there is great potential for fast tracking these candidates through such 
piggy back approaches to clinical trials. These advances in genomics and 
proteomics have not only increased the potential for utilisation of existing 
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antineoplastic drugs, but also provided opportunities for a target based approach 
in drug design. 
Target assessment is first carried out by genetic validation using techniques such 
as RNAi or gene knockouts. Essential genes identified in this manner can then be 
analysed in vitro through the production of recombinant proteins, development 
of protein assays and ultimately screening of inhibitor libraries. If, in addition, 
the crystal structure of the target can be determined, designed improvements 
and modifications to individual inhibitors are possible. Finally, animal models 
and clinical trials are required to test inhibitors in vivo. With a targeted 
approach, it is possible to infer toxic effects in the mammalian host, track 
resistance occurring from mutations in the target protein, and assess whether 
the drug may be a good candidate for the treatment of other diseases (broad 
spectrum drugs may, for example, target conserved but kinetoplastid-specific 
proteins with potential for treating Chagas disease or Leishmaniasis). This 
approach has recently been used to good effect in the identification of N-
myristoyltransferase inhibitors (Frearson et al., 2010) and inhibitors of 
trypanothione synthetase (Torrie et al., 2009).  Other compounds under 
investigation include the Oxaborole 6-carboxamides (Nare et al., 2010) and 
DB289 and its derivatives (Wenzler et al., 2009); the latter are currently in 
Phase III trials, and as these drugs can be orally administered and some of these 
compounds are effective against early and late stage disease, these are 
currently the most promising alternatives to traditional treatments. 
1.4.1 Alternative strategies for drug discovery – exploiting natural 
resistance mechanisms  
Human serum is trypanolytic to T. b. brucei, and contains high density 
lipoprotein particles (HDLs), containing a protein called ‘Apolipoprotein L-I’ 
(Apo-LI). This protein has been shown to enter trypanosomes via the endocytic 
pathway, where it is trafficked to the lysosomes (Vanhamme et al., 2003b). Apo-
LI forms pores in the lysosomal membrane, causing an influx of chloride ions into 
the lysosome, which results in osmotic swelling (Perez-Morga et al., 
2005;Vanhamme et al., 2003a;Vanhamme et al., 2003a). The swollen lysosome 
eventually occupies most of the cell body, and it is thought that this could 
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compromise the outer plasma membrane, and ultimately kill the parasites 
(Perez-Morga et al., 2005). T. b. rhodesiense can be resistant (depending on 
antigenic variation) to the effects of Apo-LI due to the production of a protein 
called ‘Serum resistance associated protein’ (SRA), and it has been shown that 
SRA interacts with Apo-LI though a coiled-coil protein-protein interaction, the 
consequence of which is to abolish the liposome fusogenic activity of Apo-LI, 
thus allowing the parasite to evade Apo-LI induced lysosomal swelling 
(Vanhamme et al., 2003a). Variant forms of Apo-LI which possess mutations at 
the binding site of SRA can still kill T. b. rhodesiense parasites, and it has been 
shown that these Apo-LI variant genes are common in African Americans, but 
absent from European Americans; suggesting that the acquisition of this variant 
form of Apo-LI is a relatively recent event (Genovese et al., 2010). It appears 
that humans have evolved a way to counter the T. b. rhodesiense resistance 
mechanism, albeit at cost, as inheritance of the resistant form of Apo-LI was 
found to be associated with two genes involved in kidney disease (focal 
segmental glomerulosclerosis (FSGS) and hypertension-attributed end-stage 
kidney disease (H-ESKD).  
T. b. gambiense, which does not express SRA, is still able to infect humans. It 
has recently been found that resistance to the trypano-toxic HDL particles in 
human serum (trypanolytic factor-1 (TLF-1)) is associated with downregulation of 
a receptor for TLF-1: TbgHpHbR (Kieft et al., 2010). The equivalent receptor in 
T. b. brucei (TbbHpHbR) binds to another component of TLF-1, the haptoglobin 
(Hp)-related protein (Hpr) (and co-factor Hb), a high affinity interaction which 
occurs at the flagellar pocket and leads to uptake of TLF-1 into the parasites, 
ultimately leading to killing of T. b. brucei. Reduced expression of this receptor 
was found to be associated with resistance of T. b. brucei to TLF-1. Ectopic 
expression of TbbHpHbR but not TbgHpHbR (which has some amino acid changes 
compared to TbbHpHbR) in TLF-1 resistant T. b. brucei restored TLF-1 
sensitivity. Thus, resistance mechanisms to TLF-1 in T. b. gambiense could 
involve decreased expression of TbgHpHbR, or coding sequence mutations in the 
receptor, which may alter the affinity of this receptor towards Hpr (Kieft et al., 
2010).  
In addition to TLF, small hydrophobic peptides produced by the mammalian 
immune system including defensins, cathelicidins and neuropeptides have been 
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shown be effective against trypanosomes in vitro (Delgado et al., 2008;Haines et 
al., 2009;McGwire et al., 2003). These molecules, like Apo-LI have the ability to 
disrupt membranes, and possess a highly positively-charged amphipathic alpha 
helical structure. Neuropetides, for example,  were found to lyse bloodstream 
form parasites via a mechanism involving uptake into the endocytic pathways, 
disruption of lysosome integrity, cytosolic distribution of metabolic enzymes and 
ultimately metabolic failure (Delgado et al., 2008). The association with parasite 
membranes probably results in more than osmotic disruption, and it has been 
proposed that signalling pathways could also contribute the their trypanocidal 
effect (McGwire and Kulkarni, 2010). Recently it has also been shown that 
hydrophobic peptides (derived from the signal sequences of haptoglobin related 
protein (SHP-1) and paraoxonase-1 (SHP-2)) can affect both motility and 
membrane rigidity, and that these effects occur before any evidence of osmotic 
swelling, providing evidence that there are more complex processes involved in 
the trypanocidal effects of these peptides (Harrington et al., 2010).  
Knowledge of these and possibly other natural resistance mechanisms will 
hopefully prove useful towards developing drugs which mimic components of the 
natural killing mechanisms so effective against T. b. brucei species.  Indeed, 
molecules which mimic or modify the host response could provide useful 
alternatives to chemical inhibitors, and some have been shown to effectively 
treat trypanosome infections in mice. For example, a truncated form of Apo-LI 
which lacks the SRA interaction domain caused trypanosome lysis when the 
truncated molecule was targeted to the cell surface through conjugation with a 
nanobody (a single-domain antigen-binding fragment) targeted against variable 
surface glycoproteins (Baral et al., 2006). The antibiotic minocycline inhibits the 
immune response to neuroinflammation by decreasing leukocyte invasion into 
the central nervous system, and has also been shown to inhibit the expression or 
activity of adhesion molecules involved in leukocyte transmigration. 
Interestingly, trypanosome invasion of the central nervous system has 
similarities to leukocyte invasion, and treatment of trypanosome-infected mice 
with minocycline alleviated late stage disease symptoms and reduced parasite 
invasion (Masocha et al., 2006).The reduction in leukocyte and trypanosome 
invasion and consequential reduction in cytokine production in the brain were 
described as probable explanations for alleviation of late stage symptoms. 
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Although minocycline cannot be used as a monotherapy, it is a potential 
candidate for use in combination with other treatments (Masocha et al., 2006). 
Methods of disease prevention that are based on naturally produced immune 
defence molecules, or which modulate the immune system, could have 
advantages over chemical inhibitors as potential toxic effects in the host 
organism may be less likely, which would increase patient adherence to 
treatment programmes. 
1.5 Transmission intervention strategies 
Methods which target the trypanosome transmission cycle rather than the 
disease itself can also be useful intervention strategies e.g. selective breeding of 
trypanotolerance in cattle (based on red blood cell percentage), the use of pour-
on cattle insecticides, and large scale insecticide application (Bauer et al., 
1995;Kgori et al., 2006;Murray et al., 1990). Sterilisation of tsetse flies through 
gamma irradiation has also successfully reduced tsetse fly populations on the 
island of Unguja in Zanzibar, although this is not a practical approach for 
mainland Africa (Vreysen et al., 2000).  
Improvements in disease surveillance and diagnosis are also important 
considerations for control of HAT. Current diagnosis of HAT uses serological and 
parasitological techniques. The card agglutination test is a useful aid in 
detecting individuals producing T. b. gambiense antibodies. However, this alone 
is not sufficient to confirm trypanosome infection, and in addition, blood and 
lymph samples must be analysed by microscopy for the detection of 
trypanosomes. Stage determination involves lumbar puncture and extraction of 
cerebrospinal fluid for detection of trypanosomes and monitoring of white blood 
cell count. The necessity for invasive procedures and analysis of samples by 
microscopy stipulates that health workers have training and equipment, which 
can be problematic in field situations. 
Investigation into new diagnostic approaches is ongoing, and focussed on 
producing a test that is non-invasive and easy to use. Advances in molecular 
techniques have enabled the development of polymerase chain reaction (PCR) 
tests which are capable of differentiating between T. b. gambiense and T. b. 
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rhodesiense (Radwanska et al., 2002), which is impossible by morphological 
analysis, and the development of loop-mediated isothermal amplification (Njiru 
et al., 2008) should eliminate the need for field PCR (thermocycling reactions). 
Simpler methods for interpretation of PCR results are also in progress. The 
‘molecular dipstick’ test uses oligochromatography to detect a positive PCR 
product, which is an extremely quick procedure resulting in the presence or 
absence of a single line, very much like a pregnancy test (Deborggraeve et al., 
2006). Whilst these methods still rely on blood sampling, tests which use salivary 
samples are also being developed (Lejon et al., 2006). Replacing lumbar 
puncture for stage determination is more problematic and sleep-rapid eye 
movement tests using polysomnography are unreliable. Hopefully identification 
of stage makers in serum, urine or saliva will replace the need for this highly 
invasive procedure (Simarro et al., 2008). The development of new drugs, 
diagnostic tests and implication of intervention strategies requires collaboration 
between Governments, aid agencies, academic institutions and pharmaceutical 
companies. The World Health Organisation has a central role in these efforts and 
in 2000, African Governments launched the Pan African Tsetse and 
Trypanosomiasis Erradication Campaign, and with Governmental backing, it is 
more likely that these efforts could lead to eradication of this terrible disease.  
1.6 The life cycle of T. brucei 
The cyclical life cycle of T. brucei parasites (Figure 1-1) involves alternation of 
replicative and differentiated forms in the vector and host organisms. The 
parasites are exposed to different environmental conditions in the tsetse fly 
vector and mammalian hosts, and exhibit an array of adaptations in order to 
survive, varying from metabolic and morphological changes to expression of 




Figure 1-1 -The life cycle of T. brucei. 
Scanning electron microscope images showing the life cycle stages of T. brucei in the 
mammalian and tsetse fly hosts. Circular arrows indicate replicative life cycle stages. 
Reproduced with permission from Dave Barry. 
1.6.1 Life cycle stages in the mammalian host and immune 
evasion mechanisms 
The biting tsetse fly deposits metacyclic trypanosomes within the dermal 
connective tissue of the mammalian host where localised inflammation 
facilitates the entry of trypanosomes into the draining lymphatics and 
bloodstream. These cell cycle arrested metacyclic parasites quickly undergo 
morphological changes and cell cycle re-entry, proliferating rapidly in the 
bloodstream and lymphatic system as a long slender bloodstream 
trypomastigote. Proliferation is accompanied by antigenic variation. The cell 
surface is coated in a monolayer of variant surface glycoprotein homodimers 
(VSG), which comprise 10-15 % of the total cell protein, and act to shield other 
cell surface membrane epitopes from the immune system of the mammalian 
host. The diploid trypanosome genome encodes around 1700 distinct VSGs at 
subtelomeric loci; around 1500 of these are located in silent gene arrays, around 
200 are found on minichromosomes, and 20 are located at VSG expression sites 
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(McCulloch, 2004). VSG expression sites are transcribed as polycistronic mRNAs 
by RNA polymerase I and consist of tandem gene arrays containing VSG and 
expression site associated genes (ESAGs, which in T. b. rhodesiense, include the 
serum resistance associated (SRA) gene). For transcription of a particular VSG 
gene, it must be located at the single active expression site, found in a sub-
compartment of the nucleus known as the expression site body (Navarro and 
Gull, 2001). VSG switching occurs at a rate of approximately 10 -2 per cell per 
cell cycle (Turner and Barry, 1989), and occurs in a stochastic and spontaneous 
manner, independently of host antibody presence (Lythgoe et al., 2007). 
Expression of different VSGs in the early stages of infection is ordered to an 
extent, and this is thought to result from hierarchical differences in the 
probabilities of expression site activation (Morrison et al., 2005). Coincident 
silencing and activation of different expression sites is referred to as epigenetic 
or ‘in situ’ switching. For the parasite to increase its VSG repertoire beyond 
those encoded in the 20 expression sites, it must move VSG genes from the 
minichromosomes or silent gene arrays into an expression site. This occurs 
through gene conversion, whereby homologous recombination at the 70 bp 
repeats located upstream of the VSG gene, and the conserved 3’ end of the VSG 
gene results in VSG replacement at the expression site. At chronic stages in the 
infection, complex gene conversion can result in the expression of chimeric or 
mosaic VSGs. Complex gene conversion makes use of the many VSG pseudogenes, 
which are otherwise non-functional. 
In addition to antigenic variation, clearance of bound antibody from the cell 
surface is important for immune evasion. Bloodstream form parasites appear to 
remove bound antibody though a combination of directional cell motility and 
high rates of membrane recycling. Directional cell motility is important for 
generating forces involved in selectively trafficking VSG/antibody complexes to 
the cell posterior and flagellar pocket where endocytosis occurs, a process 
referred to as hydrodynamic sorting (Engstler et al., 2007). Further, as discussed 
above (Section 1.4.1), T. b. rhodesiense is largely resistant to the effects of host 
Apo-LI as a result of expression of the SRA protein. This protein is a truncated 
form of VSG and can bind to apolipoprotein L-I in early endocytic vesicles, and 
this prevents apolipoprotein L-I activation, thus protecting the parasite 
(reviewed in (Wheeler, 2010)).These immune evasion strategies allow the 
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parasites to survive in the mammalian host for long periods, during which time 
parasites can enter a multitude of different organs including the central nervous 
system, producing the typical symptoms associated with Trypanosomiasis.  
Bloodstream form parasites (slender form) can proliferate rapidly in the 
mammalian host due to the abundant supply of nutrients, and glucose can 
passively enter the cytoplasm and subsequently the spherical glycosomes where 
the majority of glycolysis takes place (Vickerman, 1965). The mitochondrion of 
bloodstream form cells is tubular, lacks cristae and most Krebs cycle enzymes, 
and is incapable of oxidative phosphorylation. One of the functions of the 
mitochondrion in bloodstream form parasites is to oxidise glycerol-3-phosphate 
and therefore quell the excess of reducing power generated by glycolysis. This 
occurs at the inner mitochondrial membrane where glycerol-3-phosphate oxidase 
is located (Hannaert et al., 2003b). Bloodstream form slender parasites can 
differentiate to stumpy form parasites during periods of high parasitaemia. 
Differentiation is density dependent and is thought to initiate in response to an 
unidentified ‘stumpy induction factor’. The mechanism of differentiation 
involves asymmetric cell division of slender parasites, resulting in shorter 
daughter flagellum extension in the daughter cell; after cell division, both 
daughter cells becomes committed to differentiation (Tyler et al., 2001b). Cells 
that are undergoing differentiation are called intermediate forms, which 
undergo dramatic changes to the mitochondrial morphology. The tubular 
mitochondria become swollen and develop cristae, and also contain enzymes 
associated with amino acid-based metabolism. These changes represent 
preadaptations to the tsetse fly environment (Vickerman, 1985). Stumpy form 
parasites do not undergo VSG switching, which leaves them vulnerable to attack 
by host antibodies. However, increased pinocyctosis (and the ability to clear 
antibodies by hydrodynamic sorting), lysosomal activity and cholesterol content 
of the surface membrane (and therefore greater rigidity) can help compensate 
for this weakness.  
Molecular regulation of slender form differentiation is known to involve the PX-
FVYVE family zinc finger kinase (ZFK), and the mitogen-activated protein kinase 
family member TbMAPK5 (Pfister et al., 2006;Vassella et al., 2001). Stumpy form 
parasites are prevented from differentiating further, into procyclic form cells by 
the activity of the tyrosine phosphatase TbPTP1 (Szoor et al., 2006), and one 
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target of TbPTP1 has recently  been identified as the DxDxT phosphatase, 
TbPIP39 (Szoor et al., 2010). In the absence of TbPTP1, TbPIP39 exhibits 
increased phosphorylation (transferred by an unknown kinase), enabling it to 
accumulate in the glycosomes from where it can promote a differentiation 
response. A preadaptation to stumpy differentiation in the tsetse fly is the 
expression of the surface transporter proteins, Protein Associated with 
Differentiation proteins PAD1 and PAD2 (Dean et al., 2009). PAD1 is found on the 
cell surface at the stumpy form cells, and thus acts as a molecular marker for 
this life cycle stage. When stumpy form parasites are taken up by the tsetse fly, 
and enter the tsetse fly midgut, they experience both a drop in temperature, 
and change in chemical environment. Citrate and cis-aconitate (CCA) have long 
been known to trigger the differentiation of stumpy parasites, although the 
levels required in vitro were much higher than those present in a tsetse fly 
environment (reviewed in (MacGregor and Matthews, 2010)). A decrease in 
temperature however can increase sensitivity to CCA to physiological levels 
(Engstler and Boshart, 2004), and this hypersensitivity is mediated by both PAD1 
and PAD2, the surface translocation of the latter being induced by the decrease 
in temperature (Dean et al., 2009). These studies imply that the PAD proteins 
are the environmental sensors in the differentiation response responsible for the 
transition from stumpy to procyclic form parasites, whose downstream effect is 
the inactivation of TbPTPI, and the activation and glycosomal localisation of 
TbPIP39, where possible targets could include regulators of metabolism.   
1.6.2 Life cycle stages in the tsetse fly vector 
Tsetse flies become infected when they take a blood meal from an infected 
mammalian host. Ingested stumpy form parasites accumulate in the crop and 
midgut lumen of the tsetse fly, where they differentiate into procyclic form 
parasites (Vickerman et al., 1988). The differentiation process is characterised 
by morphological and metabolic changes, which include increased cell length 
accompanied by kinetoplast migration, extensive mitochondrial branching and 
increased mitochondrial volume, increased expression of mitochondrial enzymes 
and proteins (including Krebs cycle enzymes and respiratory chain proteins), 
alterated glycosome morphology (from spherical to bacilloform), reduced 
endocytosis and replacement of the VSG surface coat with procyclins 
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(EP/GPEET). The changes to mitochondrial morphology and protein/enzyme 
expression allow metabolism of the amino acid substrate proline which is 
abundant in the tsetse fly midgut. As the infection of the tsetse fly midgut 
progresses, parasites move across the peritrophic membrane into the 
ectoperitrophic space and migrate to the salivary glands via the oesophagus, 
mouthparts and salivary glands, a route which is necessary to avoid trypanolysis 
in the haemocoel. During migration, the parasites are cell cycle arrested and 
experience an increase in length to become mesocyclics. These proventricular 
mesocyclics no longer express GPEET procyclin on the cell surface. After 
differentiation, mesocyclics undergo cell division, which involves extension of a 
short new daughter flagellum, and nuclear migration towards the cell posterior 
during mitosis, such that the kinetoplasts and nuclei appear to switch position. 
Asymmetric cell division of these proventricular mesocyclics produces long and 
short daughters, and the latter are able to differentiate into an epimastigote 
upon arrival at the salivary gland (Sharma et al., 2007). These short, unattached 
epimastigotes are believed to represent the sexual stage of the trypanosome life 
cycle. This evidence was obtained by infecting tsetse flies with parasites 
expressing either red or green fluorescent protein, and screening infected tsetse 
flies for yellow hybrids. These hybrids were observed in the tsetse fly salivary 
glands as unattached short epimastigotes. In addition, genetic markers 
confirmed genetic exchange had occurred, implying meiosis like mechanisms 
occur (Gibson et al., 2008). 
Epimastigote differentiation involves huge structural changes. Dendritic 
outgrowths appear at the flagellum (‘flagellipodia’) which wrap around the 
microvilli of the salivary gland epithelium, and together with newly formed 
hemidesmosome like junctional complexes facilitate epimastigote adherence 
(Vickerman et al., 1988). Epimastigotes proliferate whilst remaining attached to 
the salivary gland epithelium, which is probably facilitated by the more anterior 
positioning of the basal body and kinetoplast (Vickerman et al., 1988). 
Epimastigotes express alanine rich surface proteins (BARP) in place of procyclins 
(Urwyler et al., 2007). Differentiation of epimastigotes to metacyclics occurs at 
later stages of infection, which involves two intermediate stages before full 
maturation to metacyclic parastites. These intermediate stages are cell cycle 
arrested and described as pre- and nascent metacyclics (Vickerman et al., 1988). 
  
16 
These cells display increasingly reduced flagellar outgrowths (but maintain 
attachment to salivary epithelial cells via junctional complexes), changes to the 
mitochondrial and glycosomal morphology (mitochondria lose the extensive 
branching and cristae, and glycosomes become more spherical), and increasing 
expression of VSG surface protein. There are over 20 metacyclic-specific VSG 
expression sites (Turner et al., 1988), and the expression of  metacyclic-specific 
VSG prior to detachment from the epithelium of the salivary gland  prepares the 
metacyclics for invasion of the mammalian host (Tetley et al., 1987).  
1.7 The basic structure of the T. brucei cell 
The structure of the cytoskeleton and associated cytoskeletal organelles (Figure 
1-2) are described in detail in Chapter 2. Briefly, the shape of the T. brucei cell 
is defined by the subpellicular microtubule corset. Covering the cytoskeleton is a 
membrane coated with antigenic surface proteins, and at the posterior end of 
the cell this features a region of endo and exocytosis (Overath and Engstler, 
2004), which is referred to as the flagellar pocket, as a result of also being the 
site for the emergence of the single flagellum. The flagellum extends from the 
mature basal body, which is associated with an immature or probasal body, and 
adheres to the cell body via junctional complexes collectively referred to as the 
flagellum attachment zone (Vaughan et al., 2008). A single mitochondrion runs 
along the length of the cell body, and the mitochondrial DNA is contained in a 
single organelle called the kinetoplast, found at the posterior end of the 
mitochondrion. The kinetoplast DNA is composed of catenated maxi and 
minicircles (Klingbeil and Englund, 2004), the latter encoding guide RNAs which 
are essential for the unique form of kinetoplast RNA editing. The kinetoplast and 
basal bodies are connected by a set of filaments at a differentiated region of the 
mitochondrial membrane referred to as the tripartite attachment complex 
(Ogbadoyi et al., 2003). The region between the flagellar pocket and single 
nucleus is a major site for vesicle trafficking, and also contains the single 
lysosome, where protein degradation occurs (reviewed in (Field and Carrington, 
2004)). The single Golgi stack can also be found within this posterior region. The 
many glycosomes are distributed throughout the cytoplasm and represent the 




Figure 1-2 -The basic structure of the T. brucei cell. 
 A simplified cartoon of the T. brucei cell adapted with permission from Tansy Hammarton. 
Cell division in T. brucei features requires faithful replication and segregation of 
its single copy organelles (Figure 1-2 and Figure 1-3) in order to generate viable 
progeny. The timing of cell cycle events varies according to life cycle stage, and 
in general, the cell cycle duration in bloodstream and procyclic form parasites 
lasts around 6 or 8.5 hours, respectively (Tyler et al., 2001a;Sherwin and Gull, 
1989a). Early cell cycle events include maturation of the probasal body and 
assembly of the new flagellum at the newly matured basal body, which is 
accompanied by basal body duplication to form two new probasal 
bodies(Lacomble et al., 2010;Sherwin and Gull, 1989a). Golgi duplication also 
occurs at the beginning of the cell cycle, commencing just after basal body 
duplication, and involving the de novo appearance of a new Golgi close to the 
endoplasmic reticulum exit site and partially derived from the old Golgi (He et 
al., 2004). Replication of the subpellicular corset occurs in a semi-conservative 
manner throughout the cell cycle (Sherwin and Gull, 1989b). Nuclear and 
kinetoplast replication cycles are independent, and kinetoplast replication 
occurs earlier, and lasts for a shorter duration (Woodward and Gull, 1990). 
Kinetoplast segregation is followed by branching of the mitochondrion, although 
the final detachment of the duplicated mitochondria occurs after mitosis is 
completed (Tyler et al., 2001b). Mitosis in procyclic form cells is accompanied 
by migration of the nucleus towards the anterior end of the cell, between the 
recently segregated basal body and associated kinetoplast (Robinson et al., 
1995), producing a linear arrangement of organelles described as ‘KNKN’ (where 
K and N refer to kinetoplasts and nuclei, and the order is taken from posterior to 
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anterior). Basal body segregation in bloodstream form cells is not so extensive, 
and the result is a ‘KKNN’ organelle configuration (Tyler et al., 2001b).  
 
Figure 1-3 –The order of major events in the T. brucei cell cycle. 
Organelle replication and positioning during the cell cycle is shown for a procyclic form 
cell. The cell cycle stage (top; G1/G2: gap phases; S: DNA synthesis; M: mitosis), and the 
number of nuclei (N) and kinetoplasts (K) at different cell cycle stages (bottom) are 
indicated. The nuclei and kinetoplasts are shown in light blue, basal bodies in pink, Golgi in 
green, flagella and flagellum attachment zones in purple (the new flagellum and flagellum 
attachment zone are in the lighter purple), and spindle in red. The grey arrow indicates the 
direction of furrow ingression. Adapted with permission from Tansy Hammarton. 
The equal distribution of organelles between daughter cells at cytokinesis 
involves the lateral ingression of a furrow, which proceeds until daughter cells 
remain attached at their posterior ends (Figure 1-4). The final event in 
cytokinesis is referred to as abscission, and describes the detachment of these 
nascent daughters into separate cells (reviewed in(Hammarton, 2007)). 
               
Figure 1-4 -The three stages of cytokinesis in T. brucei.  
Scanning electron microscope images showing bloodstream form T. brucei parasites at the 
three stages of cytokinesis. 
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1.8 Tools for studying the cell cycle in T. brucei 
1.8.1 Assessing cell cycle stage 
Cell cycle stage in T. brucei can be broadly assessed through classification of 
cells according to DNA content. This can be achieved through the application of 
4’,6-diamidino-2-phenylindole (DAPI) stain, which can penetrate both the 
nucleus (N) and kinetoplast (K), and bind to DNA. Excitation of DAPI stain with 
ultraviolet light leads to the emission of blue fluorescence. Due to the staggered 
timing of kinetoplast and nuclear replication cycles, 1N1K, 1N2K and 2N2K 
categories are taken to represent cells at G1 or S, G2 or M, or post-mitotic 
stages of the cell cycle, respectively (illustrated in Figure 1-3). To distinguish 
cells undergoing S phase, cells can be treated with 5’-bromodeoxyuridine 
(BrdU), a synthetic nucleoside and thymidine analogue which can substitute for 
thymidine during DNA replication. Detection of BrdU by immunofluorescence can 
be used to distinguish whether 1N1K cells are at the G1 or S stage of the cell 
cycle. Flow cytometry is a useful tool for assessing the ploidy of whole 
populations of cells. Propidium iodide staining of the DNA in individual cells 
followed by determination of whole cell fluorescence using a laser based 
detection system ensures a high frequency of measurements is obtained (e.g. 
10000 cells per sample), allowing comparison of the proportions of cells at G1, S 
and G2/M stages of the cell cycle across different samples. This is a useful tool 
for detecting cell cycle problems, as cells with abnormal ploidy due to abnormal 
cell division or inhibition of cytokinesis will exhibit abnormal levels of 
fluorescence.  
1.8.2 Determining subcellular localisation 
In order to study the function of a protein, it is very useful to be able to localise 
the protein by immunofluorescence. Where an antibody is unavailable, genetic 
manipulation can be carried out in order to add an epitope tag or fluorescent 
protein to the N or C terminus and the latter method has become increasingly 
popular (Shaner et al., 2007). Green fluorescent protein was originally isolated 
from the jellyfish Aequorea Victoria, and subsequent modifications have given 
rise to blue, cyan and yellow derivatives; additionally, proteins are available 
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that emit fluorescence from the other end of the spectrum including red 
fluorescent protein from non-bioluminescent reef coral.  
For some proteins it is necessary to use an inducible expression system, as near 
endogenous levels of the protein may be difficult to detect. Inducible expression 
enables selection of genetically modified parasites without the need to express a 
potentially toxic gene product, and a tetracycline-inducible expression system 
has been developed for trypanosomes(Biebinger et al., 1997;Wirtz and Clayton, 
1995). Tetracycline inducible gene expression utilises the tet operator and the 
tetracycline repressor (TetR) gene from the prokaryotic transposon Tn10 (Hillen 
and Berens, 1994). TetR is a DNA binding protein which inhibits expression of 
genes situated downstream from the tet operator. TetR is extremely sensitive to 
small amounts of tetracycline-Mg2+, which cause conformational changes 
preventing further interaction with the tet operator, allowing transcription of 
downstream genes. Trypanosome cell lines expressing constitutive levels of TetR 
can be used in conjunction with expression vectors featuring the desired epitope 
tagged protein under the control of a modified promoter (for example, the 
procyclin acidic repetitive protein (PARP) promoter) containing tetracycline 
operator sites. Expression vectors also contain a selectable marker (antibiotic 
resistance gene) under the control of an alternative, constitutively regulated 
promoter (commonly the VSG promoter) to allow selection of genetically 
modified parasites. The expression vector is designed to integrate at a 
transcriptionally silent region, for example the ribosomal DNA locus to minimise 
the possibility for unregulated gene expression. 
However, to study the localisation of cell cycle regulators, it may be preferable 
to express them at near to endogenous levels, as these proteins are often toxic 
in large amounts. In addition, it is also desirable to minimise the possibility of 
binding site saturation to avoid misinterpreting the localisation of the protein. A 
series of plasmid constructs for N- or C-terminal tagging of the protein of 
interest with a variety of epitope and fluorescent protein tags have been 
developed and allow expression from the endogenous locus (Kelly et al., 
2007;Alsford et al., 2005;Alsford and Horn, 2008). The level of expression 
achieved is likely to be near to but not equivalent to endogenous levels, since 
either the 5` or 3` UTR is disrupted by integration of the expression construct.  
  
21 
However, N-terminal tagging is believed to be less disruptive to gene expression 
in comparison to C-terminal tagging (Clayton, 2002).  
1.8.3 Cell cycle synchronisation 
In asynchronous trypanosome cultures, a large proportion of cells are at the G1 
and S phases of the cell cycle, making it difficult to characterise large numbers 
of cells that are undergoing mitosis or cytokinesis. Recently, methods of cell 
synchronisation using hydroxyurea have been adapted for use with T. brucei 
cultures (Chowdhury et al., 2007;Forsythe et al., 2009). Treatment of cells with 
hydroxyurea stalls DNA synthesis through inhibition of ribonucleotide reductase, 
and subsequently depletion of dNTPs. This can be lethal to the parasites at high 
concentrations; however, through optimisations of the concentration and 
duration of treatment it is now possible to stall cells of both life cycle stages 
reversibly at S phase. Synchronisation is extremely useful for investigating 
proteins which have a dynamic localisation and/or expression pattern in the cell 
cycle, which is a common feature of cell cycle regulators, although it must 
always be borne in mind that any chemical treatment of cells may cause off-
target effects.  Alternative Fluorescence Associated Cell Sorting (FACS) 
approaches, which may help to alleviate this issue, have been described using 
Vybrant DyeCycle Orange and Vybrant DyeCycle Violet for procyclic and 
bloodstream form cells, respectively (Siegel et al., 2008;Kabani et al., 2010).  
1.8.4 Gene knock out and RNA interference 
Studying the function of a protein traditionally involves the generation of knock 
out cell lines. Knock out cell lines can be generated through targeted gene 
replacement of both alleles for single copy genes. However, this is not a useful 
method for investigating the function of cell cycle regulators, which are likely to 
be essential. As an alternative, the tetracycline inducible system can be used to 
generate conditional null mutants, whereby exogenous expression of the target 
gene can compensate for the loss of endogeous expression during selection. 
Additionally, dominant negative cell lines (generated, for example, by the 
inducible ectopic expression of an inactive (dead) mutant enzyme) may be 
useful for characterising protein function.  However, following the discovery of a 
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functional RNA interference (RNAi) pathway in T. brucei, faster and simpler 
methods for generating a knock down phenotype are possible. RNAi is an 
evolutionarily conserved mechanism believed to have originated as a defence 
mechanism against transposable elements or viruses, and has also been shown to 
be a means of post-transcriptional gene regulation (reviewed in (Cerutti and 
Casas-Mollano, 2006). RNAi mediated gene silencing involves recognition and 
cleavage of double stranded RNA (dsRNA) by a dicer endoRNase into small 21-26 
nucleotide fragments known as silencing RNAs (siRNAs). These small fragments 
are subsequently recognised and loaded onto a protein complex called RISC, 
which is activated by removal of one of the siRNA strands allowing the remaining 
siRNA strand to act as a guide for another endo-RNAse known as Slicer. Slicer 
subsequently identifies and selectively degrades corresponding mRNAs. Two 
Dicer nucleases and one Slicer nuclease have been shown to be involved in the 
T. brucei RNAi pathway (Durand-Dubief and Bastin, 2003;Patrick et al., 2009). 
While dsRNA can be transfected into T. brucei to transiently knock down the 
gene of interest, stable RNAi lines require the integration of an RNAi plasmid 
into the genome, allowing the inducible expression of dsRNA. The RNAi plasmid 
can either be a stem-loop plasmid where two identical inverted fragments of the 
desired gene are separated by an irrelevant ‘stuffer’ sequence and expressed via 
a tetracycline-inducible promoter (Shi et al., 2000a), or can feature two 
opposing tetracycline-inducible T7 promoters either side of a fragment of the 
gene of interest (LaCount et al., 2000), which are expressed by integrating this 
RNAi plasmid into a T. brucei cell line constitutively expressing T7 polymerase 
and TetR (Wirtz et al., 1999). 
1.9 The cell cycle 
Cell replication involves growth, organelle replication and segregation, and 
distribution of organelles and cytoplasm between daughter cells. These 
processes are typically carried out in a precise order, which is determined by the 
activity of key regulatory proteins including cyclins, and cyclin-dependent 
kinases or CDKs (reviewed in (Hochegger et al., 2008)). CDKs are generally 
expressed throughout the cell cycle, but only become active once bound by a 
cyclin partner. Cyclin interaction also acts to target the CDK to appropriate 
substrates. Control of CDK activity is further exerted through activatory or 
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inhibitory phosphorylations, and through interaction with inhibitory proteins 
(which cause conformational change at the CDK active site). Cyclin abundance is 
regulated through transcriptional control, and through ubiquitylation and 
proteolysis. 
The cell cycle stages in order are referred to as G1, S, G2, M, and cytokinesis, 
where G1 and G2 describe ‘gap’ phases, where cell growth may occur, S 
describes the DNA synthesis phase and M refers to mitosis (nuclear division). 
Cytokinesis is typically defined as the division of cytoplasm. To ensure that cell 
cycle processes only occur under favourable conditions, environmental and 
internal signals influence the relative abundance, localisation and activity of 
cyclin/CDK complexes, and only when a threshold level of activity is breached 
can the cell cycle proceed. These checkpoints control the timing of major cell 
cycle transitions, and are vital for ensuring the viability of daughter cells. If 
conditions are not favourable for growth, or upon differentiation, cells can enter 
a quiescent stage known as G0. This quiescent state is irreversible for some cell 
types, but for others sufficient mitogenic signals can cause re-entry to the cell 
cycle at G1. 
In addition to the general cell cycle stage descriptors, mitosis can itself be 
divided into different stages. These stages refer to the major mitotic events 
including: chromosome condensation and spindle assembly (prophase), 
chromosome attachment to the spindle (prometaphase), chromosome alignment 
(metaphase), chromosome segregation (anaphase), and finally chromosome 
decondensation (telophase). Spindle generation requires the duplication and 
maturation of the centrosome, a complex containing γ-tubulin which can 
nucleate microtubule polymerisation and regulate microtubule dynamics. The 
spindle is unstable and highly dynamic. Located at the growing ends of 
microtubules are microtubule-associated proteins which interact with 
centromeric chromatin to ‘capture’ chromosomes, mediating their attachment 
at regions called kinetochores. Sister chromatids are held attached to each other 
until anaphase by protein complexes called cohesins.  At anaphase, the activity 
of the conserved cell cycle regulatory complex called the ‘anaphase-promoting 
complex’ (APC), which ubiquitylates cell cycle regulators, targeting them for 
degradation by the proteosome, results in the activation of separase. Separase 
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cleaves a component of the cohesins allowing sister chromatids to separate, a 
process that is facilitated by forces generated by mitotic spindle dynamics. 
In mammalian cells, cytokinesis is included as a sixth stage of mitosis, since 
mitosis in these cells involves the breakdown of the nuclear envelope, and the 
spindle therefore bisects the whole cell during cytokinesis where it is well 
placed to direct cleavage plane positioning, assembly of the cleavage apparatus 
(an actomyosin contractile ring) and vesicle targeting during abscission. 
Specialised regions of the spindle known as the spindle midzone and the mid-
body are important for early and late cytokinesis mechanisms, respectively. The 
‘chromosomal passenger complex’ (CPC) describes proteins which localise to 
centromeres and then relocate to the spindle midzone. The CPC is vital for 
maintenance of the spindle midzone and for regulation of important cytokinesis 
events. 
1.9.1 Cell cycle regulation in T. brucei 
T. brucei possesses several conserved homologues of cyclins (CYCs) and CDKs 
termed cdc2-related kinases (CRKs); these include CRK1-4, CRK6-12 and CYC2-
11. The CYC/CRK complexes which have been identified involve CRK3 which can 
bind to CYC2 and CYC6 (Hammarton et al., 2003;Van Hellemond et al., 2000), 
and there is also some evidence to suggest that CRK1 and CRK2 can interact with 
CYC2 (Gourguechon et al., 2007). However the latter evidence is debatable, 
since it came from in vitro data only and a previous in vivo study was not able to 
demonstrate these interactions (Van Hellemond et al., 2000).  
RNAi has been used extensively to investigate the roles of these putative cell 
cycle regulators in trypanosomes, and these studies revealed that regulation of 
the G1/S transition involves CRK1,  CYC2 and possibly also CYC4 (Hammarton et 
al., 2004;Li and Wang, 2003). RNAi of CRK2, CRK4 and CRK6 independently had 
no effect on the cell cycle; however, when these kinases were depleted 
simultaneously with CRK1, they seemed to accentuate the effect of CRK1 on the 
G1/S transition, suggesting that they may have accessory roles at this cell cycle 
stage(Tu and Wang, 2005). RNAi studies have also revealed regulators of the G2 
and M phases, which were shown to include CRK3 and CYC6 (Hammarton et al., 
2003; Li and Wang, 2003; Tu and Wang, 2004) and CRK9 (Gourguechon and 
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Wang, 2009). These experiments revealed differences in cell cycle checkpoints 
between bloodstream form and procyclic form parasites. Pairwise knockdown of 
CRK1 and CRK2 blocked DNA synthesis in procyclic but not bloodstream form 
cells, implying differences in regulation of the G1/S transition (Tu and Wang, 
2005a). Additionally, while CYC6 downregulation inhibited mitosis in both 
bloodstream and procyclic trypanosomes, this only prevented cytokinesis in 
bloodstream form parasites, suggesting that procyclic form cells lack a mitotic 
exit checkpoint (Hammarton et al., 2003).   
1.9.1.1 Mitosis 
The T. brucei genome consists of 11 diploid pairs of megabase chromosomes, 1-5 
intermediate chromosomes, and around 100 minichromosomes of uncertain 
ploidy (Gottesdiener et al., 1990; Melville et al., 1998). The megabase 
chromosomes encode the housekeeping genes, and the smaller chromosomes are 
thought to function largely as a reservoir for VSG genes. Organisation of genetic 
material requires association with histone proteins. T. brucei possesses four 
canonical histones (H2A, H2B, H3 and H4), four variant histones (H2Az, H2Bz, 
H3v and H4v) and one divergent H1 linker histone (reviewed in (Figueiredo et 
al., 2009)). Post-translational modification of histone proteins is important for 
transcriptional activation, chromatin organisation, and signalling for DNA repair. 
Histone modifications observed in T. brucei include acetylation and methylation 
and these modifications are important for mitotic progression (Ingram and Horn, 
2002; Janzen et al., 2006; Kawahara et al., 2008). Unusually, chromosome 
condensation has not been observed in T. brucei (Galanti et al., 1998), and 
nuclear membrane disintegration does not occur (Ogbadoyi et al., 2000) during 
mitosis. The formation of the mitotic spindle therefore occurs inside the nuclear 
membrane. Spindle generation does not appear to involve typical microtubule 
organising centres (centrioles), and spindle nucleation sites can be observed by 
transmission electron microscopy as small fibrous ring shaped structures found 
close to the nuclear envelope with emergent microtubules (Ogbadoyi et al., 
2000). Nucleation of spindle microtubules requires γ-tubulin, which localises in 
late mitotic cells to either end of the spindle poles as two punctate dots (Scott 
et al., 1997), and depletion of γ-tubulin prevents spindle formation and mitosis 
(McKean et al., 2003). Molecular regulation of spindle formation involves 
proteins of the T. brucei chromosomal passenger complex (CPC), which include 
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Aurora kinase 1 (AUK1), CPC1, and CPC2, and also proteins which interact with 
this complex, including Tousled-like kinase 1 (TLK1), Kinesin A (KINA) and 
Kinesin B (KINB). These proteins were shown to localise to the nucleus and 
spindle (including the spindle midzone (AUK1, KINA and B, and CPC1 and 2) and 
spindle poles (TLK1)), and downregulation of any of these proteins in procyclic 
or bloodstream form parasites inhibited mitosis (Li et al., 2007; Li et al., 2008a; 
Li and Wang, 2006; Li et al., 2008b; Tu et al., 2006). Analysis of the nuclei in 
procyclic form cells in which either CPC components or CPC interacting proteins 
had been depleted, revealed a lack of spindle formation (Li et al., 2007; Li et 
al., 2008a; Tu et al., 2006) which was also observed following the depletion of 
AUK1 in bloodstream form cells (Li et al., 2009). Therefore, despite the lack of a 
canonical microtubule organising centre, the roles of γ-tubulin and an Aurora 
kinase (AUK1) in spindle generation at least are conserved in T. brucei. The 
attachment of spindle microtubules to chromosomes, and their segregation at 
anaphase, however, occurs in an unusual and divergent manner.  
The components of the T. brucei kinetochore have not yet been identified, 
although kinetochore-like structures have been observed as electron dense 
laminated plaques penetrated by up to four microtubules (Ogbadoyi et al., 
2000), and interestingly, these seem to undergo changes during mitosis, whereby 
a new, opaque layer forms prior to chromatid separation. However, only 100 
spindle microtubules, and  eight kinetochore-like structures have been observed, 
which does not correspond to the total number required to segregate all T. 
brucei chromosomes with one kinetochore and two spindle microtubules 
attached to each. Additionally, segregation of megabase chromosomes and 
minchromosomes were shown by fluorescent in situ hybridisation to have 
different dynamics (Ersfeld et al., 1998), suggesting that anaphase mechanisms 
for different chromosomes vary. Megabase chromosomes but not smaller 
chromosomes possess sites of enriched Topoisomerase II activity (Obado et al., 
2007), which localise to strand switch regions where the DNA sequence is 
repetitive (these regions represent points at which transcription of polycistronic 
mRNA changes to the opposite strand). Topoisomerase II is required for 
decatenation of DNA which is important for separation of sister chromatids at 
the centromeric regions of chromosomes. Differences in the separation kinetics 
of megabase and smaller chromosomes and the small numbers of spindle 
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microtubules and kinetochores observed suggested that megabase chromosomes 
probably segregate via classical mechanisms, but smaller chromosomes use 
different means of segregation. It has been proposed that intermediate and 
minichromomes segregate through association with antiparallel microtubules and 
that interaction with motor proteins directed towards the negative ends of 
microtubules would propel the sister chromatids to opposite spindle poles (Gull 
et al., 1998).  
The mechanisms by which chromosomes interact with the mitotic spindle are not 
understood, since a centromere specific histone protein has not yet been 
identified in T. brucei, and the only potential candidate (H3v) was found to be 
dispensable for cell viability and moreover was found to associate with 
minichromomes rather than megabase chromosomes (Lowell and Cross, 2004). 
Post-translational modifications of histones may play roles in signalling during 
mitosis, as inferred from the sudden appearance of dimethylated histone H3 at 
the onset of mitosis, and its disappearance at G1 (Janzen et al., 2006). 
Intriguingly, investigations into the role of histone modifications revealed that 
bloodstream form T. brucei parasites do not possess a checkpoint to ensure that 
only replicated chromosomes are segregated during anaphase. Reduced 
methylation of histone H3 or reduced acetylation of histone H4 resulted in the 
appearance of 1N1K cells with a 1C DNA content, or 2N2K cells with a 2C DNA 
content, respectively, providing evidence that anaphase occurred in the absence 
of DNA synthesis (Janzen et al., 2006; Kawahara et al., 2008).  
Despite T. brucei possessing divergent mechanisms for chromosome segregation, 
the attachment of sister chromatids is believed to involve conserved SMC 
complexes, and components of cohesin and condensin complexes have been 
identified (Gluenz et al., 2008). Depletion of SCC1 (a homologue of α-kleisin in 
the cohesin complex) led to mitotic arrest during metaphase (inferred from the 
presence of kinetochores in abnormal nuclei) in both procyclic and bloodstream 
form parasites. Mutation of a conserved cleavage site (targeted by separase to 
trigger chromatid separation) caused a similar mitotic arrest; implying conserved 
upstream mechanisms for anaphase regulation are functional in T. brucei. Seven 
core components of the APC are conserved in T. brucei and two components, 
APC1 and CDC27 have essential roles in mitotic progression (Kumar and Wang, 
2005). In procyclic form parasites, depletion of either of these proteins led to a 
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metaphase arrest (as judged from the spindle morphology), suggesting a 
conserved mechanism of anaphase initiation, although in bloodstream form 
parasites, mitosis was arrested at a later stage implying that other regulators or 
the combined action of multiple APC components control anaphase initiation at 
this life cycle stage. 
Spindle dynamics are important for anaphase, and it is not known how spindle 
dynamics are regulated in T. brucei. One hypothesis is that microtubule severing 
enzymes could stimulate catastrophe events, contributing to the rapid collapse 
and extension associated with spindle behaviour. T. brucei possesses homologues 
of the microtubule severing enzymes fidgetin and spastin (Casanova et al., 
2009). Spastin (with the addition of either an N- or C-terminal GFP tag) was 
found to localise at the nucleus and more specifically, to discrete foci at 
perinucleolar regions (in procyclic form cells), and these cells additionally 
displayed abnormal nuclear morphology. Despite the intriguing localisation 
exhibited by spastin, overexpression or depletion of spastin had no effect on 
mitosis in procyclic form parasites; similarly no mitotic defects were observed 
following the overexpression or depletion of fidgetin in procyclic form cells. 
Mitosis requires the coordination of many diverse proteins, which can involve 
enzymes other than the kinases traditionally thought of as ‘master regulators’ 
(e.g. AUK1); for example, PRMT6 (a methyltransferase), and ubiquitin-like 
modifier SUMO (involved in SUMOylation, a type of reversible modification 
involving covalent attachment of SUMO to target proteins in coordination with 
activating and conjugating enzymes). Depletion of either protein led to mitotic 
arrest in procyclic form parasites (Fisk et al., 2010; Liao et al., 2010), and 
binding partners of PRTM6 included nuclear pore proteins and histones, 
indicating that methylation could influence trafficking into the nucleus during 
mitosis (Fisk et al., 2010). Coordination of signalling pathways in mitosis may 
require scaffold proteins, which are molecular chaperones capable of interacting 
with multiple and diverse binding partners. 14-3-3 proteins are important for a 
wide range of processes in mammalian cells, plants and yeast, including cell 
cycle regulation. T. brucei possess two 14-3-3 homologues, 14-3-3 I and 14-3-3 II, 
both of which were localised to the cytoplasm, and downregulation of either 
protein affected cell cycle progression (Inoue et al., 2005). Further, 
downregulation of 14-3-3 I (but not 14-3-3- II) caused inhibition of mitosis. The 
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binding partners of these proteins are not known, and although it was suggested 
that protein phosphatase 1 could be a potential candidate, no interaction with 
this protein could be determined. 
1.9.1.2 Cytokinesis 
Mitosis is succeeded by cytokinesis, and the transition from mitosis to cytokinesis 
has been shown to involve the T. brucei CPC (comprising AUK1, CPC1 and CPC2). 
TLK1, KINA and KINB are necessary for the translocation of the CPC components 
to the anterior tip of the nascent daughter cell, which is the site of furrow 
initiation. During furrow ingression, this novel complex migrates along the 
furrow apex (Li et al., 2008b). Depletion of either the components of the CPC, 
TLK1, KINA or KINB inhibited cytokinesis in both procyclic and bloodstream 
parasites (Li et al., 2007; Li et al., 2008a; Li et al., 2008b). The effect of CPC 
depletion on cytokinesis was found not to be a downstream effect of mitotic 
block. This was demonstrated through the application of an AUK1 inhibitor to 
hydroxyurea-synchronised procyclic form parasites. Treatment of parasites with 
the AUK1 inhibitor 3 hours after release from S-phase allowed these parasites to 
complete mitosis, but inhibited migration of the CPC to the site of furrow 
initiation, preventing cytokinesis (Li et al., 2009). This implied that the CPC can 
independently regulate mitosis and cytokinesis, although phenotypes obtained 
with synchronised and drug-treated parasites must be interpreted with caution.  
Mitotic constraints on the regulatory mechanisms associated with cytokinesis 
vary according to life cycle stage. Completion of mitosis is not required for 
cytokinesis in procyclic form parasites, even though this results in the generation 
of anucleate daughter cells (Hammarton et al., 2003; Ploubidou et al., 1999). By 
contrast, inhibition of mitosis was shown to prevent cytokinesis in bloodstream 
form cells (Hammarton et al., 2003). This apparent dissociation of mitotic exit 
from cytokinesis in procyclic form parasites is highly unusual. In yeasts, the 
mitotic exit network (S. cerevisiae) and septation initiation network (S. pombe) 
are important for both mitotic exit, and for mitotic exit-independent regulation 
of cytokinesis, and therefore, these pathways link these important cell cycle 




1.9.1.2.1 Regulation of mitotic exit and cytokinesis in yeast 
SIN and MEN involve the yeast orthologues of polo-like kinase (PLK), Mps One 
Binder 1 (MOB1) and nuclear DBF1-related (NDR) kinases. Both of these pathways 
are initiated by GTPase activity at spindle poles, resulting in activation of a 
kinase cascade and culminating in the activation of MOB1/NDR kinase complexes 
(reviewed in (Balasubramanian et al., 2004; Bardin and Amon, 2001; Wolfe and 
Gould, 2005)). NDR/MOB1 activation leads to phosphorylation of Cdc14 (Clp1 in 
S. pombe) causing this phosphatase to be retained in the cytoplasm, ultimately 
leading to mitotic exit. The NDR/MOB1-mediated cytoplasmic retention of Cdc14 
occurs through different mechanisms in S. pombe and S. cerevisiae. 
Phosphorylation occurs at residues adjacent to the nuclear localisation signal of 
Cdc14 and phosphorylated Cdc14 which exits the nucleus is not able to re-enter 
(Mohl et al., 2009), while Clp1 is phosphorylated at a binding site for the 14-3-3 
scaffold protein Rad24, and the Clp1 which exits the nucleus is sequestrated in 
the cytoplasm through interaction with Rad24 (Chen et al., 2008; Mohl et al., 
2009). In S. cerevisiae, the cytoplasmic localisation of Cdc14 is important for the 
dephosphorylation of Cdh1 and Swi5, proteins which upon dephosphorylation, 
are able to enter the nucleus, and activate the APC or stimulate the 
transcription of Sic1 (an inhibitor of the mitotic CDK), respectively. In S. pombe, 
Clp1 has a role in mitotic exit through dephosphorylation of the CDK activating 
phosphatase Cdc25 (for a review of yeast Cdc14 phosphatases, see (Queralt and 
Uhlmann, 2008)).  
Cytokinesis regulation by both the SIN and MEN pathways involves several 
components. Cytokinesis regulation by the yeast polo kinase homologues Cdc5 
(S. cerevisiae) and Plo1 (S. pombe), is discussed in Section 7.2. Briefly, Cdc5 is 
involved in the contraction of the actomyosin contractile ring, through 
activation of the GTPase Rho1 (Yoshida et al., 2006) and Plo1 is involved in the 
positioning of the actomyosin contractile ring as a result of its role in the 
translocation of Mid1 from the nucleus, and in the formation of Mid1 ‘nodes’ at 
the cell equator prior to mitosis and cytokinesis onset (Bahler et al., 1998). 
SIN/MEN components other than PLK proteins also have direct roles in 
cytokinesis. For example, recruitment of Clp1 by Mid1 to the contractile ring is 
required for dephosphorylation of Cdc15, a protein which contributes to the 
stability of this ring (Clifford et al., 2008). Further, in S. cerevisiae, the MEN 
pathway was found to be required for translocation of the Inn1, Cyk3 and Chs2 
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proteins to the bud neck (Meitinger et al., 2010). Chs2 is a chitin synthase 
involved in chitin deposition at the primary septum (the chitin cell wall), while 
Inn1 and Cyk3 are part of a complex involved in formation of the primary 
septum, which initially separates the nascent daughter cells prior to secondary 
septum deposition. 
1.9.1.2.2 The function and localisation of T. brucei orthologues of 
yeast SIN and MEN proteins  
T. brucei PLK, MOB1A and MOB1B, and the NDR kinases, PK50 and PK53, were 
shown to have direct roles in cytokinesis in bloodstream form parasites 
(Hammarton et al., 2005; Hammarton et al., 2007; Kumar and Wang, 2006; Ma et 
al., 2010). Depletion of PK50 led to a rapid increase in post-mitotic cells that 
had not initiated cytokinesis  (Ma et al., 2010), whilst depletion of PK53, PLK or 
MOB1 proteins caused an increase in post-mitotic cells undergoing furrow 
ingression (Hammarton et al., 2005; Hammarton et al., 2007; Ma et al., 2010). 
The roles of PLK and MOB1 proteins have additionally been investigated in 
procyclic form parasites. Depletion of these proteins at this life cycle stage also 
affected cytokinesis, but there were differences in the resultant phenotypes 
compared to the bloodstream form life cycle stage. Depletion of MOB1 proteins 
did not inhibit furrow ingression, but compromised the accuracy of furrow 
ingression (Hammarton et al., 2005). PLK depletion inhibited the initiation of 
cytokinesis, resulting in the generation of multinucleate cells, although basal 
body replication and kinetoplast segregation were also inhibited following PLK 
depletion, and it was not possible to determine whether inhibition of cytokinesis 
was a direct result of PLK depletion or solely a downstream effect of delayed 
basal body/kinetoplast segregation (Hammarton et al., 2007). In a separate 
study, Golgi bilobe (described in Section 2.1.2) and Golgi biogenesis were also 
found to be affected in procyclic form parasites depleted of PLK (Graffenried et 
al., 2008). Cells depleted of PLK produced malformed Golgi bilobes associated 
with an abnormally high number of Golgi. This further suggests that cytokinesis 
inhibition in these parasites may be a downstream effect of other cell cycle 
problems. 
The localisation of regulatory proteins of the SIN and MEN pathways in yeasts is 
highly dynamic, involving movement between the spindle poles, spindle midzone 
and finally the cleavage site (septum or bud neck in S. pombe and S. cerevisiae, 
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respectively). The nuclear localisation of these proteins is of fundamental 
importance to their function in mitotic exit, and intriguingly the T. brucei 
homologues of these proteins do not exhibit nuclear localisation. MOB1 and the 
NDR kinases exhibit a cytoplasmic pattern of localisation (Hammarton et al., 
2005; Ma et al., 2010), while PLK localises to the basal bodies, Golgi bilobe and 
the flagellum attachment zone (Graffenried et al., 2008; Kumar and Wang, 2006; 
Umeyama and Wang, 2008). Localisation of PLK to the flagellum attachment 
zone (FAZ) is cell cycle-related. Appearance of PLK at the posterior end of the 
FAZ occurs at S phase, and later some PLK co-migrates with the extending FAZ to 
the mid-dorsal region of the cell. Both signals at the posterior and mid-points of 
the FAZ disappear at anaphase, when PLK disperses into the cytoplasm and then 
disappears. Therefore, 1N2K cells display distinctive PLK localisation while 2N2K 
cells do not appear to express PLK (Li et al., 2010c; Umeyama and Wang, 2008). 
Interestingly, the CPC is found at a similar location to PLK, but at later stages in 
the cell cycle, and treatment of synchronised cells with an inhibitor of PLK, or 
depleting PLK in these cells by RNAi, prevented CPC components from localising 
to the anterior tip of the cell (Li et al., 2010b). The role of PLK in cytokinesis, 
and the apparent requirement for PLK in the localisation of the CPC after its 
disappearance from post-mitotic cells, suggests that PLK can activate the 
relevant proteins early on in the cell cycle, when it is localised at the FAZ, 
implying that signals deposited before anaphase can persist until cytokinesis 
when CPC migration and cytokinesis initiation occur. 
1.9.1.2.3 The role of scaffold proteins and checkpoints in T. brucei 
cytokinesis 
Localisation is an important factor in regulating the activity of cell cycle 
regulators, and also for bringing these proteins into contact with other 
regulators and substrates. Scaffold proteins, which can bind to multiple different 
binding partners, can integrate different molecular pathways, and one scaffold 
protein, 14-3-3 II has been shown to have a role in cytokinesis in T. brucei 
procyclic form parasites (Inoue et al., 2005). Cells depleted of 14-3-3 II were 
inhibited at the stage of cytokinesis initiation, resulting in the accumulation of 
multinucleated cells. Receptor for activated C- kinase 1 (RACK) is another 
scaffold protein with multiple signalling roles, and a homologue has been 
identified T. brucei (Rothberg et al., 2006), which was shown to localise to the 
cytoplasm and perinuclear regions of cells, and was found to be a component of 
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the translational apparatus through association with eukaryotic translation 
elongation factor 1a (Regmi et al., 2008). Depletion of TbRACK1 inhibited 
cytokinesis in both bloodstream and procyclic form cells; procyclic form 
parasites were unable to complete furrow ingression, whilst bloodstream form 
cells could not initiate furrow ingression (Rothberg et al., 2006). The furrow 
arrested procyclic form parasites were capable of reentering the cell cycle, 
again arresting at furrow ingression, resulting in the accumulation of 
multinucleate cells with many furrows. Application of an inhibitor of translation 
(anisomycin) did not have the same effect, although it did act synergistically to 
increase the number of furrow arrested cells following TbRACK1 depletion in 
procyclic form parasites (Regmi et al., 2008). These results suggested that the 
cytokinesis defect was caused by decreased translation of another protein 
(which was exacerbated further by the translational inhibition by anisomycin), 
and not due to global inhibition of translation. 
The furrow ingression arrest described for procyclic form cells depleted of 
TbRACK1 (described above) reflects a common theme for the depletion of 
cytokinesis regulators, whereby furrow ingression appears to be inhibited at a 
specific point along the cell body (Hammarton et al., 2005; Hammarton et al., 
2007; Ma et al., 2010). This may imply the presence of a novel furrow ingression 
checkpoint in T. brucei. Whilst depletion of individual molecular regulators 
revealed the possibility of checkpoints in furrow ingression, ablation of VSG 
synthesis or inhibition of mitochondrial fission also produced phenotypes which 
alluded to the presence of cytokinesis-specific checkpoints. VSG depletion in 
bloodstream form parasites caused a very specific and unique cell cycle arrest 
whereby cells accumulated at the pre-cytokinesis stage of the cell cycle; 
unusually, this post-mitotic arrest was not succeeded by additional rounds of 
organelle replication implying that this was a very stringent cell cycle arrest 
(Sheader et al., 2005). Depletion of dynamin and inhibition of mitochondrial 
fission had a similar effect on the cell cycle, although post-mitotic cells 
accumulated partway through cytokinesis, but again without subsequent rounds 
of organelle replication (Chanez et al., 2006). The tight control over the cell 
cycle exerted by VSG synthesis and mitochondrial fission suggested that there 
are unique checkpoints associated with very specific processes, and that these 
are activated at cytokinesis. 
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In addition to the involvement of molecular regulators in cytokinesis, the 
cytoskeleton, flagella, and flagellar-associated organelles are important for 
furrow initiation, ingression and abscission, and the role of these cytoskeletal 




2 Review of the trypanosome cytoskeleton, and its 
role in cell division 
2.1 The composition of the trypanosome cytoskeleton 
The complexity of the T. brucei cytoskeleton creates unique challenges during 
cell division, and unusual physical mechanisms are employed to ensure accurate 
daughter cell generation.  Although the main component of the cytoskeleton 
comprises the subpellicular microtubule corset, which encompasses the cell and 
denotes cell shape, it is generally accepted that the flagellum and associated 
organelles are also important features (Figure 2-1).  
                              
Figure 2-1 -Negatively stained electron microscopic image of a T. brucei cytoskeleton 
obtained by detergent extraction. 
The basal bodies (BB), flagellar axoneme (A), paraflagellar rod (PFR), flagellum attachment 
zone (FAZ), subpellicular microtubules (PMT), and nucleus (N) are indicated. Adapted with 
permission from (Gull, 1999). 
2.1.1 The subpellicular microtubule corset 
The subpellicular corset is a tubulin-based structure (Kleinschmidt and Kinder, 
1950), and the microtubules are arranged in parallel and form a left handed 
helix ((Angelopo, 1970); see also Figure 2-6). The corset is extremely stable, and 
displays resistance to cold and to classical inhibitors of microtubule stability 
(Macrae and Gull, 1990); in part this stability is conferred by the presence of 
microtubule-associated proteins (MAPs), which link adjacent microtubules 
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(Sherwin and Gull, 1989a). Stability is not compromised during growth of the 
subpellicular corset, as replication occurs in a semi-conservative manner: new 
microtubules are inserted into the microtubule array between older 
microtubules (Sherwin and Gull, 1989b). Initiation of a new microtubule occurs 
at randomly distributed nucleation sites (Scott et al., 1997), where microtubules 
can grow to varying lengths (Angelopo, 1970). All microtubules of the 
subpellicular corset have common polarity, and with their plus end extending 
towards the posterior end of the cell (Robinson et al., 1995). At the extreme 
posterior end is a small ring-like opening, which may represent a cap, stabilizing 
positive microtubule ends (Rindisbacher et al., 1993). The corset accommodates 
two specialised regions: the flagellum attachment zone (FAZ, Figure 2-2) and the 
flagellar pocket (Figure 2-3). In order for the flagellum to attach along the cell 
body, a gap exists between two microtubules, wherein lies a filament of 
relatively unknown composition (Sherwin and Gull, 1989a) and also four 
microtubules that are associated with membrane of the endoplasmic reticulum 
(Taylor and Godfrey, 1969). These four specialized microtubules are nucleated 
near to the basal bodies and exhibit opposite polarity relative to those within 
the corset. The flagellar pocket is the sole site of endo- and exocytosis, and is 
an invagination of the pellicular membrane, separated from the corset by an 
electron dense structure (Sherwin and Gull, 1989a) which is described as the 
flagellar pocket collar (Bonhivers et al., 2008). These structures are discussed in 
more detail below. 
2.1.1.1 Post-translational modifications of cytoskeletal tubulin  
Tubulin within the cytoskeleton is subject to post-translational modifications, 
which include acetylation, detyrosination and polyglutamylation. Acetylation of 
α-tubulin at a conserved  lysine residue (Woods et al., 1989) is a feature of 
tubulin in the flagellum and, to a lesser extent, in the subpellicular corset 
(Schneider et al., 1987). Both α- and β-tubulin contain a C-terminal tyrosine 
residue which can be removed and replaced. Detyrosination of α-tubulin (but not 
β-tubulin) appears to be a feature of tubulin incorporation into growing 
microtubules (Sherwin and Gull, 1989b), and as such, is a useful marker for cell 
cycle events and cell polarity (Sherwin et al., 1987a). Glutamylation of both α- 
and β-tubulin (at glutamic acid residues 445 and 435, respectively) is unusually 
extensive and is observed in both flagellar and subpellicular microtubules 
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(Schneider et al., 1997). The function of this extensive post-translational 
modification in T. brucei is not known, but it may serve to facilitate binding of 
MAPs as this has been demonstrated for some major neuronal MAPs (Bonnet et 
al., 2001).  
2.1.2 The flagellar axoneme and associated organelles 
The flagellar axoneme of T. brucei exhibits the classical ‘9 + 2’ structure of nine 
outer doublet microtubules and two central single microtubules (Figure 2-2); 
other conserved features of the axoneme include inner and outer dynein arms, 
radial spokes, nexin links, and components of a dynein regulatory complex and 
intraflagellar transport system (Ralston et al., 2009). The flagellum extends from 
a mature basal body, which comprises nine triplet microtubules that become 
doublets to form the transition zone. Nucleation of the central pair is initiated 
at this transition zone at a region termed the basal plate to form the full 
flagellar axoneme. Incorporation of tubulin into the axoneme seems to involve a 
process of flagellum-specific quality control at transitional fibres associated with 
the basal body (Stephan et al., 2007). 
                             
Figure 2-2 -Transverse section through the flagellum of a T. brucei cell. 
The transmission electron microscopy section shows the flagellar axoneme (A), 
paraflagellar rod (PFR), subpellicular microtubules (PMT) and flagellum attachment zone 
(FAZ). The electron dense structure to the right of the microtubule quartet is the FAZ 
filament, and the membrane in the region of these microtubules is derived from the 
endoplasmic reticulum but forms part of the FAZ. Reproduced with permission from (Gull, 
1999).   
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T. brucei parasites are highly motile and swim in a corkscrew-like fashion at 
speeds of up to 20 µm per second (Hutchings et al., 2002). Directionality is 
achieved by the production of a low amplitude and high frequency tip to base 
flagellar beat (Absalon et al., 2007a), which is occasionally interspersed with 
base to tip beating of high amplitude and low frequency, causing ‘tumbling’ and 
reorientation of the parasite (Baron et al., 2007a; Hutchings et al., 2002). 
Recently, bioinformatic (Baron et al., 2007b) and proteomic studies (Broadhead 
et al., 2006; Portman et al., 2009; Zhou et al., 2010) have identified conserved 
and novel components of the T. brucei flagellum, and there are ongoing studies 
to investigate the roles of these proteins in this highly complex and unusual 
mechanism of motility. Adjacent to the flagellar axoneme lies an accessory 
structure called the paraflagellar rod (PFR) (Vickerman, 1962). This structure 
has a lattice-like composition and is attached to both the flagellar axoneme (at 
doublets 4-7) and flagellum attachment zone (Figure 2-2 and Figure 2-3). The 
lattice has three distinct layers (proximal, intermediate and distal domains) 
constructed from core components, PFR A and C. Ablation of PFR A causes 
paralysis (although some abnormal ‘twitching’ of the flagellum occurs), 
suggesting a role for the PFR in motility (Bastin et al., 1999; Bastin et al., 2000). 
Interestingly, recent studies have localized cyclic nucleotide and calcium 
signalling pathways to the PFR, suggesting an additional role in environmental 
sensing (Portman and Gull, 2010), and also supporting a more regulatory role in 
motility (for example, as a phosphotransfer relay, supplying ATP to the distal 
portions of the flagellum).                                  
The flagellum is attached to the cell body at the FAZ via regularly spaced fibres 
connecting the FAZ filament to the axoneme and paraflagellar rod (Vickerman, 
1969). Adjacent to the FAZ filament lie four specialized microtubules and 
associated endoplasmic reticular membrane (Figure 2-2). FAZ1 and FLA1 are two 
proteins that have been shown to be components of the FAZ (LaCount et al., 
2002; Vaughan et al., 2008). Trypanin also appears to localize to the FAZ and is 
required for flagellum attachment as well as acting as a regulator of flagellum 
motility (Hutchings et al., 2002). In addition to being attached to the cell body, 
the flagellum is attached via the basal body to the mitochondrial DNA (kDNA), by 
the tripartite attachment complex (TAC), composed of interstitial and exclusion 
zone filaments, at the mitochondrial and cytoplasmic faces of a region of 
  
39 
differentiated mitochondrial membrane (Ogbadoyi et al., 2003). Only two 
components of the TAC have so far been identified: p166, a nuclear encoded 
protein, and AEP-1, a kinetoplast encoded protein which is expressed from 
alternatively edited mRNA for cytochrome c oxidase III (Ochsenreiter et al., 
2008; Zhao et al., 2008). Both p166 and AEP-1 are required for kDNA 
segregation, and AEP-1, which binds kDNA, has been shown to play a role in the 
maintainance of kDNA. Therefore the TAC has dual roles, anchoring the kDNA to 
the basal bodies, and maintaining the integrity and structure of kDNA 
(Ochsenreiter et al., 2008). Additional structural cohesion within the 
cytoskeleton is demonstrated by the existence of the ‘bilobe’ which links the 
basal body to the Golgi, and marks the site of Golgi assembly (He et al., 2005). 
Although both Centrin2 and Centrin4 are located at the bilobe, only depletion of 
Centrin2 was shown to inhibit Golgi assembly (Shi et al., 2008). 
In addition to attachment to internal structures, a mobile junction called the 
flagellar connector (Moreira-Leite et al., 2001) (Figure 2-3) couples the external 
old and new flagella during procyclic form replication (Briggs et al., 2004), and 
differentiation to epimastigotes (Sharma et al., 2008). The flagellar connector 
has a distinctive trilaminar structure with a thicker central core between the 
two layers abutting the flagella. The overall structure is asymmetric and 
triangular in appearance. This structure has been implicated as a possible 
facilitator of the cytotaxis concept (Sonneborn, 1964), as it appears to have 
roles in both basal body segregation and positioning the elongating daughter 
flagellum (Absalon et al., 2007a;Absalon et al., 2007a). Growth of the flagella 
and associated paraflagellar rod utilises a system of intraflagellar transport 
(Bastin et al., 1999). The transport machinery operates along specific tracks in 
antero and retrograde directions along axonemal tubules 3-4 and 7-8 (Absalon et 
al., 2008b). Surprisingly, assembly and motility of the flagellar connector occurs 




                                    
Figure 2-3 -Field emission scanning electron microscope images of T. brucei flagellar 
structures.  
A: The new (NF) and old (OF) flagella in a dividing cell. It is possible to distinguish the 
paraflagellar rod (the lattice-like structure to the right of the old flagellum), and the flagellar 
connector (arrow) connecting the new and old flagella. B: The helical arrangement of 
subpellicular microtubules and the flagellar pocket (FP). Scale bars:  1.6 μm (panel A) and 
1.8 μm (panel B). Adapted with permission from (Sant'Anna et al., 2005). 
The flagellar pocket (Figure 2-3B) itself is not a cytoskeletal structure, but there 
is evidence that cytoskeletal elements are involved in its replication, positioning 
and function (Absalon et al., 2008a; Bonhivers et al., 2008), and in defining 
subdomains within the pocket (Gadelha et al., 2009). The regions within the 
pocket include the flagellar pocket neck, a constricted site defined by the 
flagellar pocket collar (FPC), and the lumen, which contains a collarette at the 
base where the flagellum enters the pocket (Field and Carrington, 2009). 
Recently, a flagellar pocket channel has also been identified (Lacomble et al., 
2009). This is a region adjacent to an individual short subpellicular microtubule 
and the specialised microtubule quartet, and is thought to function as the main 
site of endocytosis into the lumen (Gadelha et al., 2009). The horseshoe-shaped 
FPC is an important structure as it is required for maintaining a barrier between 
the flagellar pocket lumen and the cell surface membrane (Absalon et al., 
2008a). BILBO1 is the first protein found to localise to the FPC (Bonhivers et al., 
2008). 
2.1.3 Perspectives 
The main cytoskeletal components, the subpellicular corset and flagellum (and 
associated organelles) are tightly associated, forming a cohesive unit, which in 
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turn, associates with the kinetoplast via the TAC. This structural cohesion 
dictates that tight orchestration of organelle replication is required during cell 
division, and implies that novel checkpoints are likely to operate in the 
regulation of these events. The role of minor cytoskeletal elements in the 
replication of organelles like the Golgi and flagellar pocket, demonstrates how 
structural elements can act to define and facilitate the replication of internal 
structures.  
2.2 Timing of cell cycle events 
2.2.1 Spatial and temporal analysis of the major cell cycle events 
The tight order of cell cycle events in T. brucei was evident from detailed 
morphological analysis of procyclic cells growing as asynchronous cultures 
(Sherwin and Gull, 1989a). Temporal linkage of major events was carried out by 
relating generation time to cumulative percentage of cells at different 
predetermined stages (according to the particular organelle or event in 
question). To facilitate classification, organelles or structures were labelled with 
antibodies, DAPI stain and/or BrdU as appropriate. The outcome of these 
experiments was a timeline of the duration of major events, including nuclear 
and kinetoplast replication and segregation, basal body replication, and 
paraflagellar rod elongation. These were described in terms of ‘cell cycle units’ 
(Sherwin and Gull, 1989a;Woodward and Gull, 1990). Intriguingly, the 
kinetoplast and nuclear replication events were temporally independent, with 
the kinetoplast cycle being of a shorter duration and occurring earlier.  
Spatial changes to the T. brucei cytoskeleton during the cell cycle have been 
extensively investigated. It is now known that the cell length increases 
throughout the cell cycle (from 18.9 ±0.3 to 24.9 ±0.3 µm in procyclic form 
Lister 427 cells (Robinson et al., 1995)), although the temporal and spatial 
pattern of microtubule extension varies (Sherwin et al., 1987b). Measurements 
of relative organelle positions revealed that basal body segregation is associated 
with cell extension and flagellum elongation. The increase in cell length was 
similar to maximum inter-basal body distance (Robinson et al., 1995). 
Intriguingly, flagellum extension rate relative to basal body separation altered at 
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a particular point, which coincided with an inter-basal body distance of ~2 µm; 
and a flagellar extension of 0.5 of a cell length (Robinson et al., 1995). This is 
also the distance at which flagellar connector migration ceases (Absalon et al., 
2007a; Davidge et al., 2006b). 
With the sequence of the main cell cycle events in place, both temporally and 
spatially, it is possible to position the replication and segregation of other 
cytoskeletal features within this framework. 
2.2.2 Replication of the basal bodies, Golgi bilobe, tripartite 
attachment complex and flagellar pocket  
At the G1/S transition, basal body maturation occurs. This involves the extension 
of the probasal body to form the transition zone and basal plate, from where 
flagellum extension is initiated. The probasal body is positioned anterior to the 
existing flagellum/basal body, which is counterintuitive, given that the new 
flagellum is positioned at the posterior end of the cell. This contradiction has 
recently been resolved through an elegant tomography study, which revealed 
that during flagellum extension, after invasion of the flagellar pocket and 
association with the flagellar connector, the basal body and extending flagellum 
rotates around the old flagellum, a movement involving anticlockwise rotation of 
the flagellar connector (Lacomble et al., 2010). This rotation positions the new 
flagellum at the posterior end of the cell. It was suggested that the new 
microtubule quartet, which is initiated before probasal body maturation, could 
provide the forces required for this rotational movement as it is closely 
associated with the basal body, and extends in a helical fashion around the basal 
body and flagellum before inserting into the subpellicular corset after the 
rotation has occurred (which would generate forces opposing those produced by 
extension of the microtubule quartet). Probasal body duplication was shown to 
precede the rotational event and the duplicated basal bodies were located at 
anterior positions relative to their respective basal body/flagellum complexes. It 
was suggested that one reason for the basal body/flagellum complex rotation 
could be to facilitate segregation of the flagellar pocket membrane, which was 
shown to involve partitioning of the existing membrane as opposed to de novo 
generation of a separate flagellar pocket. In accordance with this suggestion, 
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the FPC was formed during the rotation, which would coincide with the proposed 
membrane segregation.  
Basal body replication and kinetoplast S-phase occur at similar times. 
Kinetoplast S-phase coincides with the replication of the TAC and remodelling of 
the kDNA/TAC association (Ogbadoyi et al., 2003), and also coincides with the 
duplication of the Golgi bilobe (He et al., 2005) and growth and duplication of 
the FPC (Bonhivers et al., 2008). Flagellar pocket segregation is completed by 
the end of kinetoplast S-phase; however, segregation of the duplicated bilobes 
occurs later, during basal body segregation.  
2.2.3 The replication of the flagellar axoneme, flagellar connector, 
flagellum attachment zone, and paraflagellar rod   
Flagellum extension at the matured basal body coincides with the assembly of 
the FAZ. Once the flagellum has entered the flagellar pocket, PFR assembly is 
initiated. The rates of PFR and FAZ assembly differ, and although extension of 
the FAZ is initiated earlier, PFR assembly occurs more rapidly (Kohl et al., 1999). 
There is evidence that the flagellar connector is associated with the new 
flagellum within the flagellar pocket, coincident with initiation of the central 
pair singlet microtubules (Briggs et al., 2004). The rate and extent of flagellar 
connector migration appears to be consistent, although dissociation of the 
flagellar connector is variable (cells can occasionally remain attached by the 
flagellar connector following cytokinesis). It has frequently been shown that the 
daughter flagellum is shorter than the old flagellum, a discrepancy that appears 
to be due to continued flagellum extension beyond cytokinesis (Farr and Gull, 
2009). The events described are shown within the context of nuclear and 




Figure 2-4 -Schematic representation of the major events in the T. brucei cell cycle. 
Cell cycle units and the relative timing of nuclear and kinetoplast cell cycles are shown at 
the top (Woodward and Gull, 1990) (M: mitosis; C: cytokinesis; SN and SK: nuclear and 
kinetoplast S phase, respectively; D: kinetoplast division; A: kinetoplast segregation). 
Estimates for the duplication (Du) and segregation (Se) of the basal bodies and extension 
(Ex) of the flagellum are indicated. Arrows indicate the extension of the FAZ and PFR, and 
the star indicates the arrest of the flagellar connector (FC). Adapted with permission from 
(Ploubidou et al., 1999). 
2.3 Coordination of cell cycle events  
2.3.1 The interplay between kinetoplast and basal body 
segregation 
Kinetoplast replication can be inhibited by the application of Topoisomerase II 
inhibitors, for example ethidium bromide, teniposide and acriflavine, which 
affect decatenation and catenation of the minicircles of the kinetoplast DNA. 
Application of these inhibitors to procyclic T. brucei cultures affected 
kinetoplast segregation, but not basal body segregation, and the basal bodies 
remained attached to the kinetoplasts (Robinson and Gull, 1991). However, it 
has also been demonstrated that in the absence of attachment of the TAC to 
kDNA, basal body segregation still occurs (Ogbadoyi et al., 2003). Inhibition of 
microtubule dynamics though the application of ansamitocin did not inhibit kDNA 
replication, but inhibited both basal body and kinetoplast segregation (Robinson 
and Gull, 1991). A similar phenotype was observed through the application of 




Genetic studies have also demonstrated that kinetoplast segregation is 
absolutely dependent on the basal bodies. TbLRTP is a negative regulator of 
basal body biogenesis, and overexpression of this protein dramatically reduced 
basal body duplication, resulting in an increase of cells with unsegregated 
kinetoplasts (Morgan et al., 2005). Centrins 1 and 2 are positive regulators of 
basal body duplication, and downregulation of these proteins had a similar 
effect on kinetoplast segregation (He et al., 2005). NKRC and KMP11 are 
regulators of basal body segregation; cells deficient in NKRC display delayed 
basal body segregation and accumulate at the four basal body stage. The effect 
on kinetoplast morphology was not described for these cells (it was only 
recorded that kinetoplast enlargement occurred in cells with abnormal numbers 
of basal bodies) and no cell cycle arrest was observed (Pradel et al., 2006). More 
dramatically, downregulation of KMP11 abolished basal body replication and 
cells with enlarged kinetoplasts appeared (Li and Wang, 2008).  
The combined evidence from chemical and genetic studies suggests therefore 
that kinetoplast replication can occur in the absence of basal body duplication, 
but that kinetoplast segregation requires both duplication and segregation of the 
basal bodies. Conversely, basal body duplication and segregation appear to be 
independent of kinetoplast replication. 
2.3.2 The role of the flagellum, flagellum attachment zone and 
flagellar connector in kinetoplast and basal body replication 
and segregation 
When the structure of the flagellar axoneme is disrupted, motility defects can 
arise; frequently, cells displaying defective motility also have problems with 
basal body segregation. Downregulation of different axonemal components 
caused different motility phenotypes. Axonemal defects and cell paralysis were 
reported following simultaneous downregulation of two PACRG homologues 
(Dawe et al., 2005) and the paralysed PACRG mutants also displayed basal body 
segregation defects, although flagellar motility was not investigated. In other 
cases, however, the motility defect was analysed in detail, and particular 
flagellar wave forms were associated with different mutants. When assembly of 
the central pair was ablated (through knockdown of PF16 or PF20 (Absalon et 
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al., 2007b), both types of flagellar wave formation were abolished (tip to base 
and base to tip). When components of the dynein arms were downregulated 
(dynein intermediate chain (DNAI1) and dynein light chain (LC1)), tip to base 
motility was abolished, although the parasites still exhibited base to tip motility. 
In the case of DNAI1 downregulation, cells were totally paralysed (Absalon et al., 
2007b), while LC1 depleted parasites displayed backwards swimming (Baron et 
al., 2007a). Inhibition of base to tip (central pair mutants) but not tip to base 
(DNAI1 mutant) wave forms affected basal body migration. Motility defects are 
not limited to axonemal mutants, however. A mutant lacking a PFR was 
paralysed due to an almost total deficiency of tip to base and base to tip 
flagellar movement (Branche et al., 2006); this mutant did not exhibit basal 
body segregation defects, which implied that occasional base to tip flagellar 
motility could be sufficient for basal body segregation.  
The flagellar connector is also likely to be important for basal body segregation, 
since the halting of flagellar connector migration coincides with basal body 
segregation, and when the flagellar connector is absent (as is the case when 
TBBC (Trypanosome Basal Body Protein), a cytoskeletal protein, is 
downregulated), basal body segregation is inhibited (Absalon et al., 2007b). The 
flagellar connector may be required to transduce the forces generated by base 
to tip flagellar movement, which could be important for basal body segregation, 
or alternatively it could be involved in signal transduction, and halting of 
flagellar connector migration may trigger a signalling cascade, stimulating basal 
body segregation. Bloodstream form parasites, which appear not to possess a 
structure analogous to the flagellar connector, may not require such a structure 
to segregate basal bodies, as the distance involved is much smaller.  
Interference with the intraflagellar transport (IFT) system affects construction of 
the flagellum, PFR and FAZ, and therefore can also influence basal body 
segregation. The severity of flagellar defects observed when IFT system 
components are downregulated is dependent upon the particular component and 
the duration of downregulation. Che2 downregulation had no effect on the 
flagellum-associated organelles (FAZ or flagellar connector) but completely 
abolished assembly of the axoneme (Davidge et al., 2006). Downregulation of 
IFT20, IFT88 and DHC1b inhibited both flagellum and FAZ assembly, causing the 
appearance of cells only capable of producing short flagella and FAZs, which 
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were frequently abnormal. Basal body segregation was inhibited when the FAZ 
was abnormal (IFT20 and DHC1b mutants (Absalon et al., 2007b)), or absent 
(IFT88 mutant (Kohl et al., 2003), but surprisingly, was unaffected in the total 
absence of a flagellar axoneme with intact FAZ and flagellar connector (Che2 
depletion). This would imply that an intact FAZ/flagellar connector (rather than 
force or motility) is essential for basal body segregation, but this does not hold 
true in all cases. For example, the flagellum attachment defects present in FAZ1 
or FLA1 mutants do not cause inhibition of basal body segregation (LaCount et 
al., 2002; Vaughan et al., 2008). Therefore, it is most likely that basal body 
segregation requires the combined presence of three functional structures: the 
flagellar axoneme, (providing base to tip motility forces), the flagellar connector 
(for force transduction or signalling/checkpoint regulation), and the FAZ (for 
flagella attachment and positioning cues). 
It should also be noted that flagellum extension is independent of flagellar 
pocket formation, and vice versa; however, the positioning of either in the 
absence of the other is abnormal, demonstrating another example of structural 
cohesion within the cytoskeleton (Absalon et al., 2008a; Bonhivers et al., 2008). 
 
2.4 The cytoskeleton and cytokinesis 
2.4.1 Stages of cytokinesis 
Cytokinesis can be considered as a three stage process, comprising initiation, 
furrow ingression and abscission. If a cell becomes committed to cytokinesis in 
the absence of successful organelle replication or segregation, abnormal 
daughter cells will arise which may not be viable. Cytokinesis initiation pathways 
are usually associated with mitotic exit to avoid the generation of anucleate 
cells; however, in T. brucei, initiation is also associated with replication and 
segregation of cytoskeletal elements. Furrow ingression in T. brucei is 
longitudinal and appears to follow the axis of the subpellicular microtubules. 
The pathways governing furrow placement, and the mechanism of furrow 
ingression are unknown at present. Abscission is the process responsible for 
remodelling the region of daughter cell attachment following furrow ingression. 
The region of cytoplasmic continuity between daughter cells is spanned by small 
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numbers of microtubules and has a small surface area, and evidence suggests 
that abscission in T. brucei may be accomplished by mechanical breakage. The 
roles of individual components of the cytoskeleton in cytokinesis are discussed in 
detail below. 
 
2.4.2 Basal bodies 
The kinetoplast organelle is unique to Kinetoplastids.  As described above, it has 
been demonstrated that the nuclear and kinetoplast cycles are temporally 
independent, and in T. brucei, successful kinetoplast replication seems to have a 
more prominent role in cytokinesis regulation, since inhibition of nuclear S phase 
or mitosis does not prohibit cytokinesis (Ploubidou et al., 1999), but inhibition of 
kinetoplast and/or basal body segregation does (Das et al., 1994; He et al., 
2005; Li and Wang, 2008a; Morgan et al., 2005; Pradel et al., 2006; Robinson and 
Gull, 1991). To ensure faithful segregation of the kinetoplast organelle, basal 
body duplication and segregation must proceed correctly, as the two organelles 
are linked by the TAC. Evidence implies that basal body segregation is in fact the 
main regulator of cytokinesis in T. brucei, as cells treated with acriflavine do 
not undergo kinetoplast replication, but still segregate basal bodies and undergo 
cytokinesis (Ogbadoyi et al., 2003).  
2.4.3 Flagellum attachment zone 
The FAZ is well placed to have roles in determination of cell polarity as it is 
associated with the flagellar pocket and the flagellum, and in close proximity to 
the kinetoplast and basal bodies. Polarity is important for the correct positioning 
of the cleavage plane in cells which have a linear arrangement of organelles. 
Furthermore, it has been identified as a putative site for furrow ingression 
because the gap in the subpellicular microtubules at this site could facilitate 
membrane ingression (Dolan et al., 1986). There has also been speculation with 
regards to the section of endoplasmic reticular membrane associated with the 
microtubule corset, which could potentially be involved in localised release of 
calcium, thus affecting signalling or microtubule dynamics (Dolan et al., 1986). 
Analysis of cells undergoing cytokinesis by electron microscopy clearly identifies 
the anterior end of the cell as the site of furrow initiation. Furthermore, 
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flagellum length directly correlates with cell length (Sherwin and Gull, 1989a). 
The FAZ has been shown to be essential for cytokinesis and correct positioning of 
the cleavage plane through the downregulation of FLA1 (LaCount et al., 2002) 
and FAZ1 (Vaughan et al., 2008), respectively.  
It has been demonstrated on multiple occasions that inhibition of the IFT system 
can inhibit the assembly of FAZ and flagellum (Absalon et al., 2008b), resulting 
in inhibition of cytokinesis. Detailed analysis of IFT88 and DHC1b mutants, where 
dividing cells assembled a short daughter flagellum and FAZ, revealed that 
division of these cells was asymmetric. The length of the FAZ and flagellum in 
the daughter cells correlated with cell length, suggesting that the cell inheriting 
the shorter flagellum received a proportional quota of the cytoplasm and 
cytoskeleton, implying that the cleavage plane is determined by flagellum or 
FAZ extension. Furthermore, cells producing a short daughter FAZ, but lacking a 
flagellum, were still capable of dividing, thus emphasising that the FAZ and not 
the flagellum determines the cleavage site (Kohl et al., 2003). 
 
2.4.4 Flagellum 
Through the recent advances in identification of putative flagellar proteins, 
there is an accumulation of evidence that the flagellum is important for 
cytokinesis, and interestingly, the role of the flagellum in this process differs 
dramatically according to life cycle stage. When components of the flagellar 
axoneme or PFR are downregulated in procyclic form cells, the parasites 
frequently display abscission defects, and clusters of parasites attached by their 
posterior ends accumulate (Baron et al., 2007b; Broadhead et al., 2006; Ralston 
et al., 2006). The cytokinesis defect observed upon depletion of PFR2 (Ralston et 
al., 2006) was not described previously (Bastin et al., 2000); however, these 
original mutants were later found to exhibit cytokinesis defects and the 
differences in the severity of these defects were attributed to differences in the 
generation of mutants or culture technique (discussed in (Ralston et al., 2006)). 
The abscission defect could be reversed by shaking the culture medium (Ralston 
et al., 2006), perhaps suggesting that in lieu of membrane insertion or 
microtubule severing, membrane and microtubule attachments at cell posterior 
ends could be broken by the rotational forces generated from the two flagella 
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beating in opposite directions.  In bloodstream form parasites, downregulation 
of axonemal or PFR components caused inhibition of cytokinesis initiation, 
resulting in the production of multinucleated cells with a distinctive morphology 
comprising loss of cell polarity, enlargement of the flagellar pocket, and 
multiple flagella which occasionally possessed two axonemes (Broadhead et al., 
2006). This phenotype could not be reversed by growth of these mutants in vivo, 
suggesting that, unlike in procyclic form parasites, a lack of flagellar motility 
could not be compensated for by shear forces (Griffiths et al., 2007). 
 
2.4.5  Subpellicular corset 
The subpellicular corset is present throughout the cell cycle, which is a 
predicament for furrow ingression, as presumably the cell membrane must 
invaginate and coalesce during cell division. The cytoskeleton is highly stable, a 
consequence of microtubule crosslinking by microtubule-associated proteins. 
Additionally, MAPs attach the cell membrane to the subpellicular corset (shown 
in Figure 2-6). Although the cytoskeleton does not disassemble globally at any 
point during the cell cycle, it has been proposed that local disassembly must 
occur for the ingression of the furrow and to allow remodelling of the membrane 
bilayers, although this has not yet been observed. Downregulation of α-tubulin 
causes a dramatic phenotype, characterised by cell rounding and inhibition of 
cytokinesis (Ngo et al., 1998). These cells have been dubbed ‘fat cells’; so 
dramatic and reproducible is the phenotype, it has been used to test the 
efficacy of new RNAi systems (Shi et al., 2000b). Inhibition of cytokinesis 
following induction of α-tubulin RNAi was rapidly induced, and whilst this was 
attributed in part to axonemal and FAZ defects, the cytokinesis phenotype was 
not reversible, suggesting that α-tubulin turnover and cytoskeletal assembly 
could represent an important cytokinesis checkpoint. The unsubtle and global 
effect on the T. brucei cytoskeleton makes depletion of tubulin an unsuitable 
method for investigating furrow ingression. Other methods of studying the role 
of the cytoskeleton in furrow ingression include the application of inhibitors of 
microtubule dynamics (discussed in Chapter 6) and the manipulation of 





2.5 Microtubule structure and dynamics 
Microtubules are hollow tubes constructed from polymerised tubulin 
protofilaments, with typically thirteen protofilaments making up one 
microtubule (Amos and Schlieper, 2005). For polymerisation of tubulin to occur, 
α and β isoforms of tubulin first dimerise producing heterodimers. The 
incorporation of these heterodimeric subunits into protofilaments requires 
hydrolysis of GTP. Protofilaments interact with other protofilaments in a lattice 
sheet, which folds to form a hollow tube. In typical microtubules, the 
protofilament lattice is an ‘A’ lattice, meaning that α and β subunits in adjacent 
protofilaments alternate. The subunits within the lattice are slightly offset, 
forming a shallow helix. This pattern of alternating isoforms is not continuous in 
a typical microtubule (due to the odd numbers of protofilaments), and there is a 
region along one side of the tubule where identical isoforms are adjacent, 
referred to as the microtubule seam. 
The α- and β–tubulin isoforms each possess two globular domains, which are 
spatially separated by a core helix (Figure 2-5), and have different functions. 
The larger globular domain, located at the N-terminus, contains a GTP binding 
site. The second globular domain contains three important regions: the 
activation domain (which comprises loop T7 and helix 8), the taxol binding 
pocket, and the M-loop. The activation loop stimulates GTP hydrolysis, the taxol 
binding pocket is important for interactions with MAPs (and small molecules, for 
example, taxol), and the M-loop is involved in maintaining inter-protofilament 
bonds. There are two crucial differences between α- and β-tubulin isoforms. 
Firstly, the GTP bound to the α-tubulin is not hydrolysed due to a substitution of 
glutamic acid for lysine within helix 8 of the β-tubulin activation domain, 
preventing the association of β-tubulin helix 8 with the GTP binding site of α-
tubulin from resulting in hydrolysis. GTP is therefore permanently bound at the 
α-tubulin subunit. The second difference concerns the taxol binding pocket, 
which is closed in α-tubulin due to an extension of the L-loop obstructing the 
pocket opening. In addition to the globular domains and core helix, there is a C-
terminal domain consisting of two helices, a U-turn and crucially, a disordered 
domain of 13 (α-tubulin) or 9 (β-tubulin) residues that are acidic. These are 
believed to project from the microtubule polymer where they can form binding 
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sites for basic and positively-charged MAPs. The C-termini are frequently 
modified by post-translational modifications, which are believed to mediate 
interactions with MAPs. 
                            
Figure 2-5 -Ribbon diagram of an α/β tubulin heterodimer. 
Electron crystallography structure of bovine brain tubulin in complex with taxol orientated 
to correspond to the inside view of a microtubule. Red: GTPase domains; blue: activation 
domains; yellow: the core helix connecting the two globular domains; green: C-terminal 
domain on the external surface. GTP, bound to α-tubulin by loops T7-T6 and making contact 
with loop T7 of β-tubulin, is shown between the α and β subunits of each heterodimer. The 
nucleotide bound to β-tubulin has been hydrolysed to GDP through contact with helix H8 
and loop T7 of the activation domain of another α-tubulin subunit. Taxol sits at the taxol 
binding pocket of β-tubulin. Reproduced with permission from (Amos and Schlieper, 2005). 
GTP hydrolysis is important for the polarity and dynamics of microtubule 
assembly. GTP-bound heterodimers associate more readily with positive 
microtubule ends, resulting in polarized microtubule growth. When net loss at 
the negative pole and net gain at the positive pole reach equilibrium, the length 
of the microtubule remains constant, a process known as ‘treadmilling’. GTP 
hydrolysis is also responsible for conformational changes within the tubulin 
heterodimer, and GTP-bound heterodimers form straight protofilaments which 
become curved upon GTP hydrolysis. This phenomenon can be observed when a 
  
53 
microtubule is growing; growing microtubule ends form straight sheet-like 
structures, whilst shrinking microtubules appear to curve outwards, shedding 
ring-like pieces of protofilaments (Howard and Hyman, 2003).  
The pattern of microtubule assembly features four phases: nucleation, 
elongation, stationary phase and disassembly (Valiron et al., 2001). Nucleation 
and assembly can occur spontaneously in vitro, providing the conditions are 
right, which is evidence that self assembly is an intrinsic property of tubulin. In 
vitro assembly has also shown that the initial concentration of GTP-bound 
heterodimers is important for nucleation. In vivo, the dynamics of tubulin 
assembly are similar; however, nucleation only occurs at designated microtubule 
organising centres, such as centrioles. Protein complexes called γ-tubulin rings 
are found at these regions and are thought to act as templates, mimicking 
microtubule ends to recruit tubulin heterodimers (Job et al., 2003). Once 
protofilaments begin to elongate, the energy released by GTP hydrolysis keeps 
GDP-bound heterodimers in a straight but strained conformational state, and 
continued incorporation of GTP-bound heterodimers with naturally straight ends 
act as a cap, stabilising the structure beneath. If incorporation of tubulin ceases, 
then the cap is lost, and the microtubule disassembles. The cap can be as small 
as one layer thick. Loss of the cap may occur stochastically, even when 
conditions for assembly are favourable, and this is described as a catastrophe 
event. Catastrophe events do not necessarily cause the whole microtubule to 
disintegrate, and rescue events can restore microtubule extension. 
The simplest way to alter microtubule dynamics in vitro is to increase the supply 
of GTP-bound tubulin heterodimers. Temperature is also important for 
mammalian microtubules, which are unstable at 4˚C. Regulation of microtubule 
dynamics in vivo is far more complex, as there are different layers of regulation 
involving post-translational modifications and association of MAPs. The field of 
MAP research is biased towards those MAPs linked to degenerative neurological 
diseases, and comparatively little is known about other MAPs. However, current 
knowledge suggests that microtubule binding domains, and binding sites within 
microtubules are diverse. Perhaps this diversity reflects the plethora of 
functions which range from general roles in cell morphology and polarity, and 
cell cycle roles at mitosis and cytokinesis, to cell type-specific roles in vesicle 
transport, and motility.  
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2.5.1 General features of common microtubule-associated 
proteins 
MAPs can inhibit microtubule disassembly by counteracting the tendency of GDP-
bound microtubules to bend outwards by forming intra-protofilament bonds, and 
by forming links between adjacent heterodimers to strengthen lateral 
associations (non-specifically or at the lattice seam). MAPs frequently possess 
repetitive regions, enabling them to contact more than one heterodimer, and 
frequently these regions contain basic and positively-charged residues, which 
mediate the interaction with the acidic C-terminus of tubulin. These proteins 
often have a random coiled structure, and some may only form an ordered 
structure upon binding to the microtubule, which makes it very difficult to 
predict how and where a MAP binds.  
‘Typical’ MAPs are exemplified by MAP2 and Tau. Both proteins bind 
microtubules via their C-termini which contain PGGG repeats and proline-rich 
repeats, which each bind independently to microtubules. The PGGG repeats bind 
to the taxol binding pocket of β-tubulin (Kar et al., 2003), laterally joining up to 
as many as four heterodimers along the inside face of the microtubule, whilst 
the proline-rich repeats have less specificity, and bind to the acidic microtubule 
surface linking heterodimers longitudinally along microtubule ridges (Al Bassam 
et al., 2002). 
‘Unusual’ MAPs include MAP1A, doublecortin and members of the Ds1 / TOG 
family. MAP1A controversially possesses an acidic microtubule binding domain: 
the ‘SS2’ domain. This domain is thought to assemble an α helix, and the regular 
intervals between acidic and basic residues suggests that these cluster on 
opposite sides of the helical loop, an arrangement that could allow protein 
interactions at one side, and microtubule binding to the acidic microtubule 
surface at the other (Cravchik et al., 1994). Microtubule binding does not always 
involve repetitive regions or α-helices. Doublecortin, for example, has two DCX 
motifs, which share a common ubiquitin-like fold; moreover, the C-terminal 
motif has globule-like properties suggesting that it is in fact a disordered 
structure. Both domains can bind to microtubules, and it has been suggested 
that the C-terminal DCX motif binds free tubulin, supplying heterodimers to the 
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growing microtubule (Moores et al., 2003). The site of doublecortin binding has 
been mapped to ‘valleys’ between heterodimers, whereby one doublecortin 
molecule can interact with four heterodimers, thus stabilising both longitudinal 
and lateral bonds (Moores et al., 2004). The Dis1/TOG family encompasses a 
large group of highly conserved proteins which possess distinctive motifs called 
TOG domains. The TOG domain is a paddle-like structure, and has two wide 
faces composed of HEAT repeat helices flanking a hydrophobic core (Al Bassam 
et al., 2007). Members of this family can possess multiple TOG domains, and it 
has been shown that different TOG domains within a protein can have 
preferential affinity for different tubulin isoforms, which could allow the 
proteins to interact with more than one heterodimer. The exact binding 
mechanism has not yet been elucidated. This family of proteins have diverse 
cellular functions, and the TOG domain is believed to facilitate interactions with 
many different proteins in addition to tubulin (Ohkura et al., 2001).  
These examples represent just a small number of microtubule-associated 
proteins. There are other classes of MAPs, which bind preferentially to growing 
microtubule ends (for example EB1), or possess ATPase activity for microtubule 
severing (katanins) or trafficking (dynein and kinesins). The diversity observed in 
well studied eukaryotic systems seems to be increasing; however, very little is 
currently known about MAPs in T. brucei. 
2.6 Microtubule-associated proteins in T. brucei 
2.6.1 Identification of T. brucei microtubule-associated proteins 
MAPs can be visualised by electron microscopy of T. brucei subpellicular 
microtubule arrays (Figure 2-6). Cytoskeletons of Trypanosoma species are highly 
immunogenic, and immunisation of mice and rabbits with either whole 
cytoskeletons, or the salt extracts thereof, has proven to be a successful method 
for the identification of novel MAPs. Verification of sera specificity can be 
achieved by immunofluorescence microscopy analysis, and the epitope 
recognised by the sera can be assigned to a particular protein by screening 
expression libraries. Proteins identified though immunological methods include 
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WCB (Woods et al., 1992), CAP5.5 (Hertz-Fowler et al., 2001) and Autoantigen 
I/6 (Detmer et al., 1997).  
MAPs have also been isolated directly from cytoskeletons, either by purifying 
proteins found in salt-extracted cytoskeletal fractions using gel filtration, or by 
passing the salt-extracted fractions through a tubulin affinity column, and 
analysing the eluted proteins. Proteins isolated by these methods were 
characterised either by peptide sequencing, or through the production of 
antibody and screening of expression libraries. Proteins identified from 
cytoskeletal fractions included p15 (Balaban and Goldman, 1992), p52 (Balaban 
et al., 1989), MARP1 and MARP2 (Schneider et al., 1988b).  
Other MAPs were identified indirectly; for example, GB4 was identified in a 
screen for cell surface proteins (Rindisbacher et al., 1993), CAP15 and CAP17 
(Vedrenne et al., 2002) were identified primarily as stage-specific proteins 
(CAP15 is expressed in bloodstream form parasites, whereas CAP17 is expressed 
in procyclic form parasites), and a metabolic labelling study to identify fatty 
acid-associated proteins led to the discovery of the MAP, p41 (Schneider et al., 
1988a). 
                 
Figure 2-6 -Quick-freeze deep-etch electron microscope image showing the localisation of 
MAPs in a T. brucei subpellicular microtubule array. 
The high density of MAPs localised at the membrane-oriented face of the subpellicular 
microtubule array can be seen (protein knobs above). The cytoplasmic face is relatively 
smooth (not shown). Occasionally, MAPs can be seen bridging adjacent microtubules. 




2.6.2 Characterisation of microtubule-associated proteins 
2.6.2.1 Roles in microtubule stability 
Techniques for purification of calf brain, porcine and Trypanosoma tubulin have 
enabled the binding, and polymerisation capabilities of MAPs to be assessed in 
vitro. Tubulin polymerisation in the presence or absence of the MAP in question 
can be assessed biochemically (by monitoring the dynamics of polymerisation), 
or visually using electron microscopy. Additionally, S-tubulin, a form of tubulin, 
which lacks the C-terminal region usually associated with the binding of MAPs, 
can be used in affinity assays to probe the nature of the binding interaction.  
To assess the effect of MAPs on microtubule stability in vivo, different genetic 
approaches have been used. Expression of MAPs in mammalian cell lines is a 
useful method for testing whether a protein has a stabilising effect on 
microtubules. Mammalian microtubules are not stable at low temperatures or in 
the presence of destabilising agents like nocodazole. Therefore, the morphology 
of the mammalian cell cytoskeleton can be compared in the presence or absence 
of a trypanosome MAP. This method effectively showed that MARP1 and MARP2 
and CAP15 can stabilise microtubules (Affolter et al., 1994; Hemphill et al., 
1992; Vedrenne et al., 2002). Genetic techniques, for example RNAi and protein 
overexpression, have been used to alter the levels of some MAPs in T. brucei 
cells. Parasites with an altered level of a particular MAP were analysed by 
electron microscopy in order to determine the impact on cytoskeletal 
organisation and integrity. RNAi was used to investigate the roles of CAP5.5, 
CAP5.5v and WCB (Baines and Gull, 2008; Olego-Fernandez et al., 2009). 
Parasites subjected to the downregulation of these MAPs displayed abnormal 
cytoskeletal morphologies. Cells depleted of WCB exhibited uneven spacing of 
the microtubules and poor membrane/microtubule attachment, indicating that 
WCB is involved in linking the subpellicular corset to the cell membrane. (Baines 
and Gull, 2008). Additionally, cytoskeletons showed a loss of integrity following 
detergent extraction, and downregulation of  WCB caused an accumulation of 
2N2K cells and the production of equal numbers of 0N1K and 2N1K cells, 
suggesting cytokinesis was delayed, and that the cleavage plane was then 
abnormally positioned (Baines and Gull, 2008) generating these abnormal 
daughter cells. Cells depleted of CAP5.5 or CAP5.5v exhibited abnormal 
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microtubule spacing, and possessed bundles of microtubules beneath the cell 
membrane, defects, which were more severe at the posterior ends of cells, and 
abnormal placement of the cleavage furrow was observed (Olego-Fernandez et 
al., 2009). Overexpression of CAP15 or CAP17 (Vedrenne et al., 2002) also 
caused abnormal cleavage furrow placement, although this may have been a 
consequence of inhibited kinetoplast segregation also observed in these cell 
lines. Hence, although few T. brucei MAPs have been identified to date, four 
have been shown to have roles in cytokinesis.                    
In addition to microtubule binding, some MAPs were identified as potentially 
interacting with membranes. Liposome binding assays identified p15 as a protein 
involved in crosslinking microtubules to phospholipid membranes (Rasooly and 
Balaban, 2002). 
2.6.2.2 The structural characterisation of T. brucei microtubule-associated 
proteins 
No crystal structures for the T. brucei MAPs have been determined; however, 
protein structure has been investigated through bioinformatic approaches. Some 
proteins displayed features characteristic of MAPs, namely the presence of 
repetitive motifs and regions rich in basic amino acids. MAPs containing repeat 
sequences include MARP1 and MARP2, which contain repeats of 38 amino acids 
which have a low pI (Affolter et al., 1994); p15, which contains sixteen repeats 
rich in positive and hydrophobic amino acids that are predicted to be distributed 
equally around an α-helix (Rasooly and Balaban, 2002); Autoantigen I/6, which 
contains six tandem repeats each eight amino acids in length (Detmer et al., 
1997); and WCB, which possesses five repeats all 32 amino acids in length 
(interestingly incorporating alternating acidic and basic residues) (Baines and 
Gull, 2008). MARP1 and MARP2 possess basic N-termini (Affolter et al., 1994), 
and CAP5 and CAP5.5v possess proline-rich N-termini (Hertz-Fowler et al., 2001). 
The non-repetitive N-terminus of MARP2 has been shown to bind microtubules 
(Affolter et al., 1994; Hemphill et al., 1992). In some cases, common sites of 
post-translational modification were present, including sites for fatty acid 
addition by palmitoylation or myristoylation (p41 (Schneider et al., 1988a), CAP5 
and CAP5.5v (Hertz-Fowler et al., 2001)), glycosylation (GB4 (Rindisbacher et 
al., 1993)), and phosphorylation (WCB (Woods et al., 1992)). These observations 
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have functional implications; fatty acid addition suggests a role in membrane 
interaction, and phosphorylation could suggest a signalling role.  
The cellular localisation for most of these proteins has now been determined 
(excluding p52 and p41). Proteins that are evenly distributed throughout the 
microtubule array include MARP1, MARP2, WCB, Autoantigen I/6, CAP15, CAP17 
and p15 (Detmer et al., 1997; Hemphill et al., 1991; Vedrenne et al., 2002; 
Woods et al., 1992). CAP5, CAP5.5v and GB4 show different localisation patterns 
within the corset; CAP5 and CAP5.5v are found only in the anterior region 
(Olego-Fernandez et al., 2009), whilst GB4 forms a ring-like distribution at the 
posterior end (Rindisbacher et al., 1993). 
MAPs in the subpellicular corset of T. brucei are a diverse collection of 
molecules.  From a structural angle there are no strong patterns that would 
implicate a common binding site within the microtubule structure. The unusual 
properties of T. brucei MAPs are highlighted by the MARP proteins, which 
perversely exhibit the classical MAP structural features, yet do not bind the 
acidic tubulin C-terminus. These unique proteins clearly have a role in 
maintaining the integrity of the microtubule structure in the subpellicular 
corset, but there are several indications that some proteins could have other 
roles, for example, in signalling, cell polarity, cytokinesis, and differentiation. 
2.6.3 Microtubule-associated proteins, cytokinesis and parallels 
with other organisms 
The subpellicular corset has obvious roles in maintaining cell shape and polarity, 
and via the FAZ, it is also associated with the flagellum. These factors place the 
subpellicular corset in a uniquely advantageous position for determining the 
cleavage plane and regulating furrow ingression, which is all the more poignant 
given the absence of an actomyosin contractile ring, and unusually reduced 
importance of mitosis in regulating these processes. 
Novel MAPs may provide a link to bridge cytoskeletal replication and cytokinesis 
regulation. MAPs can regulate microtubule dynamics, establish 
membrane/microtubule association, interact with signalling pathways (involving 
kinase-mediated phosphorylation), and recruit other proteins (i.e. by acting as 
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scaffolds). These properties strongly implicate this group of proteins as key 
putative regulators of cytokinesis. Potential roles for MAPS in T. brucei 
cytokinesis include: marking the initiation site, perhaps through association with 
the CPC (Section 1.9.1.2); recruiting other proteins to the site of furrow 
initiation or ingression (either directly or by participating in signalling 
pathways); in the mechanical process of furrow ingression (by remodelling the 
microtubules and microtubule/membrane association along the furrow); or 
finally in positioning the cleavage axis (localisation of MAPs is likely to be 
necessary for maintaining cell polarity).  
Microtubules and their associated proteins are important for cytokinesis in 
mammalian cells. However, the microtubules in this case are those comprising 
the spindle, not the cortical cytoskeleton. Since T. brucei can undergo 
cytokinesis in the absence of mitosis, there may be more mechanistic parallels 
to be drawn between plant cytokinesis processes, than mammalian ones, as 
positioning of the cleavage axis in plants involves novel cytoskeletal structures 
and MAPs.  
2.7 Cytokinesis in plants 
2.7.1 General principles 
In plants cells, the cleavage plane is positioned prior to mitosis, via the 
formation of a structure called the ‘preprophase band’, which is composed of 
cortical microtubules and actin filaments. The preprophase band disassembles at 
the transition between prophase and prometaphase, but markers deposited at 
the site of the preprophase band remain, comprising the ‘cortical division site’.  
During late telophase, the phragmoplast forms. This microtubule-based structure 
is the target for vesicle trafficking from the Golgi, and at the phragmoplast 
midzone, these vesicles fuse to form the cell plate, a membranous structure 
containing cell wall precursors and enzymes. Cell plate expansion continues until 
the plate encounters the cortical division site; contact with this region coincides 
with cross wall maturation, which finally separates the two daughter cells 




2.7.2 Cleavage plane determination, the preprophase band and 
the cortical division site 
The strong correlation between preprophase band position and cell wall 
insertion implied a role for the preprophase band in cleavage plane 
determination. However, the mechanism behind this process has only recently 
been revealed through the discovery of preprophase band components, and 
there is still much to be elucidated. Summarised below is an account of 
preprophase band formation (see also Figure 2-7) and a description of the roles 
of preprophase band components in cytokinesis (reviewed by (Jurgens, 2005; 
Muller et al., 2009; Van Damme et al., 2007; Van Damme and Geelen, 2008)). 
During interphase, microtubule nucleation occurs at discrete sites throughout 
the cortical array, and is thought to involve acentrosomal γ-tubulin complexes 
(although the exact role of γ-tubulin is not understood). The accumulation of 
microtubules to form the preprophase band appears to occur at the expense of 
cortical microtubules, and this process requires the MAPs MOR1 and MAP65, 
which can both bind to, and cause bundling of, microtubules. The transition 
from cortical to preprophase band microtubule assembly is probably a 
consequence of changes in microtubule dynamics mediated by these MAPs. The 
preprophase band stretches across the cell bilaterally, and contact with the cell 
wall is thought to be assisted by CLASP, a positive microtubule end-associated 
protein. Initiation of preprophase band formation requires a putative homologue 
of the regulatory subunit of protein phosphatase 2a called FASS (or Discordia and 
Alternative Discordia in maize) which is thought to regulate TON1, a protein with 
homology to centrosomal proteins; absence of either of these proteins 
completely inhibits preprophase band formation. Both preprophase band 
formation and the expression of kinesins POK1 and POK2 are vital for the 
recruitment of TAN and RanGAP1 to the cortical division site. The preprophase 
band is implicated in the establishment of spindle bipolarity and nuclear 
orientation, and RanGAP1 is suspected of coordinating nucleus/preprophase 
band interactions. At the onset of mitosis, the CDKA/cyclinB kinase complex 
signals degradation of the preprophase band (this process may also involve 
AURORA 1 kinase), but the cortical attachment site persists and plays a role in 
guiding the cell plate to the cell wall during telophase. The cell plate is located 
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at the centre of the phragmoplast, which is a microtubule-based structure 
composed of overlapping microtubules of opposite polarity, and Golgi-derived 
vesicles. The phragmoplast also incorporates some of the proteins previously 
located at the preprophase band, including the MAPs, MOR1, AIR9, MAP65 and 
CLASP (Figure 2-7). The cell plate contains cytokinesis regulators TPLATE (a 
protein with homology to adaptin and βCOP coat proteins), the kinesin, KCA1, 
and RanGAP1, in addition to cell wall precursors and enzymes (Figure 2-7). 
TPLATE and AIR9, also localise to the cortical division site immediately before it 
comes into contact with the cell plate, implicating these proteins in cell plate 
positioning. Contact between the cell plate and the cortical division site is 
believed to be required for cell wall maturation, as demonstrated by AIR9, which 
migrates from the cortical division site into the maturing cross wall where it 
influences maturation processes (probably through microtubule-mediated 
mechanisms). Ectopically inserted cell plates do not exhibit AIR9 labelling and 
do not mature into cell walls. It has been proposed that the cortical division site 
could have dual roles in cell plate guidance and localisation of cross wall 
maturation factors. In contradiction to this theory, POK1/2 double mutants 
display ectopic cell plate insertion and normal cell wall maturation. 
 
Figure 2-7 -Schematic of plant cytokinesis with preprophase band and cortical division site 
regulators. 
The prophase cell is illustrated as a 3D projection, and other cell cycle stages are shown as 
mid-plane cross sectional views. The preprophase band (PPB) is coloured blue, the cortical 
division site (CDS), purple; the spindle and phragmoplast microtubules, green; and the cell 
plate, red. Proteins which associate with the structures described are indicated in the 
corresponding colours, and not all of the cytokinesis regulators are shown for simplicity. 
Reproduced with permission from (Muller et al., 2009). 
This condensed description of plant cell cytokinesis processes emphasises the 
prominent role of microtubule-based structures in cytokinesis, and although 
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knowledge of this process is patchy, MAPs comprise a large proportion of known 
cytokinesis regulators. Plant cell cleavage plane determination at preprophase 
rather than after mitosis does not preclude the nucleus from influencing 
cleavage site selection, however, as demonstrated by the physical displacement 
of nuclei in onion cotyledon cells (Mineyuki et al., 1991). Nuclear displacement 
resulted in the formation of two phragmoplasts, one at the site of the displaced 
nucleus, and one positioned midway along the cell. This suggests that whilst the 
preprophase band can form in a position where there is no nucleus, there is an 
element of redundancy, which ensures that in adverse circumstances, 
production of anucleate cells can be prevented by formation of a phragmoplast 
in the absence of preprophase band assembly. Small changes of nuclear 
positioning can also be corrected for by the preprophase band, suggesting that 
cells are able to compensate for slight positioning problems, and under normal 
circumstances, given the robust structure of the plant cell, physical deformation 
and subsequent nuclear displacement are unlikely to occur (reviewed in (Van 
Damme and Geelen, 2008)). For plant cells, early determination of the cleavage 
plane is likely to be an advantage as it gives the cell longer to prepare for the 
complex cell wall assembly and there are minimal risks that organelle 
segregation could be compromised. 
Plant and T. brucei cytoskeletons are quite similar in the way that microtubules 
are nucleated, cross-linked, and positioned beneath the plasma membrane. It is 
tempting to speculate that less stringent association between mitosis and 
cytokinesis may suggest that T. brucei cells determine the cleavage axis in ways 
which parallel the formation of a pre-prophase band in plant cells; that is, 
through deposition of molecular markers at the site of furrow initiation or maybe 
even along the site of ingression, before mitosis occurs. It is possible that the T. 
brucei chromosomal passenger complex (Section 1.9.1.2) localises to the site of 
furrow initiation as a result of such signals, perhaps via MAPs. Intriguingly, AIR9, 
a component of the pre-prophase band in plants (Section 2.7.2) is conserved in 
T. brucei. The results of investigations into the function of this T. brucei AIR9 




3 Project aims 
To date, little is known about the molecular pathways regulating cytokinesis in 
T. brucei, and while a number of proteins are known to play important roles in 
this process, how individual regulators are connected remains unclear in many 
cases, and little is known about how the activity of key players such as protein 
kinases are regulated.  Additionally, the physical mechanism of furrow ingression 
remains to be elucidated.  It is not, for example, understood how the 
cytoskeleton is divided during furrow ingression, or clear what role microtubule 
dynamics might play during this process or to what extent microtubule-
associated proteins contribute to furrow ingression.  
Initially, this project aimed to follow on from RNAi studies of PLK (Section 
1.9.1.2.2 and Hammarton et al., 2007) to address how PLK activity is regulated 
in vitro and in vivo. Additionally, since PLK plays an important role in furrow 
ingression in bloodstream form parasites, and microtubule dynamics are likely to 
be important in this aspect of cytokinesis, a second aim was to investigate 
whether microtubule inhibitors affected cytokinesis in T. brucei parasites and to 
compare any effects on furrow ingression with the PLK RNAi phenotype, where 
depletion of PLK blocked furrow ingression part way through. PLK has been 
shown to influence microtubule dynamics in other organisms (McNally et al., 
2002; Yarm, 2002; Archambault et al., 2008; see also Chapter Error! Reference 
source not found.) and it was therefore hypothesised that cell cycle regulators 
such as PLK might control the mechanical aspects of furrow ingression, 
potentially through regulation of microtubule dynamics, and that there could be 
novel furrow ingression checkpoints which control this process.   
During the course of this project, literature searching coupled with bioinformatic 
analyses also indicated that a plant MAP, AIR9, with roles in plant cytokinesis 
(Section 2.7.2), was likely to be conserved in T. brucei (Section 5.1.2) and had 
not previously been studied in the parasite.  Given the important roles of MAPs 
in microtubule stability (Sections 2.1.1 and 2.5), the likely importance of 
microtubule dynamics in trypanosome cytokinesis (Section 2.4.5), and studies 
  
65 
indicating that depletion of other T. brucei MAPs compromises cytokinesis 
(Section 2.6.2.1), it was therefore of interest to functionally characterise the T. 
brucei AIR9 protein.  
Hence, this project covered three different aspects of cytokinesis: the roles of 
microtubule dynamics and putative microtubule-associated protein AIR9; and 
investigations into the activity of PLK.  
Specifically the project aims were: 
 To determine whether a putative T. brucei orthologue of the plant 
cytoskeleton-associated protein, AIR9, is microtubule-associated and to 
characterise its role in cytokinesis and the cell cycle more generally 
 
 To investigate the importance of microtubule dynamics in cytokinesis by 
characterising cell cycle progression in T. brucei cells treated with 
microtubule inhibitors 
 
 To determine how PLK activity is regulated in T. brucei 
 
AIR9 characterisation and microtubule inhibitor studies are described in Chapters 
5 and 6, respectively, while the investigation of the regulation of PLK activity is 
discussed in Chapter 7. 
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4 Materials and Methods 
4.1 Chemicals  
All chemicals and reagents were obtained from Sigma-Aldrich Company Ltd 
unless otherwise stated.  Before use, media and solutions were autoclaved at 
121oC, 15 psi for 20 minutes, or filter sterilised using a 0.1 µm syringe filter 
(Sartorius) for small volumes or 0.1 µm bottle top filters (Millipore) for larger 
volumes, as appropriate. 
4.2 Cell culture: Routine techniques 
4.2.1 Culture of bacterial cells 
4.2.1.1 Bacterial strains 
Details of bacterial strains and plasmids used and generated during this study are 
given in Table 4-1, Table 4-2, Table 4-3 and Table 4-4. 
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Table 4-1 -E. coli strains used in this study 
 










Table 4-4 -Plasmids generated in this study. 
 
 
4.2.1.2 Media and growth conditions 
Strains were cultured at 37 ˚C in Luria-Bertani broth (L-broth) medium 
(Miller.J.H., 1972) or 2X-YT broth medium, with shaking at 200 rpm to ensure 
adequate aeration, or on L-agar (LA). Overnight cultures were obtained after 12-
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16 hours of aerated growth; single bacterial colonies were visible on L-agar 
plates after the same period of growth.  
L-broth comprised 86 mM NaCl, 10 gL-1 tryptone, and 5 gL-1 yeast extract. The 
pH of the medium was adjusted to pH 7.0 with NaOH. To generate L-agar, L-
broth was supplemented with 15 gL-1 agar. L-agar plates were made by heating 
L-agar until homogenous in a microwave, allowing to cool to 60 ˚C and pouring 
the warm medium into petri dishes. L-agar plates were stored at 4 ˚C for up to 1 
month. 2X-YT broth comprised 171 mM NaCl, 16 gL-1 tryptone, and 10 gL-1 yeast 
extract, adjusted to pH 7.64 with NaOH. 
Media were supplemented with antibiotics (from 1000X stock solutions) as 
appropriate to give the final concentrations: 100 μgml-1 ampicillin, 20 μgml-1 
tetracycline, 25 μgml-1 chloramphenicol, and 25 μgml-1 kanamycin. Ampicillin 
and kanamycin were dissolved in dH20, while chloramphenicol and tetracycline 
were dissolved in 50 % ethanol. Antibiotic stock solutions were stored at -20 ˚C. 
4.2.1.3 Determination of cell density 
Cell density was determined by sampling 1 ml of the bacterial culture, placing in 
a cuvette (Fisher Scientific) and measuring the OD600nm using a 
spectrophotometer (Shimadzu Biospec-mini DNA/RNA/protein analyser ). 
4.2.1.4 Storage of strains 
Bacterial strains grown on L-agar plates were stored for up to 2 weeks at 4˚C. 
For long term storage, strains were maintained as glycerol stocks at -80 ˚C. To 
make a glycerol stock, 5-10 ml cells were harvested from an overnight culture by 
centrifugation at 5285 x g for 5 minutes at 4 ˚C to pellet the bacteria. The pellet 
was resuspended in a 1/10 volume of sterile L-broth and added to an equal 
volume of a 2 % peptone / 40 % glycerol mix. The glycerol stock was stored at -
80 ˚C. When needed, a small amount of glycerol stock was defrosted and 
streaked onto an LA plate to give single bacterial colonies after overnight 
incubation at 37 ˚C. 
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4.2.2 Culture of T. brucei parasites 
4.2.2.1 T. brucei strains 
Details of T. brucei strains used and generated during this study are given in 
Table 4-5 and Table 4-6.  




Table 4-6 -T. brucei strains generated in this study. 
 
4.2.2.2 Media and growth conditions 
Bloodstream form T. brucei parasites were cultured at 37 ˚C in HMI-9 medium 
(Section 4.2.2.2.1) in the presence of 5 % CO2 and passaged to maintain mid-log 
phase growth (1 x 105 - 1 x 106 cellsml-1). Procyclic form T. brucei parasites were 
grown at 27 ˚C in SDM-79 medium (Section 4.2.2.2.2) in the presence of 5 % CO2 
and passaged to maintain mid-log phase growth (1 x 106 - 1 x 107 cellsml-1). 
Antibiotics were added to media as appropriate (Table 4-7) to select for 
integrated plasmid constructs or in the case of tetracycline, to induce the RNAi 







Table 4-7 –Antibiotic concentrations for the culture of T. brucei. 
Final concentrations of antibiotics are given for both life cycle stages. 
 
 
For downstream analyses, trypanosomes were harvested by centrifuging at 600 x 
g (procyclic form) or 1500 x g (bloodstream form), and where required, cells 
were washed in phosphate buffered saline (PBS: 137 mM NaCl, 2.7 mM KCl, 8 mM 
Na2HPO4 and 1.8 mM KH2PO4, adjusted to pH 7.4, procyclic form) or 
trypanosome dilution buffer (TDB: 20 nM Na2HPO4, 2 mM NaH2PO4.2H20, 80 nM 
NaCl, 5 mM KCl, 1 mM MgSO4.7H2O, and 20 mM glucose, adjusted to pH 7.4, 
bloodstream form). 
4.2.2.2.1 HMI9 medium 
HMI-9 medium (Hirumi and Hirumi, 1989) was made by dissolving one pot of HMI9 
powder (sufficient for 5 L HMI9, custom made by Invitrogen), 15 g Na(CO3)2  and 
71.5 µl β-mercaptoethanol in 4 L dH2O and stored at 4 ˚C. 
Prior to use, HMI-9 was supplemented with 10 % (v/v) heat-inactivated 
tetracycline-free foetal bovine serum (BioSera), 10 % (v/v) serum plus (JRH 
Biosciences), 500 Uml-1 penicillin and 50 µgml-1 streptomycin, and preheated to 
37 ˚C.  
4.2.2.2.2 SDM79 medium 
SDM-79 medium (Brun and Schonenberger, 1979) was made by dissolving one pot 
of SDM79 powder (sufficient for 5 L SDM79, custom made by Invitrogen) and 10 g 
Na(CO3)2,  in 4.5 L dH2O, adjusting the pH to pH 7.3 with NaOH before adding 10 
ml hemin stock (25 mgml-1 in 50 mM NaOH) and storing at 4˚C. Prior to use, SDM-
79 was supplemented with 10 % (v/v) heat-inactivated tetracycline-free fetal 
calf serum (BioSera), 500 Uml-1 penicillin and 50 µgml-1 streptomycin, and 
preheated to 27˚C. 
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4.2.2.3 Determination of cell density  
A 10 μl sample of cell suspension (or an appropriate dilution) was loaded into the 
chamber of a Neubauer Improved haemocytometer, and at least 200 cells were 
counted by phase contrast microscopy. The concentration was determined using 
the following calculation: cells ml-1 = average number of cells counted per 1 
mm2 x 104 x dilution factor. 
4.2.2.4 Storage of T. brucei strains 
T. brucei parasites were typically passaged to maintain a density corresponding 
to the mid-log phase of growth for 3 -7 days prior to making stabilates. Cells 
(typically 10 ml of a mid-log phase culture) were harvested (Section 4.2.2.2 and 
resuspended in a 4 ml culture medium supplemented with 5 % (v/v) glycerol and 
1 ml aliquots placed into cryotubes.  Stabilates were frozen in an insulated 
container at -80 ˚C overnight before being transferred to liquid nitrogen. 
Stabilates removed from liquid nitrogen were slowly defrosted at room 
temperature before transferring to 10 ml pre-warmed HMI-9 or SDM-79 (without 
antibiotics). Parasites were grown in medium lacking antibiotics for 1 day 
following removal from stabilate before appropriate selective drugs were added. 
4.3 Genetic manipulation 
4.3.1 Transformation of bacterial cells 
4.3.1.1 Production of chemically competent cells 
From an appropriate overnight bacterial culture, cells were diluted 1/100 into 
50 ml L-broth supplemented with the appropriate antibiotics and cultured at 37 
˚C with shaking at 200 rpm until the culture density reached an OD600nm of 0.6. 
The culture was incubated on ice for 10 minutes, and then centrifuged at 957 x g 
for 15 minutes at 4 ˚C to pellet the bacteria. The pellet was resuspended in 16 
ml cold RF1 buffer (100 nM RbCl, 50 mM MnCl2·4H20, 30 mM CH3COOK, 10 mM 
CaCl2, and 15 % (v/v) glycerol, adjusted to pH 5.8 with acetic acid) by slow 
vortexing. The suspension was incubated on ice for 15 minutes, and then 
centrifuged at 775 x g for 15 minutes at 4 ˚C to pellet the bacteria. The pellet 
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was resuspended in 4 ml cold RF2 buffer (10 mM MOPS, 10 mM RbCl, 75 mM 
CaCl2·4H20, and 15 % glycerol, adjusted to pH 6.8 by addition of NaOH) and 
incubated on ice for 1 hour. Cells were aliquoted (100 μl), frozen rapidly in a dry 
ice/ethanol slurry, and stored at -80 ˚C. 
4.3.1.2 Transformation of chemically competent E. coli with plasmid DNA or 
ligation product 
Competent cells (Section 4.3.1.1) were thawed on ice, before the addition of β-
mercaptoethanol (0.85 μl per 100 μl cells) and DNA (10 ng plasmid DNA or 5 μl of 
a ligation product). The cells were shaken gently to mix the DNA and incubated 
on ice for 15 minutes prior to a 45 second heat-shock at 42 ˚C. Following the 
heat-shock treatment, 500 μl L-broth were added, and the cells were incubated 
with shaking at 37 ˚C, 200 rpm for 30-60 minutes. To obtain single colonies, cells 
were harvested by centrifugation at 17 968 x g for 1 minute, resuspended in 100 
μl L-broth and spread on an L-agar plate containing the appropriate selective 
antibiotic. To control for cell viability and efficacy of antibiotic selection, 
separate aliquots of competent cells received equivalent volumes of dH20 
instead of DNA and were grown on LA plates in the absence or presence of 
appropriate antibiotic, respectively. 
To transform ligation products involving pSC-A/pSC-B or pCR4-TOPO vectors 
(Table 4-2), SoloPack Gold competent cells (Stratagene), or TOP10 cells 
(Invitrogen), respectively (Table 4-1), were used in accordance with the 
manufacturers’ instructions.  
4.3.2 Transfection of T. brucei 
4.3.2.1 Purification of linearised plasmid DNA for transfection of T. brucei 
parasites 
To prepare plasmid DNA for transfection, 100 μg was digested with the 
appropriate restriction enzyme (Section 4.5.2) and the digestion efficiency 
verified by analysis of 1 μl of the digestion product by agarose gel 
electrophoresis (Section 4.5.1) prior to purification. To purify the DNA, 1/2 
volume of phenol and 1/2 volume of chloroform:isoamyl alcohol (24:1) were 
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added and the mixture was vortexed for 30 seconds prior to being centrifuged at 
17 968 x g at room temperature for 2 minutes to separate the lower organic 
phase (containing precipitated proteins) from the upper aqueous layer 
(containing the DNA). The aqueous layer was decanted and further purified by 
the addition of 1 volume chloroform:isoamyl alcohol, and centrifuging as 
described above. The aqueous layer was decanted, and the chloroform 
extraction step repeated. To precipitate the extracted DNA, 1/10 volume 3 M 
CH3COONa (pH 5.2), and 1 volume of isopropanol were added to the aqueous 
phase, and the mixture was vortexed before the precipitated DNA was pelleted 
by centrifugation at 17 968 x g for 15 minutes at 4 ˚C. The DNA pellet was 
washed in 1 ml ice cold 70 % ethanol, following which the ethanol solution was 
decanted under a sterile hood, and the DNA pellet was air dried and 
resuspended in dH2O to a final concentration of 1 μgμl
-1. Linearised plasmid DNA 
was stored at -20 ˚C prior to transfection. 
4.3.2.2 Transfection of T. brucei cells using an Amaxa Nucleofector 
Cells were grown to mid-log phase and 3-5 x 107 cells were harvested by 
centrifugation (Section 4.2.2.2) of an appropriate volume of cell culture. The 
medium was decanted, and any residual medium removed using a pipette before 
the cells were resuspended in 100 μl Amaxa human T-cell nucleofactor solution 
(Amaxa Biosystems) and transferred to a cuvette (Amaxa Biosystems) containing 
10 μg purified linearised DNA (Section 4.3.2.1). The DNA/cell suspension was 
mixed by slow pipetting before transferring to an Amaxa Nucleofector II machine 
and transfecting the parasites using programme X-001. The transfected parasites 
were transferred immediately to 30 ml (bloodstream form) or 10 ml (procyclic 
form) of warmed medium, (which for procyclic form cells was supplemented 
with 30 % conditioned medium (prepared by growing procyclic form Lister 427 
wild type parasites in SDM-79 to a density of 1 x 107 cells ml-1, pelleting the 
cells by centrifugation (Section 4.2.2.2), decanting and filter sterilising the 
spent medium). Selection of genetically modified parasites was carried out by 
limiting dilution and growth in the presence of the appropriate selective 
antibiotic (Table 4-4 and Table 4-7). The exact method used varied according to 
life cycle stage. For bloodstream form parasites, immediately after transfection, 
10 fold serial dilutions (10-1 – 10-3) were prepared before plating 1 ml aliquots 
in 24 well plates and allowing cells to recover for 6 hours at 37 ˚C prior to the 
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addition of an equivalent volume of medium containing a 2X concentration of 
selective antibiotic (Table 4-7). Clonal parasites were typically obtained after 1 
week of selection and growth at 37 ˚C. Clonal cell lines were deemed to be 
those populations that derived from a well on a plate where less than 10 % of the 
wells contained living parasites after the selection period. For procyclic form 
parasites, immediately following transfection, three 10-1 dilutions were prepared 
from the neat cell suspension of transfected parasites and the cells were 
allowed to recover for 16 hours at 27 ˚C before addition of the appropriate 
selective antibiotic.  Appropriate dilutions (10-1 – 10-3) in SDM79/30 % 
conditioned medium were prepared from the neat culture flask and the three 
independent 10-1 dilution flasks, and 100 µl aliquots plated in 96 well plates 
Clonal parasites were typically obtained 3 weeks following transfection. 
Once clonal cell lines had been obtained, culture volumes were gradually 
increased, with cell lines being transferred to larger well plates and flasks as 
appropriate, until stabilates could be generated (Section 4.2.2.4).  
4.4 DNA preparation 
4.4.1 Preparation of plasmid DNA from E. coli 
The QIAprep spin Miniprep or Midi prep kits (Qiagen) were used for small or large 
scale purification of plasmid DNA, from 3 ml or 50 ml overnight culture, 
respectively. Purification of plasmid DNA was carried out in accordance with the 
manufacturer’s instructions. 
4.4.2 Preparation of genomic DNA from T. brucei 
Genomic DNA was extracted from T. brucei cells using the DNeasy blood and 
tissue kit (Qiagen). 5 x 106 parasites were harvested (Section 4.2.2.2) and 
washed once in TDB (Section 4.2.2.2, bloodstream form cells) or PBS (Section 
4.2.2.2, procyclic form cells). DNA was extracted from the cell pellets according 
to the manufacturer’s instructions. 
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4.4.3 Determination of DNA concentration 
DNA concentration was determined using a spectrophotometer (Eppendorf 
biophotometer) or Nanodrop (Nanodrop 1000, Thermoscientific) by measuring 
the absorption at OD260nm. Ratios of OD260nm/OD280nm were also obtained to assess 
the purity of the DNA, with a ratio of 1.8 – 2 indicated low levels of protein 
contamination.  Alternatively, when an estimate of DNA concentration was 
sufficient, 1 μl of DNA was analysed by agarose gel electrophoresis (Section 
4.5.1). The mass of DNA was estimated from its intensity relative to the 1650 bp 
band of the 1 kb plus ladder (Section 4.5.1), which had a known mass of 41 ng 
when 10 μl ladder were loaded. 
4.5 DNA manipulation 
4.5.1 Agarose gel electrophoresis 
DNA was prepared for agarose gel electrophoresis by the addition of 6X DNA 
loading buffer (15 % Ficoll, 0.25 % xylene cyanol and 0.25 % bromophenol blue) 
to give a final concentration of 1X. Agarose gels were prepared by adding 
agarose (0.5-1 % (w/v)) to 0.5X TBE buffer (44.6 mM Tris base, 44.5 mM boric 
acid and 1 mM EDTA) and heating in a microwave oven until all agarose 
dissolved. The agarose/TBE solution was cooled before adding SYBR Safe stain 
(Invitrogen; diluted 1/30,000 from the 10,000X stock) and pouring into a suitable 
gel tray. Once set, the gel was placed in a gel tank and immersed in 0.5X TBE 
buffer prior to the loading of suitably prepared DNA samples and 10 μl of 1 kb 
plus DNA ladder (0.052 µgµl-1 in 1X DNA loading buffer, Invitrogen).  DNA was 
electrophoresed at 100 V for typically 45 minutes and visualised under blue or 
UV light.  
4.5.2 Restriction endonuclease digestion of DNA 
Restriction endonucleases and buffers were purchased from New England Biolabs 
(NEB), with the exception of AspI, which was obtained from Roche.  
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To confirm or check the identity of plasmid DNA, 0.2 μg plasmid DNA was 
incubated with 10 U of the chosen restriction endonuclease, 1X appropriate 
buffer and, if recommended by the manufacturer, 1X bovine serum albumin 
(BSA, NEB) in a total volume of 10 μl at the appropriate temperature for 1 hour.  
Variations in this protocol were employed for digestion of plasmid DNA for 
subcloning (which typically involved digestion of 2 μg DNA with 20 U enzyme in a 
total volume of 50 μl for 2 hours) and for linearising DNA for transfection of T. 
brucei parasites (which typically involved digestion of 100 μg DNA with 40 U 
enzyme in a total volume of 500 μl for 16 hours). In all cases, digested DNA was 
analysed by agarose gel electrophoresis (Section 4.5.1) prior to using it for 
downstream applications. 
4.5.3 Extraction of restriction endonuclease digested DNA 
fragments from agarose gels 
To purify DNA fragments (eg from a restriction endonuclease digestion (Section 
4.5.2) from an agarose gel, the desired fragment(s) was/were visualised under 
blue light and excised from the gel using a clean scalpel blade. The gel slices 
were weighed and DNA was extracted from them using the QIAEX spin gel 
extraction kit (Qiagen) according to the manufacturer’s instructions.  
4.5.4 Polymerase chain reaction (PCR) 
PCR was used for multiple applications, including amplification of specific 
regions of plasmid (Section 4.4.1) or genomic (Section 4.4.2) DNA, mutation of 
genes by Gene SOEing (splicing by overlap extension (Horton et al., 1990)) or site 
directed mutagenesis (Section 4.5.5), and in colony screening of E. coli. PCR 
reactions were carried out in a ‘pX2 Therma Cycler’ PCR machine (Thermo 
Electron Coorporation) using the active tube system, or for a gradient PCR, the 
heat block system. PCR reactions used Taq DNA polymerase (NEB), or if the 
target sequence was to be used subsequently for cloning, the high fidelity proof 
reading polymerases Pfu Turbo (Stratagene) or Phusion DNA polymerase 
(Finnzymes) which have 3’→5’ exonuclease activity were used. 
Typical reaction mix compositions are given for each enzyme in Table 4-8.   
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Table 4-8 -Typical compositions of PCR reaction mixes. 
 
*10 X Taq PCR mix: 1.13 mgml-1 BSA, 450 mM Tris (pH 8.8), 110 mM (NH4)2SO4, 45 
mM MgCl2, 0.47 % (v/v) β-mercaptoethanol, 44 μM EDTA (pH 8) and 10 mM dNTPs 
(Invitrogen). 
** genomic or plasmid DNA, or PCR product(s), or alternatively a small portion of 
an E. coli colony 
PCR reaction cycles were typically as follows:  
1 cycle of 95 ˚C for 30 s;  
25-35 cycles of 95 ˚C for 50 s, Tm for 50 s, Te for 1-2 minutes;  
1 cycle of Te for 5-10 minutes.  
The annealing temperature (Tm) was adjusted according to the melting points of 
the primers. Extension temperatures (Te) were 68 ˚C (Phusion DNA polymerase) 
or 72 ˚C (Taq and Pfu Turbo polymerases) and the extension time was adjusted 
according to the length of the product being amplified.  For colony PCR, the 
length of the initial denaturation step was increased to 5 minutes to ensure cell 
lysis. The oligonucleotides used for PCR are listed in Table 4-9 and Table 4-10. 
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Table 4-10 -PLK oligonucleotides. 
 
 
PCR reactions were analysed by agarose gel electrophoresis (Section 4.5.1). 
Optimisation of PCR reactions was frequently required, which involved 
alterations to the annealing temperature (increasing the annealing temperature 
increased the specificity of the reactions giving a cleaner PCR product, whilst 
decreasing the annealing temperature increased yield but sometimes produced 
multiple PCR products), the extension time (to allow the completion of more 
PCR reactions), the number of cycles (to increase yield), or the efficiency (which 
involved the addition of 5 % dimethyl sulphoxide (DMSO) to decrease the 
secondary structure of the DNA, allowing greater access for the primers). 
4.5.4.1 Addition of 3’ adenine residues 
PCR products generated using Pfu Turbo or Phusion DNA polymerase were 
generally used for downstream cloning procedures. These enzymes produce PCR 
products with blunt ends. Thus, these products were either cloned into the blunt 
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ended cloning vector pSC-B (Strataclone), or were modified by the addition of a 
3` A tail to allow cloning into vectors pSC-A (Strataclone) and pCR4-TOPO 
(Invitrogen), which possess 5’ U overhangs (Table 4-2). To A-tail PCR products, 1 
U Taq DNA polymerase was added to the PCR reaction mix and the mix was 
incubated at 72 ˚C for 8-10 minutes before placing the PCR product on ice and 
proceeding with the ligation reaction. 
4.5.4.2 Purification of PCR products 
PCR product purification was carried out before performing Gene SOEing PCR 
reactions (Section 4.5.4). PCR products were purified using the QIAquick PCR 
purification kit (Qiagen) according to the manufacturer’s instructions.  
4.5.5 Site-directed mutagenesis 
Site-directed mutagenesis was performed using the QuikChange II Site-Directed 
Mutagenesis kit (Stratagene) according to the manufacturer’s instructions. 
Oligonucleotides (Table 4-10) containing the desired mutation were designed 
according to the parameters recommended by the manufacturer.  Following 
transformation of the mutagenised plasmid into XL1-Blue supercompetent cells 
(Stratagene), plasmid DNA was prepared (Section 4.4.1) from selected colonies 
and analysed by DNA sequencing (Section 4.5.8) to confirm the introduction of 
the desired mutation and the absence of any other changes to the sequence of 
the mutagenised gene.  
4.5.6 Cloning of PCR products into generic cloning vectors 
PCR products were routinely ligated into a generic cloning vector (pSC-A, pSC-B 
or pCR4-TOPO; Table 4-2) according to the manufacturers’ instructions to 
facilitate sequencing of the PCR product and to provide a source of sequenced 
PCR product for use in downstream subcloning applications. Ligations were 
transformed into SoloPack Gold (pSC-A/pSC-B ligations) or TOP10 (pCR4-TOPO 
ligations) cells according to the manufacturers’ guidelines, and to facilitate the 
identification of colonies harbouring inserts, transformed cells were plated onto 
LA plates spread with 40 µl 5-bromo-4-chloro-3 indolyl-β-D galactopyranoside (X-
Gal; 2% (w/v) in dimethylformamide).  The multiple cloning site within each 
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cloning vector is located within the LacZ gene.  Colonies harbouring empty 
vectors should retain a functional LacZ gene and therefore be able to metabolise 
X-Gal to a blue product, while colonies harbouring vectors containing an insert 
will have a disrupted LacZ gene and remain white.  Further screening of white 
colonies was performed by colony PCR (Section 4.5.4) and by appropriate 
restriction endonuclease digests of DNA preparations (Section 4.4.1) from the 
colonies (Section 4.5.2). The sequence of the PCR products was also checked by 
DNA sequencing (Section 4.5.8) to confirm that no mutations had been 
introduced during the PCR. 
4.5.7 Subcloning of PCR products from generic cloning vectors 
into destination plasmids 
PCR-amplified DNA fragments were excised from the generic cloning vectors 
pSC-A, pSC-B or pCR4-TOPO (Table 4-2) by appropriate restriction endonuclease 
digestion (Section 4.5.2), analysed by agarose gel electrophoresis (Section 4.5.1) 
and purified from agarose gels (Section 4.5.3) before being ligated into the 
appropriate destination vector (also appropriately digested, analysed and 
purified). Where required, the destination vector was treated with calf 
intestinal alkaline phosphatase (CIP) to prevent the vector self-ligating during 
the ligation reaction.  Following restriction endonuclease digestion of the 
destination vector, 1 U CIP was added to the reaction, before incubating it at 37 
˚C for 1 hour to remove 5` phosphate groups and then heating the reaction to 65 
˚C for 15 minutes to inactivate CIP. 
To determine the appropriate relative amounts of insert and vector to use for 
the ligation reaction, the concentration of the purified DNA fragments was first 
determined (Section 4.4.3) before using the formula below (Equation 1) to 
calculate the desired quantities. Generally a ratio of 1:3 (insert:vector) was used 
for ligations, and to control for self-ligation of the vector, a separate reaction 
comprising only vector was carried out. 
Equation 1 -Formula to calculate quantities of insert for ligation of DNA fragments into 
plasmids.                                                                                                                                                                                                        
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To ligate the DNA 
fragments, 1X T4 DNA ligase buffer and 0.4 U of T4 DNA ligase were added to the 
DNA fragments and sterile dH2O was added to a final volume of 10 μl. The 
ligation reaction was incubated for 16 hours at 17 ˚C prior to transformation into 
XL-1Blue E. coli (Section 4.3.1). Colony PCR (Section 4.5.4) was used to identify 
colonies harbouring plasmids with the desired insert, before overnight cultures 
were set up for selected colonies to facilitate DNA preparation (Section 4.4.1) 
and restriction digests (Section 4.5.2) to check that the ligation had been 
successful.  Where appropriate, plasmids were also analysed by DNA sequencing 
(Section 4.5.8). 
4.5.8 DNA sequencing 
DNA sequencing was performed by the University of Dundee sequencing service 
(http://www.dnaseq.co.uk/home.html), using an ABI automatic sequencer. The 
oligonucleotides used for DNA sequencing are listed in Table 4-11.  
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Table 4-11 -Oligonucleotides for DNA sequencing 
 
4.6 Protein techniques 
4.6.1 Polyacrylamide gel electrophoresis  
Polyacrylamide gel electrophoresis (PAGE) was used to separate denatured 
proteins according to their electrophoretic mobility. Both NuPAGE (Invitrogen) 
and sodium dodecyl sulphate PAGE (SDS PAGE) systems were used and are 
described below. To determine the molecular weight of proteins analysed using 
either buffer system, the unstained protein standard Benchmark protein ladder 
(Invitrogen) prepared according to the manufacturer’s instructions, or 
prestained protein standard See Blue Plus 2 ladder (Invitrogen) were used for 
Coomassie staining and Western blotting, respectively.   
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4.6.1.1 SDS PAGE 
A 12 % SDS PAGE separating gel was prepared by adding all the reagents 
described with the exception of TEMED and ammonium persulphate (Table 4-12), 
mixing and then adding the final components and mixing again before pouring 
the gel into a gel case (Invitrogen) and covering with a thin layer of isopropanol. 
Once the separating gel had set, the 4 % stacking gel was prepared. The stacking 
gel components with the exception of TEMED and ammonium persulphate were 
mixed (Table 4-13), before adding the final reagents and mixing again. The 
isopropanol layer was decanted, the stacking gel poured into the gel case, and a 
comb inserted. The set gels were used immediately or stored at 4 ˚C in moist 
conditions for up to 1 week. 
Table 4-12 -12 % Separating gel. 
 
 
Table 4-13 -4 % Stacking gel. 
 
 
Samples were prepared for SDS PAGE by adding Laemmli loading dye (4 X 
Laemmli buffer: 20 mM Tris, 10 % (w/v) SDS, 40 % (v/v) glycerol, 28 % (v/v) β-
mercaptoethanol, 0.2 % Bromophenol blue), to a final concentration of 1X, and 
boiling for 3 minutes. Laemmli buffer was stored at 4 ˚C. For electrophoresis, 
gels were immersed in SDS running buffer (25 mM Tris, 250 mM glycine and 0.1 % 
SDS). After loading the samples, gels were electrophoresed at 200 V for 
approximately 1 hour at room temperature. 
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4.6.1.2 NuPAGE  
4-12 % Bis-Tris gradient gels or 12 % Bis-Tris gels (Invitrogen) were used with a 1X 
MES running buffer (Invitrogen). Prior to running the gels, an antioxidant solution 
was added to the inner chamber (according to the manufacturer’s instructions). 
Samples were prepared for NuPAGE by adding NuPAGE sample buffer (Invitrogen) 
to a final concentration of 1X and heating to 70 ˚C for 10 minutes. NuPAGE gels 
were electrophoresed at 200 V for approximately 45 minutes. 
4.6.2 Coomassie staining 
Following PAGE, proteins were stained by incubating the SDS PAGE/NuPAGE gels 
in a solution containing 0.25 % Coomassie Blue R-250, 10 % acetic acid, and 45 % 
methanol for at least 2 hours at room temperature before destaining with 10 % 
acetic acid, and 45 % methanol for approximately 2 hours at room temperature. 
Stained gels were dried using a BioRad gel dryer (model 583) between filter 
paper and cellophane, or air dried between pre-wetted cellophane sheets. 
4.6.3 Western blotting 
To analyse proteins by Western blotting, proteins were first transferred from 
PAGE gels (Section 4.6.1) onto PVDF or nitrocellose membrane by 
electrotransfer. 
PVDF transfer membrane (Perkin Eimer) or Hybond ECL nitrocellulose membrane 
(GE Healthcare), were prepared by incubating for 10 minutes in 100 % methanol 
or transfer buffer, respectively. For SDS-PAGE gels, transfer buffer comprised 1X 
SDS-PAGE running buffer and 20% methanol, while for NuPAGE gels, 1X NuPAGE 
transfer buffer (Invitrogen) supplemented with 20 % methanol was used. The 
transfer module (Invitrogen) was assembled by placing a layer of transfer buffer-
soaked sponges, soaked filter paper (2 layers) and the protein gel into the 
module and covering with prepared membrane, soaked filter paper (2 layers) 
and soaked sponges. The assembled module was inserted into the gel tank and 
transfer buffer was added to cover the membrane, gel and sponges, before 
filling the outer compartment with dH2O. Transfer was carried out at 30 V 
(constant voltage) for 2 hours at room temperature. Following transfer, proteins 
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were visualised by staining with Ponceau reagent at room temperature for 5 
minutes before washing in dH2O to reveal the stained proteins.  
Following transfer and Ponceau staining, membranes were blocked in the 
appropriate blocking solution (PBS-T/milk or TBS-T/BSA, see Section 4.6.3.1) for 
2 hours at room temperature or for 16 hours at 4 ˚C. The blocking solution was 
decanted, the blot washed briefly in PBS-T or TBS-T before primary antibody 
diluted appropriately in blocking solution (Table 4-14) was added and the blot 
incubated for 2 hours at room temperature on a shaking platform or for 16 hours 
at 4 ˚C. Blots were washed three times for 10 minutes at room temperature in 
PBS-T or TBS-T on a shaking platform to remove unbound antibody.  Membranes 
were then incubated, shaking, in an appropriate dilution of secondary antibody 
(Table 4-15) in PBS-T/milk or TBS-T/BSA for 45 minutes at room temperature. 
The membranes were then washed once for 30 minutes and twice for 10 minutes 
in PBS-T or TBS-T before adding a chemiluminescent detection agent (Pierce). 
West Dura reagent was generally used to detect T. brucei proteins from cell 
lysates, while West Pico reagent was used for analysing recombinant proteins. 
However, occasionally, where a higher level of sensitivity was required, 
Supersignal West Femto reagent was used. Blots were incubated with the 
chemiluminescent detection reagents (prepared according to the manufacturer’s 
instructions) for 5 minutes, before being drained and exposed to X-ray film 
(Kodak). Films were processed using an X-Omat automatic developer machine. 
4.6.3.1 Buffer solutions 
PBS-T: PBS (Section 4.2.2.2) plus 0.5% (v/v) Tween 20 
PBS-T/milk: PBS-T plus 5% (w/v) Marvel skimmed milk powder 
Tris buffered saline (TBS): 500 mM NaCl and 20 mM Tris-Cl. TBS-T: TBS plus 0.5% 
(v/v) Tween 20 
 




4.6.3.2 Antibodies for Western blotting 
Table 4-14 -Primary antibodies for Western blotting. 
 
 





4.6.4 Recombinant protein purification from bacteria 
4.6.4.1 Expression of recombinant proteins in E. coli 
The expression of recombinant proteins was carried out using BL21-derived 
E.coli strains (Table 4-1). Overnight cultures of appropriate bacterial strains 
were diluted 1/100 in L-broth and grown at 37 ˚C, shaking at 200 rpm to a 
density of 0.6 -1 OD600nm (Section 4.2.1.3). Cultures were cooled, if necessary, to 
the expression temperature (optimised individually for each protein, but 
between 15 ˚C-37 ˚C) before protein expression was induced by the addition of 
isopropyl-beta-D-thiogalactopyranoside (IPTG) to a final concentration (0.5 mM – 
1 mM, as optimised for each individual protein, see Section 7.8.2). After an 
appropriate period of growth under the optimal conditions for expression, cells 
were harvested by centrifugation at 5285 x g for 10 minutes at 4 ˚C. The cells 
were resuspended in a 1/50 or 1/20 volume of ice cold lysis buffer. For 6XHis 
tagged proteins, this comprised 50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole, 
adjusted to pH 8 using NaOH, while for GST-tagged proteins, PBS was used. The 
cell suspension was incubated with lysozyme (1 mgml-1) and DNAseI (5 μgml-1) in 
the presence of 1X complete EDTA free protease inhibitor cocktail (Roche) on ice 
for 1 hour. The resulting lysate was divided into 5 ml aliquots and immediately 
placed in an ice/water slurry before sonicating for 18 cycles of 10 seconds on/10 
seconds off using a Soniprep 150 sonicator at 22 µ amplitude. The insoluble and 
soluble fractions were separated by centrifugation at 17 418 x g for 20 minutes 
at 4 ˚C. 
4.6.4.2 Purification of recombinant proteins from E. coli 
4.6.4.2.1 Purification of His-tagged proteins 
6XHis tagged proteins were purified using 250 µl of a 50% slurry of nickel NTA 
beads (Qiagen) per ml of cleared cell lysate. Beads were prepared by washing 
them in 16 bed volumes of wash buffer (50 mM NaH2PO4, 300 mM NaCl, 20 mM 
imidazole, adjusted to pH 8 using NaOH) before transferring them to a 5 ml 
disposable polypropylene column (Pierce). The washed beads were incubated 
with the soluble fraction of cell lysate (Section 4.6.4.1) for 1 hour on a rotary 
mixer at 4 ˚C in order to allow 6XHis-tagged proteins to bind. The lysate was 
then drained, the flow through fraction containing unbound proteins collected, 
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and the beads washed in 16 bed volumes of chilled wash buffer to remove the 
remaining traces of unbound proteins. Elution was carried out by incubating the 
beads and interacting proteins with 1 bed volume of cold elution buffer (50 mM 
NaH2PO4, 300 mM NaCl, 250 mM imidazole, adjusted to pH 8 using NaOH) for 15 
minutes, before collecting the proteins by draining the column. This was 
repeated four times. To determine the efficiency of the purification, samples 
were collected at each stage and prepared for PAGE (Section 4.6.1) and analysed 
by Coomassie staining (Section 4.6.2) and/or by Western blotting (Section 4.6.3) 
with anti-tetra-His antibody (Table 4-14). 
4.6.4.2.2 Purification of GST-tagged proteins 
GST-tagged proteins were purified using glutathione sepharose beads (GE 
Healthcare). A 75 % slurry of glutathione sepharose beads was centrifuged at 500 
x g to and the beads were washed in cold PBS (Section 4.2.2.2) and centrifuged 
again (as above), before being resuspended in an appropriate volume of PBS to 
achieve a 50 % slurry. Cell lysate (Section 4.6.4.1) was incubated with a 1/50 
volume of the 50 % slurry of glutathione sepharose beads for 1 hour at 4 ˚C on a 
rotary mixer. The lysate/bead mixture was then transferred to a 5 ml 
polypropylene column (Pierce), the unbound proteins were allowed to flow 
through, before washing the beads 3 times with 1/10 of the lysate volume of 
cold PBS. GST-tagged proteins were eluted from the beads by adding 1/100 
lysate volume of elution buffer (10 mM glutathione, 50 mM Tris HCl, pH 8), 
incubating for 15 minutes on ice, and collecting the eluate from the column. 
This was repeated four times. To determine the efficiency of the purification, 
samples were collected at each stage and prepared for PAGE (Section 4.6.1) and 
analysed by Coomassie staining (4.6.2) and/or Western blotting (4.6.3) with anti-
GST antibody (Table 4-14). 
4.6.5 Determination of protein concentration by Bradford assay 
The concentration of purified protein in eluates was determined using a Bradford 
assay. Protein standards for the assay were obtained by performing serial 
dilutions of bovine serum albumin (BSA; 31.25 - 500 μgml-1). Protein standards, 
appropriate dilutions of protein sample, and a sample buffer control, were 
transferred to a 96 well plate (10 μl per well) before 200 μl Bradford reagent 
was added and the samples mixed gently and incubated at room temperature for 
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5 minutes. The plate was analysed at a wavelength of 595 nm using a Versamax 
spectrophotometer and Softmax Pro 5 software. The A595nm values for the BSA 
protein standards were used to plot a standard curve of A595nm against standard 
concentration, and the formula of the regression line was used to calculate the 
sample protein concentration.  
4.6.6 Dialysis of proteins 
Dialysis tubing (Medicell International, cut off 12-14 kDa) was prepared by 
immersing in 1 L of 2 % (w/v) NaHCO3, 1 mM EDTA, and boiling for 10 minutes; 
the tubing was then rinsed in dH2O before being boiled again in dH2O for 10 
minutes. The tubing was removed from the dH2O and stored in 50 % ethanol, 1 
mM EDTA at 4 ˚C. Before use, the prepared dialysis tubing was rinsed in dH20. 
Protein samples were added to sealed portions of dialysis tubing and incubated 
at 4 ˚C with stirring, in the appropriate buffer. After 3-4 hours, the buffer was 
removed and replaced with fresh buffer and the process was repeated. The 
process was repeated once more, for a longer duration of 16 hours. 
4.6.7 Storage of proteins 
For long term storage, proteins were dialysed into a buffer comprising 40 mM 
Tris HCl (pH 7.6), 50 mM NaCl, 2 mM DTT, 10 % (w/v) glycerol and 1X EDTA free 
protease inhibitor (Roche), frozen in a slurry of dry ice and ethanol and stored at 
-80 ˚C. 
4.6.8 Mass spectrometry 
Proteins were prepared for mass spectrometry by dialysis into a buffer 
comprising 40 mM Tris HCl pH 7.6, 50 mM NaCl, 2 mM DTT and 1X EDTA free 
protease inhibitor (Roche). Mass spectrometry analysis was performed by Richard 
Burchmore, Sir Henry Wellcome Functional Genomics Facility, University of 
Glasgow. Samples were digested with trypsin and analysed using a Q Star Pulsar I 
spectrometer (set to detect positive ions), in conjunction with Mascot Software. 
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4.6.9 Preparation of cell extracts from T. brucei parasites 
To prepare T. brucei whole cell lysates, cells were harvested (Section 4.2.2.2) 
and washed twice in 5 volumes of PBS (procyclic form) or TDB (bloodstream 
form). For downstream analysis by SDS-PAGE or NuPAGE (Section 4.6.1), cell 
pellets were resuspended 1X Laemmli or NuPAGE loading buffer at a 
concentration of 105 cells μl-1 and boiled for 3 minutes or heated to 70 ˚C for 10 
minutes, respectively, before being stored at -20 ˚C. For all other downstream 
analyses, cell pellets were frozen in a slurry of dry ice and ethanol and stored at 
-80 ˚C for at least one hour before proceeding. When needed, 1 ml of ice-cold 
lysis buffer (LSGI, 4.6.9.1) per 5 x 107 cells was added to the frozen cell pellet, 
which was left on ice until the cell pellet had thawed. Cells were resuspended in 
lysis buffer by vortexing and then incubated on ice for 15 minutes before being 
centrifuged at 100, 000 x g for 45 minutes in an ultracentrifuge at 4 ˚C to 
separate soluble and insoluble fractions for use in downstream analyses. Samples 
of these fractions were prepared for analysis by SDS PAGE/NuPAGE (Section 
4.6.1) and Western blotting (Section 4.6.3) by the addition of Laemmli or 
NuPAGE sample buffer to a final concentration of 1X and heating the samples as 
described above.  
4.6.9.1 LSGI buffer 
Lysis solution with glycerol and inhibitors (LSGI; (Mottram and Grant, 1996)) 
comprises LSG buffer (50 mM MOPS (pH 7.4), 100 mM NaCl, 1 mM EDTA, 1 mM 
EGTA, 10 mM NaF, 1 mM NaOVa, 1 % Triton X-100 and 10 % glycerol), 
supplemented with protease inhibitors (100 μgml-1 leupeptin, 0.5 mM PMSF (in 
ethanol), 5 μgml-1 pepstatin A (in methanol), 0.5 mgml-1 pefabloc SC, and 1 mM 
1,10 phenanthroline (in 50 % ethanol).  
 
4.6.10 Preparation of cytoskeletal and flagellar fractions from 
T. brucei parasites 
Preparation of cytoskeletons and flagella preparations was based on the protocol 
described in (Broadhead et al., 2006). T. brucei cells were harvested (Section 
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4.2.2.2), washed once in PBS or TDB, resuspended in ice cold PEME buffer (100 
mM PIPES, 2 mM EGTA, 0.1 mM EDTA, 1 mM MgSO4, adjusted to pH 6.9) 
containing 1 % (v/v) Nonidet P40 detergent and supplemented with 1X complete 
EDTA-free protease inhibitor cocktail (Roche), and incubated for 2 minutes on 
ice before being centrifuged at 800 x g for 10 minutes.  Following centrifugation, 
cytosolic proteins were located in the supernatant (S1), while cytoskeletons 
were present in the pellet (P1). The cytoskeletons were resuspended in an ice 
cold  high salt buffer (PEME with 1 M NaCl, supplemented with 1X complete 
EDTA free protease inhibitor cocktail (Roche), 200 μgml-1 DNAse I, and 50 μgml-1 
RNAse A) and incubated on ice for 10 minutes to partially depolymerise the 
cytoskeletons. Depolymerised cytoskeletons (P2) were harvested by 
centrifugation at 16 000 x g for 15 minutes at 4 ˚C, leaving extracted 
microtubule-associated proteins and tubulin present in the supernatant (S2). The 
cytoskeletal pellet was incubated with the high salt buffer for a second time and 
centrifuged as above, in order to extract any remaining non-flagellar MAPS and 
tubulin (S3) and to obtain flagella in the pellet (P3). Samples from the various 
stages of fractionation were prepared for PAGE. Pellets containing 
cytoskeletons, depolymerised cytoskeletons, and flagella were resuspended in 1X 
NuPAGE sample buffer (Section 4.6.1.2) to a concentration equivalent to 0.5-1 x 
105 cells μl-1. Supernatants corresponding to the cytosolic and solubilised 
cytoskeletal fractions (including MAPs and tubulin) were diluted in NuPAGE 
sample buffer equivalent to a concentration of 5 x 104 cells μl-1. The samples 
were heated at 70 ˚C for 10 minutes and stored at -20 ˚C until analysed by PAGE 
(Section 4.6.1) and Western blotting (Section 4.6.3). 
4.6.11 Immunoprecipitation of TY epitope tagged proteins 
from T. brucei cell lysates 
For immunoprecipitation, 5 x 107 T. brucei cells were harvested (Section 4.2.2.2) 
and resuspended in 1 ml high salt lysis buffer (50 mM MOPS (pH 7.4), 500 mM 
NaCl, 1 mM EDTA, 1 mM EGTA, 10 mM NaF, 1 mM NaOVa, 1 % Triton X 100 and 10 
% glycerol) supplemented with protease inhibitors as described in Section 
4.6.9.1, before being centrifuged at 100, 000 x g for 45 minutes at 4 ˚C. 
Following centrifugation, 1 ml of the S100 lysate was incubated with 50 μl anti-
TY antibody (Table 4-14 and (Bastin et al., 1996)) and 100 μl of a 50 % slurry of 
  
96 
protein G agarose beads (prepared by washing 1 bed volume of  protein G 
agarose slurry (Pierce) three times in 5 bed volumes of PBS and resuspending the 
beads in 1 bed volume of high salt lysis buffer with protease inhibitors). The 
lysate, anti-TY antibody and protein G beads were incubated for 2 hours on a 
rotary mixer at 4 ˚C, before the beads were pelleted by centrifugation at 366 X 
g for 3 minutes. The beads were washed 4 times in 1 ml high salt buffer 
containing protease inhibitors. After the final wash, the beads were resuspended 
in an appropriate buffer for downstream analyses (Section 4.7).  
4.7 Kinase assays 
4.7.1 Kinase reactions 
Kinase assays were performed with recombinant proteins or proteins 
immunoprecipitated from trypanosome cell lysates. Purified recombinant 
proteins were dialysed (Section 4.6.6) into kinase assay buffer (KAB: 50 mM 
MOPS (pH 7.4), 20 mM MgCl2, 2 mM DTT, 10 mM EGTA (pH 8), and equal amounts 
of each recombinant protein were added to kinase assay mix (4 μM ATP, 5 μg 
substrate and 0.37 MBq γ32P-ATP per reaction in KAB) prewarmed to 30 ˚C to 
give a final volume of 20 μl. Generic kinase substrates used in these assays 
included histone HI (Calbiochem), α- or β-casein (Invitrogen) or myelin basic 
protein (Invitrogen).  Kinase assays were incubated at 30 ˚C with shaking for up 
to 30 minutes, before the reaction was halted by the addition of protein sample 
buffer (NuPAGE or SDS PAGE (Section 4.6.1)) to 1X final concentration, and 
boiling for 5 minutes. The kinase assay reactions were stored at -20 ˚C or 
analysed immediately.  
When a preincubation step was required, the relevant recombinant proteins 
were added to KAB (without ATP) to a final volume of 10 μl, and incubated at 30 
˚C for the desired amount of time before adding a further 10 μl of KAB 
containing a 2X (8 μM) concentration of ATP, 0.74MBq γ32PATP and 5 μg substrate 
(if required). 
To analyse kinase activity of proteins immunoprecipitated from T. brucei cell 
lysates (Section 4.6.11), proteins immobilised on protein G sepharose beads 
  
97 
were equilibrated in an equal volume of kinase assay buffer and warmed for 5 
minutes at 30 ˚C with shaking. The protein/bead complexes were pelleted by 
centrifugation at 366 X g for 3 minutes, before 50 μl of prewarmed kinase assay 
mix was added and kinase assays performed as described above. 
4.7.1.1 Analysing kinase activity 
Proteins in kinase assay samples were separated by PAGE (Section 4.6.1) and 
visualised by Coomassie staining (Section 4.6.2). Stained gels were dried using a 
BioRad gel dryer (model 583) between filter paper and cellophane before 
exposing to a phosphor-imaging screen overnight at room temperature. 
Radiolabelled proteins were detected by scanning the phosphor-imager screen 
using a Typhoon scanner.  
4.8 Dephosphorylation of recombinant proteins  
To dephosphorylate proteins, 10 μg of recombinant protein were treated with 
200 U lambda protein phosphatase (New England Biolabs) in a reaction buffer 
comprising 1X supplied lambda phosphatase buffer and 2 mM MnCl2 in a total 
volume of 50 μl at 30 ˚C for 1 hour with shaking, before halting the reaction by 
the addition of NuPAGE sample buffer (to 1X final concentration) and heating for 
10 minutes at 70 ˚C. To perform time course experiments, 10 μl aliquots were 
removed at the desired intervals and the reaction was halted as described. The 
samples were analysed by PAGE (Section 4.6.1) and Coomassie staining (Section 
4.6.2). 
4.8.1 Preparation of dephosphorylated recombinant  proteins for 
kinase assays 
Where dephosphorylated recombinant proteins were required for kinase assays, 
their purification was carried out as described (Section 4.6.4), but halted after 
the washing stage (Section 4.6.4.2.1). An equal volume of 1X lambda protein 
phosphatase (λPPase) buffer (Section 4.8) was then added to the washed beads 
to create a 50 % slurry.  The beads were pelleted by centrifugation of 200 μl of 
slurry at 91 x g for 30 seconds and resuspended in 500 μl 1X λPPase buffer 
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containing 2000 U λPPase (New England Biolabs) or the equivalent volume of 
dH2O (untreated control). The reaction was incubated for 1 hour at 30 ˚C with 
shaking, before the bead suspension was transferred to a 5 ml polypropylene 
column (Pierce) and purification of the recombinant protein was continued, 
commencing from the washing stage (Section 4.6.4.2.1). Samples of the eluted 
proteins were prepared for PAGE (Section 4.6.1), Coomassie staining (Section 
4.6.2) and Western blotting (Section 4.6.3) with anti-phosphothreonine antibody 
(Table 4-14) to determine the efficiency of the dephosphorylation reaction. 
Fractions with the highest protein concentration determined by Coomassie 
staining (Section 4.6.2) were transferred to an Amicon Ultra-15 centrifugal 
device with a 50 kDa cut off, to which kinase assay buffer (Section 4.7.1) was 
added, and the samples were centrifuged at 300 x g for 10 minutes. The flow 
through was removed and the process was repeated four times to remove any 
residual λPPase (25 kDa).  The protein concentration of the retentate was 
determined (Section 4.6.5) before proceeding with kinase assays (Section 4.7). 
4.9 Binding assays 
To investigate the interaction of 6XHis:PBD with ty:PLK, purification of 
6XHis:PBD was carried out as described (Section 4.6.4), but halted after the 
washing stage (Section 4.6.4.2.1). Twenty microlitres of 6XHis:PBD-bound beads 
or a beads only control washed and resuspended with high salt lysis buffer 
(Section 4.6.11) were incubated with 1 ml S100 lysates (Section 4.6.9) of cells 
expressing ty:PLK (or of a non-induced control) prepared in the same lysis buffer 
supplemented with protease inhibitors (Section 4.6.11)  on a rotary mixer for 2 
hours at 4 ˚C. After the incubation, the beads and interacting proteins were 
pelleted by centrifugation at 91 x g for 30 seconds and washed twice in 8 bed 
volumes of wash buffer (Section 4.6.4.2.1). 6XHis:PBD and any interacting 
proteins, were eluted from the beads by incubating in 1 bed volume of elution 
buffer (Section 4.6.4.2.1) for 15 minutes followed by centrifugation as above. 
Samples were prepared for PAGE (Section 4.6.1) and Western blotting with anti-
TY antibody (Section 4.6.3 and Table 4-14). 
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4.10 Flow cytometry 
To prepare cells for DNA content analysis by flow cytometry, 4 X 106 cells were 
harvested (Section 4.2.2.2) and washed in 1 culture volume of either TDB or PBS 
for bloodstream and procyclic form cells, respectively. Cell pellets were fixed in 
1 ml of 70% methanol/30 % PBS, and stored at 4 ˚C for 16 hours-1 month prior to 
analysis. The fixed cells were harvested by centrifugation, washed once in 10 
mls of PBS, resuspended in 1 ml of PBS containing 10 μgml-1 propidium iodide 
and 10 μgml-1 RNAse A, and incubated for 45 minutes at 37 ˚C in the dark. DNA 
content analysis was carried out with a Becton Dickinson FACSCalibur using 
detector FL2-A. Data were analyzed using the software CellQuest Pro. 
4.11 Microscopy 
4.11.1 DAPI staining and fluorescence microscopy 
DAPI staining was employed to visualise nuclei and kinetoplasts in trypanosome 
cells. 5 x 105 cells were harvested (Section 4.2.2.2), resuspended in 
approximately 50 μl medium dispensed onto glass slides (prepared by incubating 
in a 1/10 dilution of poly-L-lysine solution for 5 minutes before air drying), and 
spread using a cover-slip.  Cells were allowed to air dry before being fixed in 
methanol (-20˚C) for 30 minutes to 16 hours prior to analysis.  To analyse the 
cells, the slides were allowed to air dry, and PBS was added to rehydrate the 
cells at room temperature for 10-15 minutes. After rehydration, the PBS was 
decanted, and one drop of Vectashield (Vector Laboratories), a mounting 
medium containing 4,6-diamidino-2-phenylindole (DAPI) to stain DNA, was added 
and spread by the application of a cover-slip, which was sealed with nail varnish. 
Microscopy was performed using a Zeiss Axioskop fluorescent microscope at 1000 
X magnification with oil immersion. Cell morphology was analysed by differential 
interference contrast (DIC) microscopy, and UV light with a 480 nm filter set was 
used to visualise fluorescently stained kinetoplast and nuclear DNA. Images were 
processed and analysed with Openlab Version 5.5 software. 
For visualisation of GFP tagged proteins, cells were fixed and prepared as 
described above and visualised with a Zeiss Axioskop fluorescent microscope 
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under UV light with a FITC (540 nm) filter set, or alternatively, were fixed and 
visualised as described in Section 4.11.2.  
4.11.2 Immunofluorescence microscopy 
For immunofluorescence microscopy, 1 x 106 T. brucei cells were harvested 
(Section 4.2.2.2) and washed in 1 culture volume of TDB or PBS for bloodstream 
and procyclic form cells, respectively. The cells were then resuspended in 500 μl 
PBS or TDB (as appropriate), placed onto an area of 1.0 cm2 on poly-L lysine 
coated slides (Section 4.11.1) which had been outlined by nail varnish, and 
incubated for 15 minutes at room temperature to adhere the cells to the slides. 
The cells were fixed in freshly prepared 1 % formaldehyde in PBS for 30 minutes 
at room temperature, before being washed twice in PBS for 10 minutes. 
Alternatively, cytoskeleton preparations fixed in methanol (Section 4.11.3) were 
used. Slides were transferred to a dark box lined with moist tissues and the cell 
coated area of each slide was covered with 1 % Triton X-100 in PBS and 
incubated at room temperature for 5 minutes to permeablise the cells. The 1 % 
Triton X-100/PBS solution was replaced with 1 M glycine in PBS for 10 minutes to 
neutralize free aldehyde bonds and diminish any background fluorescence. This 
was then replaced with 0.1 % Triton X-100, 0.1 % BSA containing primary 
antibody at the appropriate concentration (Table 4-16). Cells were incubated 
with primary antibody for 1 hour and then washed with 10 X 1 ml aliquots of 
PBS. Secondary antibody (Table 4-17) was diluted 1/1000 in 0.1 % Triton X-100, 
0.1 % BSA, and incubated with the cells for 1 hour before washing with 20 X 1 ml 
aliquots of PBS. The residual PBS and the nail varnish were removed, and 
Vectashield mounting medium with DAPI (Vector laboratories) was added to the 
stained cells before covering with a cover-slip, and sealing with nail varnish. 
Sample fluorescence was observed under UV light with DAPI (480 nm), FITC (540 
nm) or RHO (580 nm) filter sets, as appropriate, while cell morphology was 
visualised by DIC microscopy. Cells were viewed using a DeltaVision RT 
Epifluorescence Imaging System (Applied Precision), or using a Zeiss Axioskop 
fluorescent microscope at 1000 X magnification with oil immersion and image 
processing was carried out using SoftWoRx (for deconvolution of images acquired 
with the DeltaVision) or Openlab Version 5.5 software (Axioskop).  
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Table 4-16 -Primary antibodies used for immunofluorescence microscopy. 
 
 
Table 4-17 -Secondary antibodies used for immunofluorescence microscopy. 
 
 
4.11.3 Preparation of trypanosome cytoskeletons for analysis 
by microscopy 
1 x 106 cells were harvested, washed and settled onto slides as described in 
Section 4.11.2. Cytoskeletons were prepared by adding 1 % NP40 in PEME 
(Section 4.6.10) buffer (procyclic form) or 0.75 % NP40 in PEME buffer 
(bloodstream form) and incubating for 1 minute or 30 seconds, respectively. The 
buffer was decanted and the cells were either immediately fixed in methanol at 
-20 ˚ C for 30 minutes prior to analysis by DAPI staining and fluorescence 
microscopy (Section 4.11.1), or by immunofluorescence microscopy (Section 
4.11.2), or processed further (procyclic form only) to obtain depolymerised 
cytoskeletons. To depolymerise microtubules, 1 M NaCl/PEME supplemented 
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with protease inhibitor cocktail, DNAse I (200 μgml-1) and RNAse A (50 μgml-1) 
was added and the cells were incubated for 15 minutes at 4 ˚C. The 
depolymerised cytoskeletons were either fixed in methanol or incubated in 1M 
NaCl/PEME a second time to obtain flagella before being fixed and analysed by 
DAPI staining/immunofluorescence.  
4.11.4 Transmission Electron Microscopy 
To examine subcellular structures in detail, 5 x 107 - 1 x 108 procyclic cells were 
harvested (Section 4.2.2.2) and the culture medium decanted, leaving a residual 
layer to help stabilise the cells. Fixation was carried out by adding fixative (2.5 
% glutaraldehyde in 0.1 M sodium cocodylate buffer) and incubating for 1 hour at 
room temperature. Downstream processing of the specimens was carried out by 
Mrs Margaret Mullin under the direction of Dr Laurence Tetley in the Integrated 
Microscopy Facility, University of Glasgow.  In summary, fixed cells were washed 
three times (5 minutes each) in 4 ˚C 0.1 mM sodium cocodylate buffer, before 
being incubated in 1 % osmium tetroxide/0.1 mM sodium cocodylate for 1 hour 
at room temperature. Three 10 minute rinses in dH2O were then carried out 
before treating with 0.5 % uranyl acetate for 1 hour in the dark, performing 
three 5 minute washes in dH20 and dehydrating the samples in an alcohol series. 
Cells were incubated for 10 minutes at room temperature in 30 % ethanol, 50 % 
ethanol, 70 % ethanol, 90 % ethanol, followed by two 10 minute incubations in 
absolute alcohol and one 3 minute incubation in propylene oxide. The cells were 
incubated for approximately 16 hours in a 1:1 mix of propylene oxide and epon 
resin before performing three 30 minute incubations in pure epon resin. The 
samples were then placed in fresh embed, in gelatine capsules and heated in an 
oven at 60 ˚C until polymerised. Samples were sectioned to a thickness of 60 -70 
nm, and contrast stained by treating the sections for 5 minutes each with 2 % 
methanol/aqueous uranyl acetate, and Reynold’s lead citrate.  
Specimens were viewed on a Leo 912 AB energy filtering transmission electron 
microscope using an Olympus camera, and images were analysed using iTEM 
imaging platform software (Olympus). 
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4.11.5 Analysis of vincristine-treated cells by Scanning 
Electron Microscopy 
Bloodstream form cells were treated with 0.2 μM vincristine sulphate (Section 
4.12) for 6 hours before being harvested and washed in TDB (Section 4.2.2.2). 
Cells were fixed in 2.5 % (v/v) glutaraldehyde/0.1 M sodium phosphate buffer 
(NaPi) for 1 hour at room temperature with mixing by slow inversion. After 
fixation, cells were harvested by centrifugation and washed 3 times and 
resuspended in 0.1 M NaPi buffer before transferring approximately 1 x 107 cells 
per sample to poly-L-lysine-coated cover-slips (Section 4.11.1) and leaving to 
settle for 30 minutes. Cell-coated cover-slips were incubated in 1 % osmium 
tetroxide (w/v) in 0.1 M NaPi buffer for 1 hour at room temperature. The cells 
were washed in 0.1 M NaPi buffer (three 10 minute rinses) before incubating 
them in a 0.5 % aqueous uranyl acetate solution for 1 hour at room temperature 
in the dark. This was followed by two five minute rinses in distilled water before 
the samples were dehydrated in an alcohol series. Cells were incubated for 10 
minutes at room temperature in 30 % ethanol, 50 % ethanol, 70 % ethanol, 90 % 
ethanol, followed by two incubations each in absolute alcohol and dried absolute 
alcohol. The cells were then incubated in hexamethyldisilazane (HMDS) for 5 
minutes, and this step was repeated before transferring specimens to a 
dessicator for 16 hours before mounting. Samples were mounted on aluminium 
stubs with copper double sided tape and silver paint, and an approximately 20 
nm thick coating of gold-palladium was applied using a Polaron SC515 SEM 
coating machine. Samples were viewed on a Jeol 6400 Scanning Electron 
Microscope. 
4.12 Microtubule inhibitor experiments 
Microtubule inhibitors (Vincristine sulphate, Vinblastine sulphate and Paclitaxol 
(taxol)) were obtained from Calbiochem, and stored at 4 ˚C (vincristine and 
vinblastine) or -20 ˚C (taxol). 10 mM stock solutions were prepared using dH2O 
(vincristine), methanol (vinblastine) or dimethyl sulphoxide (DMSO) (taxol) 
solvents; further 1000X stock solutions corresponding to the final concentrations 
listed in Table 4-18 were also produced. Lister 427 procyclic and bloodstream 
form cells were diluted to a density corresponding to low to mid log phase 
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growth (Section 4.2.2.2) in a volume of 10 ml; inhibitor (to a final concentration 
of 1X) or equivalent volume of solvent or dH2O) was added and determination of 
cell density (Section 4.2.2.3) and sampling for DAPI staining (Section 4.11.1) 
were carried out at regular intervals.  
Table 4-18 Concentrations of microtubule inhibitors (µM) used to treat T. brucei cells. 
 
 
4.13 Statistical Analyis 
Values were expessed as means ± standard error of the mean (SEM). Levels of 
significance were calculated by unpaired t-tests using the Data Analysis add-on 






5 The role of AIR9 in T. brucei 
5.1 AIR9: structure and function 
5.1.1 AIR9 in plants 
AIR9 (Auxin induced in root cultures 9) was first identified in a screen to detect 
auxin-induced genes in lateral root cells of Arabidopsis thaliana using a cDNA 
expression library (Neuteboom et al., 1999); a separate screen to identify genes 
involved in male gametophytic development using transposon insertion mutants 
found that AIR9 was required for male and female gametophytic transmission 
(Lalanne et al., 2004), suggesting that it was an essential Arabidopsis gene.  A 
further study isolated AIR9 protein from plant microtubules, and subsequently 
identified cell cycle functions of AIR9 (Buschmann et al., 2006), which were first 
investigated through localisation studies, and subsequently through the 
expression  of truncated recombinant proteins in vivo to determine the 
molecular basis for localisation and function. These findings are described 
below. 
Structural analysis revealed that there were three characteristic regions in the 
AIR9 protein (Figure 5-1): an N-terminal disordered basic serine-rich domain, a 
leucine-rich repeat domain (containing six repeats), and a C-terminal domain 
containing eleven tandemly-repeated A9 domains (Buschmann et al., 2006). The 
C-terminal A9 repeats were found to be immunoglobulin (Ig)-like domains which 
are generally involved in protein:protein interactions.  
 
Figure 5-1 -Schematic to show the structural domains of AIR9 proteins from Arabidopsis 
and T. brucei (Tb11.01.8770). 
The N-terminal basic domain (yellow), the leucine rich repeats (green) and the A9 domains 
(blue; 11 for A. thaliana AIR9 and 5 for the T. brucei homologue) are shown.  
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Full length AIR9 was expressed in BY-2 (Bright Yellow Tobacco) cells as a GFP 
fusion protein, and analysis of cells at different stages revealed a precise cell 
cycle-dependent localisation pattern (Buschmann et al., 2006). Briefly, the 
cortical microtubules were labelled at interphase, the preprophase band at G2, 
and weak labelling of the spindle was observed during metaphase. At the onset 
of cytokinesis, GFP:AIR9 labelled the phragmoplast and also the cortical division 
site. Localisation at the cortical division site appeared to occur immediately 
prior to contact between this region and the cell plate and, intriguingly, 
labelling seemed to spread from the cortical division site into the immature 
cross wall. The staining pattern was at first homogenous but became filamentous 
as the cross wall matured (suggesting GFP:AIR9 was associated with 
microtubules). Induction of ectopic phragmoplast insertion prevented GFP:AIR9 
migration into the cross wall, and this also inhibited the conversion of callose to 
cellulose, which accompanies maturation. GFP fusion proteins corresponding to 
different truncations of AIR9 revealed that localisation to the cortical 
microtubules required the basic serine-rich N-terminus, whereas localisation to 
the cortical division zone and cross wall required the C-terminal A9 repeats.  
Whilst this study highlights the dynamic nature of AIR9, there are some issues 
that were not addressed. For instance, while the filamentous microtubule-like 
distribution of AIR9 in the cross wall was noted for full length AIR9 and it was 
remarked that this could be a consequence of microtubule association, there 
was no comment regarding the distribution of N-terminally truncated AIR9 at the 
cross wall. If truncated AIR9 was capable of localising to microtubules 
specifically within the cross wall this would be very interesting, as it could 
indicate an indirect association via other MAPs, or perhaps an association of the 
C-terminal region specifically with the phragmoplast as opposed to cortical 
microtubules. 
5.1.2 AIR9 in Trypanosomatids 
AIR9 is of interest to parasitologists as there are homologues of AIR9 in several 
protozoan parasites including the Trypanosomatids (Buschmann et al., 2007). 
AIR9 is also found in other land plants (although not green and red algae), but is 




Figure 5-2- Phylogenetic relationship of AIR9-like proteins. 
Phylogenetic comparison based on the leucine-rich repeat domain. Reproduced with 
permission from (Buschmann et al., 2007). 
 
 T. brucei AIR9 possesses five conserved A9 domains, and a leucine-rich repeat 
region (Figure 5-1, Figure 5-3 and Figure 5-4). However analysis of N-terminal 
amino acids by amino acid scanning did not detect significant enrichment of 
serine, arginine or lysine residues in the 104 most N-terminal residues for 
Trypanosomatid AIR9 homologues, indicating that the microtubule binding 
domain was not conserved.  
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Figure 5-3 -Multiple alignment of the leucine-rich repeat region of AIR9. 
The amino acid sequences for A. thaliana AIR9 (bottom) and its trypanosomatid 
homologues (accession numbers from top to bottom correspond to T. cruzi, T. brucei and L. 
major AIR9) were aligned to show conservation of the leucine-rich repeat region (black box). 
Sequences were sourced from GeneDB (www.genedb.org) and aligned using AlignX 
software. 
 
Figure 5-4-Multiple alignment of A9 domains of AIR9. 
The amino acid sequences for A. thaliana AIR9 (bottom) and its Trypanosomatid 
homologues (accession numbers from top to bottom correspond to T. cruzi, T. brucei and L. 
major AIR9) were aligned to show conservation of the A9 domains.  The first six A9 domains 
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of A. thaliana AIR9 are labelled I-VI, with alternating A9 domains shown in red and black 
boxes for clarity. Note that the first A9 domain is not conserved in Trypanosomatid 
parasites. Sequences were sourced from GeneDB and aligned using AlignX software. 
5.1.3 Acquisition of T. brucei AIR9 
AIR9 is one of several proteins in T. brucei to be described as a plant homologue, 
and the origins of plant-like genes in this parasite are the source of great 
debate.  
The Trypanosomatids, Bodenida and Euglenida form the order Eugelozoans. 
Some Euglenida are phototrophic, which has led some to believe that 
Trypanosomatids, Bodenida and some Euglenida once possessed a plastid but 
have subsequently lost it (Hannaert et al., 2003a). Comparisons of cytoskeletal 
morphology and phylogenetic analysis imply, however, that this is not the case. 
Euglenida are free living, and are a diverse collection of bacterivorous, 
eucaryovorous and phototrophic organisms. Their mode of nutritional acquisition 
is reflected in their cytoskeletal morphology. Bacterivorous and eukaryovorous 
Euglenida possess elaborate feeding apparata, which involves the highly 
developed flagellar pocket (for prey ingestion), and in some cases, a feeding rod 
and vane (eukaryovorous Euglenida). The mode of motility in bacterivoric and 
eukaryovoric Euglenida is a gliding mechanism known as Euglenoid movement. 
Phototrophic Euglenida have a reduced ingestion apparatus, and the ‘vane’ is 
used for swimming motility; these Euglenida show reduced or absent Euglenoid 
motility. Another feature of the phototrophic Euglenida is their large cell size 
and reduced number of pellicle strips, which may help to increase light 
harvesting (Kivic and Walne, 1984). Phylogeny has shown that eukaryovorous 
Euglenida are derived from bacterivorous ancestors, and that phototrophic 
Euglenida have eukaryovoric ancestors. The change in feeding apparatus 
accompanying the transition of prey choice (from small bacteria to larger 
eukaryotic cells) is believed to have led to a secondary endosymbiosis with a 
green alga, resulting in phototrophy (Leander, 2004). Together, the specialised 
specific cytoskeletal adaptations exhibited by phototrophic Euglenida, and the 
phylogeny analysis imply late acquisition of the plastid in evolutionary terms, 
which does not explain the presence of plant-like traits in other Euglenozoans. 
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T. brucei and Leishmania possess genes with apparently both prokaryotic and 
plant sources, which would suggest that  another, earlier, secondary 
endosymbiosis event actually occurred in a Euglenozoan ancestor (Hannaert et 
al., 2003a). The situation looks more complicated when individual genes are 
studied. For example, genes representing components of the pyrimidine pathway 
are present (6-phosphogluconate dehydrogenase, adenylate kinase, fructose1,6-
bisphosphate aldolase, and trypanothione reductase) suggesting a cyanobacterial 
origin from a primary endosymbiosis; the presence of YC4F-related proteins  
(which contain AAA-type ATPase domains and cytochrome P450-like domains) 
suggests a green algal origin implying a secondary endosymbiosis; and finally, 
phylogenetic analysis of components of the biosynthetic pathway for fatty acids, 
for example the enzyme Δ4 desaturase, groups the Trypanosomatid enzyme with 
haptophytes and stramenophiles, which evolved from an endosymbiosis with a 
red alga. This evidence supports a tertiary endosymbiosis of a haptophyte alga 
by a Trypanosomatid ancestor (Bodyl et al., 2010). This presents a rather 
confusing picture of multiple endosymbioses and subsequent losses of the 
plastids. A rather more elegant explanation for the origin of plant-like traits in 
Trypanosomatids is given in (Opperdoes and Michels, 2007). Briefly, this study 
suggested that a primary endocytosis of a cyanobacterium by an ancestral 
Euglenozoan led to gene transfer of plastid genes to the nucleus and the 
formation of glycosomes, and that following plastid loss, subsequent acquisition 
of genes occurred through lateral gene transfer, probably by viruses encountered 
in the arthropod vector. 
Whatever the source of plant-like genes, the absence of these genes from 
mammalian cells indicates that the glycosome and plant-like proteins in 
trypanosomes could be good drug targets. What is interesting about the 
endosymbiosis theory is that it implies that only a small percentage of genes 
were retained. Selective gene retention could suggest that those genes retained 
aided in the adaptation to a parasitic lifestyle. A possible example would be 
dihydroorotate dehydrogenase (DHODase), which in trypanosomes is a soluble 
version of the ‘inner mitochondrial membrane-bound DHODase’, and as such, it 
donates electrons to fumarate as opposed to the mitochondrial respiratory 
chain, which could be an advantage in the absence of a functional mitochondrial 
respiratory chain. Incidentally S. cerevisiae also possesses soluble DHODase and 
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this is believed to be an important modification for allowing anaerobic growth 
(Opperdoes and Michels, 2007). 
The presence of AIR9 in the T. brucei genome is not surprising viewed from the 
context of such a complex evolutionary history, and the selective retention of 
‘useful’ genes suggests that T. brucei AIR9 could have a functional role. 
Moreover, both plants and trypanosomes possess a rigid cell structure, namely 
the plant cell wall and the subpellicular corset, respectively, features which 
might suggest convergent evolution of pre-mitotic cleavage site selection during 
cytokinesis. As a component of both the preprophase band and cortical division 
site, AIR9 has a proven function in this process in plants.  One of the aims of this 
project is to address whether AIR9 has a comparative role in cytokinesis in T. 
brucei. 
 
5.2 Strain differences between Lister 427 and TREU 927 
GUTat.10.1 
T. brucei Lister 427 was used as the host strain for all experiments in this study. 
To investigate the possibility of strain variation between T. brucei Lister 427 and 
the genome strain, TREU 927 GUTat.10.1, AIR9 was PCR-amplified (Section 
4.5.4) from Lister 427 genomic DNA (Section 4.4.2) using oligonucleotides PR226 
and PR227 (Table 4-9); two independent PCR products were then cloned into 
pSC-A (Section 4.5.6) and sequenced (Section 4.5.8). The sequence of each PCR 
product was identical, and the plasmid generated was named pHG129 (Table 
4-4). The Lister 427 and TREU 927 GUTat.10.1 AIR9 sequences were compared to 
each other using Vector NTI software and the differences between them are 
listed in Table 5-1. T. brucei AIR9 possesses a conserved leucine rich repeat 
region, and 5 A9 domains (Figure 5-1 and (Buschmann et al., 2007)). The base 
pair changes amounted to 4 amino acid mutations, only one of which (V773L) 
was located within a conserved region of AIR9 (the fifth A9 domain); K226N was 
located between the leucine rich repeat region and the first A9 domain, whilst 
D896G and G920D were located at the variable C-terminus of the protein. In 
addition, a number of deletions were present at the 3’ end of the gene, causing 




Table 5-1-A comparison of AIR9 for the T. brucei genome strain, TREU 927 GUTat.10.1, and 
strain Lister 427. 
Sequence differences for AIR9 between the T. brucei genome strain (TREU 927 GUTat.10.1) 
and the laboratory strain used in this study (Lister 427) are detailed in the Table, and the 
effect of these DNA sequence changes on AIR9 protein sequence are also indicated. 
 
5.3 Downregulation of AIR9 in the bloodstream form and 
procyclic form life cycle stages of T. brucei 
In order to study the function of AIR9 in T. brucei, inducible RNAi cell lines were 
constructed in procyclic and bloodstream form parasites and analysed for 
defects in proliferation or cell cycle progression following depletion of AIR9. 
5.3.1 Construction of plasmid pHG27 for inducible expression of 
AIR9 dsRNA in T. brucei 
Primer design for the amplification of a small, unique fragment of the AIR9 gene 
(Tb11.01.8770) was carried out using ‘TrypanoFAN RNAit’ software 
(trypanofan.path.cam.ac.uk/software/RNAit.html; (Redmond et al., 2003)); 
additionally the exclusivity of the selected 413 bp sequence was verified using 
BLAST software. The primers OL2696 and OL2697 (Table 4-9) were used to PCR-
amplify (Section 4.5.4) the AIR9 fragment from 427 genomic DNA (Section 4.4.2), 
which was subsequently ligated into the cloning vector pSC-A (Strataclone, 
  
113 
Section 4.5.6), generating pGL1785 (Table 4-4), sequenced (Section 4.5.8) and 
subcloned (by restriction digest using enzymes BamHI and HindIII (Section 4.5.2)) 
into the RNAi vector pT27TiA (LaCount et al., 2000; LaCount et al., 2002), 
generating pHG27 (Figure 5-5 and Table 4-4), which was verified by performing 
suitable analytical restriction digests.  

















NotI ( 27 3)
 
Figure 5-5 -Plasmid map for pHG27. 
The features annotated on the plasmid map indicate the location of the opposing T7 
promoters and T7 terminators which flank the AIR9 fragment (bp 1803-2215), the opposing 
tetracycline operators (‘Tet operators’) which regulate expression from the T7 promoters, 
the NotI restriction site for linearization, the ribosomal DNA sequences for integration into 
genomic DNA, the HindIII and BamHI restriction sites used to clone the AIR9 fragment into 
the RNAi vector (pT27
Ti
A (LaCount et al., 2000; LaCount et al., 2002), and the bleomycin 
resistance gene (selectable marker), with flanking actin 5’ and 3’ UTR sequences.  
5.3.2 Downregulation of AIR9 in the procyclic form life cycle stage 
of T. brucei 
5.3.2.1 Generation of procyclic form RNAi cell lines 
The AIR9 RNAi plasmid (pHG27; Figure 5-5) was linearised by NotI restriction 
digest (Section 4.5.2 and Section 4.3.2.1) and transfected into procyclic form 
427 pLew13 pLew29 cells (Wirtz et al., 1999) (Section 4.3.2.2). Clones were 
selected by limiting dilution in medium supplemented with hygromycin, G418 
and zeocin (the latter to select for the RNAi plasmid). Six independent clones 
were generated and of these, four failed to thrive in culture. Subsequent 
experiments were performed with clones 4 and 5 only. 
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To verify targeted AIR9 downregulation following RNAi induction, additional cell 
lines were generated expressing tyGFP:AIR9 from the endogenous locus. 
Construction of the tyGFP:AIR9 expression construct is described in Section 
5.4.1. The tyGFP:AIR9 expression plasmid (pHG172) was linearised (by restriction 
digest using NotI) and transfected into cell lines 427 pLew13 pLew29 pHG27 
clone 4 and 5 (as above). Clones were selected by limiting dilution in medium 
supplemented with hygromycin, G418, zeocin and blasticidin (the latter to select 
for the expression construct). Six independent clones were obtained from each 
transfection. The clones were screened by Western blotting of cell lysates with 
anti-GFP antibody (Section 4.6.3), which revealed that two clones derived from 
RNAi cell line ‘clone 4’, and one clone derived from RNAi cell line ‘clone 5’ 
expressed tyGFP:AIR9 (Figure 5-6). Subsequent experiments were performed 
with cell lines 427 pLew13 pLew29 pHG27 clone 4 pHG172 clone 2, and 427 
pLew13 pLew29 pHG27 clone 5 pHG172 clone 2. 
     
Figure 5-6-Western blot analysis of cell lysates from procyclic form RNAi cell lines 
transfected with pHG172 for endogenous expression of tyGFP:AIR9. 
Procyclic RNAi cell lines transfected with pHG172 (Section 5.4.1) were screened for 
expression of tyGFP:AIR9 by preparing cell lysates for SDS PAGE and Western blotting 
(upper panel) with anti-GFP antibody. The parental RNAi cell lines are indicated at the 
bottom, and the clones derived from these cell lines are indicated at the top. The positive (+) 
and negative (-) controls corresponded to cell lysates from bloodstream form 427 pHG172 
clone 3 (Section 5.4.2), and procyclic form 427 parasites, respectively. To control for 
loading, the blot was stained with Ponceau reagent (lower panel). The signal for tyGFP:AIR9 
(upper panel) was observed at its predicted size of 137 kDa.   
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5.3.2.2 Kinetics of AIR9 downregulation in procyclic form AIR9 RNAi cell 
lines expressing tyGFP:AIR9  
Two independent AIR9 RNAi cell lines expressing tyGFP:AIR9 from the 
endogenous locus were grown in the presence or absence of tetracycline for 
three days (Section 4.2.2.2). Western blotting (Section 4.6.3) of cell lysates 
revealed a dramatic decrease in the level of tyGFP:AIR9 by 24 hours, and by 48 
hours little tyGFP:AIR9 remained (Figure 5-7). The amount of tyGFP:AIR9 
detected was slightly variable for the uninduced cells over time, which may 
reflect a degree of inconsistent repression of the tetracycline-inducible T7 
promoter. However, these results show that in this system, AIR9 can be 
efficiently downregulated at the protein level, to the extent that AIR9 
expression is undetectable by 72 hours post-induction. 
              
Figure 5-7 -Downregulation of tyGFP:AIR9 in procyclic form  AIR9 RNAi cell lines. 
Cells expressing tyGFP:AIR9 derived from procyclic form AIR9 RNAi cell lines: 427 pLew13 
pLew29 pHG27 clone 4 pHG172 clone 2 (panel A), and 427 pLew13 pLew29 pHG27 clone 5 
pHG172 clone 2 (panel B); were grown in the presence (T +) or absence (T -) of 1 μgml
-1 
tetracycline for 3 days, and cell lysates were prepared at 24 hour intervals for analysis by 
SDS PAGE and Western blotting with anti-GFP antibody (to detect tyGFP:AIR9), and anti-
OPB antibody (to control for loading).  
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5.3.2.3 The effect of AIR9 downregulation on growth and DNA content in 
procyclic form parasites 
Growth of the two independent AIR9 RNAi cell lines was affected by 72 hours of 
induction with tetracycline (Figure 5-8) with cells proliferating at a slower rate, 
although no growth arrest was observed throughout the period of induction (174 
hours). The slow growth phenotype appeared to coincide with the point at which 
AIR9 protein had diminished to undetectable levels (Figure 5-7), implying that 
low levels of AIR9 may be sufficient for normal growth in culture.  
                   
Figure 5-8 -Cumulative growth curves of procyclic AIR9 RNAi cell lines. 
Triplicate cultures of two independent AIR9 RNAi cell lines (A: clone 4; B: clone 5) were 
grown in the absence (Tet-) or presence (Tet+) of 1 μgml
-1
 tetracycline; growth was analysed 
by determining the cell density at regular intervals (shown) over a period of 174 hours.  
To investigate the possibility of cell cycle defects being responsible for the slow 
growth defect observed, the two independent RNAi cell lines were analysed by 
flow cytometry (Section 4.10). Uninduced and induced cells were sampled at 
approximately 24 hour intervals for the duration of the induction, fixed with 
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methanol and stained with propidium iodide prior to performing flow cytometry. 
Histograms of frequency versus whole cell fluorescence (FL2-A) were used to 
compare populations. 2C and 4C ploidy is easily discernable as two peaks, which 
represent cells in G0/G1, and G2/M, respectively (Figure 5-9, ‘T=0’). Cells 
undergoing S-phase have intermediate fluorescence and are distributed between 
these peaks. Results for the induced clones are shown in Figure 5-9B and D; 
alterations in the cell cycle profile are apparent at 72 hours post-induction, 
when an abnormal peak arises, corresponding to a DNA content of less than 2C, 
which could represent cell debris or anucleate cells (e.g. 0N1K). At 96 hours 
post-induction, other abnormal peaks appear, representing cells emitting 
abnormally high levels of fluorescence which correspond to a more than 4C 
ploidy; and implies that individual cells are undergoing a second round of DNA 
replication. The abnormal peaks become more prominent over time, 
accompanied by a steady decrease in the height of the 2C peak. Together these 
changes suggest that cytokinesis might be impaired, and abnormalities in the 
DNA profile coincide with both growth inhibition and significant decreases in 
AIR9 expression. There was some variation between the sizes of 2C and 4C peaks 
in the uninduced controls (see Figure 5-9A and C), but cells with abnormal ploidy 







Figure 5-9 -Flow cytometry analysis of procyclic AIR9 RNAi cell lines. 
Two independent AIR9 RNAi clones (A+B: clone 4; C+D: clone 5) grown in the absence 
(A+C: ‘Tet –‘) or presence (B+D: ‘Tet +’) of tetracycline were analysed by flow cytometry (x-
axis: FL2A; y-axis: cell count). Time points of sampling, and ploidy are shown. 
5.3.2.4 Downregulation of AIR9 causes cytokinesis defects in procyclic form 
parasites 
To further characterise any cell cycle defects appearing following the depletion 
of AIR9, cells grown in the presence or absence of tetracycline were sampled at 
approximately 24 hour intervals, fixed and stained with DAPI for analysis by 
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microscopy (Section 4.11.1). Over 200 individual cells were examined at each 
time point. Cells were classified according to the number of kinetoplasts and 
nuclei contained within them and the relative positions of these organelles; if 
relevant, the cytokinesis stage (no furrow, furrow, abscission) was recorded.  
Initially, the cell populations comprised 70-80% 1N1K cells, 10-20% 1N2K cells, 5-
10% 2N2K cells with <3% cells exhibiting other (abnormal) N-K configurations 
(Figure 5-10). Images of cells with normal N-K configurations can be seen in 
Figure 5-12. In procyclic form parasites, the G2/M transition is marked by the 
dramatic basal body and coincident kinetoplast segregation and by the 
elongation of the replicated nucleus, and cells at early and late stages of this 
process (as implied from inter-kinetoplast distances and nuclear morphology) are 
shown in Figure 5-12Bi and Bii, respectively. Mitosis features segregation of the 
nuclei resulting in the typical KNKN organelle arrangement (from posterior to 
anterior), as shown in Figure 5-12C. 
 
Figure 5-10 -DAPI staining of procyclic AIR9 RNAi cell lines. 
Procyclic AIR9 RNAi cells (A: clone 4; B: clone 5) were grown in the presence of 1 µg ml
-1
 
tetracycline and at the time points indicated, cells were stained with DAPI and >200 
cells/time point were classified according to the number of nuclei and kinetoplasts per cell. 
DAPI staining revealed a steady decrease over time in 1N1K cells (Figure 5-10). 
The decrease in 1N1K cells coincided with the appearance of 2N1K and 0N1K 
cells, images of which are shown in Figure 5-13A and B. These abnormal cell 
types were present in equal numbers at earlier stages of the induction, but at 
later time points, 2N1K cells were outnumbered by the 0N1K cells (Figure 5-10). 
Stastical analysis (Section 4.13) determined that although a small number of 
these abnormal cell types were sometimes observed in uninduced populations, 
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the numbers seen in induced populations were significantly higher at 72 or 24 
hours post-induction for clones 4 and 5 respectively (Figure 5-11 and Table 
5-2).The initial generation of equal numbers of these abnormal cell types 
suggests that they are sibling cells, which probably arose from a 2N2K parental 
cell. 
 
Figure 5-11 -Stastical analysis of 0N1K and 2N1K cells in AIR9 RNAi procyclic form cells. 
Procyclic form AIR9 RNAi cells grown in the absence or presence of 1 µgml
-1
 tetracycline 
(‘Tet –‘ or ‘Tet +’, respectively ) were analysed by DAPI staining and scored according to the 
whether cells contained two nuclei an one kinetoplast (2N1K) or were anucleate (0N1K). The 
results from two experiments were used to generate a mean, with values ±SEM. ‘*’ indicates 





Figure 5-12 –Normal N-K configurations in procyclic form cells. 
Representative DAPI-stained images of procyclic form cells containing normal quotas of 
nuclei (N) and kinetoplasts (K, arrows), as indicated. Left panels: DAPI; right panels: 
DAPI/DIC merge. Scale bars: 10 μm.  
 
At later time points, multinucleate cells were observed (grouped within the 
‘Other’ category in Figure 5-10), which in general resembled the cell shown in 
Figure 5-13C. Cells rarely possessed more than four nuclei and these cells 
maintained their characteristic spindle morphology. An example of a rare 
multinucleate cell with eight nuclei is shown in Figure 5-13D. Multinucleate cells 
were occasionally seen dividing to produce 0N1K daughters, which may have 
contributed to the asymmetric rise in 0N1K cells over 2N1K cells at these later 
time points. 
 
Figure 5-13 -Abnormal cell types observed following induction of AIR9 RNAi in procyclic 
cells. 
Representative DAPI-stained images of procyclic form AIR9 RNAi cells (induced) containing 
abnormal quotas of nuclei (N) and kinetoplasts (K, arrows), as indicated. While some cells 
displayed normal morphology (cells A-C), others had an abnormal rounded morphology 




Both clones displayed some variability with regards to the proportions of 1N2K 
and 2N2K cells in their populations overtime, but since overall the proportion of 
these cell types did not change greatly (Figure 5-10), this implies that although 
the 2N2K cells appear to be dividing asymmetrically, cytokinesis still occurs at a 
similar rate. 
These data are consistent with the flow cytometry analysis, which clearly 
showed a transition in the DNA profile of the population at 72 hours (Figure 5-9). 
The appearance of a small peak corresponding to an abnormally low DNA content 
coincided with a significant accumulation of 0N1K cells (comprising 8.6% or 11.3 
% of the population for clones 4 and 5, respectively; Figure 5-10). Later, at 96 
hours post-induction, the appearance of peaks corresponding to a DNA content 
greater than 4C coincided with an accumulation of multinucleate cells 
(comprising 2.5 % and 7.8 % of the population for clones 4 and 5, respectively).   
5.3.2.5 Downregulation of AIR9 affected organelle positioning in procyclic 
form parasites 
Examination of the DAPI-stained cells revealed that a striking proportion of cells 
with a normal quota of nuclei and kinetoplasts displayed atypical positioning of 
these organelles, as tabulated in Error! Reference source not found.. Despite 
the appearance of some cells with abnormal organelle positioning in non-induced 
populations, the proportion of cells with this phenotype were significantly 
greater in induced populations at 72 and 48 hours for clones 4 and 5 respectively 




Figure 5-14-Organelle positioning defects observed following induction of AIR9 RNAi in 
procyclic cells. 
Procyclic AIR9 RNAi cells induced with 1 µgml
-1
 tetracycline and examined by DAPI staining 
(Figure 5-10), are presented here scored according to whether organelle positioning was 
normal (darker colours, standard font) or abnormal (lighter colours, italic font). ‘Others’ 
comprises those cells with an abnormal quota of nuclei (N) and/or kinetoplasts (K).  
 
Figure 5-15-Stastical analysis of the organelle positioning defects in AIR9 RNAi procyclic 
form cells. 
Procyclic form AIR9 RNAi cells grown in the presence or absence of 1 µgml
-1
 tetracycline 
(‘Tet –‘ or ‘Tet +’, respectively ) were analysed by DAPI staining and scored according to 
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whether organelle positioning was normal. The results from two experiments were used to 
generate a mean, with values ±SEM. ‘*’ indicates P=0.05 by an unpaired t-test (one-tail). 
Table 5-2-P values from unpaired t-tests assuming equal variance (one-tail) to determine the 
significance of the appearance of abnormal cell types in induced AIR9 RNAi procyclic cells. 
The significance of the appearance of abnormal cells in AIR9 RNAi procyclic form cell lines 
grown in the presence of 1µgml
-1
 tetracycline at different times during the experiments was 




The positioning defects in 1N1K cells included cells with the kinetoplast and 
nucleus positioned laterally to each other (sometimes the kinetoplast appeared 
to be directly above the nucleus when focussing through the cell), which are 
here referred to as ‘K^N’ cells, and cells where the kinetoplast was positioned 
anteriorly to the nucleus which are referred to as ‘NK’ cells. Example images of 
normal and both abnormal cell types are shown in Figure 5-16Ai-iii. The 
abnormal 1N1K cells comprised a large proportion of the whole population, and 
to compare the relative proportions of the different atypical cell types over the 
course of the induction, 1N1K cell types are displayed separately in Figure 
5-16Bi-ii. Comparing the chronology of the appearance of K^N and NK cells 
reveals that K^N cells appear in larger numbers during the first three to four 
days, and afterwards, the proportion of 1N1K cells displaying the more severe NK 
phenotype increases to levels similar to the proportion of K^N cells within the 





Figure 5-16 -Organelle positioning defects observed in 1N1K cells following induction of 
AIR9 RNAi in procyclic cells. 
Following induction of AIR9 RNAi, cells were stained with DAPI and the relative positions of 
the nucleus (N) and kinetoplast (K, arrows) in 1N1K cells were examined.  A: examples of 
the three types of 1N1K cells (Ai: normal organelle positioning (KN); Aii: kinetoplast lateral 
to nucleus (K^N); Aiii: kinetoplasts anterior to nucleus (NK)). Left panels: DAPI images; 
right panels DIC/DAPI merge. Scale bars: 10 μm. Bi and Bii: graphs indicating the 
proportions of the different 1N1K types within whole populations over time for clones 4 and 
5, respectively. 
1N2K cells displayed a variety of positioning defects, ranging in severity 
according to how anterior the kinetoplast positioning was relative to the 
nucleus. Examples of abnormal 1N2K cells are shown in Figure 5-17. A minor 
positioning defect where the nucleus and one kinetoplast were located at similar 
distances from the anterior of the cell (i.e. this kinetoplast was lateral to the 
nucleus) was referred to as ‘KK^N’; an example of this cell type is shown in 
Figure 5-17A. Cells with a ‘KNK’ organelle arrangement were the most 
prevalent, where the nucleus was straddled by two kinetoplasts (Figure 5-17B). 
Cells with this arrangement comprised 13 % or 8 % of the whole population at 72 
hours post-induction for clones 4 and 5, respectively. More severe phenotypes 
included ‘K^NK’ cells, where one kinetoplast was lateral to the nucleus and the 
second kinetoplast was anterior to the nucleus (shown in Figure 5-17C), and 
‘NKK’ cells, where both kinetoplasts were located at anterior positions relative 
to the nucleus. 
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Figure 5-17 -Organelle positioning defects observed in 1N2K cells following induction of 
AIR9 RNAi in procyclic cells. 
Following induction of AIR9 RNAi, cells were stained with DAPI and the relative positions of 
the nucleus (N) and kinetoplasts (K, arrows) in 1N2K cells were examined.  A-C: 1N2K cells 
with organelle positions ‘KK^N’, ‘KNK’ and ‘K^NK’, respectively. Left panels: DAPI images; 
right panels: DIC/DAPI merge.  Scale bars: 10 μm. 
2N2K cells possessed the largest number of nucleus and kinetoplast positioning 
defects, probably due to the increased number of organelles and therefore 
possible positional combinations. As described above, the usual arrangement of 
the nuclei and kinetoplasts in procyclic 2N2K cells is KNKN (posterior to 
anterior), with the organelles arranged in a linear fashion following the axis of 
the cell (see Figure 5-12C). Cells displaying the organelle configuration ‘K^NK^N’ 
(describing a cell where the nuclei and kinetoplasts have segregated, but each 
kinetoplast is positioned lateral to the appropriate nucleus) were the most 
numerous of the abnormal post-mitotic cells (Figure 5-18Ai). At 96 hours post-
induction, ‘K^NK^N’ cells comprised 1.7 or 5.3 % of the whole population for 
clones 4 and 5, respectively. Other abnormalities were represented by tiny 
proportions of cells in the context of the whole population; these rarer organelle 
positioning defects included cells with a ‘KKNN’ organelle configuration 
(describing cells where the kinetoplasts appear not to have segregated fully), 
and cells with the organelle configurations ‘NKKN’, ‘KNNK’ K^NKN’, and ‘KNK^N’ 
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(where the position of only one kinetoplast was abnormal). Examples of some of 
these rare organelle positioning defects are shown in Figure 5-18Aii-iii. 
Malpositioning of organelles did not prevent furrow ingression. Examples of cells 
with both abnormally positioned organelles and visible cleavage furrows are 
shown in Figure 5-18B. Cells with abnormal organelle positioning were also 
observed at the abscission stage of cytokinesis, implying that they were capable 
of completing furrow ingression (Figure 5-18C). Occasionally, nascent daughter 
cell bodies did not appear to possess an equal quota of organelles, thus 
identifying these abnormal 2N2K parents as a potential source of 2N1K and 0N1K 
siblings (Figure 5-18Ci and iii).  
 
Figure 5-18 -Organelle positioning defects observed in 2N2K cells following induction of 
AIR9 RNAi in procyclic cells. 
2N2K cells were classified according to both organelle positioning and cytokinesis stage. A-
C: cells at the pre-cytokinesis, furrow ingression and abscission stages of cytokinesis, 
respectively. Left panels: DAPI images; right panels: DIC/DAPI merge. The N-K positioning 
designations are shown. For cells at the furrow ingression or abscission stages, the N-K 
distribution for daughter cells is not certain, but probable outcomes for the quota of nuclei 
(N) and kinetoplasts (K, arrows) in each cell are indicated by ‘/’. Scale bars: 10 μm. Asterisks 
indicate the point of abscission. 
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Cells displaying abnormal organelle positioning were present in very large 
numbers at 24 hours post-induction, at which point AIR9 levels were reduced but 
still detectable (Figure 5-7), implying that organelle positioning is sensitive to 
decreased levels of AIR9. This also suggests that the cytokinesis defects observed 
could be a downstream effect of aberrant organelle positioning. 
It was of interest to determine at which stage(s) of the cell cycle, the N-K 
positioning defects first appeared, but due to the relatively small numbers of 
1N2K and 2N2K cells present within the 200 or so cells analysed per time point, 
it was not possible to investigate the chronology of the organelle positioning 
defect from the whole population data. Therefore, more than 200 cells of each 
N-K configuration (1N1K, 1N2K and 2N2K) were classified at 0, 12 and 24 hours 
post-induction in order to address this question. Figure 5-19 shows the 
percentage of abnormal cell types at the selected time points for each N-K 
configuration. A certain degree of abnormal organelle positioning was observed 
for all N-K configurations at the start of the induction (probably due to leaky 
expression from the T7 promoter of the RNAi construct), but by 12 hours post-
induction an increase in abnormal organelle positioning for all N-K configurations 
was observed. At 24 hours post-induction, the percentage of cells with 
positioning defects for each N-K configuration was similar. Given the reduced 
growth rate of parasites depleted of AIR9, it is likely that only one cell cycle is 
completed at 24 hours (the doubling time over the first 24 hours of the time 
course was 19 hours for both clones in the presence of tetracycline). In light of 
the slow growth rate, the similar increases in the proportion of abnormal cells 
for all cell cycle stages suggests that abnormal organelle positioning arises 








                 
                  
Figure 5-19 -Emergence of organelle positioning defects in different cell types following 
induction of AIR9 RNAi in procyclic cells. 
Procyclic AIR9 RNAi cells (A: clone 4; B: clone 5) were induced with tetracycline and >200 
DAPI-stained 1N1K, 1N2K and 2N2K cell types were analysed at 0, 12 and 24 hours post-
induction. The bars show the proportions of abnormal cells for each cell type. 
A more in-depth analysis of the relative positions of the nuclei and kinetoplasts 
in 1N1K, 1N2K and 2N2K cells revealed that the position of the kinetoplast in 
1N1K cells becomes increasingly anterior over the 24 hour induction period 
(Figure 5-20A). This is demonstrated by the increased prevalence of the K^N 
and, with slightly slower kinetics, NK, cell types over time. A similar pattern was 
also observed in 1N2K cells, where cells displaying the KK^N arrangement and 
later, cells displaying the KNK arrangement, increased in abundance over the 
induction period (Figure 5-20B). For the 2N2K population, a large proportion of 
cells displaying abnormal organelle positioning were observed (Figure 5-20C). At 
12 hours post-induction the predominant abnormality comprised cells with the 
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most posterior kinetoplast being positioned abnormally anterior (K^NKN) and 
these cells comprised 61.9 % or 71.8 % of the 2N2K cells with organelle 
positioning defects (for clones 4 and 5, respectively). At 24 hours post-induction, 
K^NKN cells only comprised 35.1 % and 54. 9 % of abnormal cells (for clones 4 
and 5, respectively), as more severe abnormalities became more prevalent. An 
increasing number of cells with organelle positioning defects also appeared to be 
undergoing cytokinesis (Figure 5-20C), and a larger proportion of these cells 
were undergoing furrow ingression rather than abscission. At 24 hours post-
induction, 2N2K cells with abnormal organelle positioning that were undergoing 
furrow ingression comprised 14.1 % and 9.1% of the 2N2K cell population, while 
those undergoing abscission comprised just 3.1 % and 1.2 % of 2N2K cells (for 
clones 4 and 5, respectively). Prediction of the eventual outcome of cleavage for 
cells at the furrow ingression stage was deemed too speculative; therefore, only 
those at the abscission stage were categorised according to organelle 
distribution between the nascent daughter cell bodies. At 24 hours post-
induction, of the 2N2K cells with apparently normal organelle positioning that 
were undergoing abscission, approximately half displayed malpositioned 
cleavage planes. It is probable that 0N1K and 2N1K cells can arise from these 
cells, but it is also highly likely that some 2N2K cells with abnormal organelle 
positioning also eventually divide abnormally to produce 0N1K and 2N1K cells 
(see Figure 5-18C), and given that 2N2K cells with aberrant organelle positioning 
quickly outnumber those with normal organelle positions, these seem a more 




Figure 5-20 –Chronological analysis of organelle positioning defects for different N-K 
configurations following induction of AIR9 RNAi in procyclic form cells. 
Following induction of AIR9 RNAi, DAPI stained cells (n > 200 for each N-K configuration) 
were classified according to organelle positioning. Normal organelle positioning: solid bars; 
abnormal organelle positioning: patterned bars. A: 1N1K cells (solid bars: KN; striped: K^N; 
circles: NK); B: 1N2K cells (solid bars: KKN; striped: KK^N; checked: KNK; circles: KK^N*); 
C: 2N2K cells (solid bars: KNKN; circles: other abnormal organelle positions; either non-
dividing (dark pink) or dividing (light pink)); for clones 4 (i) and 5 (ii). F/A: furrow 
ingression/abscission. 
5.3.2.6 Nuclear positioning and cell length were affected by AIR9 
downregulation 
Abnormal positioning of either the kinetoplast, or the nucleus, or of both of 
these organelles, could have resulted in the aberrant positioning of these 
organelles relative to each other that was observed following depletion of AIR9. 
In order to differentiate between these two possibilities, the position of each of 
these organelles relative to the posterior pole of the cell was quantified (Figure 
5-21 and Figure 5-22). For simplicity, only 1N1K cells were measured, and to 
increase the accuracy of the measurements, cells were stained with the anti-β-
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tubulin antibody, KMX (Section 4.11.2), resulting in bright staining of the cell 
body and flagellum. In order to ensure sufficient numbers of abnormal cells, 
AIR9 RNAi was induced for 72 hours before analysis; as a comparison, cells with 
normal organelle positioning from uninduced cultures grown over the same 
period were examined. More than 100 cells were measured for analysis. 
  
Figure 5-21 -Schematic showing measurements of nucleus and kinetoplast positions in 
abnormal 1N1K cells. 
Procyclic AIR9 RNAi cells were induced with tetracycline for 72 hours and stained with DAPI 
(blue) and anti-β-tubulin antibody (green) to allow measurement of the position of the 
nucleus (N) and kinetoplast (K) relative to the posterior (P) end of 1N1K cells. A: 
DAPI/FITC/DIC merge of abnormal 1N1K cells, with N-K positioning indicated. B-D: 
measurements taken (cell length (L), kinetoplast to posterior end (K-P) and nucleus to 
posterior end (N-P)) are indicated with white lines overlaid on the DAPI/FITC merges. 
Organelle measurements were taken from the centre of the organelle; for the nucleus, this 
was measured by averaging the shortest and greatest distance to the posterior end (Ni and 
Nii, respectively), while the centre of the kinetoplast was estimated by eye. The images 
shown in this figure are deconvolved and, as it was subsequently found that non-





Figure 5-22 -Immunofluorescence of KMX-stained 1N1K cells. 
Procyclic AIR9 RNAi cells were induced with tetracycline for 72 hours and stained with DAPI 
(blue) and anti-β-tubulin antibody (green) to allow measurement of the position of the 
nucleus (N) and kinetoplast (K) relative to the posterior end of 1N1K cells. Examples of 
actual (non-deconvolved) images used for measurements are shown. A: 1N1K cells from 
uninduced cell population, with normal ‘KN’ positioning; B and C: 1N1K cells from induced 
populations with abnormal ‘K^N’ and ‘NK’ organelle positioning, respectively. Scale bars: 10 
μm. 
The parameters measured (see Figure 5-21) comprised cell length (posterior end 
of the cell to the anterior tip of the flagellum), the distance from the centre of 
the kinetoplast to the posterior end, and the distance from the centre of the 
nucleus to posterior end, which was calculated as the average of the distances 
from the most posterior and most anterior points of the nucleus to the posterior 
end of the cell. Kinetoplast to posterior end and nucleus to posterior end 
distances were then expressed as a ratio of cell length. The measurements 
obtained are represented graphically in Figure 5-23. Following AIR9 depletion, 
there was a significant increase in the K-P/L ratio and conversely, a significant 




Figure 5-23-Histograms to show distribution of cell dimensions in AIR9 RNAi cell lines. 
Procyclic AIR9 RNAi cells were cultured in the presence (Tet +, red bars) or absence (Tet -, 
blue bars) of tetracycline for 72 hours, and stained with DAPI and for β-tubulin to allow 
measurement of cellular dimensions (n=>100). A: ratio of nucleus to posterior/cell length (K-
P/L); B: ratio of kinetoplast to posterior/cell length (N-P/L). 
Surprisingly, there was also a significant increase in cell length upon AIR9 
downregulation (Table 5-3) with average cell lengths increasing from 21.2 μm to 
23.5 μm (clone 4) and from 19.1 μm to 22 μm (clone 5), possibly as a result of 
either an increase in flagellum length or posterior end extension. Whilst these 
two scenarios could affect relative organelle positions (exaggerated posterior 
extension in the absence of organelle movements would increase the K-P/L and 
N-P/L ratios, while flagellum extension in the absence of organelle movements 
would decrease these ratios), it is unlikely that increases in cell length alone 
directly impacted the organelle positions, as the organelles were displaced 




Figure 5-24-Histograms to show distribution of cell length in AIR9 RNAi procyclic cell lines. 
Procyclic AIR9 RNAi cells were cultured in the presence (Tet +, red bars) or absence (Tet -, 
blue bars) of tetracycline for 72 hours, and stained with DAPI and for β-tubulin to allow 
measurement of cell length (n=>100). 
Through comparisons of organelle to posterior and organelle to anterior 
distances it was possible to gain a greater insight into the nature of the 
positioning defect. Analysis of N-P and N-A distances (Figure 5-25 A and C) 
revealed a significant decrease or increase in these parameters respectively for 
both clones (Table 5-3) whilst analysis of K-P and K-A distances indicated an 
increase in both parameters (Figure 5-25 B and D). Further, the increase in K-A 
distance was only significant for clone 5 (Table 5-3). These results imply that the 
increase in cell length could occur at the posterior end of the cell, perhaps 
encompassing the region surrounding the kinetoplast (which could explain the 
significant increase in K-A distance for clone 5). Importantly, the decrease in N-P 
and increase in N-A distances implies that the position of the nucleus moves in 
induced populations. It is therefore likely that AIR9 depletion causes both an 




Figure 5-25 -Histograms to show distribution of cell dimensions in AIR9 RNAi procyclic form 
cell lines. 
Procyclic AIR9 RNAi cells were cultured in the presence (Tet +, red bars) or absence (Tet -, 
blue bars) of tetracycline for 72 hours, and stained with DAPI and for β-tubulin to allow 
measurement of cellular dimensions (n=>100). A-D show the distribution of the 
measurements corresponding to parameters N-P, K-P, N-A and K-A respectively.  
Table 5-3- P values obtained from statistical analysis of cell dimensions using an unpaired t-
test (two-tail). 
The significance of differences in cell dimensions in 1N1K cells from AIR9 RNAi procyclic 
form cell lines grown in the presence or absence of 1µgml
-1
 tetracycline at 72 hours was 
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determined by statistical analysis (Section 4.13). More than 100 cells were analysed for each 




In procyclic form parasites, AIR9 can be effectively depleted by RNAi, such that 
AIR9 protein is undetectable after three days of induction. Reduction in AIR9 
results in a rapid emergence of nucleus and kinetoplast positioning defects in 
cells at all stages of the cell cycle, and this effect is probably caused by a 
problem with cell polarity rather than cell cycle regulation. Relative nuclear and 
kinetoplast positions were affected in 1N1K populations: the kinetoplast 
appearing too anterior and the nucleus too posterior. Further analysis of cell 
dimensions revealed that a coincident increase in cell length from the posterior 
end of the cell and posterior movement of the nucleus are likely to cause the 
dramatic and opposite change in organelle positions relative to the posterior end 
of the cell. This supports the hypothesis that AIR9 is important for cell polarity. 
 
Figure 5-26 –Diagram to show the events that occur following AIR9 depletion to generate 
1N1K cells with altered cell dimensions. 
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Following AIR9 depletion in procyclic AIR9 RNAi cell lines, 1N1K cells displayed abnormal 
positioning of the nucleus and kinetoplast relative the posterior end of the cell (Section 
5.3.2.5). This was found to be a result of increased cell length and posterior movement of 
the nucleus (Section 5.3.2.6). 
AIR9 depletion had an indirect effect on cytokinesis. Post-mitotic cells displaying 
abnormal organelle positioning accumulated at the furrow ingression stage of 
cytokinesis, but 2N2K cells did not increase in the context of the whole 
population, suggesting that AIR9 depletion led to altered kinetics of cytokinesis; 
it is possible that earlier initiation of cytokinesis might have compensated for 
delays in furrowing caused by organelle malpositioning. 2N2K cells with 
organelle positioning defects are the most likely source of 2N1K and 0N1K 
siblings, and this asymmetric cell division could be responsible for the growth 
defect which was characterised by a decrease but not arrest of cell 
proliferation. Uncoupling of organelle replication and cytokinesis resulted in the 
production of multinucleate cells; this is probably a downstream effect of the 
multitude of positioning defects, which preceded the emergence of this 
phenotype. 
5.3.3 Downregulation of AIR9 in the bloodstream form life cycle 
stage of T. brucei 
5.3.3.1 Generation of T. brucei bloodstream form RNAi cell lines 
The AIR9 RNAi plasmid, pHG27, described in Section 5.3.1 was linearised by 
restriction digest (Section 4.3.2.1) and transfected into bloodstream form 427 
pLew13 pLew90 cells (Wirtz et al., 1999) (Section 4.3.2.2). Clones were selected 
by limiting dilution in medium supplemented with hygromycin, G418 and 
phleomycin (the latter to select for the RNAi plasmid). Two independent clones 
were generated and these are subsequently referred to clones 1 and 2.  
To verify targeted AIR9 downregulation, additional cell lines were generated 
expressing tyGFP:AIR9 from the endogenous locus. Construction of this 
expression construct is described in Section 5.4.1). The expression plasmid 
(pHG172; Table 4-4) was transfected into the two AIR9 RNAi clonal cell lines 
generated. Clones were selected by limiting dilution in medium supplemented 
with hygromycin, G418, phleomycin and blasticidin (the latter to select for the 
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expression construct). Transfection of RNAi clones 1 and 2 with pHG172, yielded 
3 and 4 independent clones, respectively. The clones were screened by Western 
blotting of cell lysates with anti-GFP or anti-TY antibody (Section 4.6.3), which 
revealed that one clone derived from each RNAi cell line expressed tyGFP:AIR9 
(Figure 5-27). Subsequent experiments refer to bloodstream form 427 pLew13 
pLew90 pHG27 clone 1 pHG172 clone 2, and bloodstream form 427 pLew13 
pLew90 pHG27 clone 2 pHG172 clone 1. 
 
Figure 5-27- Western blot analysis of cell lysates from bloodstream form AIR9 RNAi cell 
lines transfected with pHG172 for endogenous expression of tyGFP:AIR9. 
Cell lysates were prepared for SDS PAGE and Western blotting (upper panels) with anti-GFP 
antibody. A and B: clones derived from parental cell lines 427 pLew13 pLew90 pHG27 clone 
1 and clone 2, respectively. The identity of the clones derived from the transfection of the 
parental cell lines with pHG172 are indicated at the top. Negative control (-): uninduced 
bloodstream form 427 pHD449 pHG130 clone 1 (a cell line for inducible expression of 
ty:AIR9 (data not shown)); positive control (+): bloodstream form 427 tyGFP:AIR9 clone 15 
(A) or clone 1 (B). To control for loading, the Western blots were stained with Ponceau 
reagent (lower panels). The signal for tyGFP:AIR9 (upper panels) was observed at its 
predicted size of 137 kDa.   
5.3.3.2 Kinetics of AIR9 downregulation in bloodstream form AIR9 RNAi cell 
lines expressing tyGFP:AIR9  
Two independent bloodstream form AIR9 RNAi cell lines expressing tyGFP:AIR9 
from the endogenous locus were grown in the presence or absence of 
tetracycline for 24 hours (Section 4.2.2.2), and samples taken and prepared for 
Western blotting (Section 4.6.3) at 12 and 24 hours. Western blots of cell lysates 
with anti-GFP antibody (Section 4.6.3.2) revealed levels of tyGFP:AIR9 were 
reduced by 12 hours post-induction, and by 24 hours post-induction, tyGFP:AIR9 
was barely detectable (Figure 5-28). These results show that in this system, AIR9 
can be efficiently downregulated at the protein level, to the extent that AIR9 
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expression is almost completely depleted by 24 hours post-induction. Unlike 
procyclic form cells (see Figure 5-7), AIR9 expression did not vary in uninduced 
cells, suggesting tight regulation of the T7 promoter in the RNAi construct in 
these cell lines. 
               
Figure 5-28- Downregulation of tyGFP:AIR9 in bloodstream form AIR9 RNAi cell lines. 
Cells expressing tyGFP:AIR9 derived from bloodstream form AIR9 RNAi cell lines: 427 
pLew13 pLew90 pHG27 clone 1 pHG172 clone 2 (panel A), 427 pLew13 pLew90 pHG27 clone 
2 pHG172 clone 1 (panel B); were grown in the presence (T +) or absence (T -) of 1 µgml
-1
 
tetracycline for 24 hours, and cell lysates were prepared at 12 hour intervals for analysis by 
SDS PAGE and Western blotting with anti-GFP antibody (to detect tyGFP:AIR9), and anti-
OPB antibody (to control for loading).  
5.3.3.3 The effect of AIR9 downregulation on growth and DNA content in 
bloodstream form parasites 
Growth of the AIR9 RNAi bloodstream form parasites was arrested 18 hours post-
induction, and parasite numbers then declined over the next 30 hours (Figure 
5-29). At 48 hours post-induction, the parasites recovered from the growth 
defect, and began to proliferate at a rate comparable to uninduced cells. This 
recovery implies an escape from the RNAi, which is commonly observed in RNAi 
experiments, particularly for bloodstream form parasites (Chen et al., 2003). 
Potential mechanisms for reversion include loss of the RNAi fragment and 
mutations at the tetracycline operator or T7 promoter (Chen et al., 2003); 
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defects in the RNAi machinery or epigenetic phenomena have also been 
suggested as mechanisms for recovery from RNAi (Motyka and Englund, 2004). 
The exact mechanism responsible for reversion in these independent AIR9 RNAi 
cell lines was not investigated in this study. However, the rapid reduction in cell 
proliferation coincides with reduction in AIR9 protein, and indicates that AIR9 is 
essential for viability in this developmental stage. 
       
Figure 5-29 -Cumulative growth curves of bloodstream form AIR9 RNAi cell lines. 
Triplicate cultures of two independent bloodstream form AIR9 RNAi cell lines (A: clone 1; B: 
clone 2) were grown in the absence (Tet-) or presence (Tet +) of 1 µgml
-1
 tetracycline; growth 
was analysed by determining the cell density at regular intervals (shown) over a period of 72 
hours. 
To investigate whether the observed growth defect occurred as a result of cell 
cycle defects, both RNAi cell lines were analysed by flow cytometry (Section 
4.10). Uninduced and induced cells were sampled at 0, 12 and 24 hours post-
induction, and methanol-fixed cells were stained with propidium iodide before 




Figure 5-30 -Flow cytometry analysis of bloodstream form AIR9 RNAi cell lines. 
Two independent bloodstream AIR9 RNAi clones (A-B: clone 1; C-D: clone 2) grown in the 
absence Tet-) or presence (Tet+) of tetracycline were analysed by flow cytometry. Time 
points of sampling, and ploidy are shown. 
The resultant profiles (Figure 5-30) show that both RNAi clones had the normal 
expected DNA content profile (as described above in Section 5.3.2.3) at the start 
of the induction. At 12 hours post-induction, there were significant changes to 
the DNA profiles for both clones; the sizes of the 2C and 4C peaks were 
considerably reduced and another peak appeared, corresponding to a DNA 
content of less than 2C, which could represent the accumulation of cell debris, 
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or anucleate cells. At 24 hours post-induction, further reduction of the 2C and 
4C peaks was observed,  the peak corresponding <2C DNA content grew 
dramatically, and cells with  DNA content of >4C were also visible. Other 
experiments (not shown here) performed with additional samples taken at 
earlier time points (6 and 9 hours post-induction) revealed a normal DNA profile 
at these times, implying that abnormalities in the DNA profile first occur 
between 9 and 12 hours post-induction. The appearance of < 2C and >4C peaks 
implies that cytokinesis is impaired in these cell lines. The early abnormality in 
DNA profiles coincides with a slight reduction in AIR9 protein, but precedes the 
initiation of the growth defect. This implies that a small depletion of AIR9 can 
affect the DNA profile without immediately inhibiting growth. It is likely that 
parasites are still able to divide at 12 hours post-induction (thereby not affecting 
the growth rate), but the flow cytometry profiles indicate that cell division is 
abnormal. 
5.3.3.4 Downregulation of AIR9 causes cytokinesis defects in bloodstream 
form parasites 
To further investigate cell cycle progression following AIR9 depletion, cells 
grown in the presence or absence of tetracycline were sampled at 6 hour 
intervals over a 24 hour period, fixed with methanol and stained with DAPI for 
analysis by fluorescence microscopy (Section 4.11.1). Cells (>200 per time point) 
were classified according to the number of kinetoplasts and nuclei they 
contained and if relevant, the cytokinesis stage. Relative organelle positions and 
cell morphology were also recorded.  
As expected, uninduced cell populations consisted of around 70-80% 1N1K cells, 
10-15% 1N2K cells and 5-10% 2N2K cells with <5% abnormal cell types (Figure 
5-31) and example images of cells with normal N-K configurations are presented 
in Figure 5-33.  Organelle positioning in post-mitotic bloodstream cells (KKNN, 
posterior to anterior) differs from that observed in procyclic form parasites 
(KNKN), which arises from a reduced basal body segregation in bloodstream form 
parasites, which results in an inter-basal body distance of just 2.5 μm (Tyler et 
al., 2001b) that is reduced prior to cytokinesis when basal bodies are parallel to 
each other. Typical 2N2K cells are shown in Figure 5-33C-D. Bloodstream 
parasites undergo furrowing more rapidly than procyclic form cells but appear to 
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spend longer at the abscission stage of cytokinesis, and nascent daughter cells 
attached at their posterior ends are frequently observed in culture.  
 
Figure 5-31 -DAPI staining of bloodstream form AIR9 RNAi cell lines. 
Bloodstream form AIR9 RNAi cell lines (A: clone 1; B: clone 2) were induced with 
tetracycline and stained with DAPI at the time points indicated. More than 200 cells per time 
point were classified according to the number of nuclei (N) and kinetoplasts (K) per cell. 
F/A: furrow ingression/abscission. 
Over the first 12 hours of AIR9 RNAi induction, a rapid reduction in 1N1K cells 
occurred, but the size of the 1N2K and 2N2K populations remained essentially 
unaltered (Figure 5-31), although by 18 hours post-induction, 1N1K, 1N2K and 
2N2K cell populations all declined. From 6 hours post-induction, abnormal cell 
types began to appear (Figure 5-31). The most abundant abnormal cell types 
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were 0N1K and 2N1K cells (Figure 5-34A), which appeared initially in equal 
numbers, and were significantly greater than in uninduced populations by 24 
hours (Figure 5-32 and Table 5-4). The equal numbers of each cell type suggests 
that these are sibling cells resulting from the asymmetric cell division of 2N2K 
cells (see Figure 5-34Aiii), and probably accounts for the observed decline in 
1N1K cells. 0N1K cells outnumbered 2N1K cells at later time points (particular 
for clone 1), and these ‘extra’ 0N1K cells are probably the products of 
abnormally dividing multinucleate cells (see later).  
 
Figure 5-32- Stastical analysis of 0N1K and 2N1K cells in AIR9 RNAi bloodstream form cell 
lines. 
Bloodstream form AIR9 RNAi cells grown in the absence or presence of 1 µgml
-1
 
tetracycline (‘Tet –‘ or ‘Tet +’, respectively ) were analysed by DAPI staining and scored 
according to the whether cells contained two nuclei an one kinetoplast (2N1K) or were 
anucleate (0N1K). The results from two experiments were used to generate a mean, with 
values ±SEM. ‘*’ indicates P=0.05 by an unpaired t-test (one-tail). 
  
147 
Table 5-4- P values from unpaired t-tests assuming equal variance (one-tail) to determine 
the significance of the appearance of abnormal cell types in induced AIR9 RNAi 
bloodstream form lines. 
The statistical significance of the appearance of 0N1K and 2N1K cells in AIR9 RNAi 
bloodstream form cell lines grown in the presence of 1µgml
-1
 tetracycline was determined 





Figure 5-33 –Nucleus–kinetoplast (N-K) configurations in normal bloodstream form cells. 
Cells from uninduced bloodstream form AIR9 RNAi cell lines were stained with DAPI and 
analysed by microscopy. Left panels: DAPI images; right panels: DAPI/DIC merge. A-D: 
example images of 1N1K, 1N2K, 2N2N (pre-cytokinesis) and 2N2K (abscission) cells, 
respectively. Scale bar: 10 μm. Arrows indicate the positions of the kinetoplasts, and the 
point of abscission for the 2N2K cell in D is indicated by an asterisk. 
The appearance of 2N1K and 0N1K cells coincided with the emergence of 
multinucleate cells (Figure 5-31).  These were initially vermiform in shape 
(Figure 5-34B), and at later time points were frequently observed to be 
undergoing furrow ingression or to be in abscission (Figure 5-31 and Figure 
5-34C). This suggests that cytokinesis was not blocked, but delayed, although it 
is also possible that multinucleate cells undergoing furrow ingression were 
underrepresented at these early time points due to stochastic variation. At 24 
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hours post-induction, some multinucleate cells appeared to have lost cell 
polarity, and displayed a rounded morphology (Figure 5-31 and Figure 5-34D). 
The number of nuclei and kinetoplasts observed per cell was highly variable and 
up to 8 nuclei were recorded for one cell, although in many cases, it was 
impossible to count the actual number of these organelles.  
 
Figure 5-34 – Cells with abnormal N-K configurations observed following induction of AIR9 
RNAi in bloodstream form cells. 
Bloodstream form AIR9 RNAi cells were induced and stained with DAPI to determine the 
number of nuclei (N) and kinetoplasts (K, arrows) per cell, which revealed the presence of 
abnormal cell types. Ai-iii: 0N1K and 2N1K cells; Bi-ii: multinucleate cells without signs of 
cytokinesis intiation; Ci-ii: multinucleate cells undergoing abscission (sites indicated by 
asterisks); Di-ii: multinucleate cells with rounded morphology. Scale bars: 10 μm.  
It appears that AIR9 depletion in bloodstream form trypanosomes resulted in two 
different cytokinesis defects; initially cleavage plane positioning was affected, 
resulting in asymmetric cell division, and later the coupling of cytokinesis and 
organelle replication was disrupted resulting in multinucleate cells. The rapid 
effect of AIR9 depletion on cleavage plane positioning without increasing the 
abundance of 2N2K cells implies that the dynamics of cytokinesis were not 
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affected. Similarly, the decoupling of organelle replication and cytokinesis, such 
that cells re-replicated their organelles without having undergone cell division, 
must also have occurred rapidly. Such a rapid effect is unusual; knockdown of 
cytokinesis regulators PK50 and PK53 resulted in the production of similar 
multinucleate cells (Ma et al., 2010), but in this case, 2N2K cell numbers 
increased from 10% to 20% or 25% of the whole population (for PK50 and PK53 
RNAi cell lines, respectively) prior to the emergence of these cell types.  
To determine whether the 2N1K and 0N1K cells were indeed sibling cells of a 
parental 2N2K cell, >200 2N2K cells were examined at 0, 6 and 12 hours post-
induction (Figure 5-35).  
 
Figure 5-35 -Analysis of 2N2K cells in bloodstream form AIR9 RNAi cell lines. 
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Bloodstream form AIR9 RNAi cells (A: clone 1; B: clone 2) were induced and stained with 
DAPI and >200 2N2K cells were analysed at the time points indicated. Cells were classified 
according to the positions of nuclei (N) and kinetoplasts (K) in addition to cytokinesis stage, 
as indicated in the key. F/A: furrow ingression/abscission. 
For both RNAi clones, an increase in cells undergoing abscission was observed 
over time. At the start of the induction, 42% or 16% of 2N2K cells displaying a 
typical ‘KKNN’ arrangement were undergoing abscission, and this rose to 62% or 
52% at 12 hours post-induction for clones 1 and 2, respectively. However, many 
of the cells in abscission (23% and 15% for clones 1 and 2, respectively) displayed 
malpositioned cleavage furrows such that the two nascent daughter cells had 
0N1K and 2N1K organelle quotas, respectively (Figure 5-36A). Furthermore, a 
small proportion (approximately 5%) of 2N2K cells displayed N-K positioning 
defects at 6 hours post-induction, and by 12 hours post-induction, 2N2K cells 
with abnormal N-K positioning were also observed to be undergoing cytokinesis 
leading to non-equivalent daughter cell progeny (Figure 5-36B-C). This 
experiment determined the main source of 0N1K and 2N1K cells to be 2N2K cells 
with typical N-K positions but abnormally positioned cleavage furrows, but also 
implied that 2N2K cells displaying abnormal organelle positioning may have 




Figure 5-36 -2N2K cells displaying cytokinesis defects following induction of AIR9 RNAi in 
bloodstream form trypanosomes. 
Bloodstream form AIR9 RNAi cells were induced with tetracycline and stained with DAPI, 
revealing 2N2K cells with cytokinesis defects. Ai-ii: cells with normal kinetoplast and nuclei 
positions but abnormal furrow placement; Bi-ii; cells with abnormal organelle positions 
undergoing furrow ingression; Ci-iii; cells with abnormal organelle positions undergoing 
abscission.  The predicted organelle quota and arrangement for each nascent daughter cell 
is indicated. Scale bars: 10 µm. 
To determine whether N-K positioning defects observed in 2N2K cells were also 
present at other cell cycle stages, >200 cells of each cell cycle stage (1N1K, 
1N2K, 2N2K) were analysed at 15 hours post-induction (Figure 5-37).  
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Figure 5-37 -Lineage analysis to investigate the chronology of organelle positioning defects 
in bloodstream form AIR9 RNAi cell lines. 
Bloodstream form AIR9 RNAi cells (A: clone 1; B: clone 2) were induced with tetracycline 
(Tet) for 15 hours and stained with DAPI. The proportions of cells with abnormal organelle 
positioning (n>200 cells) for 1N1K, 1N2K, and 2N2K configurations are indicated. 
As a control, similar numbers of uninduced cells were also analysed at this time 
point, but few displayed abnormalities in organelle positioning. Amongst the 
induced cell populations, no abnormal N-K positioning was observed in 1N1K 
cells, and only a few 1N2K cells possessed N-K positioning defects (2.5 % or 5.6 % 
for clones 1 and 2, respectively).  However, much large proportions of 2N2K cells 
displayed aberrant N-K positioning (42.6 % or 22 % for clones 1 and 2, 
respectively). This implies that these organelle positioning defects are primarily 




In bloodstream form parasites AIR9 depletion was rapidly induced in the system 
described, such that AIR9 protein was barely detectable 24 hours after induction 
of the RNAi. Reduction of AIR9 protein directly affected the accuracy of 
cleavage furrow positioning, resulting in the production of 2N1K and 0N1K cells. 
In addition, organelle replication and cytokinesis became uncoupled resulting in 
the production of multinucleate cells that were capable of initiating cytokinesis, 
but that frequently did not complete cell division and instead formed clumps of 
attached cells. The dynamics of asymmetric cell division were not noticeably 
different from normal cell division, and abnormalities in N-K configurations and 
DNA profile preceded a decrease in cell proliferation. Unlike procyclic form 
cells, organelle positioning defects were not a dominant feature of the RNAi 
phenotype; however, abnormal organelle positioning was found to occur to an 
extent in post-mitotic cells, possibly suggesting a cell cycle-specific loss of cell 
polarity. 
5.4 Localisation of AIR9 in Trypanosoma brucei 
In order to shed further light on the function of AIR9, its cellular localisation was 
investigated.  Since antibodies have not yet been raised to T. brucei AIR9, its 
localisation was investigated by epitope tagging AIR9 and performing (immuno) 
fluorescence and subcellular fractionation, using anti-tag antibodies to detect 
tagged AIR9. Two different tagging strategies were used, with different tags 
being inserted at opposite ends of the protein, in order to increase the 
robustness of the results, since tagging a protein may interfere with its folding 
or trafficking in the cell. AIR9 was therefore tagged at the N-terminus with 
tyGFP and at the C-terminus with a 6xHA tag.  To further minimise artefacts, the 
tagged proteins were expressed from the endogenous locus and hence were 
likely to be expressed at near native levels.  
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5.4.1 Construction of plasmids ‘pHG172’ and ‘pHG182’ for epitope 
tagging of AIR9 at the endogenous locus  
The vector ‘pENT-6-Blast eGFP-TY’ (Kelly et al., 2007) was used to add a tyGFP 
epitope tag to the N-terminus of AIR9. A 269 bp fragment corresponding to the 
3` end of the 5` untranslated region (UTR) and a 355 bp fragment of the 5` end 
of the open reading frame (ORF) minus the start codon of AIR9 were PCR-
amplified (Section 4.5.4) from T. brucei 427 genomic DNA (Section 4.4.2) using 
oligonucleotides PR94 and PR95, and PR96 and PR97, respectively (Table 4-9). 
The UTR and ORF fragments were ligated into the pSC-A vector (Strataclone, 
Section 4.5.6) generating pHG108 and pHG109 (Table 4-4), respectively, and 
sequenced (Section 4.5.8).  The UTR and ORF fragments were excised from 
pHG108 and pHG109 by restriction digest (Section 4.5.2) with NheI/BclI and 
NheI/XbaI, respectively, purified and ligated in a three-way ligation (Section 
4.5.7) with BamHI/XbaI-cut pENT-6-Blast-tyGFPty generating pHG172 (Figure 
5-38 and Table 4-4). 
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Figure 5-38 -Plasmid map of pHG172. 
pHG172 was generated to add a tyGFP epitope tag to the N-terminus of AIR9. Important 
features of pHG172 include: AIR9 5’ UTR (269 bases upstream from the start codon) and 
ORF (bases 4-358) fragments separated by a unique NheI site for linearization of the plasmid 
to allow integration at the endogenous locus; a tyGFP epitope tag situated upstream from 
and in frame with the ORF fragment, and a blasticidin resistance gene (BLAST R) for 
selection of genetically modified parasites.  
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The vector Orc-_6XHA_Ble was used to add six haemagluttinin epitopes (6XHA) 
to the C-terminus of AIR9. Orc-_6XHA_Ble is a modified version of pNAT6MycX 
(Alsford and Horn, 2008) where the blasticidin resistance marker has been 
replaced by a bleomycin resistance marker and the 6xMyc epitope tag coding 
sequence has been replaced with 6XHA (Calvin Tiengwe, personal 
communication). A 724 base fragment corresponding to the 3` end of the AIR9 
ORF containing a unique AspI restriction site was PCR-amplified (Section 4.5.4) 
from 427 genomic DNA (Section 4.4.2) using oligonucleotides PR228 and PR229 
(Table 4-9).  The amplified gene fragment was ligated into pSC-B (Strataclone, 
Section 4.5.6), generating pHG184 (Table 4-4) and sequenced (Section 4.5.8). 
The AIR9 fragment was then excised from pHG184 by restriction digestion 
(Section 4.5.2) with HindIII and XbaI, purified (Section 4.5.3) and ligated 
(Section 4.5.7) into HindIII/XbaI-cut Orc-_6XHA_Ble, generating pHG182 (Figure 
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Figure 5-39 -Plasmid map of pHG182. 
pHG182 was generated to add a C-terminal 6XHA tag to AIR9. Important features of pHG182 
include a fragment (724 bp) of the 3’ end of the AIR9 ORF, minus the stop codon, inserted in 
frame with the 6XHA tag; a unique AspI restriction site at position 383 inside the ORF 
fragment to allow linearization of the plasmid for transfection and integration into the AIR9 
locus and a bleomycin resistance gene (Ble) for selection of genetically modified parasites.  
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5.4.2 Generation of parasites expressing epitope-tagged AIR9 
The plasmids pHG172 and pHG182 were linearised by restriction digestion 
(Sections 4.5.2 and 4.3.2.1) with NheI or AspI, respectively, and transfected into 
427 bloodstream and procyclic form T. brucei parasites (Section 4.3.2.2). Clones 
were selected by limiting dilution in medium supplemented with the appropriate 
antibiotics (Table 4-7). To verify expression of epitope tagged AIR9 protein, cell 
extracts from parasite clones were prepared for PAGE (Section 4.6.1) and 
Western blotting (Section 4.6.3) with the appropriate antibodies. Analysis of 
nine out of seventeen independent clones obtained from the transfection of T. 
brucei 427 bloodstream form parasites with pHG172 with anti-GFP antibody 
identified three clones that expressed a protein of the predicted size for 
tyGFP:AIR9 of 137 kDa (Figure 5-40A). Five independent clones were obtained 
from the transfection of bloodstream parasites with pHG182 and Western 
blotting with an anti-HA antibody detected a protein of the predicted size for 
AIR9:6XHA (117 kDa) in cell lysates of all five clones (Figure 5-40B). By similar 
means, four out of eight procyclic clones obtained from the transfection with 
pHG172 and two out of three procyclic clones obtained from the transfection 





Figure 5-40 -Western blot analysis of bloodstream form parasites transfected with pHG172 
and pHG182 for expression of tyGFP:AIR9 and AIR9:6XHA respectively, from the 
endogenous locus. 
To verify expression of recombinant AIR9, cell lysates were analysed by SDS PAGE  and 
Western blotting (upper panels) with anti-GFP antibody (Ai-ii) or anti-HA antibody (B). To 
control for loading, Western blots were stained with Ponceau reagent (lower panels). The 
numbers of clones derived from transfection of bloodstream form 427 cells are given; ‘+’: 
positive control lysate (procyclic form 427 pHG172 clone 7 (see Figure 5-41A); ‘-’: negative 
control lysate (bloodstream form 427).  
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Figure 5-41 -Western blot analysis of procyclic form parasites transfected with pHG172 and 
pHG182 for the expression of tyGFP:AIR9 and AIR9:6XHA, respectively, from the 
endogenous locus. 
To verify expression of recombinant AIR9, cell lysates were analysed by SDS PAGE  and 
Western blotting with anti-GFP antibody (A, upper panel) or anti-HA antibody (B). To control 
for loading, Western blots were stained with Ponceau reagent (A, lower panel) or treated 
with anti-OPB antibody (B). The numbers of the clones derived from transfection of  
procyclic form 427 cells are given; ‘+’: positive control lysate (bloodstream form 427 
pHG182 clone 1  (Figure 5-40B); ‘-’: negative control lysate (427 procyclic form). 
 
5.4.3 Localisation of epitope tagged AIR9 
Selected epitope tagged AIR9 clones were analysed by fluorescence microscopy 
(tyGFP:AIR9) or immunofluorescence microscopy with anti-HA antibody 
(AIR9:6XHA) (Section 4.11) to determine the localisation of AIR9.  Cells were co-
stained with DAPI (Section 4.11.1), and the pattern of fluorescence obtained was 




Figure 5-42 -Localisation of tyGFP:AIR9 and AIR9:6XHA in procyclic form parasites. 
Procyclic form clones shown to express tagged AIR9 proteins by Western blotting were 
examined by (immuno)fluorescence microscopy. A: cells expressing tyGFP:AIR9 (green, 
FITC); B: cells expressing AIR9:6XHA (red, anti-HA). Fluorescent images were deconvolved. 
DNA was stained with DAPI (blue) and the number of nuclei (N) and kinetoplasts (K) per cell 
is indicated. Cell morphology is shown in the DIC and merge (DAPI/GFP or anti-HA/DIC) 





Figure 5-43 -Localisation of tyGFP:AIR9 and AIR9:6XHA in bloodstream form T. brucei 
parasites. 
Bloodstream form clones shown to express tagged AIR9 proteins by Western blotting were 
examined by (immuno)fluorescence microscopy. A: cells expressing tyGFP:AIR9 (green, 
FITC); B: cells expressing AIR9:6XHA (red, anti-HA). Fluorescent images were deconvolved. 
DNA was stained with DAPI (blue) and the number of nuclei (N) and kinetoplasts (K) per cell 
is indicated. Cell morphology is shown in the DIC and merge (DAPI/GFP or anti-HA/DIC) 
panels. Scale bars: 5μm.  
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Cells at different cell cycle stages displayed similar levels of fluorescence and all 
exhibited bright staining of the cell body. This staining did not extend beyond 
the cell bodies to the flagella tips. The pronounced staining of the cell outline 
resembled staining of the cell surface (Engstler et al., 2007) or subpellicular 
cytoskeleton (Sherwin and Gull, 1989b; Woods et al., 1989). In addition, post-
mitotic cells displayed particularly bright staining at the midline of the cell, 
which seemed to correspond to regions where invaginations of the cell body 
occurred, possibly localising to the site of furrow ingression (Figure 5-42Aiii and 
Biii-iv, and Figure 5-43Aiii and Biii-iv) although, given the cell contours at this 
point, it is perhaps more likely to represent AIR9 beginning to localise to the 
edge of the newly forming daughter cell body as can clearly be seen in Figure 
5-42Biv and Figure 5-43Biii.  
In order to determine whether AIR9 localises to the cytoskeleton or cell 
membrane of T. brucei, cytoskeletons of cells expressing tyGFP:AIR9 were 
prepared (Section 4.11.3) and analysed by fluorescence microscopy (Section 
4.11.1). For both procyclic and bloodstream form cells, the intensity of 
fluorescence of the cytoskeletons was comparable to that observed with whole 
cells (compare Figure 5-42A and Figure 5-43A with Figure 5-44), indicating that 
tyGFP:AIR9 was not detergent extracted to any significant extent, and is 
therefore likely to localise to the cytoskeleton. Cytoskeletons of cells at all cell 
cycle stages exhibited similar, bright staining around the outline of the cell 
body. The flagella were more visible in the cytoskeleton preparations compared 
to fluorescence microscopy of whole cells, and clearly were not fluorescent, 
indicating that tyGFP:AIR9 does not localise to the flagellum to any significant 
extent. The almost identical localisation patterns obtained with the two 
different epitope tags inserted at opposite ends of the protein suggests that 




Figure 5-44 -Cytoskeletons of procyclic and bloodstream form T. brucei expressing 
tyGFP:AIR9. 
Cytoskeletons were prepared from procyclic (A) and bloodstream (B) form parasites 
expressing tyGFP:AIR9 (green, FITC) and analysed by fluorescence microscopy. 
Fluorescent images were deconvolved. DNA was stained with DAPI (blue) and the number 
of nuclei (N) and kinetoplasts (K) per cell is indicated. Cell morphology is shown in the DIC 
and merge (DAPI/GFP/DIC) panels. Scale bars: 5μm.  
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5.4.4 Subcellular fractionation of epitope tagged AIR9 
In order to more precisely examine the subcellular localisation of AIR9, 
biochemical fractionation of procyclic cells expressing tyGFP:AIR9 and both 
procyclic and bloodstream cells expressing AIR9:6XHA into cytoskeletal and 
flagellar fractions was carried out by a series of detergent extraction and high 
salt treatments (Section 4.6.10 and (Broadhead et al., 2006)). Cells treated with 
PEME buffer (Section 4.6.10) supplemented with the detergent NP-40 become 
permeablised and cytoplasmic proteins are able to diffuse out of the cells, to 
leave intact cytoskeletons. Application of 1 M NaCl to these cytoskeletons causes 
depolymerisation of subpellicular microtubules and releases microtubule-
associated proteins, without affecting the stability of the flagellum or the 
associated microtubule quartet. Following treatment, fractions were prepared 
and analysed by NuPAGE (Section 4.6.1.2) and Western blotting (Section 4.6.3). 
Epitope tagged AIR9 was detected with anti-GFP or anti-HA antibodies, while 
antibodies against cytoplasmic (OPB or EF1-α), cytoskeletal (β-tubulin) and 
paraflagellar rod (PFRA and C) markers were used to control for the efficiency of 
the biochemical fractionation (Section 4.6.3.2, Table 4-14 and Figure 5-45). 
 
Figure 5-45 - Analysis of subcellular fractions of T. brucei expressing tyGFP:AIR9 and 
AIR9:6XHA by Western blotting. 
Subcellular fractions from procyclic form cells expressing tyGFP:AIR9 (A: 427 pHG172 
clone 2), and AIR9:6XHA (B: 427 pHG182 clone 1), and bloodstream form cells expressing 
AIR9:6XHA (C: 427 pHG182 clone 3), were prepared for NuPAGE and Western blotting with 
anti-GFP antibody or anti-HA antibody (as appropriate) to detect epitope tagged AIR9; anti-
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β-tubulin antibody and anti-PFRA and C antibody to detect markers of the cytoskeleton and 
flagellum, respectively, and anti-EF1-α antibody (A and B) or anti-OPB (C) antibody to detect 
markers of the cytoplasm. WCL: whole cell lysate; S: supernatant; P: pellet; S1, cytoplasmic 
fraction; S2 and S3; depolymerised cytoskeletal fractions; P1 and P2: cytoskeletal fractions; 
P3: flagellar fraction. 10
6
 cell equivalents were loaded per lane with the exception of the 
supernatant fractions in panel A, for which 5 x 10
5
 cell equivalents were loaded.   
The control markers showed the subcellular fractionation to have worked 
efficiently.  EF1-α and OPB were detected in the whole cell lysates and 
cytoplasmic fractions, with little contaminating the cytoskeletal fractions, 
although problems with the degradation of EF1-α were encountered, despite the 
use of protease inhibitors, resulting in a reduced abundance of this protein in 
the cytoplasmic fractions. β-tubulin was detected in the whole cell lysates and 
in the P1 cytoskeleton fractions.  It was also present in the S2 depolymerised 
cytoskeleton fractions, showing the salt treatment was effective at 
depolymerising subpellicular microtubules, and some β-tubulin remained, as 
expected, in the P2 cytoskeleton and flagella fractions. PFRA and C 
predominantly remained present in the pellet fractions to a similar extent 
throughout the fractionation and were present in the flagella fraction at the 
end, indicating that the flagellar microtubules, unlike the subpellicular 
microtubules, were not depolymerised by the salt treatment. tyGFP:AIR9 and 
AIR9:6XHA were detected to similar extents in whole cell lysates and 
cytoskeleton fractions, and to a lesser extent in partial cytoskeleton fractions 
(P2). In addition, tyGFP:AIR9 and AIR9:6XHA were detected in the supernatants 
obtained from the first salt treatment of the cytoskeletons. The relative 
quantities of tagged AIR9 and β-tubulin detected in the cytoskeletal fractions 
and salt extracts of the cytoskeletons were similar, which implies that 
AIR9:6XHA behaves like a component of the subpellicular corset and is likely to 
be associated with polymerised microtubules. Very little, if any, AIR9 was 
detected in either the cytoplasmic or flagellar fractions, consistent with 
microscopy data discussed above (Section 5.4.3). 
5.4.5 Microscopical analysis of procyclic tyGFP:AIR9 subcellular 
fractions 
Analysis of subcellular fractions by microscopy (Section 4.11.3) was performed to 
further investigate the localisation of tyGFP:AIR9 in a cellular context. As 
observed previously (Figure 5-42, Figure 5-43 and Figure 5-44), both whole cells 
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and cytoskeletons exhibited bright staining of the whole cell body but not the 
flagella (Figure 5-46A and B). Salt treatment produced a curious effect whereby 
the majority of the staining was removed, but some protein remained adhered 
to the slide creating a ‘ghost cell’ imprint (Figure 5-46C). In addition, groups of 
more stable microtubules were observed which were frequently splayed out as 
cytoskeletons disintegrated. These microtubules appeared to be components of 
the subpellicular corset as opposed to the microtubule quartet (inferred from 
comparing the localisation of the brightly stained microtubules and the 
kinetoplast, which is where the microtubule quartet originates from). No 
staining of the flagella or basal bodies could be detected (Figure 5-46B-D). 
       
Figure 5-46 –Localisation of tyGFP:AIR9 in procyclic form cells, cytoskeletons and 
cytoskeletal fractions. 
Whole cells, cytoskeletons and cytoskeletal fractions for procyclic form parasites 
expressing tyGFP:AIR9 (green) were prepared, stained with DAPI, and analysed by 
fluorescence microscopy. DAPI/FITC merges, DIC and DAPI/FITC/DIC merges are shown 
above; the fluorescence images are deconvolved. Scale bars: 5 μm. 
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5.4.6 Co-localisation of AIR9:6XHA and β-tubulin in procyclic 
form cells 
To further investigate the localisation of AIR9, cytoskeletons (Section 4.11.3) 
prepared from procyclic form cells expressing AIR9:6XHA were co-stained with 
anti-HA and anti β-tubulin antibodies (Table 4-16) and analysed by 
immunofluorescence microscopy (Section 4.11.2) revealing that while the 
staining patterns of these antibodies co-localised within the subpellicular corset, 
only anti-β-tubulin stained the flagella (Figure 5-47). This was particularly 
noticeable at the region of the flagellum tip (Figure 5-47C). Interestingly, 
cytoskeletons of post-mitotic cells undergoing furrow ingression displayed bright 
staining outlining the nascent daughter subpellicular corset that was observed 
with both anti-HA and anti β-tubulin antibodies (Figure 5-47B), implying that this 
pattern of staining can occur as a result of increased microtubule density at the 
furrow. The similarity between the staining patterns obtained with anti-HA and 
anti-β-tubulin antibodies provides further evidence that AIR9:6XHA localises to 
the subpellicular microtubules. 
 
Figure 5-47 –Immunofluorescence analysis of AIR9 and β-tubulin in cytoskeleton 
preparations of procyclic form T. brucei expressing AIR9:6XHA. 
Cytoskeletons of procyclic form 427 pHG182 clone 3 cells (Section 5.4.2) were analysed by 
immunofluorescence using anti-β-tubulin (green) and anti-HA (red) antibodies. DNA was 
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stained with DAPI (blue) and the number of nuclei (N) and kinetoplasts (K) per cell are 
indicated (A: 1N1K; B: 2N2K). C: two fold enlargement of the anterior of a 1N1K cell to show 
staining at the flagellar tip. Fluorescenc images are deconvolved and the identity of each 
panel is indicated in A and B; in C, i: anti-β-tubulin; ii: anti-HA; iii: anti-β-tubulin/HA merge; 
iv: DIC.  Scale bars: 5 µm. 
5.4.7 Dynamics of tyGFP:AIR9 depletion following AIR9 RNAi 
induction 
Depletion of several T. brucei MAPs by RNAi has shown them to be depleted 
preferentially from the posterior end of the parasite (Baines and Gull, 2008; 
Olego-Fernandez et al., 2009).  It was therefore of interest to investigate the 
dynamics of AIR9 depletion in AIR9 RNAi cells.  To this end, procyclic and 
bloodstream form AIR9 RNAi cell lines expressing tyGFP:AIR9 from the 
endogenous locus (described in Sections 5.3.2.1 and 5.3.3.1) were analysed by 
fluorescence microscopy (Section 4.11.1) at 24 and 48 hours (procyclic form) or 
12 and 24 hours post-induction (bloodstream form).   
As expected, in uninduced cells or at time 0, tyGFP:AIR9 was detected at the 
outline of the cell body, but not in the flagellum (Figure 5-48Ai and Bi and Figure 
5-49Ai).  
In procyclic cell lines, induced cells were markedly less bright at their posterior 
ends (Figure 5-48Aii-iii, Bii-iii and Bv-vi), which was true for cells with and 
without organelle positioning defects (compare Figure 5-48Aii-iv with Figure 
5-48Bii-iii); the emergence of cells with organelle positioning defects in 
procyclic form RNAi cell lines is described in section 5.3.2.5. This depletion of 
fluorescence extended for up to half of the cell length in some cases (Figure 
5-48Biii), and a few cells were also observed with virtually no fluorescence at all 
(Figure 5-48iv). In addition, a bright region of fluorescence was observed in the 
vicinity of the kinetoplast (Figure 5-48Aiv and Bvi), which could potentially 
represent tyGFP:AIR9 entering the lysosome prior to degradation.  
In bloodstream form cells, induction of AIR9 RNAi also resulted in the depletion 
of tyGFP:AIR9 preferentially from the posterior end (Figure 5-49Aii and Bi).  
Some cells were also observed to be completely devoid of tyGFP:AIR9 
fluorescence (Figure 5-49Biii). However, some abnormal cells, particularly 
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multinucleate cells, were still strongly fluorescent even after 24 hours’ induction 
and displayed bright lines of staining within the cell (Figure 5-49Bvi).   
 
Figure 5-48 –Dynamics of tyGFP:AIR9 depletion in procyclic form AIR9 RNAi cell lines. 
RNAi cell lines expressing tyGFP:AIR9 (described in Section 5.3.2.1) were grown in the 
presence (Tet +) or absence (Tet -) of tetracycline for 24 (A) or 48 (B) hours. Cells were 
stained with DAPI (blue) and analysed by fluorescence microscopy (tyGFP:AIR9, green, 
FITC).  The number of nuclei (N) and kinetoplasts (K) per cell are indicated, and, where 
appropriate, the positions of these organelles are noted as described in Section 5.3.2.5. 
Fluorescence images are deconvolved. DAPI, FITC, DAPI/FITC merge, DIC and merged 
panels are indicated. Asterisks in Aiv and Bvi indicate a region of more concentrated 





Figure 5-49 –Dynamics of tyGFP:AIR9 depletion in bloodstream form AIR9 RNAi cell lines. 
RNAi cell lines expressing tyGFP:AIR9 (described in Section 5.3.2.1) were grown in the 
presence of tetracycline (Tet +)  for 0-24 hours, as indicated. Cells were stained with DAPI 
(blue) and analysed by fluorescence microscopy (tyGFP:AIR9, green, FITC).  Example 
images of cells with normal (A) and abnormal (B) nuclei (N)-kinetoplast (K) configurations, 
as indicated, are shown. Fluorescence images are deconvolved. DAPI, FITC, DAPI/FITC 




The preferential depletion of AIR9 from the posterior end of the cell is 
consistent with a MAP-like role for AIR9.  At this region, the subpellicular 
microtubules are more dynamic, which could explain the more rapid loss of 
protein from this location. The lines of bright fluorescence observed in some 
multinucleate cells are harder to interpret, but could represent ingressions of 
the cell body analogous to those observed normally in post-mitotic cells. If this is 
the case, the irregular localisation of this staining would provide another 
indicator of disrupted cell polarity. 
 
5.4.8 Organisation of subpellicular microtubules in procyclic form 
AIR9 RNAi cell lines 
To investigate the effect on microtubule structure following depletion of AIR9 by 
RNAi, the procyclic form AIR9 RNAi cell lines (clones 4 and 5; Section 5.3.2.1) 
were cultured in the presence or absence of tetracycline for 72 hours (Section 
4.2.2.2) prior to fixation and analysis by Transmission Electron Microscopy 
(Section 4.11.4). The organisation of the subpellicular microtubules appeared to 
be unaffected by depletion of AIR9 (Figure 5-50A-B). Basal body transition zones 
displayed normal quota and arrangement of doublet microtubules (Figure 5-50D), 
flagellar axonemes displayed the typical ‘9 + 2’ organisation (Figure 5-50C) and 
the position of flagella and basal bodies relative to the kinetoplast and flagellar 
pocket appeared to be comparable between uninduced and induced cells (Figure 
5-50E-F). These results demonstrate that despite the dramatic effect on 
organelle positioning, AIR9 depletion did not cause dramatic alterations to the 
cytoskeleton, and this implies that whilst AIR9 is localised to the cytoskeleton, it 





Figure 5-50 -Analysis of cytoskeletal structures in procyclic form AIR9 RNAi cells by 
transmission electron microscopy. 
Procyclic form AIR9 RNAi cells (427 pLew13 pLew 29 pHG27 clone 4 (Section 5.3.2.1)) were 
grown in the presence or absence of tetracycline for 72 hours and analysed by transmission 
electron microscopy (TEM). TEM images are shown for uninduced (‘i’) and induced (‘ii’) 
cells. Images show: transverse (A) and glancing (B) sections of subpellicular microtubules; 
transverse section of flagellum (C); transverse (D) and longitudinal (E) sections of transition 
zone of flagellum; basal bodies and kinetoplast (F). Scale bars are indicated for each image.  
5.4.9 Expression of tyGFP:AIR9 in T. brucei epimastigote 
parasites 
The organelle positioning defect observed in procyclic form cells depleted of 
AIR9 was reminiscent of the ‘NK’ arrangement of organelles in salivary gland 
epimastigote parasites (Sharma et al., 2007). This may imply that AIR9 has a role 
in the changes in organelle positioning that occur during differentiation. As 
organelle positioning was affected when AIR9 depletion occurred, it was 
hypothesised that a decrease in AIR9 in the epimastigote stage could mediate 
this change in N-K positioning. In order to investigate whether AIR9 is absent or 
expressed at lower levels during this life cycle stage, tsetse fly transmissible 
procyclic form parasites were transfected with pHG172 (Table 4-4, Section 
5.4.1), and transfectants were fed to tsetse flies which were later dissected to 
obtain salivary gland epimastigotes. These epimastigotes were analysed by 
fluorescence microscopy to detect expression of tyGFP:AIR9. (With the 
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exception of preparation of the pHG172 plasmid, this work was carried out by 
Wendy Gibson and Lori Peacock, University of Bristol). 
 
Figure 5-51 -Localisaton of tyGFP:AIR9 in epimastigotes. 
Procyclic form 427 variant 3 parasites were transfected with pHG172 (section 5.4.1), and 
clones which were found to express tyGFP:AIR9 were fed to tsetse flies as a blood meal. 
Epimastigotes from the salivary glands of dissected tsetse flies were dissected, stained 
with DAPI and analysed by fluorescence microscopy at 19 (Ai-ii) and 20 days (B) post-
infection. DAPI, FITC, DAPI/FITC merge and DIC images are shown. These data were 
generated by Prof. Wendy Gibson and Dr Lori Peacock at the University of Bristol. 
Contrary to the hypothesis, tyGFP:AIR9 was expressed in epimastigotes (Figure 
5-51) with a comparable localisation to that observed in procyclic and 
bloodstream form parasites cultured in vitro. Hence, AIR9 depletion does not 
appear to be required in epimastigote parasites to maintain the distinctive ‘NK’ 
organelle arrangement at this life cycle stage.  
5.4.10 Summary 
AIR9 displayed a cytoskeletal localisation in both bloodstream and procyclic form 
life cycle stages, which was indiscriminate of whether cells expressed AIR9 with 
a tyGFP tag at the N terminus or a 6XHA tag at the C terminus (Section 5.4.3). 
Staining of whole cell bodies but not flagella indicated localisation to the 
subpellicular corset, which was confirmed by analysis of cytoskeletons by 
microscopy, subcellular fractionation, and co-immunofluorescence of 
cytoskeletons using antibodies against β-tubulin and the AIR9 epitope tag 
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(Section 5.4.3 and Section 5.4.6). All cell cycle stages in both procyclic and 
bloodstream form cells displayed similar staining patterns, although post-mitotic 
cells displayed additional staining along the midline of the cell which was 
believed to represent staining at the edge of the nascent daughter cell. Analysis 
of cells depleted of AIR9 by RNAi revealed that downregulation of AIR9 occurs at 
the posterior end more rapidly than the rest of the cell body (Section 5.4.7), 
which is in agreement with its localisation to the subpellicular microtubules. 
Depletion of AIR9 did not result in obvious changes to the organisation of 
subpellicular microtubules as observed by TEM (Section 5.4.8) and therefore, the 
organelle and cleavage furrow positioning defects observed upon depletion of 
AIR9 are not likely to be due to loss of microtubule structural integrity. In 
addition, the expression of AIR9 in epimastigotes suggested that depletion of 
AIR9 is not required for maintaining the ‘NK’ organisation of organelles (Figure 
5-51).  
The localisation of AIR9 may explain the functional roles of this protein in 
organelle and cleavage plane orientation. The presence of Ig-like folds in the 
structure of this protein (Section 5.1) suggest that it is capable of interacting 
with other proteins, and recruitment of cytoplasmic proteins to the cytoskeleton 
could be important for communicating information regarding cell polarity. It is 
possible that AIR9 could form a scaffold for the association of proteins involved 




6 Microtubule dynamics 
6.1 Inhibitors of microtubule dynamics 
Small molecules, which inhibit the stability of microtubules are readily 
available, due to their pharmacological applications as herbicides, anthelmintics 
and antineoplastic agents. Paclitaxel (‘taxol’), vinca alkaloids and colchicine are 
natural inhibitors of microtubule dynamics, and were isolated from the pacific 
yew (Taxus brevifolia), the pink periwinkle plant (Catharanthus roseus) and the 
autumn crocus (Colchicum autumnale), respectively (Hait et al., 2007). In 
contrast, the anthelmintic benzimidazoles and dinitroanaline herbicides are 
synthetic heterocyclic aromatic compounds. The inhibitors bind to different sites 
within microtubules. Taxol (Figure 6-1) binds to microtubules at the taxol-
binding pocket, a hydrophobic pocket on the β-tubulin subunit, causing 
microtubule shortening and stabilisation. The effect of the drug is dependent on 
its concentration, and higher concentrations can also induce bundling of 
microtubules. Vinca alkaloids, including vinblastine and vincristine (Figure 6-1), 
bind to a separate binding site located between tubulin heterodimers, and 
binding of these compounds to the positive ends of microtubules inhibits their 
polymerisation. This effect is observed when low concentrations of inhibitor are 
applied, and at higher drug concentrations, binding can also occur at low affinity 
but high capacity binding sites, resulting in disintegration of microtubules. Due 
to their effect on mitotic spindle assembly, these drugs are used as anti-
neoplastic agents, and much is known about the both the mechanisms of action 
for these compounds and their off-target effects. In addition to their effects on 
mitosis, low concentrations of these compounds have been shown to causes 
changes in the phosphorylation of proteins involved in various signalling 
pathways including the immune response to lipopolysaccharides, and apoptosis. 
Colchicine and benzamidazoles bind to a high affinity site near the 
monomer/monomer interface of the β-tubulin subunit (Fennell et al., 2008), 
which is the region where α-tubulin binds to β-tubulin. The binding site of 




Figure 6-1 -Chemical structures of inhibitors of microtubule dynamics. 
The chemical structures for the vinca alkaoids vincristine, vinblastine and paclitaxol (taxol) 
are shown. Adapted with permission from (Hait et al., 2007).  
6.2 Treatment of trypanosomes with microtubule 
inhibitors 
Although microtubule inhibitors were not developed to target trypanosome 
tubulin, purification of tubulin and microtubule polymerisation assays have been 
developed and used to verify binding and the effects of microtubule inhibitors on 
microtubule stability in vitro, as well as the effects of microtubule inhibitors on 
cell viability and cell cycle progression in several Trypanosomatids. Taxol 
stimulated polymerisation of T. brucei tubulin and led to the formation of 
bundled microtubules, while vinblastine inhibited microtubule assembly (Macrae 
and Gull, 1990). Studies in Leishmania and T. cruzi imply that there are direct 
interactions between these inhibitors and microtubules in vivo. For example, 
vinblastine-resistant Leishmania possess mutations in the tubulin gene (Borges et 
al., 2005). Taxol treatment of Leishmania parasites caused a decrease in the 
levels of tyrosinated tubulin at the cell posterior where microtubules are more 
dynamic, implying stabilisation of this subpopulation of microtubules (Chavan et 
al., 2007). Aggregation of tubulin in the cytosol of Leishmania parasites treated 
with taxol has also been reported (Havens et al., 2000). Treatment of T. cruzi 
with vinblastine led to a reduction in cell length (Baum et al., 1981), and in a 
separate study (Grellier et al., 1999) inhibited furrow initiation, yielding giant, 
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rounded, multinucleated cells. Taxol treatment of T. cruzi also affected 
cytokinesis, by arresting furrow ingression at a specific point along the cell body, 
and the authors inferred that altered microtubule dynamics at the furrow were 
responsible for this phenotype (Baum et al., 1981). Treatment of T. brucei with 
vinca alkaloids is known to be lethal (Ochola et al., 2002) although the effect of 
these inhibitors on cytokinesis in this organism has not yet been explored. 
Other compounds have been shown to preferentially target mitotic microtubules 
in trypanosomes, for example, the sulphanilamides (Bhattacharya et al., 2004). 
Dinitroaniline herbicides have also been shown to bind to Leishmania tubulin 
(Chan and Fong, 1990), and to produce drastic effects on the morphology and 
viability of T. brucei parasites in vivo (Chan et al., 1993), which may reflect the 
fact that tubulin in trypanosomes is more similar to plant tubulin than to 
mammalian tubulin (Chan and Fong, 1994). 
In view of the effects of taxol and vinca alkaloids on the cytoskeletons and cell 
cycle progression in other Trypanosomatids, their effect on T. brucei was 
investigated here. Procyclic and bloodstream form 427 T. brucei were cultured 
in vitro in the presence of taxol, vincristine or vinblastine, and the effects on 
proliferation, morphology and cell cycle progression monitored. 
 
6.3 Treatment of T. brucei with taxol 
6.3.1 The effect of taxol on the growth of T. brucei 
Bloodstream and procyclic form 427 parasites were grown in the presence of a 
range of different concentrations of taxol (or the equivalent volume of solvent) 
for 24 or 35 hours, respectively (Section 4.12 and Figure 6-2). Bloodstream form 
parasites were more sensitive to the effects of taxol compared to procyclic form 
parasites and incubation with 1 µM taxol proved to be lethal (Figure 6-2A). 
Procyclic form parasites became immobile and swollen after application of the 
drug, but although growth was severely impaired (Figure 6-2B), treatment with 
the concentrations described was not lethal within the 35 hour test period. 
Bloodstream form parasites clearly demonstrated a dose-dependent 
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susceptibility to the drug, whereas a dose-dependent effect was not obvious for 
procyclic form parasites. Growth for both life cycle stages was unaffected by the 
addition of DMSO solvent. 
 
Figure 6-2 -Cumulative growth curves for taxol-treated bloodstream and procyclic form T. 
brucei strain 427. 
Bloodstream (BSF, A) and procyclic (PCF, B) form parasites were incubated with taxol at the 
concentrations (µM) indicated, or equivalent volumes of DMSO solvent or sterile water, and 
cell density monitored over time. 
6.3.2 The effects of taxol on the cell cycle and morphology of T. 
brucei  
To investigate morphology and cell cycle progression of parasites incubated with 
taxol, cells were stained with DAPI (Section 4.11.1) and >200 cells analysed by 
fluorescence microscopy at 0, 3, 6 and 9 hours (bloodstream form, Figure 6-3) or  
at 2.5, 5, 7.5 and 10 hours (procyclic form, Figure 6-5) post-treatment. For 
control cultures (incubated without taxol or with DMSO solvent), the proportions 
of 1N1K, 1N2K and 2N2K cells remained constant over the 9 or 10 hour test 
period (Figure 6-3Ai-ii and Figure 6-5Ai-ii), and changes in morphology were not 




Figure 6-3 -DAPI staining of taxol-treated bloodstream form cells. 
Bloodstream form cells treated with taxol (at the concentrations (µM) indicated in Bi-iv), or 
equivalent volumes of sterile water (Ai) or DMSO solvent (Aii) were sampled at the time 
points indicated, stained with DAPI and classified according to the number of nuclei (N) and 
kinetoplasts (K) in each cell (n>200). 
In bloodstream form parasites, the addition of 0.001 µM taxol also had little 
effect on cell cycle progression over this time period (Figure 6-3Bi). However, 
incubation of bloodstream form parasites with between 0.02 µM and 1 µM taxol 
caused a dramatic increase in the number of post-mitotic (2N2K) cells (Figure 
6-3Bii-iv) which was coincident with a decrease in cells at other stages of the 
cell cycle. Following the rise in post-mitotic cells, abnormal cells with multiple 
nuclei and kinetoplasts appeared, suggesting that post-mitotic cells underwent 
extra rounds of organelle replication in the absence of cell division, and that 
therefore taxol inhibits cytokinesis in this life cycle stage. Occasionally 
anucleate cells (0N1K) and cells lacking a kinetoplast (1N0K) were also observed 
(Figure 6-4Bi). Cells treated with 1 µM taxol, rapidly began to show severe 
morphological defects, including a loss of DNA integrity and swelling of the cell 




Figure 6-4 -Abnormal cell types observed following treatment of bloodstream form cells with 
taxol. 
Example images of DAPI-stained bloodstream form parasites treated with >0.001 µM taxol. 
Abnormal cells with rounded morphology are shown. A: 2N2K cell with abnormal organelle 
positioning; Bi-ii: cells with abnormal N-K configurations. Left panels: DAPI; right panels: 
DAPI/DIC merge N: nucleus; K: kinetoplast. Scale bar: 10 µm. 
Since taxol appeared to only affect cytokinesis and not mitosis as evident from 
both the rise in 2N2K cells and increase in abnormal multinucleate cell types, it 
seems taxol does not inhibit spindle dynamics in  bloodstream form T. brucei 
parasites as it does in mammalian cells. 
Procyclic form cultures also accumulated post-mitotic (2N2K) cells post-taxol 
treatment (Figure 6-5), and there were few differences in phenotype between 




Figure 6-5 –DAPI staining of taxol-treated procyclic form cells. 
Procyclic form cells treated with taxol (at the concentrations (µM) indicated in Bi-iv), or 
equivalent volumes of sterile water (Ai) or DMSO solvent (Aii) were sampled at the time 
points indicated, stained with DAPI and classified according to the number of nuclei (N) and 
kinetoplasts (K) in each cell (n>200). 
2N2K cells were observed at various stages of cytokinesis (Figure 6-6Ai-iii), and 
quantification showed that the majority had not initiated furrow ingression 
(Figure 6-7Bi-ii). However, abnormal cytokinesis phenotypes were also common, 
and following 10 hours of drug treatment, approximately 10 % of cells treated 
with 0.2, 1 or  5 µM taxol displayed abnormal cleavage plane positioning, 
whereby organelles were unequally distributed between nascent daughter cells 
(shown in Figure 6-6Bi-ii), resulting in 0N1K  and 2N1K daughter cells (Figure 
6-6Biii-iv). In addition to cleavage plane positioning defects, aberrant organelle 
positioning was observed (Figure 6-7Bi-iv), which was only noticed in the post-




Figure 6-6 –Images of taxol-treated procyclic form T. brucei. 
Procyclic form 427 cells were incubated with 0.2-10 µM taxol, stained with DAPI and 
analysed by fluorescence microscopy. Ai-iii: example images of 2N2K cells at different 
cytokinesis stages (indicated); daughter 1N1K cells with abnormal (blunt) posterior end 
morphology (arrows). Bi-ii: 2N2K cells undergoing abscission (asterisks) with abnormal 
furrow placement; Biii-iv: abnormal daughter cells resulting from malpositioned cleavage 
furrow. Left panels: DAPI; right panels: DAPI/DIC merge. N: nucleus; K: kinetoplast. Scale 




Figure 6-7 -Analysis of 2N2K cells observed in populations of procyclic form parasites 
treated with taxol. 
Procyclic form 427 T. brucei were treated with the concentrations (µM) indicated of taxol (Bi-
iv) or equivalent volumes of sterile water (Ai) or DMSO (Aii) and stained with DAPI.  Cells 
with 2 nuclei and 2 kinetoplasts (2N2K, see Figure 6-5) were further classified according to 
their cytokinesis stage, and also, where appropriate according to cleavage plane orientation 
and relative positions of nuclei and kinetoplasts as indicated in the key. Numbers of 2N2K 
cells of each type are expressed as a proportion of the total cells in the population. 
At later time points, multinucleate cells with up to four nuclei were observed, 
and these possessed varying numbers of kinetoplasts and were sometimes 
observed undergoing (abnormal) cytokinesis. Cells with severe morphological 
defects were also observed and were likely to be dying cells since they displayed 
problems with nuclear integrity and possessed very abnormal swollen cell 
bodies. Interestingly, other more minor morphological abnormalities were 
observed, comprising a thickening and change in shape to the posterior end of 
cells (Figure 6-6Aiv), implying that these cells either derived from an abnormal 
abscission, or that the drug directly affected the structure of the posterior end 




Hence, the application of taxol to procyclic form parasites inhibited the 
initiation of furrow ingression and lead to abnormal placement of the cleavage 
furrow, resulting in deregulation of the cell cycle. Whilst these appear to be 
direct effects, accumulation of more severe morphological defects and the 
presence of apparently dying cells implied that other processes were also being 
affected. Taxol may interfere with various signalling pathways, as implicated by 
studies in mammalian cells, and accumulation of different problems could result 
in the more severe phenotypes observed. It is also worth noting that the motility 
of taxol-treated parasites was affected, and it is possible that this may have 
contributed to the accumulation of cells at the abscission stage of cytokinesis.  
6.4 Treatment of T. brucei with vincristine 
6.4.1 The effect of vincristine on growth of T. brucei 
Bloodstream and procyclic form 427 parasites were cultured in the presence of a 
range of concentrations of vincristine (Section 4.12) for 24 or 32 hours, 
respectively (Figure 6-8). Bloodstream form parasites treated with 0.05 µM 
vincristine exhibited slightly reduced growth, but concentrations ≥0.2 µM 
vincristine, severely impaired growth (Figure 6-8A). Growth of procyclic form 
parasites was inhibited in the presence of all drug concentrations tested, and 
the effect on cell proliferation was not dose-dependent (Figure 6-8B). 
 
Figure 6-8 -Cumulative growth curves for vincristine-treated bloodstream and procyclic 
form T. brucei strain 427. 
Bloodstream (BSF, A) and procyclic (PCF, B) form parasites were incubated with vincristine 
at the concentrations (µM) indicated, and cell density monitored over time.  
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6.4.2 The effects of vincristine on the cell cycle and morphology 
of T. brucei  
DAPI staining (Section 4.11.1) of vincristine-treated bloodstream form cells 
(0.05, 0.2 and 1 µM) revealed a dramatic increase in post-mitotic (2N2K) cells at 
6 hours post-treatment (Figure 6-9Bii-iii) (with these cells comprising more than 
50 % of the population for 0.2 µM and 1 µM vincristine) that was not observed in 
control populations. At later time points, multinucleate cells accumulated, 
probably due to an uncoupling of cytokinesis and cell cycle progression. At the 
higher drug concentrations of 5 µM and 10 µM vincristine, cells at all cell cycle 
stages rapidly began to display severe phenotypes whereby the nuclear integrity 
was affected, and morphology became drastically rounded and abnormal, and it 
is likely that this was due to vincristine toxicity at these concentrations. 
 
Figure 6-9 -DAPI staining of vincristine-treated bloodstream form cells. 
Bloodstream form cells treated with vincristine (at the concentrations (µM) indicated in Bi-
v), or an equivalent volume of sterile water (A) were sampled at the time points indicated, 
stained with DAPI and classified according to the number of nuclei (N) and kinetoplasts (K) 
in each cell (n>200). 
  
185 
The 2N2K cells were classified according to cytokinesis stage (Figure 6-10), and 
at 6 hours post-treatment with 1 µM vincristine, post-mitotic cells undergoing 
furrow ingression comprised 36 % of the whole population (Figure 6-10Biii). 
These parasites appeared to be stalled at a similar stage of furrow ingression 
(Figure 6-10C), and this was investigated in more detail using Scanning Electron 
Microscopy (Section 4.11.5) to obtain more detailed images of these cells (Figure 
6-11). However, due to the undulating topology of the cell body, it was not 
possible to accurately determine the extent of furrow ingression, although 
qualitative analysis indicated that the furrow had ingressed approximately 75 % 
of the whole cell length. 
 
Figure 6-10 –Analysis of cytokinesis stages for vincristine-treated bloodstream form 2N2K 
cells. 
Bloodstream form 427 T. brucei were treated with the concentrations (µM) indicated of 
vincristine (Bi-v) or an equivalent volume of sterile water (A) and stained with DAPI.  Cells 
with 2 nuclei and 2 kinetoplasts (2N2K, see Figure 6-9) were further classified according to 
their cytokinesis stage, as indicated in the key. C: example images of 2N2K cells with 
furrows (arrows).  Left panel: DAPI; right panel: DAPI/DIC merge. Scale bar: 10 µM. Numbers 




Figure 6-11 -Scanning electron microscopy images of furrowing 2N2K cells following 
vincristine treatment of bloodstream form T. brucei. 
Bloodstream form parasites were grown for 6 hours in the presence of 1 µM vincristine prior 
to analysis by scanning electron microscopy. Typical examples of cells displaying furrows 
are shown in A-B. Arrows indicate the direction of furrow ingression. B is enlarged to better 
see the ingressing furrow. 
Hence, the effect of vincristine on bloodstream form parasites differed 
according to the concentration of drug administered. For concentrations of 0.05 
- 1 µM, dramatic cytokinesis defects were observed comprising inhibition of 
cytokinesis prior to, and part way through, furrow ingression. Cells which did not 
initiate cytokinesis were likely to become multinucleate, which implied that 
downstream of the initial cytokinesis block, cell cycle deregulation had 
occurred. Higher concentrations of drug were clearly lethal to the parasites, as 
exhibited by the defects in cell morphology and nuclear integrity.  
In contrast, procyclic form parasites were observed to lose nuclear integrity and 
display abnormal morphology very rapidly following incubation with all 
concentrations of vincristine tested (Figure 6-12), compared to cells grown in 
the absence of drug, which were normal in appearance. This suggested that 
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vincristine treatment at this range of concentrations is toxic and the drug 
probably affects multiple targets when applied in these quantities. 
 
Figure 6-12 -DAPI staining of vincristine-treated procyclic form cells. 
Procyclic form cells treated with vincristine (at the concentrations (µM) indicated in Bi-iv), or 
an equivalent volume of sterile water (A) were sampled at the time points indicated, stained 
with DAPI and classified according to the number of nuclei (N) and kinetoplasts (K) in each 
cell (n>200). C: images of cells displaying ‘other’ configurations (bracket), with diffuse DAPI 
staining of the nucleus. Left panel: DAPI; right panel: DAPI/DIC merge. Scale bar: 10 µm. 
 
6.5 Treatment of T. brucei with vinblastine 
6.5.1 The effect of vinblastine on growth of T. brucei 
Bloodstream and procyclic form 427 parasites were cultured in the presence of a 
range of concentrations of vinblastine (or the equivalent volume of solvent) for 
25 hours (Section 4.12 and Figure 6-13). Incubation of bloodstream form 
parasites with 0.05 µM or 0.2 µM vinblastine had only a minor inhibitory effect 
on proliferation but for concentrations ≥1 µM vinblastine, growth was severely 
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impaired in a dose-dependent fashion (Figure 6-13A), and 25 hours of treatment 
with 10 µM vinblastine proved lethal. Growth of procyclic form parasites was 
inhibited in the presence of all vinblastine concentrations tested (Figure 6-13B), 
and whilst parasites did continue to proliferate to a small extent in the presence 
of 5 and 10 µM vinblastine, higher concentrations arrested growth. Growth of 
parasites of both life cycle stages was unaffected by the presence of an 
equivalent volume of methanol solvent. 
 
Figure 6-13 -Cumulative growth curves for vinblastine-treated bloodstream and procyclic 
form T. brucei strain 427. 
Bloodstream (BSF, A) and procyclic (PCF, B) form parasites were incubated with vinblastine 
at the concentrations (µM) indicated, or equivalent volumes of methanol solvent or sterile 
water, and cell density monitored over time. 
6.5.2 The effects of vinblastine on the cell cycle and morphology 
of T. brucei  
As above, DAPI staining (Section 4.11.1) was performed for drug treated 
parasites.  Similarly to vincristine treatment, vinblastine caused an accumulation 
of post-mitotic cells in bloodstream form parasites (Figure 6-14). This effect was 
most dramatic when cells were treated with 1 µM vinblastine, and for this 
concentration at 6 hours post-treatment, 2N2K cells comprised 68 % of the whole 




Figure 6-14 -DAPI staining of vinblastine-treated bloodstream form cells. 
Bloodstream form cells treated with vinblastine (at the concentrations (µM) indicated in Bi-
iv), or equivalent volumes of sterile water (Ai) or methanol solvent (Aii) were sampled at the 
time points indicated, stained with DAPI and classified according to the number of nuclei 
(N) and kinetoplasts (K) in each cell (n>200). 
Over time, these post-mitotic cells comprised increasing numbers of cells 
undergoing furrow ingression (Figure 6-15). Cells that were inhibited at initiation 
or completion of cytokinesis proceeded to replicate their organelles in the 
absence of cell division. This was apparent from the coincident drop in 2N2K 
cells and dramatic increase in multinucleate cells observed at 9 hours post 




Figure 6-15 –Analysis of 2N2K cells observed in populations of bloodstream form parasites 
treated with vinblastine. 
Bloodstream form 427 T. brucei were treated with the concentrations (µM) indicated of 
vinblastine (Bi-iv) or equivalent volumes of sterile water (Ai) or methanol (Aii) and stained 
with DAPI.  Cells with 2 nuclei and 2 kinetoplasts (2N2K, see Figure 6-14) were further 
classified according to their cytokinesis stage. Numbers of 2N2K cells of each type are 
expressed as a proportion of the total cells in the population. 
In contrast, treatment of procyclic form parasites with 5-20 µM vinblastine 
(Figure 6-16) did not cause any dramatic changes to the relative proportions of 
cells at different cell cycle stages (Figure 6-16Bi-iv), although defects associated 
with mitosis and organelle segregation were observed (Figure 6-17). These 
abnormal phenotypes comprised cells with unequally sized nuclei positioned 
extremely close together, and occasionally nuclear segregation was totally 
inhibited such that it was not possible to determine whether a cell possessed 
one large nucleus or two separate nuclei. A more thorough analysis of G2/M cells 
would be required to determine the extent of the nuclear segregation defect, 
and to provide insights into whether kinetoplast segregation is also affected. At 
later time points, cells with severe abnormalities were observed and these 
comprised cells with defects in nuclear and structural integrity, and to a lesser 
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extent, multinucleate cells were observed, which frequently displayed clear 
defects in nuclear segregation (Figure 6-17).  
 
Figure 6-16 -DAPI staining of vinblastine-treated procyclic form cells. 
Procyclic form cells treated with vinblastine (at the concentrations (µM) indicated in Bi-iv), 
or equivalent volumes of sterile water (Ai) or methanol solvent (Aii) were sampled at the 
time points indicated, stained with DAPI and classified according to the number of nuclei 




Figure 6-17 –Abnormal cell types observed following treatment of procyclic form cells with 
vinblastine.  
Example images of DAPI-stained procyclic form parasites treated with 5-20 µM vinblastine. 
Abnormal cells displaying nuclear segregation (N*) defects are shown. Kinetoplasts (K) are 
indicated by arrows. Left panel: DAPI; right panel: DAPI/DIC merge. Scale bar: 10 µm. 
Vinblastine treatment of procyclic form parasites therefore appeared to cause 
inhibition of nuclear segregation, although the nature of this segregation defect 
was not investigated in detail. Vinblastine also affected cell morphology at later 
time points, which may be due to non-specific effects. 
6.6 Conclusions 
Microtubule inhibitors universally inhibited the growth of T. brucei parasites to 
varying extents. The degree of growth inhibition was associated with the 
concentration of inhibitor and was also dependent on life cycle stage. 
Bloodstream form parasites were more susceptible to all of these inhibitors, as 
inferred from the lethal effect of taxol and vinblastine and severe growth 
inhibition induced by vincristine treatment that was observed at lower 
concentrations of the drugs compared to procyclic parasites.  
Both procyclic and bloodstream form parasites exhibited cytokinesis defects 
following treatment with the microtubule stabilising agent taxol. In both life 
cycle stages, an accumulation of 2N2K cells was observed, although in 
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bloodstream form cells, inhibition of cytokinesis rapidly led to the accumulation 
of multinucleate cells. This phenotype is usually associated with the absence or 
over-riding of a cytokinesis checkpoint, which would ordinarily inhibit organelle 
re-replication. Procyclic form cells also underwent re-replication of organelles, 
but appeared to do so less readily. This may reflect the fact that procyclic 
parasites were able to undergo furrow ingression, albeit inaccurately. The rapid 
inhibition of cytokinesis in both life cycle stages is highly indicative that this 
phenotype represents a direct effect on the processes involved in cytokinesis 
initiation, and one intriguing possibility is that the taxol binding pocket on 
microtubules could be the site for interaction with MAPs associated with 
signalling pathways that regulate cytokinesis. 
Treatment of bloodstream form cells with either vinca alkaloid produced similar 
phenotypes at similar concentrations and resulted in a dramatic effect on 
cytokinesis leading to an accumulation of post-mitotic cells, a large proportion 
of which had initiated furrow ingression but were apparently stalled before 
completing cell division. Qualitatively, these cells appeared to be inhibited at a 
similar stage of furrow ingression, which could imply that there are cytokinesis 
specific checkpoints that monitor furrow ingression.  
In contrast, vincristine and vinblastine caused differing effects on procyclic form 
parasites, whereby vincristine appeared to be far more toxic. This may be due to 
the slight difference in the molecular composition of vincristine, which could 
have increased the potency of this compound relative to vinblastine against 
procyclic form parasites. This suggests the molecular target(s) of the drugs is 
different according to parasite life cycle stage, which could, for example, be 
explained by post-translational modifications of tubulin. This is not without 
precedence, since vinca alkaloids are known to exhibit differences in their levels 
of toxicity for neoplastic cells according to the specific neoplasma being treated 
(Hait et al., 2007). It was difficult to determine whether any effect on 
cytokinesis occurred in procyclic form cells treated with vincristine as they 
quickly developed severe problems with nuclear and structural integrity implying 
that the drug had multiple targets and was generally very toxic to these 
parasites. Procyclic form cells treated with vinblastine to some extent displayed 
problems with organelle segregation; however, they also went on to exhibit 
similar severe defects. The absence of an effect on cytokinesis prior to the 
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appearance of severely abnormal cells in procyclic parasites treated with 
vinblastine could add to the evidence that bloodstream form and procyclic form 
cells regulate cytokinesis in differerent ways. Alternatively, these differences in 
phenotypes may reflect the presence of stage-specific MAPs present at the vinca 
alkaloid binding site causing changes in the interactions of vinca alkaloids with 
microtubules.  
The effect of these inhibitors on microtubule dynamics in vitro  (Macrae and 
Gull, 1990) and the observation of morphological changes that are consistent 
with effects on microtubule stability, indicate that tubulin is their main target in 
vivo and, together with the evidence from other Trypanosomatid species, these 
data suggest that microtubule dynamics are important during cytokinesis. 
6.7 Effect of alterations in microtubule dynamics on AIR9 
in procyclic T. brucei 
Given that data presented in Chapter 5 indicate that AIR9 is a MAP with key roles 
in cell polarity and cytokinesis, it was of interest to determine the effects of 
microtubule inhibitors on the localisation of AIR9.  To facilitate visualisation of 
AIR9, 427 procyclic cells expressing tyGFP:AIR9 (Section 5.4.2) were used and 
were treated with taxol or vinblastine (Section 4.12) before being analysed by 
fluorescence microscopy (Section 4.11.1 and Figure 6-18). 
Treatment of tyGFP:AIR9 427 procyclic form cells with 20 μM taxol  or 40 μM 
vinblastine for 5 hours (equivalent to concentrations that affected microtubule 
dynamics in vitro (Macrae and Gull, 1990) seemed to strike a good balance 
between producing a morphological defect without also resulting in an 
accumulation of multinucleate cells. A morphological defect in multinucleate 
cells is highly likely to be a result of loss of cell polarity due to the 
multinucleate phenotype, rather than as a direct result of the effect of 
microtubule inhibitors on microtubule dynamics, and interpretation of the effect 
on localisation of a specific protein is subsequently open to misinterpretation. 
Taxol treatment of the procyclic cells, as expected from data described above 
(Section 6.3.2), resulted in a large accumulation of 2N2K cells undergoing 
abscission with aberrant cleavage furrow positioning (Figure 6-18Bi-ii). Small 
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numbers of 0N1K and 2N1K cells, and some cells displaying abnormal organelle 
positioning were also observed. In general, tyGFP:AIR9 staining appeared normal 
following taxol treatment (Figure 6-18Bi), although in post-mitotic cells 
undergoing abscission, the smaller daughter cell (typically containing just a 
single kinetoplast) possessed a region of brighter fluorescence intensity at the 
anterior tip of the cell body (Figure 6-18Bii). Cells undergoing abscission are 
rarely observed in procyclic form populations, and in order to draw an informed 
conclusion as to whether tyGFP:AIR9 is usually enriched at this region, it would 
be necessary to analyse more parasites at this stage of cytokinesis in untreated 
cells.  
 
Figure 6-18 –The effect of microtubule inhibitors on the localisation of tyGFP:AIR9 in 
procyclic form parasites. 
Procyclic form parasites expressing tyGFP:AIR9 (427 pHG172 clone 3 (section 5.4.2)) were 
grown in the presence of 20 μM taxol or 40 μM vinblastine (B); or equivalent volumes of 
solvent (DMSO and methanol, respectively), or sterile water (A) for 5 hours before being 
stained with DAPI and analysed by fluorescence microscopy. DAPI, FITC (tyGFP:AIR9, 
green), DAPI/FITC merge, DIC and DAPI/FITC/DIC (‘merge’) images are indicated. Nucleus 
(N) and kinetoplast (K) configurations for each cell are indicated, and where appropriate, the 
point of abscission is marked by an asterisk. Scale bars: 5 μm. 
Treatment of the procyclic cells with vinblastine resulted in organelle 
segregation and positioning defects, as described in Section 6.5.2. The 
morphology of treated cells was dramatically altered, and cells developed 
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pointed posterior ends and became bulbous at the nuclear region (Figure 
6-18Biii-iv). These parasites exhibited a bright but diffuse fluorescence, with 
reduced signal intensity at the cell outline implying that tyGFP:AIR9 had, to 
some extent, become localised to the cytoplasm (although this was not verified 
by other means). The binding site for vinblastine sulphate is thought to be 
conserved in T. brucei β-tubulin (due to the presence of an asparagine residue at 
position 100, and evidence from in vitro studies (Gull, 1999)), and hence, the 
apparent change in tyGFP:AIR9 localisation following vinblastine treatment could 
indicate that tyGFP:AIR9 (or a binding partner) and vinblastine sulphate bind to 
the same region of microtubules. 
 
6.7.1 Conclusions  
Taxol and vinblastine sulphate treatment caused alterations in the morphology 
of procyclic form parasites. These morphological changes comprised a 
cytokinesis phenotype whereby cells displayed stalled and asymmetric 
abscission, which occurred following taxol treatment, and a change in cell shape 
comprising a bulge at the central region and elongation of anterior and posterior 
ends, which occurred following vincristine treatment. The distribution of 
tyGFP:AIR9 was altered in vinblastine-treated cells, where the staining pattern 
appeared to indicate a change from cytoskeletal to cytoplasmic localisation. 
tyGFP:AIR9 cells treated with taxol remained brightly stained, particularly at 
around the cell body outline, and additionally, a region of more intense staining 
was observed at the anterior tip of smaller anucleate daughter cell body.  
These results have several implications. Firstly, vinblastine appeared to have an 
inhibitory effect with regards to the localisation of tyGFP:AIR9 at the perimeter 
of the cell, implying that the drug and AIR9 (or a binding partner of AIR9 
required to localise AIR9 to microtubules) interact with tubulin at the same site. 
Secondly, taxol did not have this effect so it is unlikely that AIR9 (or binding 
partner) binds to the taxol binding pocket. Finally, the intense staining observed 
at the anterior end of the anucleate daughter cells following taxol treatment 
could imply increased microtubule stability or polymerisation at the site of 
furrow ingression, resulting in increased microtubule density at this part of the 
furrow. As the initiation of furrow ingression occurs at the tip of the posterior 
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most flagellum, the effect would only be noticed at the anterior of this nascent 
cell. The potentially increased microtubule density may have led to an increased 
concentration of tyGFP:AIR9 at this region. 
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7 The Polo-like kinase family: function, structure 
and regulation  
7.1 Discovery of Polo-like kinases 
Mitotic defects in the Drosophila  melanogaster mutant polo and subsequent 
identification of a serine threonine kinase at the polo locus led to the discovery 
of a large family of highly conserved Polo-like kinases (PLKs) that were found to 
be important for many aspects of cell cycle regulation (Llamazares et al., 1991; 
Sunkel and Glover, 1988). Yeasts only possess one PLK (Kitada et al., 1993; 
Ohkura et al., 1995), mammals possess four (reviewed in (Barr et al., 2004)); C. 
elegans and X. laevis, three (Chase et al., 2000a; Chase et al., 2000b; 
Descombes and Nigg, 1998; Duncan et al., 2001); and D. melanogaster, two 
(Bettencourt-Dias et al., 2005; Sunkel and Glover, 1988). Whilst the roles of 
metazoan PLK family members: PLK1 (mammals), Plx1 (X. laevis) and polo (D. 
melanogaster); and those of the yeast PLKs: Cdc5 (S.cerevisiae) and Plo1 (S. 
pombe) are well studied, there is much to be discovered concerning the roles of 
these ‘extra’ PLKs including the divergent family members – SAK (also known as 
PLK4) and PLK4, which are found in mammals and D. melanogaster, respectively. 
SAK and PLK4 possess just a single, yet unusual, polo-box motif (Leung et al., 
2002); and as yet have only one well established role, which is in centriole 
duplication (Bettencourt-Dias et al., 2005). Human PLK2 and PLK3 have similar 
structures to PLK1, and have also been shown to have cell cycle roles, although 
these are less well understood (reviewed in (Archambault and Glover, 2009)). 
This introduction will focus on human PLK1 and the yeast PLKs. 
7.2 Cell cycle regulation by Polo-like kinases 
Phenotypic analysis of polo mutant D. melanogaster larvae revealed mitotic 
defects including circular and random arrangements of chromosomes, multiple 
centrioles, lack of spindle asters and abnormal mitotic spindle arrangement 
(Sunkel and Glover, 1988), and subsequent studies involving other PLK family 
members revealed that the mitotic function of PLK is largely conserved. An 
additional role for PLK in the spatial coordination and regulation of cytokinesis 
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was first identified in fission yeast through the analysis of temperature sensitive 
Plo1p mutants (Bahler et al., 1998; Ohkura et al., 1995), and although the 
precise mechanisms of cytokinesis regulation vary according to organism, the 
outcome of PLK involvement is similar in different systems.  
PLK1 has roles in mitotic entry, centrosomal separation and maturation, spindle 
assembly, the DNA damage response, the spindle attachment checkpoint, and 
mitotic exit; some of these functions are highly conserved, for example, the 
roles in mitotic entry and mitotic exit, which involve PLK1 homologues in other 
metazoans, and in yeasts (reviewed in (Archambault and Glover, 2009; 
Petronczki et al., 2008; Takaki et al., 2008; van Vugt and Medema, 2005)). A 
brief summary of how PLK1 is involved in these processes is given below. 
Entry into M phase involves the cyclin-dependent kinase 1-cyclin B complex 
(CDK1/CYCB). The activity of this complex is affected by the phosphorylation 
state of CDK1, which is determined by the relative activities of the inhibitory 
kinases, Wee1 and MYT1, and an antagonising phosphatase CDC25. Through 
phosphorylation of these regulators of CDK1 activity (causing inactivation of 
Wee1 and MYT1, and activation of CDC25), PLK1 is involved in a positive 
feedback pathway culminating in mitotic entry (Inoue and Sagata, 2005; Kumagai 
and Dunphy, 1996; Watanabe et al., 2004). In addition, PLK1 has a role in the 
breakdown of the nuclear envelope, as it can phosphorylate the major 
component of the dynein/dynactin motor protein complex: p150Glued, positively 
regulating its accumulation to the nuclear envelope during prophase (Li et al., 
2010a). 
Spindle pole bodies (yeast), and centrioles (mammalian cells) are important in 
the production of a nuclear spindle. These microtubule-organising centres 
(MTOCs) are the location for multiple MAPs, microtubule nucleators (including 
the γ-tubulin ring complex), motor proteins and other structural proteins and 
cell cycle regulators. Spindle generation, positioning and regulation of spindle 
dynamics are complex processes which require both PLK and Aurora kinase A. 
Recruitment and/or activation of several important nucleators and regulators 
has been shown to require PLK, including the γ-tubulin ring complex, the 
negative regulators of tubulin nucleation, Ninein-like protein and Stathmin, the 
microtubule stabilising factor, Centrobin (Budde et al., 2001; Casenghi et al., 
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2003; Lane and Nigg, 1996; Lee et al., 2010), and Aurora kinase A (De Luca et 
al., 2006).  
Attachment of kinetochores to microtubules is regulated by the spindle 
attachment checkpoint (SAC) and progression through this checkpoint is essential 
for the separation of sister chromatids during anaphase. Localisation of PLK to 
kinetochores and the contribution of PLK to these early and late mitotic 
processes varies according to the organism (Archambault and Glover, 2009; Lee 
et al., 2005). Phosphorylation of the SAC component BUBR1 by PLK1/Plx1 is 
important for stable attachment of kinetochores to the spindle microtubules in 
human cells (Elowe et al., 2007) and for the SAC in X. laevis respectively (Wong 
and Fang, 2007). Another protein regulated by PLK1 with roles in kintechore/ 
spindle attachment is CLIP-170; a protein which binds to dynactin, and localises 
to kinetochores at prometaphase. Phosphorylation of CLIP-170 by PLK1 enhances 
its association with casein kinase 2 (CK2), an event necessary for CK2 mediated 
phosphorylation and subsequent association with dynein/dynactin at the 
kinetochores (Li et al., 2010a). Phosphorylation of cohesin components by PLK1 
is thought to cause dissociation of these components from the chromatid arms 
leaving only residual cohesin at the kinetochore which is later removed by 
separase-mediated cleavage of SCC1 as a result of APC activation (Sumara et al., 
2002). In budding yeast,  cohesin dissociation does not occur in early mitosis, 
although Cdc5 mediated phosphorylation of SCC1 is thought to promote the 
cleavage of this protein by separase at metaphase (Alexandru et al., 2001). 
Dissociation of cohesin allows chromatid separation during anaphase. 
The inactivation of the CDK1-mitotic cyclin complex through degradation of the 
mitotic cyclins or inactivation of CDK1 is essential for mitotic exit. In mammalian 
cells, Cyclin B degradation is mediated by the APC, a process indirectly 
controlled by PLK1 through phosphorylation of the early mitotic inhibitor 1 
protein (EMI1) whose role is to inhibit the APC (Hansen et al., 2004; Moshe et 
al., 2004). Yeasts lack EMI1-like APC inhibitors, and instead mitotic exit is 
regulated by the septation intiation network (fission yeast) or the mitotic exit 
network and FEAR pathway (budding yeast). In both cases, these kinase cascades 
are initiated by Plo1 and Cdc5 in fission and budding yeast respectively, and lead 
to the cytoplasmic retention of the phosphatase CDC14, triggering events which 
ultimately cause inhibition of CDK1 (Section 1.9.1.2.1).  
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Cytokinesis involves several complex processes: determination of the cleavage 
site, construction of the contractile apparatus, coordination of mitosis and 
cytokinesis, constriction of the contractile ring and abscission (reviewed in 
(Balasubramanian et al., 2004; Barr and Gruneberg, 2007; Guertin et al., 2002)).  
In yeasts the cleavage site is selected early in the cell cycle. The future cleavage 
plane is referred to as the bud selection site or the cortical band in budding or 
fission yeast, respectively. Predetermination of the cleavage axis in this way 
constrains the localisation of the mitotic nucleus, which must be positioned 
accordingly, and in fission yeast, this involves trafficking one daughter nucleus 
through the bud neck. By contrast, the position of the cleavage site in 
mammalian cells is determined during the anaphase to metaphase transition 
when the central spindle is assembled. The contractile apparatus which is 
positioned at the cleavage site is largely comprised of actin and myosin forming 
a contractile ring. In yeasts, septin deposition occurs at either side of the 
actomyosin contractile ring, forming septin rings which are believed to stabilise 
the contractile ring and restrict spreading of the cleavage furrow. Abscission in 
yeasts and mammalian cells involves different processes. Septum formation 
involving the activity of chitin synthase is important in yeasts, whilst abscission 
in mammalian cells requires targeted vesicle delivery at the midbody (reviewed 
in (Bi, 2001; McCollum, 2005)). 
In yeasts, Plo1 and Cdc5 have dual roles in cytokinesis, both as components of 
mitotic exit pathways, and independently. Direct roles for Plo1 and Cdc5 in 
cytokinesis were established through the analysis of temperature sensitive 
mutants which failed to septate producing a ‘chain’ phenotype which describes 
cells that have undergone mitosis but remain attached by a thread of cytoplasm 
(Bahler et al., 1998; Ohkura et al., 1995; Park et al., 2003; Tanaka et al., 2001). 
Also, overexpression of Plo1 or expression of PLK1 (the human homologue of 
Cdc5) in budding yeast resulted in prolific septation (Lee and Erikson, 1997; 
Ohkura et al., 1995). In mammalian cells, a separate role for PLK1 in cytokinesis 
has only recently been elucidated, due to the mitotic arrest caused by activation 
of the SAC which occurs when PLK1 is downregulated (Sumara et al., 2004), or 
when dominant negative versions are expressed (Seong et al., 2002). Recently, 
the generation and application of PLK1 inhibitors (Brennan et al., 2007; 
Petronczki et al., 2007; Santamaria et al., 2007), and an analogue sensitive 
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mutant PLK1 (Burkard et al., 2007) has allowed investigations into the post-
mitotic functions of this kinase. The post-anaphase inhibition of PLK1 achieved 
in these studies inhibited furrow ingression, which was found to be a result of 
failure to construct a contractile ring. The recruitment and regulation of actin 
and myosin to form the contractile ring requires the small GTPase RhoA, which is 
in turn activated by the Rho GTPase-exchange factor (GEF) Ect2. PLK1 inhibition 
prevented recruitment of Ect2 to the central spindle, and prevented Rho A 
accumulation (Brennan et al., 2007; Burkard et al., 2007; Petronczki et al., 
2007; Santamaria et al., 2007), and it has been proposed that phosphorylation of 
Ect2 by PLK1 allows interaction of this protein with the centralspindlin complex 
(comprised of two Rho GTPase-activating protein (GAP) molecules and two 
kinesin molecules), leading to recruitment and activation of RhoA, thus linking 
the anaphase spindle with the cortical cleavage furrow, promoting timely furrow 
ingression (reviewed in (Petronczki et al., 2008). 
The diverse array of cell cycle functions involving PLKs are accompanied by 
dynamic patterns of localisation, which vary according to the organism studied 
(reviewed in (Archambault and Glover, 2009)). In human cells at prophase 
through to metaphase, PLK1 is found at the mitotic centrosomes, centromeres, 
and kinetochores, and at anaphase, PLK1 is additionally located at the spindle 
midzone. Following telophase, PLK1 is only found at the spindle midbody. In 
budding yeast, Cdc5 can be found at the spindle pole bodies at all stages of the 
cell cycle, and additionally at the mother bud neck during mitosis and 
cytokinesis. In fission yeast, Plo1 appears at the spindle pole bodies at prophase 
through to anaphase, and can be found at the spindle during mitosis. In addition, 
Plo1 marks the future site of septation during anaphase.  
The changes in PLK localisation facilitate interactions with different substrates 
according to cell cycle stage, and combined with multiple regulatory 
mechanisms controlling activity and substrate specificity, PLKs are able to 
function as versatile regulators of many cell cycle processes. 
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7.3 PLK structure 
All PLK family members contain an N-terminal serine/threonine kinase domain 
and a C-terminal polo-box domain (PBD) comprised of one (PLK4 and SAK) or two 
polo-box motifs. The crystal structures of the polo-box domains of SAK and PLK1, 
and the kinase domain of PLK1 have been solved (Bandeiras et al., 2008; Cheng 
et al., 2003; Kothe et al., 2007; Leung et al., 2002). However, the structure of 
the full length kinase has yet to be elucidated. The crystal structure of the PLK1 
kinase domain was obtained for both a mutant form of the kinase (T210V) which 
was crystallised in the presence a non hydrolyzable ATP analogue (Kothe et al., 
2007), and the wild type kinase crystallised in the presence of a selective 
designed ankyrin repeat protein, DARPin 3H10 (Bandeiras et al., 2008) and both 
forms of the kinase domain resulted in the generation of largely identical crystal 
structures. The crystal structure of the human PLK1 kinase domain is shown in 
Figure 7-1. 
                         
Figure 7-1 –Ribbon diagram of the kinase domain of human PLK1. 
The diagram shows the crystal structure of the human PLK1 kinase domain, solved in 
complex with DARPin 3H10 (Bandeiras et al., 2008). The β-sheet structures are coloured 
cyan; α-helices, red; the activation loop, green; and the C
α
 chains of the N-terminal and C-
terminal lobes are shown in grey and yellow, respectively. Adapted with permission from 
(Bandeiras et al., 2008). 
The kinase domain was found to exhibit a classical kinase fold consisting of N-
and C-terminal lobes, with an ATP binding site positioned at a cleft between 
these regions. The N-terminal lobe comprised an antiparallel β-sheet and a 
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single α-helix, and the C-terminal lobe was found to be primarily α-helical. 
Kinase activation involves the rotation of the single α-helix in the N-terminal 
lobe, breaking the salt bridge between Lys82 and Glu101 which allows the lysine 
residue in the ATP binding site to interact with the phosphate of ATP in a 
catalytically productive manner. Other conserved residues involved in kinase 
activity are the DFG motif, which interacts with magnesium ions, and the 
activation segment (T-loop), which when inactivated, can block the ATP binding 
groove, an action that is reversed by phosphorylation of various T-loop residues. 
Intriguingly, both crystal structures implicated that the kinase domains 
crystallised in the active state despite the lack of detectable phosphorylation 
within the kinase domain (as determined by mass spectrometry (Kothe et al., 
2007), and it was speculated that this active form may be the default 
conformation of the PLK1 kinase domain, and that auto-regulation of PLK1 
activity by the PBD could override the importance for strict regulation at the 
level of T-loop phosphorylation. 
The generation of a soluble and active kinase domain truncated protein was 
difficult to achieve, partly due to underestimation of the size of the core kinase 
domain through bioinformatic approaches. The final proteins for both structures 
contained an additional N-terminal β-strand termed β0, and a C-terminal loop 
which has an ordered structure. Both of these regions were essential for 
solubility. To purify the kinase domain proteins, either a 6XHis or GST epitope 
was added at the N-terminus (Bandeiras et al., 2008; Kothe et al., 2007); in both 
cases, a eukaryotic insect cell expression system was employed as expression in 
E. coli resulted in co-purification with the chaperone GroEL, indicating incorrect 
folding (Bandeiras et al., 2008). 
The crystal structure of the PLK1 PBD was solved for a complex comprising the 
PBD and an optimal phosphopeptide binding partner (Cheng et al., 2003). The 
polo-box motifs in the PBD of PLK family members share only around 20-25 % 
sequence identity (Elia et al., 2003b), and for human PLK1 the polo box motifs 
share just 12 % sequence identity. Surprisingly, both motifs exhibit very similar 
structures comprising identical folds, each based on a six stranded β-sheet and 
an α-helix (Figure 7-2). The motifs are associated by a linker region which forms 
an exposed loop, and tethered together by a region called the polo-box cap (PC) 
which wraps around the two polo-box motifs and consists of an alpha helical 
  
205 
segment, loop and 310 helix. The two polo-box motifs are arranged such that the 
α-helical regions flank the twelve β-sheets, forming a shallow positively charged 
grove surrounded by a hydrophobic surface. Solving the crystal structure of the 
PBD has greatly facilitated the understanding of how the full length PLK 
interacts with binding partners to control localisation and substrate recognition. 
 
Figure 7-2 –Ribbon diagram of the Polo-box domain of human PLK1 in complex with a pThr-
containing peptide. 
The Polo-box motifs (PB) 1 and 2 are coloured red and purple, respectively, and the Polo-
box cap (Pc) is coloured grey. The pThr-containing peptide positioned at the PBD binding 
cleft is shown as a ball and stick representation, coloured in yellow. Adapted with 
permission from (Elia et al., 2003b). 
The PBD was found to be capable of binding to phosphorylated substrates 
independently from the kinase domain through the screening of a degenerate 
phosphopeptide library with an in vitro expression HeLa cell cDNA library (Elia et 
al., 2003a). The PLK clone identified in this screen encoded a protein which 
lacked crucial residues of the kinase domain, and the production of a series of 
truncated proteins revealed that the minimum binding domain comprises the 
whole PBD (including both of the polo-box motifs and the PC), which binds to a 
consensus binding motif of [Pro/Phe}-[Ф/Pro]-[Ф]-[Thr/Gln/His/Met]-Ser-
[pThr/pSer]-[Pro/X], where Ф represents hydrophobic residues and X is any 
residue (Elia et al., 2003a; Elia et al., 2003b). Analysis of the crystal structure of 
the PBD in association with the phosphopeptide revealed that alternating 
residues from both polo-box motifs contribute to binding, forming a zipper-like 
interaction. The residues which interact with the negatively-charged phosphate 
group were referred to as the ‘His-Lys pincer’ (residues His538 and Lys540), and 
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those which form non-polar interactions with the phosphopeptide and select for 
Ser at the pThr-1 position included Try414 and Leu490. Selectivity for Ser at the 
pThr-1 position is thought to be important for targeting binding to specific 
substrates, and mutation of this residue to Ala within a minimal phosphopeptide 
abolished interaction with the PBD (Yun et al., 2009). These important residues 
were found to be highly conserved amongst different PLK1 proteins. 
The ‘His-Lys’ pincer residues, and Try414 are important for in vivo localisation 
and function. Mutations of the ‘His-Lys pincer’ residues (Archambault et al., 
2008; Elia et al., 2003b; Hanisch et al., 2006), Try414 residue (Garcia-Alvarez et 
al., 2007; Lee et al., 1998; Song et al., 2000), or all three conserved residues 
(Archambault et al., 2008; Seong et al., 2002) affected the localisation of PLK, 
and where the effect on cell cycle was investigated, cell cycle arrest at the 
spindle assembly checkpoint was reported (Elia et al., 2003b). Whilst the 
residues described are important for phospho-dependent localisation, other 
studies have shown that phospho-independent PBD-mediated interactions also 
contribute to localisation (Archambault et al., 2008), and even PBD-independent 
localisation can occur (Garcia-Alvarez et al., 2007). This suggests that 
PBD/binding partner interactions could be quite divergent, and not just 
restricted to phosphorylated proteins. 
7.4 Substrates of PLK 
A large number of in vivo phosphopeptide substrates have now been identified as 
binding partners of the PBD (reviewed in (Park et al., 2010), and through a 
screen to isolate novel binding partners, it was demonstrated that the PBD (but 
not a ‘His-Lys pincer’ mutant) was capable of binding proteins from mitotic but 
not G1/S cell lysates. These interacting proteins could be phosphorylated by full 
length PLK1 (Lowery et al., 2007), and several of these binding partners have 
also been shown to act as substrates for the mitotic kinase CDK1 (reviewed in 
(Park et al., 2010), indicating that CDK1 could prime substrates for PLK1 
interaction and PLK1-mediated phosphorylation. Intriguingly, it has been 
suggested that whilst CDK1 phosphorylation could target PLK to binding partners 
at prometaphase and metaphase, CDK1 phosphorylation could also inhibit 
recruitment of PLK to binding partners during anaphase. This suggests that upon 
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anaphase entry, cyclin B degradation and decreased CDK1 activity would lead to 
dephosphorylation of these proteins, allowing PLK to prime its own substrates 
stimulating mitotic exit and cytokinesis (Neef et al., 2007). Self priming as a 
mechanism for binding has been demonstrated in several independent studies 
(Kang et al., 2006; Neef et al., 2003; Neef et al., 2007b; Wolfe et al., 2009), 
supporting the hypothesis that PLK binding can occur through both self and non-
self priming. This mechanism for activity would allow temporal and spatial 
control of PLK activity and control over cell cycle events. 
7.5 Regulation of PLK activity 
7.5.1 Mechanisms for the activation of PLK 
In addition to substrate targeting, control of PLK activity is also regulated 
through autophosphorylation and phosphorylation by upstream kinases. It has 
been demonstrated that PLK from mitotic cell extracts migrates more slowly by 
SDS PAGE than its interphase counterpart, and this was attributed to 
phosphorylation predominantly at serine but also at threonine residues 
(Hamanaka et al., 1995; Lee et al., 1995; Mundt et al., 1997). Mitotic PLK was 
more active against an α-casein substrate, and exhibited higher levels of 
autophosphorylation. Dephosphorylation of mitotic PLK through incubation with 
a protein phosphatase has been shown to reduce PLK activity to interphase 
levels (Hamanaka et al., 1995; Mundt et al., 1997). Phosphorylation of the T-
loop of protein kinases is a common means of activation, and phosphorylation of 
the Thr210 residue has been observed for mitotic PLK1 in vivo, suggesting that 
this mechanism for activation may be conserved in PLK1 (Jang et al., 2002b). 
Mutation of the conserved Thr210 (or Plx1 Thr201) residue to aspartic acid to 
mimic phosphorylation resulted in increased activity against an α-casein 
substrate, and also increased autophosphorylation, whilst the opposite effect 
was observed when this residue was mutated to valine (Jang et al., 2002b; Lee 
and Erikson, 1997; Qian et al., 1999). These effects equated to a four fold 
increase or three fold decrease in activity against an α-casein substrate for PLK1 
T210D and PLK1 T210V, respectively (Lee and Erikson, 1997). A second potential 
regulatory residue at the kinase domain was identified as Ser137 (Jang et al., 
2002b). This residue is highly conserved and is surrounded by a similar amino 
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acid sequence to Thr210. Mutation of this residue to aspartic acid resulted in 
increased activity of PLK1 against α-casein, although a protein with the 
equivalent residue mutated to valine displayed a similar level of activity 
compared to the wild type protein. This residue was not identified as a 
phosphorylation site in vivo, and is therefore unlikely to be a target for 
upstream kinases, particularly given that Ser137 forms part of the hinge region 
connecting the N and C-terminal lobes and is at a site likely to be inaccessible to 
other proteins.  
Several protein kinases capable of phosphorylating the Thr210 residue of the PLK 
T-loop have now been identified. These include members of the Ste 20-like 
kinase family and Aurora kinase A (Aur-A). Additionally a phosphatase has been 
identified which can remove this phosphate group, potentially acting as an 
antagonist to upstream kinases (Yamashiro et al., 2008). 
Xenopus polo-like kinase kinase (xPLKK1), a member of the Ste-20 kinase family, 
purified from mitotic X. laevis oocytes was found to phosphorylate Plx1 at 
Thr201, causing activation (Qian et al., 1998). In addition, xPLKK1 was found to 
display similar kinetics of activation to Plx1 during the cell cycle. Other 
homologues of xPLKK1 have been identified including murine lymphocyte 
orientated kinase or LOK (Ellinger-Ziegelbauer et al., 2000) and its human 
homologue Stk10 (Walter et al., 2003), human Ste-20 like kinase or SLK (Ellinger-
Ziegelbauer et al., 2000), and Drosophila dPLKK (Alves et al., 2006). All of these 
kinases have been shown to phosphorylate and activate PLK in vitro, and the 
target phosphorylation site for human SLK has been confirmed as PLK1 Thr210 
(Johnson et al., 2008). The activity levels of SLK and Stk10 were found to remain 
relatively stable during the cell cycle in contrast to what was observed for xPLKK 
(Ellinger-Ziegelbauer et al., 2000; Walter et al., 2003). A direct role for the Ste 
20-like family members in PLK activation has not yet been demonstrated, and 
for several reasons there is some speculation as to the role of these kinases in 
vivo. Firstly, murine LOK is only expressed in lymphatic tissues (although this 
does not apply to the human homologue), and secondly, a further study 
investigating the activation of Plx1 by xPLKK, reported that xPLKK 
phosphorylation did not occur at the Thr201 residue (equivalent to Thr210) but 
at Thr10, and that this phosphorylation event did not increase Plx1 activity 
(Kelm et al., 2002). Finally, depletion of xPLKK does not inhibit activation of 
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Plx1, and xPLKK1 has been shown to act as a substrate of Plx1 (Erikson et al., 
2004), suggesting that xPLKK1 participates in a positive feed back loop for Plx1 
activation, rather than acting as a bona fide upstream kinase.  
Other kinases which have been shown to phosphorylate PLK in vitro but are 
unlikely to have physiological roles in activation of this kinase in vivo include 
protein kinase A and the CDK1/ CYCB complex, which phosphorylated xPLK1 
residues Thre201 and Ser340 respectively (Kelm et al., 2002). 
Phosphorylation of PLK1 at Thr210 by Aur-A has been found to involve 
interaction with an Aur-A coactivator, BORA (Macurek et al., 2008; Seki et al., 
2008). Depletion of BORA or Aur-A (or chemical inhibition of Aur-A) prevented 
phosphorylation of PLK1 at Thr210, inhibited activation of PLK1 and led to cell 
cycle arrest suggesting that these two proteins could act in the same pathway. 
The observations that Aur-A activation preceded activation of PLK1 during the 
cell cycle, and that the temporal localisation of both proteins at the 
centrosomes coincided with the detection of Thr210 phosphorylation of PLK1, 
suggested that AUR-A acts upstream of PLK1. BORA could interact with non-
phosphorylated PLK1 through association with both the kinase domain and PBD, 
and this interaction greatly stimulated Aur-A-mediated phosphorylation of the 
PLK1 Thr210 residue. Neither Aur-A nor BORA could stimulate PLK1 activity 
alone. Whilst this would suggest that PLK1, BORA and Aur-A interact as a 
complex, an association of Aur-A and BORA could not be demonstrated when 
these kinases were expressed at endogenous levels, suggesting that prior 
association of PLK1 with BORA is required for Aur-A activity against PLK1. 
Crucially, phosphorylated PLK1 was not further activated by Aur-A, and 
expression of PLK T210D partially compensated for the cell cycle arrest caused 
by Aur-A downregulation, implying that phosphorylation at Thr210 by Aur-A is 
sufficient for PLK1 activation. 
Together these studies provided substantial and physiological evidence sufficient 
to construct a model for PLK1 activation, whereby during G2, interaction of PLK1 
with BORA prevents PLK1 from targeting other substrates, until Aur-A becomes 
activated and localised to the centrosomes during the G2/M transition. 
Interaction of active Aur-A with the PLK1/BORA complex leads to 
phosphorylation and activation of PLK1, and upon degradation of BORA (which is 
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targeted for degradation at mitosis) activated PLK1 is released and able to 
localise to and target other substrates. 
7.5.2 Autoinhibition by the PBD as an important mechanism for 
PLK regulation 
A further mechanism for PLK regulation involves interaction of the kinase 
domain with the PBD. The PBD of PLK1 has been found to interact with the full 
length kinase (which was not a consequence of dimerisation, as no association of 
wild type PLK1 could be demonstrated), and this association was shown to be 
independent of the ‘His-Lys pincer’, suggesting that interaction between the 
PBD and the kinase domain involves a different association from the interaction 
of the PBD and its binding partners (Elia et al., 2003b; Jang et al., 2002a).  
Association of the PBD with PLK1 inhibited activity of this protein against α-
casein. This effect was exacerbated for a truncated form of PLK1 which lacked 
the PBD. This  effect was not due to competitive inhibition as the PBD was not a 
substrate for PLK1 (Jang et al., 2002a). In addition,  the activities of truncated 
forms of Cdc5 and PLK1 lacking the PBD were shown to be between 3 and 5 
times greater than those demonstrated by the full length kinases (Jang et al., 
2002a; Lee and Erikson, 1997). These data suggested that PLK can self regulate 
activity through an inhibitory trans interaction between the PBD and the kinase 
domain. Experiments which showed that autoinhibition of full length PLK1 could 
be relieved by the provision of an optimal phosphopeptide motif (which binds to 
the PBD truncation with a greater affinity than the full length protein), implied 
that self regulation inhibits kinase activity in the absence of a suitable substrate 
(Elia et al., 2003b). It was also found that autoinhibition only occurs in the 
absence of activation, as incubation of the PBD with mitotically-activated PLK1, 
or with a truncated PLK1 containing the T210D mutation, failed to inhibit the 
activity of these proteins (Jang et al., 2002a). 
7.5.3 Models for PLK activity 
The activation of PLK has been explained by self and non self-priming models, 
and the activity of the activated kinase domain can involve processive or 
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distributive mechanisms (Figure 7-3). These models are not mutually exclusive, 
and it is likely that a combination of different mechanisms occur in vivo. Self 
and non-self priming describe the phosphorylation of a target substrate allowing 
interaction of the PBD with the phosphoepitope and relieving autoinhibition of 
the kinase domain. Self priming defines PLK mediated phosphorylation of its own 
target substrate (Lee et al., 2008). This could be a means of recruiting PLK to 
specific regions of the cell, for instance, phosphorylation of centrosomal or 
central spindle proteins by a partially active PLK would stimulate the activity of 
bound PLK, creating more docking sites, which would lead to increased PLK 
recruitment. This model necessitates that PLK recruitment is controlled by the 
levels of PLK and/or availability of the binding partner. Non-self priming 
describes the generation of a PLK docking site through the action of another 
kinase, for example the CDK1/CYCB complex. This mechanism would allow 
regulation of PLK binding through phosphorylation of the substrate (and 
activation of the kinase responsible), rather than substrate availability. The 
processive and distributive phosphorylation models describe how PLK could 
target substrates (Lowery et al., 2004). In the first model, the PBD binding 
partner and the substrate would be one and the same, linking spatial and 
temporal regulation of kinase activity. In the second model, the binding partner 
would bring PLK to the vicinity of a separate protein which could be associated 
in a complex with this binding partner. This mechanism of activity could 
potentially lead to phosphorylation of different substrates or timely 




Figure 7-3 –Schematic illustrating non-self priming and processive models for PLK activity. 
Inactive PLK is shown above, where autoinhibition by the PBD) is indicated (‘-‘). Active PLK 
is shown below (‘+’), where ‘P’ indicates phosphorylation of the kinase domain either as a 
result of autophosphorylation, or phosphorylation by an upstream kinase. The PBD is 
shown here binding to a consensus phospho-epitope within the target substrate 
(processive model) as oppose to a non-substrate protein (distributive model), where 
phosphorylation has occurred at the PBD binding site as a result of non-self priming by 
another kinase. Phosphorylation of the target substrate by PLK is indicated by the arrow 
and ‘P’. Colours: green = polo-box; purple = kinase domain; dark purple= PBD binding site; 
red= target PLK phosphorylation site.  
7.6 T. brucei PLK 
T. brucei possesses a single PLK gene which is found on chromosome 7 
(Tb07.2F2.640) and closely aligns with S. cerevisiae Cdc5 (Graham et al., 1998). 
The levels of sequence identity between Cdc5 and TbPLK were found to be 29.6 
% and 54.1 % for the full length protein and kinase domain, respectively, where 
the kinase domain was defined as comprising residues 47-291(Graham et al., 
1998). The level of sequence identity between human PLK1 and TbPLK was found 
to be 25 % for the full length kinase, and 47.5 % for the kinase domain, described 
here as comprising residues 43-297 (Kumar and Wang, 2006). TbPLK contains the 
conserved serine/threonine kinase active site signature at residues 160-172, and 
the kinase ATP binding site signature at residues 49-70; the PBD comprises two 
polo-box motifs at residues 564-642 and 690-756, respectively (Kumar and Wang, 
2006). In addition, TbPLK was found to display a poly-asparagine insertion 
between the kinase domain and PBD, which was of variable length according to 
the T. brucei strain. This length polymorphism was speculated to be a result of 
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unequal crossing-over events or polymerase slippage (Graham et al., 1998). 
TbPLK was capable of complementing an S. cerevisiae Cdc5 mutant suggesting 
that this enzyme can perform the functions of a typical PLK protein (Kumar and 
Wang, 2006). A model of the kinase domain of TbPLK is shown in Figure 7-4, 
which was generated using Phyre software 
(http://www.sbg.bio.ic.ac.uk/~phyre/), and viewed using the molecular viewing 
tool Pymol. 
                                
Figure 7-4 -The predicted structure for the kinase domain of T. brucei PLK. 
The structure for the kinase domain of T. brucei PLK was predicted using Phyre software 
and viewed using Pymol. The β-sheet structures are shown in pink, and the α-helices in blue 
and C
α
 helices in cyan. 
The localisation and functions of TbPLK have previously been investigated and 
are discussed in context in Section 1.9.1.2.2. Briefly, RNAi of TbPLK in procyclic 
form parasites did not affect mitosis but inhibited cytokinesis (Graffenried et 
al., 2008; Hammarton et al., 2007; Kumar and Wang, 2006). In addition, 
treatment of hydroxyurea-synchronised procyclic form cells with an inhibitor of 
TbPLK, or RNAi of TbPLK followed by synchronisation of procyclic form cells led 
to cell cycle arrest at cytokinesis (Li et al., 2010b). RNAi of TbPLK in 
bloodstream form parasites also inhibited cytokinesis, although in this case, 
initiation of furrow ingression occurred and parasites accumulated partway 
through cleavage; again no problems with mitosis were observed (Hammarton et 
al., 2007). Overexpression or depletion of TbPLK in procyclic form cells inhibited 
cytokinesis, and additionally inhibited basal body duplication, kDNA synthesis 
and kinetoplast segregation. RNAi of TbPLK in bloodstream form cells was also 
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found to inhibit kinetoplast segregation (Hammarton et al., 2007). RNAi of TbPLK 
in a separate study identified problems with Golgi bilobe biogenesis and Golgi 
duplication (Graffenried et al., 2008).  
The localisation of TbPLK is dynamic and cell cycle related. Consistent with an 
inability to detect a mitotic function for TbPLK, no nuclear localisation has been 
observed, and instead TbPLK can be found at the basal bodies, Golgi bilobe and 
flagellum attachment zone (Graffenried et al., 2008; Kumar and Wang, 2006; 
Umeyama and Wang, 2008). At the flagellum attachment zone, TbPLK localises 
to a discrete spot which migrates along the cell coincident with extension of the 
FAZ, before disappearing at anaphase (Li et al., 2010c; Umeyama and Wang, 
2008). The pattern for TbPLK localisation is consistent with the functional roles 
of this protein. Whilst TbPLK has been shown to phosphorylate Centrin 2 in vitro 
(Graffenried et al., 2008), further supporting a role for PLK in Golgi bilobe 
duplication (Section 2.1.2), no other physiological PLK substrates are known. The 
apparent lack of a mitotic role for TbPLK in T. brucei indicates that, despite it 
being able to complement Cdc5 in yeast (Kumar and Wang, 2006), this is a 
divergent polo-like kinase, and hence activation of TbPLK may also differ from 
other organisms. Indeed, conserved residues associated with PLK regulation in 
other organisms are absent from TbPLK. These include the human PLK1 residues 
W414 and L490 (F561 and R652 in TbPLK strain TREU 927 GUTat.10.1) which are 
required for substrate specificity and localisation to the mitotic spindle, and also 
the ‘His-Lys pincer’ required for association with phosphorylated peptides which 
comprises residues H538 and K540 in human PLK1, and K712 and E714 in TbPLK 
(strain TREU 927 GUTat.10.1). However, it is possible that the nearby H710 and 
K712 may perform the same role in TbPLK (Figure 7-6). The Thr210 residue 
(Figure 7-5) required for activation of human PLK1 is conserved in TbPLK 
(Thr198) and the second putative target for upstream kinases, Ser137 is a 




Figure 7-5 -Conservation of the T-loop residue Thr210 
Alignment of PLKs from the organisms indicated was carried out using AlignX software 
(Invitrogen). The T. brucei PLK sequence is for the genome strain, TREU 927 GUTat.10.1. 
The conserved T-loop residue is indicated by the arrow.  
 
Figure 7-6 -Conservation of the 'His-Lys pincer'. 
Alignment of PLKs from the organisms indicated  was carried out using AlignX software 
(Invitrogen). The T. brucei PLK sequence is for the genome strain, TREU 927 GUTat.10.1. 
The conserved His and Lys residues are indicated by the arrows. Nearby histidine and 
lysine residues that could function as a potential ‘His-Lys pincer’ in TbPLK are shown at 
residues 710 and 712. 
7.7 Project aims 
The aim of this study was to investigate how the activity of TbPLK is regulated. 
Soluble, active recombinant PLK was generated, and through the use of a series 
of mutant/truncated PLKs, key residues required for the activity of PLK in vitro 
were determined (Section 7.8) and the role of the PBD in modulating the activity 
of the full length kinase investigated (Section 7.10).  Based on the in vitro data 




7.8 Regulation of in vitro activity of recombinant T. brucei 
PLK 
7.8.1 Generation of plasmids for the production of recombinant 
PLK proteins in E. coli 
To enable the activity of recombinant PLK to be studied in vitro, E. coli 
expression plasmids allowing the expression and purification of full length PLK 
with various mutations were generated (Table 4-4). Previously it has been shown 
that introducing a mutation at residue N169 (N169A) abolishes the activity of PLK 
((Hammarton et al., 2007). This mutation was therefore used to generate a 
recombinant dead kinase, which was necessary to act as a control for activity 
assays and other experiments. The role of the conserved T-loop residue, T198, 
was investigated by mutating it to either a non-polar alanine or valine residue to 
prevent phosphorylation at this position, or to a negatively charged aspartic acid 
residue to mimic the presence of a phosphate group in an attempt to generate a 
constitutively active kinase. A further mutant was generated to investigate the 
role of residues H705 and K707, which may potentially act as a ‘His-Lys pincer’ 
motif, which has been found in PLKs in other organisms to interact with 
phosphorylated proteins mediating substrate binding (Section 7.3). In addition to 
these full length mutant PLKs, plasmids allowing the expression of truncated 
proteins corresponding to the PBD and kinase domains (both wildtype (WT) and 
N169A versions) of PLK were generated in order to allow investigation of the role 
of the PBD in regulating the activity of the kinase domain. To facilitate 
purification of these PLK variants, the proteins were expressed as N-terminal 
glutathione-S-transferase (GST) or 6 x histidine (6XHis) fusion proteins in E. coli 
(see Figure 7-7).  
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Figure 7-7 -Schematic of recombinant PLK proteins purified in this study. 
The recombinant proteins generated in this study are shown with the appropriate epitope 
tag indicated (left).The location and nature of introduced amino acid mutations are indicated 
by red arrows. The PBD core with the polo-box cap (PBD) comprises residues 430-763 while 
the kinase domain (KD) comprises residues 2-294 of PLK. The corresponding plasmids are: 
PLK WT, pHG3; PLK N169A, pHG4; PLK T198A, pHG157; PLK T198V, pHG123; PLK198D, 
pHG163; PLK H705A K707A, pHG169; PBD, pHG148; KD WT, pGL1530; KD N169A, pGL1531 
(Table 4-4).  
Tetracycline-inducible T. brucei expression constructs for wildtype and kinase 
dead (N169A) PLK (pGL1278 and pGL1279, respectively) were previously 
generated (Hammarton et al., 2007). In order to generate His-tagged versions of 
wild type and kinase dead PLK, oligonucleotides OL2138 and OL2139 
(incorporating the restriction sites, NheI and XhoI, respectively (Table 4-10)) 
were used to amplify the coding sequence for PLK WT and PLK N169A from 
pGL1278 or pGL1279,respectively (Section 4.5.4). The resultant PCR products 
were ligated into the cloning vector pCR4-TOPO (Invitrogen; Section 4.5.6) 
generating plasmids pGL1780 and pGL1781 (corresponding to PLK WT and PLK 
N169A, respectively, see Table 4-4). These plasmids were sequenced (Section 
4.5.8) before the PLK genes were subcloned as NheI/XhoI fragments into 
similarly digested pET-28a(+) (Novagen) (Section 4.5.7), generating pHG3 
(6XHis:PLK WT) and pHG4 (6XHis:PLK N169A) (Table 4-4). T-loop mutations to 
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replace T198 with alanine, valine or aspartic acid were generated by site 
directed mutagenesis (Section 4.5.5) using oligonucleotides PR124 and PR125 
(T198A), PR126 and PR127 (T198V), or PR168 and PR169 (T198D) (Table 4-10) 
using pHG3 as a template. The final plasmids pHG157 (6XHis:PLK T198A), 
pHG123 (6XHis:PLK T198V), and pHG163 (6XHis:PLK T198D) (Table 4-4) were 
sequenced (Section 4.5.8) to verify the presence of the mutation and the 
absence of any other mutations in the PLK sequence.  
To generate the H705A K707A mutant, oligonucleotide pairs PR170 and OL2139, 
and PR171 and OL2138 (Table 4-10) were used to amplify two overlapping 
fragments each containing the desired mutations and either the upstream or 
downstream region of PLK WT. These PCR products were purified and used as 
templates in a Gene SOEing PCR reaction (Section 4.5.4) with oligonucleotides 
OL2138 and OL2139 (containing NheI and XhoI restriction sites, respectively; 
Table 4-10). This PCR reaction generated full length PLK H705A K707A, which 
was ligated into pSC-B (Stratagene; Section 4.5.6) generating pHG152 (Table 4-4) 
and sequenced (Section 4.5.8). PLK H705A K707A was subcloned as a NheI and 
XhoI digested fragment into the same sites in pET-28a(+), generating pHG169 
(Table 4-4).  
To generate a truncated PLK protein comprising the PBD, oligonucleotides were 
designed to incorporate a region of the PLK gene encoding the polo-box domain 
with an additional N-terminal extension to account for the possibility that, like 
human PLK1, an alpha helix (the Polo-box cap or PBC) precedes the polo-box 
motifs, and acts as a tether. JPred software 
(http://www.compbio.dundee.ac.uk) was used to determine whether an alpha 
helix was predicted at this region (Kelley and Sternberg, 2009). An alpha helix 
was predicted with the highest possible level of confidence, comprising residues 




Figure 7-8 -Schematic showing the predicted Polo-box cap for T. brucei PLK. 
The red cylinders indicate predicted alpha helices, and yellow arrows indicate predicted 
beta sheets. The numbers below indicate the confidence of the prediction from 0 (low 
confidence) to 9 (high confidence).’Sol’ predictions are predicted solvent accessibility for 25 
%, 5 % and 0 % cut offs (as indicated), ‘B’ indicates buried residues. ‘Jnet’ refers to the final 
secondary structure prediction, ‘Jhmm’ and ‘jpssm’ represent position-specific scorring 
matrix and hidden Markov profiles, respectively. ‘Lupas’ refers to the Lupas Coil prediction 
(window size of 14, 21 and 28). The boxes and red/blue text shown in the amino acid 
sequence indicate aliphatic residues, histidine residues and proline residues, respectively. 
The numbers and arrows at the top of the figure indicate the start and end residues of the 
predicted Polo-box cap. 
Oligonucleotides PR172 and OL2139 (incorporating NheI and XhoI restriction 
sites, respectively; Table 4-10) were therefore used to PCR-amplify (Section 
4.5.4) a region of PLK encoding amino acids 430-763, using pHG3 (Table 4-4) as 
template. The fragment amplified incorporated the PBD and upstream PBC and 
also some of the conserved sequence downstream from the poly-asparagine 
insertion (located at the central region). The PCR product was ligated into pSC-B 
(Section 4.5.6) producing pHG148 (Table 4-4) and sequenced (Section 4.5.8), 
before the PLK fragment was subcloned (Section 4.5.7) as an NheI/XhoI fragment 
into the same sites of pET-28a(+), generating pHG153 (Table 4-4).  
Kinase domain truncations were generated using oligonucleotides OL2142 and 
OL2141 (incorporating BamHI and XhoI restriction sites, respectively; Table 4-10) 
to PCR-amplify a PLK fragment corresponding to amino acid residues 2-294 
(comprising the kinase domain core, plus three extra amino acids downstream 
from the predicted kinase domain described in (Graham et al., 1998). In order to 
generate both an active and a dead version of the kinase domain (KD), plasmids 
pGL1278 (WT) or pGL1279 (N169A) were used as templates in the PCR reactions. 
The PCR products were ligated into pCR-4 TOPO (Invitrogen; Section 4.5.6) 
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generating plasmids pGL1525 and pGL1526 (corresponding to the KD WT and KD 
N169A, respectively; Table 4-4) which were sequenced (Section 4.5.8) and 
subcloned (Section 4.5.7) into BamHI/XhoI digested pGEX5X1 (GE Healthcare) to 
generate the plasmids pGL1530 and pGL1531 corresponding to GST:KD WT and 
GST:KD N169A, respectively (Table 4-4). 
7.8.2 Purification of recombinant proteins 
The expression plasmids for each of the PLK variants described above were 
transformed into BL21 (DE3) pLysS E.coli cells (Promega) to allow expression and 
purification of the recombinant proteins. To optimize expression (Section 
4.6.4.1), transformed E. coli were grown at different temperatures for varying 
periods in the presence of different concentrations of Isopropyl β-D-1-
thiogalactopyranoside (IPTG).  Samples were prepared at appropriate time 
points and analysed by PAGE (Section 4.6.1) in conjunction with Coomassie Blue 
staining (Section 4.6.2) and/or Western blotting with anti-His or anti-GST 
antibodies (Section 4.6.3), where appropriate, to identify conditions leading to 
expression of each recombinant protein.  Optimal conditions were established 
for each of the recombinant proteins (growth at 15oC for 16 hrs in the presence 
of 1 mM IPTG for full length PLK proteins and PBD protein; growth at 20oC for 20 
hrs in the presence of 0.5 mM IPTG for the kinase domain truncated proteins).  
Recombinant proteins were purified via affinity chromatography as appropriate 
for the purification tag (Section 4.6.4.2), and yields were typically 10-50 mg per 
200 ml of E. coli cells (Figure 7-9, Figure 7-10, Figure 7-11 and Figure 7-12).  
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Figure 7-9 -Coomassie-stained SDS-PAGE gels of 6XHis:PLK WT and 6XHis:PLK N169A 
purifications. 
Purified recombinant 6XHis:PLK proteins (predicted size 88 kDa) are indicated by the 
arrows. Lanes 1 and 2: uninduced and induced E. coli whole cell lysates, respectively; lanes 
3 and 4: soluble and insoluble fractions of E. coli cell lysates, respectively; lane 5: flow 
through; lanes 6- 7: washes 1-2; lanes 8-11: elutions 1-4; lane 12: nickel beads following 
elution. Protein loading relative to the cleared lysate corresponds to the ratios: 1:25 (lanes 
1-2), 1:1 (lanes 3-7), and 1:8 (lanes 8-12). The inaccurate loading of whole cell lysate 
fractions was due to high sample viscosity. 
 
                   
Figure 7-10 -Coomassie stained SDS PAGE gels of 6XHis:PLK T198A and 6XHis:PLK T198D 
purifications. 
Purified recombinant 6XHis:PLK proteins (predicted size 88 kDa) are indicated by the 
arrows. Lanes 1 and 2: uninduced and induced E. coli whole cell lysates, respectively; lanes 
3 and 4: soluble and insoluble fractions of E. coli cell lysates, respectively, lane 5: flow 
through; lanes 6-7 (upper gel) and lane 6 (lower gel): washes 1-2 for 6XHisPLK T198V or 
pooled washes 1-2 for 6XHis:PLK T198D, respectively; lanes 8-11 (upper gel) or 7-10 (lower 
gel): elutions 1-4 for 6XHisPLK T198V and 6XHis:PLK T198D, respectively; lane 12 (uppder 
gel) or 11 (lower gel): nickel beads following elution for 6XHisPLK T198V and 6XHis:PLK 
T198D, respectively. Protein loading relative to the cleared lysate corresponds to the ratios: 
  
222 
1:25 (lanes 1-2), 1:1 (lanes 3-7), and 1:8 (lanes 8-12). The inaccurate loading of whole cell 
lysate fractions was due to high sample viscosity. 
               
Figure 7-11 -Coomassie stained SDS PAGE gels of 6XHisPLK H705A K707A and 6XHis:PBD 
purifications. 
Purified recombinant 6XHisPLK proteins (predicted size 88 and 39 kDa, respectively) are 
indicated by the arrows. Lanes 1 and 2: uninduced and induced E. coli whole cell lysates, 
respectively; lanes 3 and 4: soluble and insoluble fractions of E. coli cell lysates, 
respectively; lane 5: flow through; lanes 6-7: washes 1-2; lanes 8-11: elutions 1-4; lane 12: 
nickel beads following elution. Protein loading relative to the cleared lysate corresponds to 
the ratios: 1:25 (lanes 1-2), 1:1 (lanes 3-7), and 1:8 (lanes 8-12). The inaccurate loading of 
whole cell lysate fractions was due to high sample viscosity. 
 
                   
Figure 7-12 -Coomassie stained SDS PAGE gels of GST:KD WT purification and elution 
fractions of purified GST:KD N169A. 
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Purified recombinant GST:PLK proteins (predicted size 60 kDa) are indicated by the arrows. 
Top gel (purification of GST:KD WT): lane 1:induced E. coli whole cell lysate; lanes 2 and 3: 
insoluble and soluble fractions of E. coli cell lysates, respectively; lane 4: flow through; lane 
5: pooled wash fractions (washes 1-3); lanes 6-9: elutions 1-4; lane 10: glutathione-
sepharose beads following elution. Protein loading relative to the original culture 
corresponds to the ratios: 1:10 (lane 1), 1:1 (lanes 2-4), 1:10 (lane 5) and 1:100 (lanes 6-10). 
Bottom gel: eluted fractions (1-4) from the purification of GST:KD N169A. 
7.8.3 Assessing activity of recombinant PLK against generic 
kinase substrates 
To investigate the activity of 6XHis:PLK WT, fresh protein was dialysed into an 
appropriate buffer (Section 4.6.6) and kinase assays were carried out using 32P γ 
ATP to detect phosphorylation of substrates, and also to detect 
autophosphorylation (Section 4.7). 6XHis:PLK WT was active against the generic 
kinase substrates α-casein, histone H1 and myelin basic protein (Figure 7-13), 
and the preferred substrate was found to be α-casein. Autophosphorylation was 
also readily detected for 6XHis:PLK WT. No autophosphorylation or 
phosphorylation of substrates could be detected for 6XHisPLK: N169A. 
 
Figure 7-13 -The activity of recombinant PLK against generic kinase substrates. 
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6XHis:PLK WT (WT),  6XHis:PLK N169A (N169A) or a buffer control (-) were used in kinase 
assays to determine the activity of recombinant PLK against generic kinase substrates. Top 
panels: autoradiographs; bottom panels: the corresponding Coomassie gels acting as 
loading controls. PLK proteins (predicted size: 88 kDa), and substrates are indicated. ‘+P’: 
phosphorylated proteins. 
 
7.8.4 Autophosphorylation of recombinant 6XHis:PLK proteins 
Whilst 6XHis:PLK N169A was found to migrate through an SDS PAGE gel at the 
predicted molecular weight of 88 kDa, migration of 6XHis:PLK WT was 
significantly impaired, corresponding to a molecular weight of approximately 
100 kDa (Figure 7-13 and Figure 7-14). In addition, the protein appeared as a 
blurred band by Coomassie staining. Both of these phenomena were suggestive 
of protein phosphorylation. 
                      
Figure 7-14 -Electrophoretic mobility of 6XHis:PLK WT and 6XHis:PLK N169A. 
Different elutions (1-3) from the purification of recombinant PLK proteins were prepared for 
SDS PAGE, and Coomassie staining to compare differences in the electrophoretic mobility 
of 6XHis:PLK WT and 6XHis:PLK N169A. The predicted size for both proteins was 88 kDa.  
To investigate whether phosphorylation could account for the apparent 
differences in electrophoretic mobility of 6XHis:PLK WT and 6XHis:PLK N169A, 
Western blotting of these proteins with anti-phosphoserine and anti-
phosphothreonine antibodies (Section 4.6.3) was carried out. 6XHis:PLK WT was 
found to be phosphorylated at both serine (Figure 7-15A) and threonine residues 




               
Figure 7-15 -Phosphorylation status of recombinant PLKs. 
6XHis:PLK WT and 6XHis:PLK N169A were prepared for SDS PAGE and Western blotting 
with anti-phosphoserine (A) or anti-phosphothreonine (B) antibodies at the appropriate 
concentrations. The Western blot membranes were stained with Ponceau reagent to control 
for loading (left panels) prior to blocking and incubating with antibody. Different length 
exposures (shorter exposure in middle panel) are shown for the detection of anti-
phosphothreonine antibody in order to show the low level of phosphorylation detected for 
6XHis:PLK N169A.  
In order to identify specific phosphorylated residues, these proteins were 
analysed by Mass Spectrometry (Section 4.6.8). No phosphorylated residues were 
detected for 6XHisPLK N169A through this method, while multiple 
phosphorylated residues were detected for 6XHis:PLK WT (Table 7-1). A number 
of detected phosphorylated peptides contained one phosphosite but more than 
one threonine or serine residue within their length, and it was not possible to 
determine which of the serine or threonine residues was phosphorylated 
(‘ambiguous’ phosphosites,Table 7-1). The majority of phosphorylated residues 
were detected within the central region of the PLK protein; however, 
phosphorylation sites were also found within the kinase and polo-box domains. 
The phosphorylation sites identified did not correspond to sites identified for in 
vivo expressed PLK where mass spectrometry analysis was performed on 
phosphopeptide enriched cytosolic cell lysates extracted from bloodstream form 
trypanosomes (five ambiguous phosphorylation sites were detected at the 
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central region of PLK: S457, T460, T461, T463, T464 (Nett et al., 2009)); or 
those residues at sites predicted to be targeted by upstream kinases (Thr198 or 
Thr125, equivalent to human PLK1 Thr210 and Ser137, respectively). The 
difference between phosphorylation sites detected in in vivo and in vitro studies 
may imply that phosphorylation of these sites were an in vitro artefact; whilst 
the inclusion of 6XHis:PLK N198A in these analyses should control for possible 
phosphorylation by E. coli Ser/Thr kinases (Macek et al., 2008), it is possible 
that 6XHis:PLK exhibits aberrant autophosphorylation in the environment of the 
E. coli cytoplasm. Alternatively, at least some of these phosphosites may be 
present in vivo but may have eluded detection. Attempts to further investigate 
phosphorylation sites for in vivo expressed PLK have to date proved 
unsuccessful. 
Table 7-1 -Phosphorylation sites for recombinant 6XHis:PLK WT identified by mass 
spectrometry analysis. 
6XHis:PLK WT and 6XHis:PLK N169A were analysed by mass spectrometry. This approach 
failed to reveal any phosphorylated residues for 6XHis:PLK N169A, although multiple 
residues were identified for 6XHis:PLK WT. The numbers of phosphorylation sites identified 
at different regions of PLK are shown above, where ‘ambiguous’ describes those residues 
identified in a trypsin digested peptide which contained more than one serine or threonine 
residue, and ‘unambiguous’ describes those residues identified in peptides with only one 
serine or threonine residue such that there could be no doubt as to the exact 
phosphorylation site. 




7.8.5 The role of autophosphorylation in PLK activity 
7.8.5.1 Dephosphorylation of recombinant 6XHis:PLK proteins 
To investigate whether the observed phosphorylation of PLK could be reversed, 
dephosphorylation of 6XHis:PLK WT was carried out using the enzyme lambda 
protein phosphatase (λPPase) (Section 4.8). Analysis of λPPase treated 6XHis:PLK 
WT by SDS PAGE revealed that both the impaired migration through an SDS PAGE 
gel, and the blurred appearance of Coomassie stained 6XHis:PLK were abolished 
following 45 minutes of treatment (Figure 7-16A). A comparison of 6XHis:PLK WT 
and 6XHis:PLK N169A treated with λPPase for 1 hour revealed that this change in 
migration by SDS PAGE was only observed for the WT PLK protein (Figure 7-16B), 
and that the electrophoretic mobilities of 6XHisPLK:WT and 6XHis:PLK N169A 
after this incubation were identical. This evidence suggested 6XHis:PLK WT, 
which is able to autophosphorylate, but not 6XHis:PLK N169A, the kinase dead 
mutant, exhibits prolific autophosphorylation at serine and threonine residues. 
This autophosphorylation was responsible for the impaired migration through SDS 
PAGE gels, and blurred appearance of the 6XHis:PLK WT band by Coomassie 
staining, since these phenomena could be reversed through treatment with 
λPPase.  
                   
Figure 7-16 -Lambda protein phosphatase (λPPase) treatment of recombinant PLK. 
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A: Coomassie-stained SDS PAGE gel of a time course of λPPase treatment of 6XHis:PLK 
WT . Time points are indicated. B: Coomassie-stained SDS PAGE gel comparing the effect 
of λPPase treatment on 6XHis:PLK WT (WT) and 6XHis:PLK N169A (N169A). 
7.8.5.2 Activity of dephosphorylated recombinant 6XHis:PLK 
In order to investigate the effect of autophosphorylation on activity, 6XHis:PLK 
WT bound to nickel beads (Section 4.6.4.2.1) was treated with lambda protein 
phosphatase (λPPase) (Section 4.8) before being extensively washed (to remove 
the λPPase), and eluted as a dephosphorylated protein (Section 4.8.1). To assess 
the efficiency of the λPPase treatment, samples from the purification were 
prepared for SDS PAGE (Section 4.6.1) and Western blotting with an anti-
phosphothreonine antibody (Section 4.6.3). Phosphorylation at threonine 
residues for untreated, but not treated 6XHis:PLK WT, was detected, implying 
that λPPase treatment had been efficient (Figure 7-17). The eluted proteins 
were filtered by centrifugation using filtration device with a 50 kDa cut off 
(Section 4.8.1) to further remove any remaining λPPase. 
 
Figure 7-17 -Purification of Lambda protein phosphatase (λPPase) treated 6XHis:PLK WT. 
6XHis:PLK WT immobilised on nickel beads was treated with λPPase prior to elution and 
preparation of eluate samples for SDS PAGE and Western blotting with anti-
phosphothreonine antibody. Phosphothreonine residues were detected in control but not 
treated samples (top panel). To control for loading of treated and untreated proteins, the 
Western blot was incubated with Ponceau reagent (bottom panel). 
Kinase assays (Section 4.7) using equal molar amounts (Section 4.6.5) of treated 
and untreated 6XHis:PLK WT (Section 4.8.1) were carried out, and to investigate 
whether autophosphorylation occurs prior to substrate phosphorylation, 
independent reactions were halted at 10 minute intervals during a 30 minute 
assay (Figure 7-18). Both treated and untreated 6XHis:PLK WT displayed 
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increasing activity towards an α-casein substrate over time; however, the 
activity of treated 6XHis:PLK WT was dramatically impaired. 
Autophosphorylation of untreated 6XHis:PLK WT was readily detectable, and this 
increased over time. Autophosphorylation of treated 6XHis:PLK WT was just 
detectable at 30 minutes post-incubation with 32P γ ATP, implying that 
autophosphorylation may not be required for activity or that small, undetectable 
amounts of autophosphorylation are sufficient for activity. These results show 
that phosphorylation of 6XHis:PLK WT is important for its activity in vitro. 
     
Figure 7-18 -Analysis of the importance of autophosphorylation for in vitro activity of PLK. 
The activities of λPPase treated 6XHis:PLK WT, or an untreated control (subjected to an 
equivalent treatment minus the λPPase enzyme) were assessed by performing kinase 
assays with an α-casein substrate. Four independent reactions of increasing duration (as 
indicated) were carried out. The positive control (6XHis:PLK WT (WT)) and negative controls 
(6XHis:PLK N169A (N169A) or assay buffer (buffer) are indicated. The autoradiograph (top 
panel) shows the detection of radiolabelled proteins, and as a loading control, the 
equivalent Coomassie-stained SDS PAGE gel is shown below. 6XHis:PLK proteins have a 
predicted size of 88 kDa. 
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7.8.6 Investigations into the importance of phosphorylation of T-
loop residue T198 for the activity of recombinant 6XHis:PLK  
7.8.6.1 Rationale 
T198 is a highly conserved residue in PLK family members (Section 7.5.1), 
including TbPLK (Section 7.6), and is an in vivo target of upstream kinase Aur-A 
in humans (Section 7.5.1). The T. brucei Aur-A homologue, AUK1 is an important 
cytokinesis regulator in T. brucei (Section 1.9.1.1), and it is possible that these 
proteins are components of the same signalling pathways. Other putative 
upstream kinases which could target T198 include members of the Ste 20-like 
kinase family (TbSLK1 (Tb927.8.5730) and TbSLK2 (Tb09.211.3820) which have 
been identified as regulators or potential regulators of PLK in other organisms 
(Section 7.5.1). 
Although this residue was not detected as a phosphorylation site in vivo (Nett et 
al., 2009), this does not preclude phosphorylation at T198. This study did not use 
synchronised cultures,  which could be necessary for the detection of in vivo 
phosphorylation sites for the following reasons: firstly, PLK is expressed at S/ 
G2/M phases of the cell cycle (Umeyama and Wang, 2008); secondly it is possible 
that phosphorylation of T198 is a cell cycle specific event; finally given the 
observation that PLK is localised to the FAZ, it is possible that sequestration to 
cytoskeletal elements decreases the amount of available PLK in the cytoplasmic 
fraction which was used for these analyses. The latter observation concurs with 
my own difficulties in extracting exogenously expressed PLK from cell lysates 
further implying that different strategies may be required for identification of in 
vivo phosphorylation sites of PLK. Given these possibilities, it was not considered 
unlikely that T198 could function to regulate the activity of PLK, and mutated 
6XHis:PLK T198 mutants were generated and purified as described in Section 
7.8.1 and Section 7.8.2 in order to analyse the phosphorylation status and 
activity of 6XHis:PLK T-loop mutants T198A, T198V and T198D.  
7.8.6.2 Autophosphorylation of 6XHis:PLK T-loop mutants 
From analysis of Coomassie-stained SDS-PAGE gels, it was demonstrated that 
6XHis:PLK WT and 6XHis:PLK T198D displayed similar electrophoretic mobility 
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and were present as a blurred band, indicating that 6XHis:PLK T198D, like 
6XHis:PLK WT, was autophosphorylated in vitro (Figure 7-19). The 
electrophoretic mobility and appearance by Coomassie staining of 6XHis:PLK 
T198V was comparable to that of 6XHis:PLK N169A, indicating that 
autophosphorylation was absent or minimal. 6XHis:PLK T198A displayed 
intermediate electrophoretic mobility suggesting that mutation of the threonine 
T-loop residue to alanine reduced, but did not abolish, autophosphorylation 
(Figure 7-19). 
               
Figure 7-19 -Comparison of electophoretic mobility of 6XHis:PLK proteins. 
Equimolar amounts of 6XHis:PLK WT and the mutants 6XHis:PLK N169A, T198A, T198V and 
T198D were analysed by SDS-PAGE and Coomassie staining.  
To investigate the nature of phosphorylation of the T-loop mutants, samples 
were prepared for SDS PAGE (Section 4.6.1) and Western blotting with anti-
phosphothreonine or anti-phosphoserine antibodies (Section 4.6.3). Similar levels 
of phosphorylated serine and threonine residues could be detected for 6XHis:PLK 
WT and 6XHis:PLK T198D (Figure 7-20 and Figure 7-21). The abundance of 
phosphorylated threonine and serine residues detected for T-loop mutants 
6XHis:PLK T198A and 6XHis:PLK T198V was much lower,  although not as low as 
for the 6XHis:PLK N169A kinase dead mutant. These results imply that the 
differences in electrophoretic mobility through SDS PAGE gels are, as predicted, 




Figure 7-20 -Western blot analysis of phosphorylated serine residues in 6XHis:PLK proteins. 
Equivalent amounts of 6XHis:PLK WT, N169A or T198A/V/D proteins were prepared for SDS 
PAGE and Western blotting with anti-phosphoserine antibody (right panel). Prior to 
incubation with antibodies, the Western blot was stained with Ponceau reagent (left panel) 
to control for protein loading. 
 
Figure 7-21 -Western blot analysis of phosphorylated threonine residues in 6XHis:PLK 
proteins. 
Equivalent amounts of 6XHis:PLK WT, N169A or T198A/V/D proteins were prepared for SDS 
PAGE and Western blotting with anti-phosphothreonine antibody (right panels; top: shorter 
exposure; bottom: longer exposure). Prior to incubation with antibodies, the Western blot 
was stained with Ponceau reagent (left panel) to control for protein loading. 
In order to identify specific phosphorylation sites on the T198 mutant PLK 
proteins, proteins were prepared for analysis by mass spectrometry (Section 
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4.6.8). No phosphorylation sites were detected for 6XHis:PLK T198V; however, 
phosphorylation sites were identified for both 6XHis:PLK T198A and 6XHis:PLK 
T198D, with the latter exhibiting the greatest number of detectable 
phosphorylated residues (Table 7-2). A comparison of the location of these 
phosphorylation sites (where ambiguous and unambiguous residues were 
analysed together) revealed that three sites were common to the WT, T198A and 
T198D 6XHis:PLK proteins(Error! Reference source not found.), and that these 
residues were located in the central region, between the kinase domain and first 
polo-box motif. There were also other residues in common between 6XHis:PLK 
WT and either T198A orT198V 6XHis:PLK mutants within the central region,  and 
one phosphorylated residue was found to be common between 6XHis:PLK WT and 
6XHis:PLK T198D and the second polo-box motif. The differences in detectable 
phosphorylation sites between the different proteins suggested that the T-loop 
residue T198 is important in influencing the sites of autophosphorylation.  
Table 7-2 -Location of phosphorylated serine and threonine residues for recombinant PLK 
proteins. 
The number and location of phosphorylation sites identified by mass spectrometry analysis 
for WT and T-loop mutated versions of 6XHis:PLK are shown below. The identification of 
phophorylated trypsin digested peptides containing one or more threonine or serine residue 
led to the classification of some phosphorylation sites as ‘ambiguous’, whilst when only 
one threonine or serine residue was present in the phosphorylated peptide residues were 





7.8.6.3 Activity of 6XHis:PLK T-loop mutants 
To compare the relative activities of T-loop mutants with 6XHis:PLK WT, in vitro 
kinase assays were carried out (Section 4.7) using equivalent amounts (Section 
4.6.5) of 6XHis:PLK proteins, and an α-casein substrate. 6XHis:PLK WT showed 
the highest level of activity against the substrate, which was approximately two 
fold (estimated) greater than the level of activity displayed by 6XHis:PLK T198D 
(Figure 7-22). This was unexpected, as other studies have reported increased 
levels of activity following substitution of the equivalent T-loop residue with 
aspartic acid (Section 7.5.1). Both 6XHisPLK:T198A and 6XHisPLK:T198V 
displayed similar and low levels of activity against the α-casein substrate (with a 
slightly higher level of activity displayed for 6XHis:PLK T198A), and as discussed 
previously (Section 7.8.3), no activity could be detected for 6XHis:PLK N169A. A 
reduction in PLK activity following mutation of the T-loop threonine to alanine 
or valine has been previously reported for mammalian PLK1 (Section 7.5.1). 
6XHisPLK WT exhibited the greatest level of autophosphorylation, whilst no 
autophosphorylation could be detected for 6XHis:PLK N169A. 6XHis:PLK T198D 
exhibited slightly less autophosphorylation in comparison to 6XHis:PLK WT, 
whilst lower and similar levels of autophosphorylation were detected for 
6XHisPLK:T198A and 6XHisPLK T198V, consistent with the data obtained by 
Western blotting with anti-phosphoserine/threonine antibodies (Figure 7-20 and 
Figure 7-21) and the abundance of phosphorylation sites detected by mass 
spectrometry (Table 7-2).  
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Figure 7-22 -The activities of recombinant 6XHis:PLK proteins. 
The activities of equivalent amounts  of WT and mutated versions of recombinant PLK 
proteins (as indicated at the top of the figure) were tested in a kinase assay (including a 
buffer control (-)) with an α-casein substrate. The autoradiograph (top panel) shows the 
detection of radiolabelled proteins, and to control for loading, the equivalent Coomassie-
stained gel is shown (bottom panel). ‘+P’ indicates phosphorylated proteins. 
7.8.6.4 Conclusions 
The studies described above demonstrate that the T-loop T198 residue is clearly 
important for in vitro activity of PLK (Figure 7-22).  Interestingly, of the 42 
residues identified as either putative or unambiguous phosphorylation sites for 
6XHis:PLK WT, only 13 of these were common to either 6XHis:PLK T198A or 
6XHis:PLK T198D, and a different pattern of autophosphorylation was detected 
between the T198A and T198V mutants. These sites of autophosphorylation may 
further contribute to the differences in activity between 6XHis recombinant 
proteins.  
Whilst the differences in the mass spectrometry data could be attributed to 
variation in the detection of phosphorylated residues, it is also possible that 
mutations at the T-loop residue could alter the specificity of 
autophosphorylation. It is important to note that these data are for in vitro 
analyses; therefore, expression of T-loop-mutated PLK proteins in vivo was 
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carried out to determine whether the T-loop is important for activity under 
physiological conditions.   
7.9 Investigation of the importance of T-loop residue 
T198 in vivo 
7.9.1 Background 
Since PLK is an essential enzyme in T. brucei, gene replacement strategies were 
not suitable to test the functional consequences of mutating T198 in vivo, and 
therefore an alternative strategy was required. Overexpression of ty:PLK WT in 
procyclic form parasites has been shown previously to inhibit basal body 
duplication,  kDNA replication, kinetoplast segregation and cytokinesis, whilst 
overexpression of ty:PLK N169A produced no discernable effect on growth or cell 
cycle regulation over a 72 hour period (Hammarton et al., 2007). Therefore, this 
system was suitable for providing an in vivo readout of activity of the T198 PLK 
mutants in procyclic form parasites.  
7.9.2 Generation of plasmids for inducible expression of ty:PLK  
with mutations at the conserved T-loop residue T198 
In order to test the activity of in vivo expressed T198 mutants, and perform 
functional studies, plasmid constructs to allow the tetracycline-inducible 
expression of these PLK variants in T. brucei were generated. Previously the 
plasmid pGL1278 was generated (Hammarton et al., 2007) for tetracycline-
inducible expression of ty:PLK in T. brucei cell lines which constitutively express 
the tetracycline repressor protein TetR (Wirtz and Clayton, 1995). To substitute 
the T198 residue for valine or aspartic acid, oligonucleotide pairs PR126 and 
PR127 or PR168 and PR169 (Table 4-10) were used for site directed mutagenesis 
(Section 4.5.5) of the pGL1278 plasmid and introduction of the desired T198V or 
T198D substitutions, respectively. This generated plasmids pHG158 (ty:PLK 
T198V,) and pHG164 (ty:PLK T198D) which were sequenced (Section 4.5.8) to 
confirm the presence of the appropriate mutations and absence of any other 
mutations. An additional plasmid was generated for the inducible expression of 
  
237 
ty:PLK T198A, although due to time constraints, clones generated from these 
transfections were not analysed, and this work will not be discussed. 
           
Figure 7-23 -Map of pHG158, a plasmid allowing inducible expression of ty:PLK T198V. 
pHG158 was generated by site directed mutagenesis of pGL1278 (Hammarton et al., 2007) 
using the oligonucleotides PR126 and PR127 (indicated). Note that the PARP promoter has 
been modified to contain two Tet operator sites to allow tetracycline-inducible expression of 
ty:PLK. The vector is linearised by digestion with NotI, integrates into the ribosomal RNA 
(rRNA) gene array, and confers hygromycin resistance.  
7.9.3 Generation of cell lines for the inducible expression of 
ty:PLK with T-loop mutations T198V and T198D 
Procyclic form 427 pHD449 parasites (Wirtz and Clayton, 1995) were transfected 
with NotI linearised (Section 4.3.2) pHG158 or pHG164 (Table 4-4), and clones 
were selected by limiting dilution in SDM79 medium supplemented with the 
appropriate drugs (Table 4-7). Transfection of procyclic form 427 pHD449 with 
pHG158 generated 18 independent clones. Twelve clones were selected for 
screening, and these parasites were grown for 16 hours in the presence or 
absence of tetracycline (1 μgml-1) before cells were harvested and prepared 
(Section 4.2.2.2) for analysis by SDS PAGE (Section 4.6.1) and Western blotting 
(Section 4.6.3) with anti-TY antibody (Section 4.6.3.2). Eleven of these clones 
were found to express ty:PLK T198V, and clones 6 and 7 (Figure 7-24) were 
selected for future experiments. Transfection of procyclic form 427 pHD449 with 
pHG164 generated two pools and two clones, which were screened for 
expression of ty:PLK T198D as described for ty:PLK T198V above. All of the pools 
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and clones were found to express ty:PLK T198D (Figure 7-25), and clones 1 and 2 
were selected for future experiments.  
                   
Figure 7-24 -Western blot analysis of procyclic form 427 pHD449 pHG158 clones. 
427 pHD449 pHG158 clones were screened for inducible expression of ty:PLK T198V by 
incubating cells with or without tetracycline (T- or T+, respectively) for 16 hours prior to 
preparation of cell lysates for SDS PAGE and Western blotting with anti-TY antibody (top 
panel). C5-C8 represent lysates from clones 5-8, respectively. Procyclic 427 WT cells and 
procyclic 427 pHD449 pGL1278 (T+) cells acted as negative (-) and positive (+) controls, 
respectively. To control for loading, the Western blot was stained with Ponceau reagent 
prior to being incubated with antibodies (bottom panel). The predicted size for ty:PLK was 
90 kDa. 
                 
Figure 7-25 -Western blot analysis of procyclic form 427 pHD449 pHG164 clones. 
427 pHD449 pHG164 clones were screened for inducible expression of ty:PLK T198D by 
incubating cells with or without tetracycline (T- or T+, respectively) for 16 hours prior to 
preparation of cell lysates for SDS PAGE and Western blotting with anti-TY antibody (top 
panel). P1-2 and C1-2 represent lysates from pools 1-2 and clones 1-2 respectively.  
Procyclic 427 WT cells and procyclic 427 pHD449 pGL1278 (T+) cells acted as negative (-) 
and positive (+) controls, respectively. To control for loading, the Western blot was stained 
with Ponceau reagent prior to being incubated with antibodies (bottom panel). The 
predicted size for ty:PLK was 90 kDa. 
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7.9.4 Comparison of inducible protein expression for cell lines 
expressing ty:PLK variants 
In order to compare the functional consequences of overexpression of different 
ty:PLK variants, it was necessary to verify that equivalent levels of protein 
expression were induced. Cell lines expressing ty:PLK WT, tyPLK N169A, and 
cells from two independent clonal cell lines expressing either tyPLK:T198V or 
ty:PLK T198D were grown for 16 hours in the presence or absence of tetracycline 
(1 μgml-1), before harvesting the cells and preparing cell lysates (Section 
4.2.2.2). Cell lysates were analysed by SDS PAGE (Section 4.6.1) and Western 
blotting (Section 4.6.3) with anti-TY antibody (Section 4.6.3.2) to detect ty:PLK 
variants, and anti-EF1α antibody (Section 4.6.3.2) to control for loading (Figure 
7-26). Whilst no ty:PLK could be detected in cell lysates obtained from 
uninduced parasites, equivalent levels of ty:PLK were detected for cell lysates 
obtained from induced cells. Interestingly, no differences in electrophoretic 
mobility were observed between the variants.  This may indicate that 
phosphorylation of PLK in vivo involves fewer residues than in vitro, potentially 
rendering detection of these phosphorylation events by SDS PAGE impossible, or 
that only a small proportion of PLK is phosphorylated in vivo, which would not be 
unexpected, especially considering that asynchronous cell populations were used 
for this analysis. 
       
Figure 7-26 -Western blot analysis to compare expression levels of ty:PLK proteins. 
Expression of ty:PLK proteins was induced by the application of tetracycline (1 μgml
-1
). 
Cells grown in the presence (T+) or absence (T-) of tetracycline were harvested at 16 hours 
post-induction. Lysates were prepared for SDS PAGE and Western blotting with anti-TY (top 
panel) and anti-EFI-α (bottom panel) antibodies to detect ty:PLK proteins or to act as a 
loading control, respectively. 
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7.9.5 The activity of ty:PLK variants  
In order to determine whether the activity of ty:PLK proteins expressed in vivo 
was affected by mutation at T198, extracts of cells (Section 4.6.9) expressing 
ty:PLK variants were incubated with anti-TY antibody-conjugated beads or 
control beads (Section 4.6.11) and, following washing, the resulting 
protein/bead complexes were used to perform kinase assays with an α-casein 
substrate (Section 4.7). ty:PLK WT was found to exhibit the greatest level of 
activity against α-casein, although this was only slightly greater than the activity 
shown by ty:PLK T198V and ty:PLK T198D (Figure 7-27). No activity was detected 
for ty:PLK N169A, and in addition, it was not possible to detect 
autophosphorylation for any of the PLK proteins. This implied that regulation of 
ty:PLK activity in vivo does not involve phosphorylation of the Thr198 T-loop 
residue, and that activity is independent of phosphorylation at this site, which 
contrasts with what was found for the equivalent recombinant proteins 
expressed in E. coli (Section 7.8.6), and what has been found for PLK variants 
expressed in other organisms (Section 7.5.1); although the activity of these 
proteins against endogenous substrates may be quite different to what is 
observed with an α-casein susbtrate. 
 
Figure 7-27 -Activity of ty:PLK proteins against an α-casein substrate. 
ty;PLK proteins were immobilised on TY beads and used to perform kinase assays with an 
α-casein substrate. To control for the non-specific interaction of other protein kinases with 
TY beads, uninduced lysate controls were included in the assay, and to control for possible 
interactions of kinases with unconjugated beads, induced lysates were incubated with 
unconjugated beads. Additionally, TY beads and beads without conjugated antibody that 
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had not been incubated with cell lysates were included as negative controls. Lanes 1 -2: 
lysate controls (uninduced lysate with TY beads (1) and induced lysate with control beads 
(2)); lane 3: induced lysate with TY beads; lanes (i-ii) no-lysate controls (control beads and 
TY beads respectively). The autoradiograph shows the radiolabelled proteins that were 
detected (top panels), and the equivalent Coomassie-stained gels (bottom panels) are 
included to show equivalent loading. 
7.9.6 The effect of overexpression of ty:PLK variants on T. brucei 
cell proliferation and DNA content 
Given that kinase assays of immunoprecipitated ty:PLK WT, T198V and T198D 
showed them all to be active in an in vitro assay using the generic kinase α-
casein substrate, it was of interest to investigate the functional behaviour of the 
T198 mutants  in vivo.  ty:PLK WT and ty:PLK N169A cell lines (Hammarton et 
al., 2007) and also two independent clonal ty:PLK T198V and ty:PLK T198D cell 
lines were grown in the presence or absence of tetracycline (1 μgml-1) for a 48 
hour period (Section 4.2.2.2). To determine the proliferation of these cell lines, 
cell density was monitored at regular intervals (Section 4.2.2.3). Induced ty:PLK 
N169A cells grew normally (Figure 7-28B); however, the growth of induced 
ty:PLK WT cells was severely impaired (Figure 7-28A), as had been reported 
previously (Hammarton et al., 2007). Induced cells expressing ty:PLK T198V or 
ty:PLK T198D also displayed impaired growth, comprising growth inhibition but 
not growth arrest, over the 48 hour induction period (Figure 7-28C-D).  The 




Figure 7-28 -Growth of T. brucei cells expressing ty:PLK proteins. 
T. brucei ty:PLK cell lines were cultured in the presence (Tet +) or absence (Tet -) of 
tetracycline for 48 hours and cell density monitored at regular intervals.  
To investigate the possibility that cell cycle defects were responsible for the 
observed growth defects, cells were analysed by flow cytometry (Section 4.10). 
Uninduced and induced cells were sampled at 0 and 12 hours and thereafter at 6 
hour intervals for 36 hours. Fixed cells were treated with propidium iodide to 
stain the DNA and the fluorescent properties of cells were analysed (Section 
4.10) and compared (Figure 7-29). Prior to induction of ty:PLK expression, cells 
exhibited normal DNA profiles, comprising distinctive 2C and 4C peaks. Cells 
expressing ty:PLK N169A retained a normal DNA profile throughout the induction 
period (Figure 7-29B). However, for cells expressing ty:PLK WT, ty:PLK T198V, 
ty:PLK T198D changes in DNA profile were observed from 12 hours post-induction 
(Figure 7-29A, C and D respectively). The changes in DNA profile comprised a 
coincident decrease in the 2C peak and increase in the 4C peak, followed by the 
appearance of a peak corresponding to cells with >4C DNA content at 18 hours 
post-induction for cell lines expressing ty:PLK WT and TYPLK: T198V, and at 24 
hours post-induction for cell lines expressing ty:PLK T198D. The DNA profiles for 
uninduced cells were normal at equivalent time points (data not shown). Both 
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ty:PLK T198V/D cell lines analysed exhibited very similar DNA profiles (data not 
shown). 
 
Figure 7-29 -Flow cytometry analysis of cell lines overexpressing ty:PLK variants. 
Cells grown in the presence of tetracycline (1 μgml
-1
) to overexpress the ty:PLK variants 
indicated were sampled at regular intervals, fixed, stained with propidium iodide and 
analysed by flow cytometry. Histograms of frequency (counts, y-axis) against whole cell 
fluorescence (FL2-A, x-axis) were used to compare the effects of overexpression of different 
ty:PLK proteins on cell ploidy. Ploidy is indicated where appropriate. C: DNA content. 
The similarity between the growth phenotypes and DNA profiles during 
overexpression of ty:PLK WT and ty:PLK T-loop mutants was unexpected and 
implied that activity of PLK in vivo does not involve phosphorylation at this 
residue. 
7.9.7 The effect of overexpression of ty:PLK variants on nucleus 
and kinetoplast configurations 
To further characterise cell cycle defects appearing following overexpression of 
different ty:PLK proteins, cells cultured in the presence or absence of 
tetracycline (1 μgml-1) were sampled at 0 and 12 hours, and thereafter at 6 hour 
intervals, fixed and stained with DAPI for analysis by fluorescence microscopy 
(Section 4.11.1). Over 200 individual cells were examined at each time point. 
Cells were classified according to the number of kinetoplasts and nuclei 
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contained within them and the relative positions of these organelles.  Initially 
the populations typically comprised 80-85 % 1N1K cells, 8 % 1N2K cells and 5 % 
2N2K cells, with the rest comprising abnormal cell types (Figure 7-30). 
Populations of uninduced cells displayed similar proportions of these cell types 
throughout the experiment (data not shown). Overexpression of ty:PLK N169A 
had no effect on the composition of cells in the population for the duration of 
the induction (Figure 7-30B). However, overexpression of ty:PLK WT, ty:PLK 
T198V or ty:PLK T198D had similar and dramatic effects on the cell cycle (Figure 
7-30A, C and D). The second clone for each of the ty:PLK T198V/D mutant cell 
lines displayed almost identical N-K configurations to those presented below for 
the first clone (data not shown).  
 
Figure 7-30 -Analysis of cells overexpressing ty:PLK variants by DAPI staining. 
Cells expressing ty:PLK WT or T198V/D were cultured in the presence of tetracycline (1 
μgml
-1
) and the number of nuclei (N) and kinetoplasts (K) per cell was determined by DAPI 
staining (n>200 cells/time point).  
A decrease in 1N1K cells was apparent from 12 hours post-induction, which was 
accompanied by the appearance of 2N1K cells and these abnormal cells 
continued to accumulate over the next 12 hours (Figure 7-30A, C and D; and 
Figure 7-31). At 18 hours, 2N2K cells with abnormal organelle positioning 
appeared (KKNN) (Figure 7-32), and 24 hours post-induction, multinucleate cells 
with one kinetoplast (Figure 7-30 and Figure 7-33), which was later succeeded by 
the appearance of smaller numbers of multinucleate cells with two kinetoplasts 
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(Figure 7-30). An increase in total 2N2K cells was also observed, although since 
only relatively small proportions of these cells are present in the whole 
population, there was some stochastic variation between cell lines (Figure 7-30). 
The decrease in 1N1K cells, accumulation of 2N1K cells and appearance of 
multinucleate cells would account for the changes in DNA profile observed by 





Figure 7-31 -2N1K cells observed during the overexpression of ty:PLK T198V/D. 
Example images of DAPI-stained 2N1K cell types for procyclic cell lines expressing ty:PLK 
T198V (Ai-iii) and ty:PLK T198D (Bi-iv). Left panels: DAPI; middle: DIC; right: merged image. 
A selection of 2N1K cells with variable organelle positioning, and furrow ingression status 
are presented. Organelle configurations are given and refer to the positions of these 
organelles relative to the posterior end of the cell; ‘^’ indicates where the kinetoplast is 




             
Figure 7-32 -Abnormal organelle positioning in 2N2K cells during the overexpression of 
mutated ty:PLK T198V/D. 
Example images of 2N2K cells with abnormal organelle positions ‘KKNN’ observed 
following the overexpression of ty:PLK T198V (A) or ty:PLK T198D (B) are shown above. 
Arrows indicate the positions of kinetoplasts. Scale bar: 10 μm. 
 
Figure 7-33 -Multinucleate cells observed during the overexpression of ty:PLK T198V/D. 
Example images of DAPi-stained multinucleate cells observed following the overexpression 
of ty:PLK T198V (A) or ty:PLK T198D (B) are shown above. Arrows indicate the positions of 




The position of the single kinetoplast in 2N1K cells was variable (Figure 7-31), 
and 2N1K cells displayed KNN and NKN organelle configurations, and in some, 
the kinetoplast was positioned lateral to the most posterior nucleus (Figure 
7-31Aiii and Biv). When 2N1K cells were classified according to organelle 
positions, KNN organelle configurations were found to be the most prevalent 
(Figure 7-34), and this was the case for all the cell lines analysed (with the 
exception of cells overexpressing ty:PLK N169A, where no 2N1K cells were 
observed), again consistent with previous data for ty:PLK WT (Hammarton et al., 
2007).  
 
Figure 7-34 -Analysis of organelle positioning in 2N1K cells. 
2N1K cells observed following the overexpression of ty:PLK WT and T198V/D were 
classified according to the relative positions of the nuclei (N) and kinetoplasts (K). Only the 
three dominant organelle positions are shown (see key and Figure 7-31), with the order of 
the organelles given relative to the posterior end of the cell. ‘^’ indicates that the kinetoplast 
was positioned lateral to the nucleus.  
2N1K cell types can arise as a consequence of abnormal cell division, or 
premature entry into mitosis. Abnormal cell division of 2N2K cells was not 
observed, and furthermore, the proportions of 2N1K cells far exceeded those of 
0N1K cells (Figure 7-30) suggesting that 0N1K cells arise from the aberrant 
division of other cell types, although no obvious source for the 0N1K cells could 
be identified from analysis of whole populations. This excluded the possibility 
that abnormal cell division caused the accumulation of 2N1K cells in this study. 
The possibility that premature entry into mitosis caused these cells to arise was 
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also deemed unlikely as, if this was the case, a dramatic increase in 2N2K cells 
could be expected following the rise in 2N1K cells, and this did not occur. From 
the enlarged and elongated appearance of kinetoplasts in some 2N1K cells 
(Figure 7-31Aii and Bi), it seemed possible that in cell lines expressing ty:PLK 
T198V and ty:PLK T198D, impaired kinetoplast segregation rather than abnormal 
cell division or premature entry into mitosis, caused the accumulation of 2N1K 
cells and the later accumulation of multinucleate cells with one kinetoplast, as 
had been described previously for cells overexpressing ty:PLK WT (Hammarton et 
al., 2007). However, since there was a slight increase in 2N2K cells, and 
multinucleate cells with two kinetoplasts appeared at later time points, 
kinetoplast division was probably impaired but not totally inhibited following 
overexpression of ty:PLK WT or T198V/D variants. Eventual kinetoplast division 
in some of these KNN 2N1K cells may account for the appearance of KKNN 2N2K 
cells (Figure 7-32). 
7.9.8  Summary of in vivo studies  
Mutation of T198 in the T-loop of PLK was hypothesised to impair (T198V) or 
override (T198D) in vivo regulation by upstream kinases. The activities of T-loop 
mutants were comparable to the wild type kinase (Figure 7-27), suggesting that, 
in fact, regulation of PLK activity probably occurs at other residues or via other 
mechanisms. A comparison of expression levels confirmed that the equivalent 
levels of activity were not a consequence in the variation of expression levels 
between T-loop mutants and wild type PLK (Figure 7-26).  
The evidence that ty:PLK  T-loop mutants and ty:PLK WT exhibit similar levels of 
activity does not necessarily contradict the results obtained from recombinant 
assays; the activity of T-loop mutants in vitro (Section 7.8.6.3) may well be a 
result of the variable ability of these proteins to autophosphorylate (Section 
7.8.6.2). It is possible that autophosphorylation is inhibited in vivo, which could 
account for the similarities in the activities of proteins when they are expressed 
in T. brucei cells. Possible mechanisms by which this could occur include 
regulation by phosphatases, inhibitory phosphorylation by other kinases or 
interaction with substrates, and the prolific autophosphorylation observed in 
vitro for 6XHis:PLK WT and 6XHis:PLK T198D may not be physiologically relevant 
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(Peck, 2006). Phosphorylation at sites other than the T-loop T198 residue could 
also account for the almost identical phenotypes observed for the 
overexpression of ty:PLK WT and the ty:PLK T-loop mutants. Although it was not 
possible to obtain sufficient quantities of ty:PLK proteins by 
immunoprecipitation for mass spectrometry analysis (data not shown), further 
knowledge of in vivo phosphorylation sites may help to explain these results. 
Overexpression of all three proteins led to an accumulation of 2N1K cells, and 
multinucleate cells with one kinetoplast, most likely as a result of impaired 
kinetoplast segregation (Section 7.9.7). The number of basal bodies was not 
analysed in this study; however, previously, overexpression of tyPLK: WT 
inhibited basal body duplication and it would be interesting to investigate 
whether this was also the case for the overexpression of ty:PLK T-loop mutants. 
It was previously suggested that the similar effects observed through RNAi-
mediated depletion of PLK, and overexpression of ty:PLK could be the result of a 
negative feedback pathway. As the overexpression of WT and T-loop mutated 
versions of ty:PLK produced the same phenotype, possible positive feedback 
pathways probably do not involve phosphorylation at this residue. 
 
7.10 The role of the polo-box domain in autoregulation of 
PLK 
The PBD has been shown to have roles in PLK localisation and substrate 
recognition in vivo (Section 7.5.3). Intriguingly, in vitro studies have shown that 
the activity of the full length kinase is regulated through interaction with this 
domain (Section 7.5.2).  
In order to investigate whether T. brucei PLK is regulated by similar 
autoregulatory mechanisms, a truncated protein comprising the polo-box domain 
was generated (Sections 7.8.1 and 7.8.2). In addition to studies concerning 
autoregulation, the role of the residues His705 and Lys707 in the PBD was 
investigated. The important in vivo role for these residues in other organisms led 
to the generation of a construct for overexpression of ty:PLK H705A K707A. 
However, analysis of these cell lines could not be completed due to time 
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constraints, and only the in vitro work concerning the 6XHis:PLK H705A K707A 
recombinant protein will be discussed.  
7.10.1 Interaction of the PBD with full length PLK  
To investigate the possibility that the PBD can interact with full length PLK, 
recombinant 6XHis:PBD was immobilized on nickel beads (Section 4.6.4.2.1) and 
incubated with cell lysate from cells expressing ty:PLK WT (Section 4.9). 
Following incubation, the beads were washed before eluting 6XHis:PBD and any 
interacting proteins (Section 4.6.4.2.1). Appropriate fractions from the 
purification were analysed by SDS PAGE (Section 4.6.1) and Western blotting 
with an anti-TY antibody (Section 4.6.3) in order to detect ty:PLK WT (Section 
7.9). ty:PLK WT was detected in the input (cell lysate fraction), but only small 
amounts of ty:PLK WT were apparently present in the flow through fractions (for 
nickel beads with and without 6XHis:PBD) (Figure 7-35). For the beads without 
6XHis:PBD, significant amounts of ty:PLK WT were detected in the wash fraction, 
and little in the elution, although a substantial amount of ty:PLK WT remained 
on the beads following elution, suggesting ty:PLK WT non-specifically interacts 
with nickel beads. However, for nickel beads bound by 6XHis:PBD, little 
6XHis:PLK WT was detected in either the flow through or the wash fractions, yet 
significant amounts were present in the elution fraction, arguing that in addition 
to interacting with the nickel beads, 6XHis:PLK WT was also able to specifically 
interact with 6XHis:PBD (Figure 7-35).  No proteins were detected using the anti-
TY antibody for a non-induced lysate used as a negative control, confirming that 
this antibody exclusively detected ty:PLK WT . These results show that ty:PLK 




Figure 7-35 - Interaction of ty:PLK WT with 6XHis:PBD. 
Potential interactions between the PBD of PLK and the full length protein were investigated 
through the incubation of cell lysate containing ty:PLK WT, with 6XHis:PBD immobilised on 
nickel beads (far right of figure). Following the incubation, unbound proteins were removed 
by washing the beads and both the 6XHis:PBD and any interacting proteins were eluted 
from the beads for analysis by SDS PAGE and Western blotting with an anti-TY antibody to 
detect ty:PLK WT (upper panels). To detect the 6XHis:PBD, Western blots were stained with 
Ponceau reagent (lower panels). To control for non-specific interactions of ty:PLK WT with 
the nickel beads, nickel beads without 6XHis:PBD were incubated with ty:PLK WT lysate 
(right of figure), and to ensure that the anti-TY antibody specifically recognised ty:PLK WT 
and not other proteins that could interact with 6XHis:PBD, a non-induced cell lysate control 
was included (left of figure).  
7.10.2 6XHis:PBD does not inhibit the activity of 6XHis:PLK 
WT 
The evidence that ty:PLK WT interacts with 6XHis:PBD gave rise to the possibility 
that an autoinhibitory mechanism might regulate T. brucei PLK. To investigate 
this, 6XHis:PBD was incubated with either 6XHisPLK WT (untreated) or lambda 
protein phosphatase (λPPase) treated 6XHisPLK WT for 30 minutes (to maximise 
binding) in the absence of ATP prior to performing kinase assays with an α-casein 
substrate. The inclusion of λPPase treated 6XHis:PLK WT was necessary to 
control for the possibility that autoinhibition only occurs when the protein is in 
its unphosphorylated state, as has been demonstrated previously in other studies 
of PLKs (Section 7.5.1). In addition, a time course was carried out as a 
precaution to avoid any potential masking effects, should autophosphorylation of 
dephosphorylated 6XHis:PLK WT occur which could potentially lead to or prevent 
its interaction with 6XHis:PBD.  
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Untreated 6XHis:PLK WT displayed detectable levels of autophosphorylation, 
while autophosphorylation of  λPPase treated 6XHis:PLK WT was barely 
detectable over the 30 minute duration of the kinase assay (Figure 7-36). The 
level of autophosphorylation exhibited by untreated 6XHis:PLK WT was 
unaffected by the presence of the 6XHis:PBD.  Phosphorylation of the α-casein 
substrate was greater for phosphorylated 6XHis:PLK WT than for 
dephosphorylated enzyme, as previously demonstrated (Section 7.8.5), and was 
not altered by the  presence of 6XHis:PBD (Figure 7-36). Together, these results 
suggested that unlike in other organisms, interaction of the PBD with PLK does 
not inhibit the activity of full length PLK. 
 
Figure 7-36 -Kinase assays to investigate autoinhibition of full length PLK by the PBD. 
Kinase assays of full length PLK (6XHis:PLK WT, either untreated or treated with PPase) 
were performed with α-casein substrate in the presence (right panels) or absence (left 
panels) of 6XHis:PBD.  Independent reactions were set up and halted at 10 minute intervals. 
To control against possible effects due to the conditions of λPPase treatment, 6XHis:PLK 
WT which had not been subject to these conditions was also included (far right of each gel). 
Negative controls were provided by the kinase dead 6XHis:PLK N169A protein (‘N169A’), or 
an equivalent volume of kinase assay buffer (‘buffer’). The autoradiographs (top panels) 
show the detection of radiolabelled proteins, and the equivalent Coomassie-stained gels 
show equal loading (bottom panels). 
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7.10.3 6XHis:PBD acts as a substrate for full length 6XHis 
PLK variants, and does not inhibit the activity of these 
proteins 
In order to further investigate the potential for an autoinhibitory mechanism of 
regulation involving the PBD, and phosphorylation of the PBD by full length PLK, 
full length 6XHis:PLK T-loop mutants and a PBD mutant (see below) were 
incubated with 6XHis:PBD for 30 minutes prior to performing kinase assays in the 
presence or absence of an α-casein substrate.  
In the absence of 6XHis:PBD, all the PLK variants exhibited autophosphorylation, 
with the exception of 6XHis:PLK N169A (Figure 7-37A). Addition of the 6XHis:PBD 
had no effect on autophosphorylation (compare Figure 7-37A and B), and 
6XHis:PBD was found to be a substrate of active  full length 6XHis:PLK variants. 
Phosphorylation of the 6XHis:PBD was readily detected due to both the impaired 
migration of 6XHisPBD through an SDS PAGE gel, and incorporation of 
radiolabelled phosphate as detected in the autoradiograph (Figure 7-37B). 
Activity against α-casein was not affected for any of these proteins in the 
presence of 6XHis:PBD (compare Figure 7-37C and D). Phosphorylation of 
6XHis:PBD was slightly reduced in the presence of α-casein, suggesting that 
there was competitive inhibition between the substrate and 6XHis:PBD (compare 
Figure 7-37C with Figure 7-37D). Phosphorylation of 6XHis:PBD was not 
unexpected, as mass spectrometry analysis identified several 
autophosphorylation sites within the PBD of the full length 6XHis:PLK proteins 
(Sections 7.8.4 and 7.8.6.2). However, this phenomenon has not been observed 
for human PLK1, and for human PLK1, the PBD was found to inhibit the activity 
of the full length kinase (Section 7.5.2). It is possible that T. brucei PLK is 
regulated through alternative mechanisms, although differences in experimental 
approach could also account for these results. Due to difficulties associated with 
immunoprecipitation of ty:PLK, it was not possible to attempt these assays with 
a more physiologically relevant version of PLK. 
Mutation of the residues H705 and K707 within the second polo-box motif of T. 
brucei PLK was carried out (Section 7.8.1) to determine whether a functional 
equivalent of the ‘His-Lys pincer’ is present (Section 7.5.2). These residues were 
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substituted with alanine residues which are non polar, and should prevent 
potential interactions with the negatively charged phosphate group of 
phosphorylated substrates. Kinase assays with an α-casein substrate revealed 
that 6XHis:PLK H705A K707A exhibited similar levels of autophosphorylation and 
substrate phosphorylation as those observed for 6XHis:PLK WT (Figure 7-13 and 
Figure 7-37). Further in vitro investigations into the role of these residues would 
preferably involve kinase assays with physiologically appropriate substrates, for 
example Centrin 2 (Graffenried et al., 2008); however, until identification of 
phosphorylated target proteins are identified, the scope for further in vitro 




Figure 7-37 -Kinase assays investigating the PBD as a substrate of 6XHis:PLK variants. 
Kinase assays of 6XHis:PLK variants (WT, N169A, T198A/V/D, H710A/K712A) were 
performed in the absence or presence of an α-casein substrate (A-B and C-D, respectively), 
with (B and D) or without (A and C) the addition of 6XHis:PBD. A buffer only control (-) 
controlled for any contaminating kinase activity of the 6XHis:PBD or the kinase assay 
buffer. The autoradiographs (upper panels) show the detection of radiolabelled proteins, 





7.10.4 Truncation of the C-terminus of PLK abolished activity 
Proteins corresponding to WT and dead versions of the kinase domain (KD) of T. 
brucei PLK were generated (Sections 7.8.1 and 7.8.2) in order to determine 
whether deletion of the PBD could stimulate kinase activity. Whilst GST epitope 
tagged active and dead (N169A) recombinant proteins were extremely soluble 
(Figure 7-12), neither autophosphorylation nor activity against an α-casein 
substrate could be detected during in vitro kinase assays (Figure 7-38).  
                            
Figure 7-38 –The activity of recombinant PLK kinase domain. 
6XHis:PLK WT (WT),  6XHis:PLK N169A (N169A) GST:PLK KD (WT), GST:PLK KD (N169A) or 
a buffer control (-) were used in kinase assays to determine the activity of recombinant PLK 
kinase domain against generic kinase substrates. Top panels: autoradiographs; bottom 
panels: the corresponding Coomassie gels acting as loading controls. PLK proteins 
(predicted size: 88 kDa and 60 kDa for full length and kinase domains respectively), and 
substrates are indicated. 
It is possible that the inactivity of GST:KD WT could be explained by the 
presence of the relatively large GST epitope tag which may have impeded access 
to the active site; alternatively, the presence of a 70 kDa band observed in 
eluted fractions of GST:KD WT and N169A may indicate that the E. coli 
chaperone DnaK copurifed with these proteins (Figure 7-12). Should this be the 
case, the inactivity of GST:KD WT could be a result of inappropriate protein 
folding, a phenomenon which has been commonly observed for the PLK KD in 
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other organisms. The PLK1 KD reportedly proved difficult to purify. To achieve 
purification of soluble and active human PLK1 KD it was necessary to incorporate 
a loop downstream of the core kinase domain, and in addition expression 
required the utilization of eukaryotic expression systems (discussed in Section 
7.3). Whilst a GST tagged version of the T. brucei KD incorporating amino acids 
residues 2-294 is inactive, it is likely that through testing a variety of 
truncations, a soluble and active version of the T. brucei KD could be obtained, 
which would allow investigation into the role of the PBD using this experimental 
approach.  
7.11 Summary  
Previous studies involving T. brucei PLK have identified potential 
phosphorylation sites in endogenous PLK (Nett et al., 2009), and reported 
activity of overexpressed PLK against generic and T. brucei specific substrates 
(Graffenried et al., 2008; Hammarton et al., 2007). In addition, a recent study 
has shown that a recombinant GST:PLK protein is active against α-casein in vitro 
(Li et al., 2010b). Whilst these investigations show that T. brucei PLK is both 
active and phosphorylated, no investigations into the mechanism of activity or 
roles of these phosphorylation sites have been published. This study aimed to 
investigate these unresolved issues through a combination of in vitro and in vivo 
approaches.  
This study found that recombinant T. brucei PLK is extensively phosphorylated at 
both serine and threonine residues (Section 7.8.4), and that phosphorylation of 
the wild type recombinant protein is important for its activity (Section 7.8.5). In 
addition, it was revealed through the generation of recombinant T-loop mutants 
that in vitro activity can be influenced by mutation of the T198 residue, 
although a T198D mutant surprisingly showed reduced activity in comparison to 
the equivalent wild type equivalent (Section 7.8.6.3). In vivo experiments 
implied that this residue is not important for activity in a physiological 
environment, which indicated that T. brucei PLK may be activated by alternative 
upstream kinases to those identified in other organisms and at a different site 
(Section 7.8.6 and Section 7.9). This result was not unexpected, given that 
TbPLK exhibits divergent roles in the cell cycle in comparison to other 
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organisms, particularly with regards to mitosis, which does not appear to require 
PLK (Graffenried et al., 2008; Hammarton et al., 2007; Kumar and Wang, 2006). 
The localisation and regulation of PLK in other organisms is tightly associated 
with the mitotic function of this protein (Section 7.2) and given the divergent 
role of PLK in trypanosomes, it is highly probable that regulation occurs through 
alternative means.  
The involvement of TbPLK in cytokinesis may indicate that kinases involved in 
cytokinesis could be candidates as upstream regulators of TbPLK. PK50 and PK53 
and MOB1B, like TbPLK have been shown to have roles in cytokinesis in 
bloodstream form T. brucei  (Hammarton et al., 2005; Ma et al., 2010) and it 
would be interesting to establish whether these proteins are involved in the 
same regulatory pathways (either as upstream kinases (PK50 or PK53), or as 
substrates of PLK (PK50, PK53, MOB1B). TbLRTP, which is a negative regulator of 
basal body biogenesis could be a potential substrate for TbPLK, as TbPLK is 
important for basal body duplication (Hammarton et al., 2007), although in vitro 
kinase assays performed using 6XHis:PLK WT and recombinant GST:TbLRTP 
during the course of this study did not detect any phosphorylation of TbLRTP by 
PLK (data not shown). 
Investigations into the potential role of the PBD in the regulation of PLK activity 
revealed that there is an interaction between the PBD and the full length 
protein (Section 7.10.1); however, no inhibitory effect of the PBD on 
autophosphorylation or trans-phosphorylation of PLK could be determined 
through in vitro studies (Section 7.10.2 and Section 7.10.3). The ability of the 
full length protein to phosphorylate the PBD confirmed that autophosphorylation 
can occur at the C-terminal region of the protein, and revealed that this can 
happen through trans mechanisms (Section 7.10.2 and Section 7.10.3). A 
recombinant GST-tagged protein corresponding to the kinase domain of PLK was 
purified during the course of this study, but was inactive (Section 7.10.4), 
hampering efforts to investigate potential autoinhibition by the PBD through 
other means. Mutation of the putative ‘His-Lys pincer’ within the polo-box 
domain had no apparent effect on in vitro activity (Section 7.10.3). It is more 
likely that the function of these residues will be identified through future in vivo 
investigations, as the main role for this motif is believed to be association of the 
full length protein with phosphorylated substrates, rather than association with 
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the kinase domain of the protein (which could potentially be investigated in 
vitro).       
Cytokinesis in T. brucei has been shown to involve unique mechanisms, and it is 
likely that substrates of TbPLK could be functionally divergent or novel proteins. 
The identification of these substrates and elucidation of how TbPLK is regulated 
in vivo will greatly improve the current knowledge of how these processes occur. 
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8 General discussion 
8.1 Mechanisms of cytokinesis 
8.1.1 Furrow ingression in T. brucei 
Cytokinesis in T. brucei occurs via the longitudinal ingression of a cleavage 
furrow, and does not involve the formation of an actomyosin contractile ring. 
Initiation of furrow ingression occurs at the anterior end of the new FAZ, which 
is known to involve the molecular regulators: PLK and AUK1. At S phase, PLK 
localises to the extending FAZ, dissociating from the anterior tip of the new FAZ 
at anaphase which coincides with the translocation of the CPC (comprising AUK1, 
CPC1 and CPC2) to the site vacated by PLK. Furrow initiation occurs at the site 
of CPC localisation, and the CPC migrates with the furrow during furrow 
ingression apparently guiding the furrow along the dividing cell. It has been 
speculated that PLK phosphorylates a component of the flagellum attachment 
zone to mark the site for CPC translocation and therefore furrow initiation.  
Whilst some molecular regulators associated with the site of furrow initiation 
and the furrow apex have been identified, how these molecular regulators 
mediate furrow ingression is not understood, and there are many questions 
remaining as to what occurs during ingression of the cleavage furrow. Firstly, 
furrow ingression is constrained by the heavily cross-linked and stable 
subpellicular microtubules, which must presumably disassemble to allow 
membrane to coalesce dividing the cytoplasm of the daughter cells. Disassembly 
of microtubules at the furrow has not been observed, although it is possible that 
this involves very small numbers of microtubules. Secondly, before the furrow is 
initiated cells display a ‘piggy back’ phenotype, characterised by localised 
indentation of the cell surface demarcating the outline of the new daughter cell. 
This suggests that the cleavage axis is determined before furrow ingression 
occurs and it is not known what proteins are involved in the remodelling of the 
cytoskeleton to produce the ‘piggy back’ phenoptype.  
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There are several models to explain the mechanisms of furrow ingression in 
mammalian cells, which may contribute towards an explanation of how furrow 
ingression in T. brucei might occur. 
8.1.2 Models for furrow ingression in mammalian cells  
8.1.2.1 Forces in cytokinesis 
Mechanical factors which affect furrow ingression in mammalian cells include 
inward constriction or contraction forces, hydrostatic pressures in the 
cytoplasm, and elastic forces of the cell cortex (reviewed in (Wang, 2005)). 
Forces can be generated by cytoskeletal proteins and motor proteins, which are 
regulated by a variety of other proteins during furrow ingression. The 
mechanical properties of cells can be measured using a number of techniques for 
example, micropipette aspiration, atomic force microscopy and laser-tracking 
microheology (reviewed in (Reichl et al., 2005)). The roles of different 
cytoskeletal proteins and structures in cytokinesis can be investigated through 
the application of inhibitors such as cytochalasin D which inhibits actin 
polymerisation, or monastrol which inhibits centrosome separation to generate 
monopolar spindles. In addition, micromanipulation experiments for example, 
removal of centrosomes, severing of spindle microtubules, and the application of 
glass beads to cell surfaces have proved effective in identifying structures 
important for cleavage furrowing (reviewed in (Maddox and Oegema, 2003)).   
Determination of furrow ingression mechanisms using these and other 
approaches has led to the belief that models other than the contractile ring 
hypothesis can describe the mechanics of furrow ingression (reviewed in 
(Pollard, 2010;Wang, 2005)). 
8.1.2.2 Models for furrow ingression in eukaryotic cells 
The contractile ring hypothesis describes a process where the accumulation of 
actin and myosin II at the equator of the cell is followed by sliding of antiparallel 
actin filaments, which are cross linked to myosin II filaments. This results in 
constriction of the contractile ring and membrane ingression. This ‘purse string’ 
model involves a localised increase in constriction forces, however, cortical 
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sinking describes how the contraction of actin filaments, when associated with 
the cell membrane in addition to myosin II filaments, could produce 
perpendicular forces resulting in furrow ingression. This implies that the 
actomyosin ring could alternatively cause furrow ingression through the 
generation of contractile forces. The ‘global contraction-equatorial deformation 
mechanism’ describes how signalling from the central spindle might trigger 
localised deformation of the cell equator, disrupting the balance of outward 
elastic and inward contractile forces within the cytoskeleton causing a net 
inward contractile force and ingression of a cleavage furrow. 
In contrast to the previous three models, the polar relaxation model emphasises 
the importance of signals from the spindle asters. Whilst signals emanating from 
the central spindle lead to the formation of the actomyosin contractile ring, 
signalling from the spindle asters at opposite poles of the cell triggers polar 
relaxation and expansion of the cell poles. This generates a tension differential 
between the cell poles and equator. It has been proposed that the changes in 
hydrostatic pressures resulting from the production of a tension differential in a 
cell with a finite volume, could lead to equatorial shrinkage and accumulation of 
contractile elements at the cell equator (by cortical flow) generating a ‘crumple 
zone’ of filaments which would then become organised to form the contractile 
ring (He and Dembo, 1997).  
More specific models have been proposed to explain cleavage furrow ingression 
in motile cells. The cortical ripping model describes how the definition of cell 
polarity in the new daughter cell could lead to the equator marking the posterior 
of both daughters, and motile forces pulling the cell in opposite directions would 
literally rip the cell apart. Also, adherence of the cell to the substratum at the 
equatorial region and the production of stress fibres emanating from the point of 
attachment to the cell cortex would generate a net inward force causing furrow 
ingression. 
8.1.3 Thoughts on furrow ingression in T. brucei 
The lack of an actomyosin contractile ring, lateral ingression of the cleavage 
furrow and apparent independence of furrow ingression from mitosis in procyclic 
form cells, precludes the involvement of the central spindle microtubules, 
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spindle asters and actomyosin contractile rings in furrow ingression in T. brucei. 
In addition whilst it is attractive to speculate that flagella motility could be 
involved in furrow ingression through a process similar to the cortical ripping 
model described above, the fact that procyclic form cells can still produce 
furrows without flagella motility contradicts this. The ‘global contraction-
equatorial deformation mechanism’ which involves localised deformation of the 
cell may well be applicable to T. brucei cytokinesis: changes in the 
membrane/cytoskeleton association and microtubule depolymerisation could be 
mediated by microtubule-associated proteins, causing localised deformation 
generating the inward forces required for furrow ingression. Potentially this 
might involve furrow associated proteins for example, components of the CPC; 
microtubule-associated proteins, or post-translational modifications of tubulin. 
During furrow ingression it is likely that remodelling occurs at the furrow apex. 
Membrane and cytoskeletal modelling could potentially involve kinesins, as over 
40 kinesins have been identified in the T. brucei genome (Berriman et al., 2005), 
and already two have been assigned to roles in cytokinesis (Li et al., 2008a). 
These motor proteins may be involved in targeting proteins to the site of the 
furrow apex for remodelling of the cytoskeleton and membrane at this location.  
Unfortunately analysis of T. brucei cells using the methods described in Section 
8.1.2.1 are unlikely to be useful in investigating mechanisms of T. brucei 
cytokinesis due to the highly motile nature of these cells and it remains to be 
seen whether changes in microtubule dynamics occur, or whether changes in 
microtubule dynamics alone could be sufficient to cause furrow ingression.  
8.1.4 Aims of this study 
This study aimed to investigate different aspects of furrow ingression in T. 
brucei cytokinesis. Firstly, an orthologue of a microtubule-associated protein 
required for cytokinesis in plants, AIR9 was characterised to explore the 
potential that in T. brucei this protein could localise to the cytoskeleton and 
regulate cytokinesis. Secondly, the importance of microtubule dynamics in 
furrow ingression was assessed through inhibitor studies. Finally, this study 
aimed to further understanding of the regulation of cytokinesis by PLK by 
investigating how its activity is regulated in vitro and in vivo.   
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8.2 The role of AIR9 in T. brucei 
Prior to this study, the localisation and function of AIR9 had only been 
investigated in plants (Buschmann et al., 2006), although the identification of 
Trypanosomatid homologues was reported (Buschmann et al., 2007). RNAi was 
used to evaluate the role of AIR9 in T. brucei. Depletion of AIR9 caused a growth 
arrest in bloodstream form cells, indicating that AIR9 is essential in this life 
cycle stage. AIR9 was also shown to be required for normal growth rates of 
procyclic populations. Following AIR9 depletion, cell cycle progression was 
affected in both life cycle stages, as evidenced by their flow cytometry profiles 
that indicated the presence of cells with an abnormally low or excessive DNA 
content. Analysis of nucleus and kinetoplast (N-K) configurations in these cells 
established that this was a result of the production of both anucleate (0N1K) and 
multinucleate cells. Additionally, sizeable numbers of 2N1K cells were also 
detected. In both life cycle stages, post-mitotic (2N2K) cells with cleavage plane 
positioning defects were observed, indicating that these 2N2K cells were likely 
to be the parents of the observed 0N1K and 2N1K daughters following an 
asymmetrical division, and that depletion of AIR9 results in defects in 
cytokinesis.   
Depletion of AIR9 was also found to result in abnormal relative positioning of 
nuclei and kinetoplasts.  This phenotype was found to be the most striking in 
procyclic trypanosomes, where organelle positioning defects were apparent in 
cells at all cell cycle stages. Detailed morphometric analyses of 1N1K cells in 
AIR9-depleted procyclic populations revealed that nuclei were displaced 
posteriorly, while kinetoplasts were malpositioned anteriorly relative to the 
posterior end of the cell. This was found to be the result of an increase in cell 
length (by posterior end extension) and posterior directed movement of the 
nucleus.The positions of other organelles were not determined in this study, and 
future work would involve investigations into whether the organelle positioning 
defect was specific to nucleus positioning, or whether a general disruption in 
polarity had occurred. It is also necessary to confirm that the increase in cell 
length was indeed at the posterior end of the cell through staining induced cells 
with anti-tyrosinated tubulin antibody. 
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In bloodstream form AIR9 RNAi cell lines, organelle positioning defects were only 
observed in post-mitotic cells, suggesting that the organelle positioning defect 
at this life cycle stage could be cell cycle associated. It was not determined 
whether for this life cycle stage kinetoplasts or nuclei were abnormally 
positioned, or indeed whether the kinetoplasts apparently anterior to the 
adjacent nucleus was associated more frequently with the old or new flagellum. 
The association of an abnormally positioned kinetoplast and new flagellum has 
been observed previously during the downregulation of the axonemal protein 
PACRG (Dawe et al., 2005). Whilst no obvious motility defects were observed 
following AIR9 downregulation, suggesting that reduced motility is unlikely to 
account for the positioning defect, a higher proportion of abnormally positioned 
posterior kinetoplasts could suggest that the newly positioned basal body needs 
to be anchored into position following segregation, and as AIR9 is a cytoskeletal 
protein (see below), it could potentially be involved in anchoring organelles to 
the cytoskeleton. 
AIR9 therefore plays a role in organelle positioning, predominantly in the 
procyclic life cycle stage, and while cytokinesis is also affected in this stage, it is 
likely that this represents a downstream effect of the organelle positioning 
defects.  In the bloodstream form, organelle positioning was normal up until 
mitosis, and only a subset of post-mitotic cells showed abnormal relative 
positioning of nuclei and kinetoplasts.  Thus the organelle positioning defect is 
more minor in this life cycle stage, and the cytokinesis furrowing defects 
observed, may occur as a direct effect of the downregulation of AIR9, 
particularly as some 2N2K cells with apparently normal N-K positioning were 
observed to be undergoing unequal furrow ingression.  The observation of 
different AIR9 RNAi phenotypes for different life cycle stages was not 
unexpected, as many aspects of the cell biology, and cell cycle regulation of 
procyclic and bloodstream form parasites are different. 
Expression of AIR9 with an N-terminal tyGFP tag or C-terminal HA tag from the 
endogenous locus revealed that AIR9 is localised to the cytoskeleton but not to 
the flagella in both life cycle stages, which was confirmed through both 
microscopical analyses and cell fractionation studies. In addition, analysis of the 
dynamics of AIR9 depletion through endogenous expression of tyGFP:AIR9 in AIR9 
RNAi cell lines concurred with these observations, as depletion was first 
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observed at the posterior ends of cells where there is a greater turnover of 
microtubules. However, it cannot be concluded from these data whether AIR9 
interacts directly with microtubules, or is localised to the microtubules by 
interaction with another MAP.  Indeed, depletion of AIR9 did not cause obvious 
abnormalities in the organisation of subpellicular microtubules, as analysed by 
transmission electron microscopy, indicating that AIR9 is not crucial to the 
structure or stability of microtubules in T. brucei. To confirm the localisation of 
AIR9 it would be necessary to analyse the localisation of native AIR9 through the 
production of an antibody, as epitope tagging may have caused impairment of 
localisation. It is of great interest to determine how localisation to the 
cytoskeleton occurs. Given that the N-terminal microtubule binding domain of 
Trypanosoma AIR9 proteins is not conserved it would be interesting to see 
whether TbAIR9 can bind to microtubules, and if so which region of the protein 
is involved in the interaction. Attempts to determine a more specific localisation 
for AIR9 by immuno transmission electron microscopy were unsuccessful. 
Therefore, it was not possible to determine whether AIR9 decorates 
microtubules as has been previously observed for other microtubule-associated 
proteins. Potentially, investigations into the microtubule binding ability of AIR9 
could involve binding assays using preformed microtubules and recombinant 
versions of AIR9.   
Localisation of AIR9 to the cytoskeleton may allow AIR9 to have roles in cell 
polarity, or anchoring of organelles to the cytoskeleton. Given that the C-
terminal A9 domains of AIR9 are conserved in T. brucei AIR9, it is possible that 
AIR9 is a scaffold protein whose potential binding partners could include 
signalling proteins, such as those involved in cytokinesis. PLK, which has been 
shown to bind and phosphorylate microtubule-associated proteins in other 
organisms (Yarm, 2002;Archambault et al., 2008), and components of the CPC 
could be potential binding partners. The global cytoskeletal localisation does not 
preclude a specific role for AIR9 at the furrow, as potentially post-translational 
modifications of AIR9 or association with particular binding partners may 
specifically occur at the future site of furrow ingression.  
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8.3 Microtubule inhibitors 
Application of inhibitors of microtubule dynamics in other Trypanosomatid 
species has been shown previously to inhibit cytokinesis (Baum et al., 
1981;Grellier et al., 1999); although phenotype analysis of T. brucei cells 
treated with different inhibitors of microtubule dynamics has not previously 
been reported. 
Treatment of T. brucei cells with both destabilising and stabilising agents led to 
inhibition of cytokinesis. Treatment of bloodstream form cells with Vinca 
alkaloids led to an accumulation of post mitotic cells displaying stalled furrow 
ingression. Vincristine treated cells were examined by scanning electron 
microscopy, and qualitative analysis revealed that the furrow had ingressed 
approximately 75 % of the whole cell length. Furrow ingression may be subject 
to regulation by checkpoints at specific points, as downregulation of molecular 
regulators PLK, PK50 and MOB1B similarly caused arrested furrow ingression 
(Hammarton et al., 2007;Ma et al., 2010;Hammarton et al., 2005). However 
detailed analysis is required in order to determine whether furrow ingression 
arrested at a similar point in these RNAi cell lines, and for vincristine treated 
cells. Treatment of bloodstream and procyclic form cells with taxol caused 
different cytokinesis defects. Bloodstream form cells displayed impaired 
cytokinesis initiation, whilst procyclic form cells displayed abnormal cleavage 
plane positioning. Taxol treatment caused paralysis in both cell types, and it is 
possible that taxol has a potent effect on flagellar tubulin, and that impaired 
motility contributed to the cytokinesis defects observed, as flagellar motility is 
important for cytokinesis in T. brucei (section X). However, the effect of 
microtubule inhibitors on cell morphology whereby cells became rounded (taxol) 
or exhibited bulging at the central regions and long pointed tips (vinblastine), 
suggested that these inhibitors were interacting directly with subpellicular 
microtubules, implying that inhibition of microtubule dynamics caused the 
cytokinesis defects described.  
Application of the microtubule inhibitor vinblastine to procyclic form cells 
expressing tyGFP:AIR9 affected the localisation of AIR9. Instead of brightly 
staining the outline of the cell, tyGFP:AIR9 exhibited a diffuse staining pattern, 
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similar to cytoplasmic proteins. It is possible that vinblastine could displace 
microtubule-associated proteins which share the same binding site within tubulin 
heterodimers. These could potentially include AIR9, or alternatively, other 
microtubule associated proteins involved in AIR9 localisation at the 
cytoskeleton. Vinca alkaloid treatment may also affect the localisation of 
microtubule-associated proteins in T. cruzi. Treatment of T. cruzi epimastigotes 
with Vincristine caused a decrease in staining with anti-polyglutamylated tubulin 
antibody. This was thought to result from displacement of microtubule-
associated proteins from microtubules as oppose to a decrease in post-
translational modification of tubulin, as the total amount of polyglutamylated 
tubulin in cell lysates was unchanged (Grellier et al., 1999).  
8.4 Regulation of Polo-like kinase activity in vitro and in 
vivo 
PLK has previously been shown to be important for cytokinesis (Hammarton et 
al., 2007;Kumar and Wang, 2006), and to have additional roles in basal body and 
Golgi duplication (Hammarton et al., 2007;Graffenried et al., 2008). However it 
is not known how the activity of T. brucei PLK is regulated. 
To investigate the regulation of PLK activity, a series of recombinant versions of 
PLK were generated. 6XHis:PLK was found to prolifically autophosphorylate, and 
removal of these phosphorylations through lambda protein phosphatase 
treatment impaired the ability of 6XHis:PLK to transphosphorylate generic kinase 
substrates. This could be an in vitro artefact, as bacterially expressed kinases 
have been known to lose substrate specificity (reviewed in (Peck, 2006)), and 
therefore attempts to perform mass spectrometry analysis on ty:PLK extracted 
from trypanosome lysates were attempted. Unfortunately these experiments 
were not successful, and to verify the relevance of these phosphorylation sites it 
may be necessary to mutate some of these residues and assess the activity of T. 
brucei expressed PLK. An ideal situation would be to express mutated versions of 
PLK in a null mutant genetic background, and verify whether the mutated 
proteins can compensate for the loss of function phenotype. 
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T. brucei PLK contains a conserved T198 residue at the T-loop. This residue is 
phosphorylated by upstream kinases in other organisms resulting in stimulation 
of PLK activity (section X). In humans, Aur-A is a major regulator at this site, and 
as AUK1 is conserved in T. brucei it was thought phosphorylation at this site by 
AUK1 may regulate the activity of T. brucei PLK. Substitution of T198 with non-
polar (A/V) or phosphomimetic (D) residues revealed that T198 is important for 
in vitro activity. All three T-loop mutants displayed reduced auto and trans 
phosphorylation. Whilst this was expected for T198A and T198V 6XHis:PLK 
mutants, it was not expected for 6XHis:PLK T198D. However, phosphomimetic 
substitutions have previously been found to cause a reduction in kinase activity, 
and it was suggested this could be a result of steric constraints preventing 
effective mimicry of a phosphate group by a negatively charged amino acid side 
chain at the site of the substitution (Millward et al., 1999). Analysis of the 
activity of T. brucei expressed PLK T-loop mutants, and phenotype analysis of 
procyclic form cells overexpressing ty:PLK T198V or tyPLK T198D implied that T-
loop is not a site of in vivo regulation. Alternatively, it may be the case that T. 
brucei PLK is constitutively active, and that activity of PLK may be influenced by 
other factors such as localisation or binding partners.  
To assess whether activity is negatively regulated by trans association with the 
polo-box domain, binding experiments and kinase assays were carried out using 
ty:PLK and 6XHis:PLK proteins. Although tyPLK was found to bind to recombinant 
PBD, no inhibitory effect on the activity of 6XHis:PLK was detected. Further, the 
PBD was found to be phosphorylated by the full length kinase, which has not 
previously been reported, but was consistent with the identification of 
autophosphorylated residues within the PBD. Recombinant kinase domain 
(GST:KD) was not active, and it was therefore not possible to assess whether 
deletion of the PBD stimulates activity. Given the time constraints of this study 
it was not possible to attempt other recombinant versions of the KD, and it is 
likely that the KD requires downstream structural motifs for correct folding and 
activity. As PLK localises to the FAZ in T. brucei cells, it is possible that PLK 
phosphorylates cytoskeletal proteins. Future investigations could involve 
determination of substrates through in vitro kinase assays with cytoskeletal 
preparations and recombinant AIR9.  
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Generation of recombinant active PLK was important step towards assessing 
whether PLK could be a good drug target, and although high throughput inhibitor 
screening using 6XHis:PLK purified in this study failed to identify suitable 
compounds (work carried out by Raffaella Grimaldi, University of Dundee). PLK 
is a major drug target in a number of human cancers due to the association of 
elevated levels of PLK1 in various human tumours, and it is now known that PLK1 
is a negative regulator of p53 in carcinogenisis (reviewed in (Strebhardt, 2010)). 
This may provide an opportunity to take the ‘piggy back’ approach to drug 
design. The potential for treating cancers using inhibitors of human PLK1 PBD 
are currently being explored (Liao et al., 2010), and it is possible that 
compounds directed towards the PBD might be effective at inhibiting T. brucei 
PLK through impairing its ability to localise to the FAZ or basal bodies in vivo. 
Also, new compounds are being developed to target PLK1 in its inactive 
conformation, which allows greater selectivity due to the accessibility of a 
hydrophobic pocket containing less well conserved residues when PLK1 is in the 
inactive conformation (Keppner et al., 2010). Such an approach could also be 
used in drug design for T. brucei PLK to increase specificity against the T. brucei 
as oppose to human PLK proteins. 
8.5 Conclusions and future directions 
Characterisation of a novel cytoskeleton associated protein: AIR9, revealed a 
role for this protein in cleavage plane determination and nuclear positioning. 
How the cleavage plane is determined is not well understood in T. brucei, and 
the identification of a protein involved in this process will hopefully lead to 
further understanding of how this occurs. An area for future study could be to 
establish whether AIR9 can bind to microtubules, and to determine possible 
binding partners. It is also important to verify the localisation of AIR9 through 
the generation of an antibody and analysis of localisation of natively expressed 
AIR9. 
Inhibition of microtubule dynamics through the application of inhibitors of 
microtubule stability revealed a role for microtubule dynamics in both furrow 
ingression and cleavage plane positioning. Furrow ingression in T. brucei occurs 
by divergent mechanisms, and increasing knowledge of this process is crucial to 
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further understanding of T. brucei cytokinesis. A future focus for research into 
the role of microtubule dynamics in cytokinesis could involve analysis of vinca 
alkaloid treated bloodstream form cells stalled at furrow ingression by 
transmission electron microscopy, in order to observe the organisation of 
microtubules at the cleavage furrow. In addition, analysis of the extent of 
furrow ingression in vincristine treated bloodstream form cells and cells 
depleted of PLK or other regulators of furrow ingression may be a useful 
approach for investigations into the potential existence of a furrow ingression 
checkpoint. Vinca alkaloid treatment may prove to be a useful tool in enriching 
for cells with furrows, although as with all inhibitors, it must be taken into 
account that off target effects may cloud results. 
 Investigations into the regulation of PLK activity resulted in the generation of 
soluble and active recombinant protein, production of a series of mutant 
versions of recombinant PLK, and the generation of cell lines overexpressing 
versions of PLK where the T-loop residue T198 was substituted with valine or 
aspartic acid. PLK was found to exhibit prolific autophosphorylation which was 
shown to be important for activity. In addition, the T-loop residue T198 was 
found to be required for in vitro but not in vivo activity. Finally, regulation 
through autoinhibition via interaction with the PBD was shown to be unlikely. As 
PLK is an important regulator of cytokinesis in T. brucei, knowledge of how the 
activity of this protein is regulated could be important for furthering 
understanding of how molecular regulators are involved in directing the physical 
events which occur in cytokinesis. Also, given the importance of PLK1 in human 
cancers, there is real potential for drug development against T. brucei PLK using 
the ‘piggy back’ approach.  
There are many areas for future research into the regulation and function of 
PLK. It is crucial that the relevance of the sites of autophosphorylation of 
recombinant PLK is established, as at present it is not known whether this is an 
in vitro artefact resulting from indiscriminate activity of the kinase, or whether 
these are real sites of autophosphorylation. This could be assessed by 
determination of the phosphorylation sites for ty:PLK. Whilst attempts to 
perform this experiment failed in this study, it may be useful in future 
investigations to extract PLK from cells which have been synchronised in order to 
enrich for PLK. It is also important to establish whether the PBD can direct 
  
273 
localisation of PLK. This could be achieved by analysing the localisation of a C-
terminally truncated version of PLK in vivo. In addition, the effects of 
substituting residues H705 and K707 with alanine residues on the localisation of 
full length PLK may establish whether the potential ‘His-Lys’ pincer is important 
for localisation to phosphorylated substrates in vivo. Since a recombinant version 
of the PLK PBD was generated in this study, recombinant PBD could be used to 
identify binding partners of PLK from T. brucei cell lysates. Similarly 6XHis:PLK 
could be used to identify potential PLK substrates, potentially through the 
screening of a phage display library that was recently generated in the 
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